OG_ID,loading,group_id,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_03116,0.3907958070655482,OG_03116,FUN_012430-T1,Peve_00026925,Pocillopora_meandrina_HIv1___RNAseq.g23681.t1,three_way,55.942,FUN_012430-T1,Q7TXL8,,,,,25.4,2226.0,7.9e-140,501.5,sp|Q7TXL8|PPSC_MYCBO Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) OX=233413 GN=ppsC PE=1 SV=1,,,,,,
OG_02366,0.3561842607520677,OG_02366,FUN_008973-T1,Peve_00044338,Pocillopora_meandrina_HIv1___RNAseq.g3943.t1,three_way,66.187,FUN_008973-T1,P70057,,,,,37.0,573.0,1.5999999999999999e-83,312.4,sp|P70057|KCNQ1_XENLA Potassium voltage-gated channel subfamily KQT member 1 OS=Xenopus laevis OX=8355 GN=kcnq1 PE=1 SV=2,,,,,,
OG_01314,0.3490134111079002,OG_01314,FUN_005177-T1,Peve_00022720,Pocillopora_meandrina_HIv1___RNAseq.g7584.t1,three_way,78.689,FUN_005177-T1,Q7Z401,MYCPP_HUMAN,,C-myc promoter-binding protein (DENN domain-containing protein 4A),Homo sapiens (Human),34.8,1885.0,8.6e-282,971.8,sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2,GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483,regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08539,0.3477389986163733,OG_08539,FUN_037489-T1,Peve_00020410,Pocillopora_meandrina_HIv1___RNAseq.g1305.t1,three_way,76.29033333333334,FUN_037489-T1,A2VEI2,MICU1_DROME,,"Calcium uptake protein 1 homolog, mitochondrial (Mitochondrial calcium uptake 1)",Drosophila melanogaster (Fruit fly),53.7,376.0,1.5e-108,394.8,"sp|A2VEI2|MICU1_DROME Calcium uptake protein 1 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=MICU1 PE=2 SV=1",GO:0005509; GO:0005758; GO:0007615; GO:0036444; GO:0051560; GO:0051561; GO:0072375; GO:1990246,anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246],calcium ion binding [GO:0005509],GO:0050877; GO:0055085,nervous system process; transmembrane transport
OG_10186,0.3450448880674587,OG_10186,FUN_043601-T1,Peve_00040384,Pocillopora_meandrina_HIv1___RNAseq.g6949.t1,three_way,45.54,FUN_043601-T1,Q4LDE5,SVEP1_HUMAN,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)",Homo sapiens (Human),28.0,1276.0,2.1e-133,478.8,"sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3",GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193,epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0034330; GO:0043226; GO:0048856; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell junction organization; organelle; anatomical structure development; cell adhesion mediator activity
OG_10180,0.3383952261887036,OG_10180,FUN_043593-T1,Peve_00010457,Pocillopora_meandrina_HIv1___RNAseq.g6971.t1,three_way,55.73066666666666,FUN_043593-T1,Q96PZ7,,,,,29.0,497.0,3.2e-52,208.4,sp|Q96PZ7|CSMD1_HUMAN CUB and sushi domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CSMD1 PE=1 SV=3,,,,,,
OG_07037,0.3375788586610795,OG_07037,FUN_032232-T1,Peve_00043437,Pocillopora_meandrina_HIv1___RNAseq.g24836.t1,three_way,68.60266666666666,FUN_032232-T1,Q6DG22,ADA_DANRE,,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),Danio rerio (Zebrafish) (Brachydanio rerio),48.0,350.0,3.3e-91,336.7,sp|Q6DG22|ADA_DANRE Adenosine deaminase OS=Danio rerio OX=7955 GN=ada PE=2 SV=2,GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0042110; GO:0043103; GO:0046103; GO:0046936; GO:0060169; GO:0060205; GO:0070161,adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110],anchoring junction [GO:0070161]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764],2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08101,0.3352112716072911,OG_08101,FUN_035845-T1,Peve_00032505,Pocillopora_meandrina_HIv1___RNAseq.g11954.t1,three_way,74.447,FUN_035845-T1,A0JMQ0,,,,,61.0,623.0,8.5e-230,798.1,sp|A0JMQ0|BOP1_DANRE Ribosome biogenesis protein bop1 OS=Danio rerio OX=7955 GN=bop1 PE=2 SV=1,,,,,,
OG_04241,0.3324637264901867,OG_04241,FUN_017762-T1,Peve_00003285,Pocillopora_meandrina_HIv1___RNAseq.g441.t1,three_way,80.27833333333334,FUN_017762-T1,Q8BPM2,,,,,46.1,857.0,7.6e-203,708.8,sp|Q8BPM2|M4K5_MOUSE Mitogen-activated protein kinase kinase kinase kinase 5 OS=Mus musculus OX=10090 GN=Map4k5 PE=1 SV=2,,,,,,
OG_08928,0.3316425046973735,OG_08928,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_05881,0.3315664140962405,OG_05881,FUN_026034-T1,Peve_00022184,Pocillopora_meandrina_HIv1___RNAseq.g10547.t1,three_way,87.94766666666666,FUN_026034-T1,P29074,PTN4_HUMAN,,Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1),Homo sapiens (Human),43.1,929.0,2e-217,757.3,sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1,GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254,protein dephosphorylation [GO:0006470],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00053,0.323939141705178,OG_00053,FUN_000323-T1,Peve_00012596,Pocillopora_meandrina_HIv1___RNAseq.g29002.t2,three_way,82.90066666666667,FUN_000323-T1,Q9QYF3,MYO5A_RAT,,"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle)",Rattus norvegicus (Rat),51.1,1879.0,0.0,1338.6,sp|Q9QYF3|MYO5A_RAT Unconventional myosin-Va OS=Rattus norvegicus OX=10116 GN=Myo5a PE=1 SV=1,GO:0000146; GO:0000149; GO:0001726; GO:0001750; GO:0003774; GO:0003779; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005777; GO:0005783; GO:0005790; GO:0005794; GO:0005829; GO:0005882; GO:0005884; GO:0006582; GO:0006887; GO:0006892; GO:0007015; GO:0007268; GO:0007601; GO:0008021; GO:0015629; GO:0016020; GO:0016192; GO:0016236; GO:0016459; GO:0016461; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0030048; GO:0030050; GO:0030073; GO:0030141; GO:0030318; GO:0030424; GO:0030425; GO:0031267; GO:0031982; GO:0031987; GO:0032252; GO:0032400; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0033602; GO:0042417; GO:0042438; GO:0042470; GO:0042476; GO:0042552; GO:0042641; GO:0042642; GO:0042759; GO:0042802; GO:0043008; GO:0043025; GO:0043473; GO:0044877; GO:0048066; GO:0048306; GO:0048820; GO:0050808; GO:0050885; GO:0051015; GO:0051643; GO:0051967; GO:0055037; GO:0065003; GO:0072659; GO:0097718; GO:0098685; GO:0098794; GO:0098871; GO:0098978; GO:0099089; GO:0099566; GO:0099640; GO:0150103; GO:1900078; GO:1903078; GO:1904754; GO:1990904,"actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; axo-dendritic protein transport [GO:0099640]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; developmental pigmentation [GO:0048066]; dopamine metabolic process [GO:0042417]; endoplasmic reticulum localization [GO:0051643]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; macroautophagy [GO:0016236]; melanin biosynthetic process [GO:0042438]; melanin metabolic process [GO:0006582]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; myelination [GO:0042552]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuromuscular process controlling balance [GO:0050885]; odontogenesis [GO:0042476]; pigmentation [GO:0043473]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; reactive gliosis [GO:0150103]; regulation of exocytosis [GO:0017157]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin, myosin complex part [GO:0042642]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; recycling endosome [GO:0055037]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]",actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075],GO:0003774; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0023052; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0050877; GO:0065003; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; lysosome; endosome; vacuole; peroxisome; endoplasmic reticulum; Golgi apparatus; cytosol; cytoskeleton; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; signaling; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; nervous system process; protein-containing complex assembly; protein localization to plasma membrane; ATP-dependent activity
OG_06060,0.3230527342285553,OG_06060,FUN_026826-T1,Peve_00021661,Pocillopora_meandrina_HIv1___RNAseq.g2905.t1,three_way,81.5875,FUN_026826-T1,Q6PHS6,,,,,41.4,950.0,6.9e-205,715.7,sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1,,,,,,
OG_09889,0.3214102392731228,OG_09889,FUN_042965-T1,Peve_00039044,Pocillopora_meandrina_HIv1___RNAseq.g7111.t1,three_way,59.85383333333333,FUN_042965-T1,Q80ZJ6,,,,,34.8,771.0,3.4e-101,370.9,sp|Q80ZJ6|ZER1_MOUSE Protein zer-1 homolog OS=Mus musculus OX=10090 GN=Zer1 PE=1 SV=1,,,,,,
OG_09806,0.3178983597303076,OG_09806,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_06273,0.3138693201374324,OG_06273,FUN_028309-T1,Peve_00037726,Pocillopora_meandrina_HIv1___RNAseq.g16424.t1,three_way,73.845,FUN_028309-T1,O15550,KDM6A_HUMAN,,Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A),Homo sapiens (Human),40.4,1012.0,2.5e-115,418.3,sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2,GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558,chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468],histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016491; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; oxidoreductase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05951,0.3102043744960032,OG_05951,FUN_026211-T1,Peve_00044665,Pocillopora_meandrina_HIv1___RNAseq.g3049.t1,three_way,49.01616666666666,FUN_026211-T1,A2AX52,CO6A4_MOUSE,,Collagen alpha-4(VI) chain,Mus musculus (Mouse),24.8,1256.0,9.1e-63,246.1,sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2,GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991],collagen binding [GO:0005518],GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_07665,0.3092920251276871,OG_07665,FUN_034720-T1,Peve_00033269,Pocillopora_meandrina_HIv1___RNAseq.g28723.t1,three_way,62.28366666666667,FUN_034720-T1,P82094,TMF1_HUMAN,,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),Homo sapiens (Human),40.1,685.0,2.8999999999999997e-43,179.1,sp|P82094|TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens OX=9606 GN=TMF1 PE=1 SV=2,GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845,acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006355; GO:0007018; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; regulation of DNA-templated transcription; microtubule-based movement; programmed cell death; reproductive process; cell differentiation; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_00386,0.3091139603761237,OG_00386,FUN_001238-T1,Peve_00002842,Pocillopora_meandrina_HIv1___RNAseq.g2515.t2,three_way,45.375,FUN_001238-T1,Q8IVU1,,,,,32.5,517.0,1.1e-67,260.4,sp|Q8IVU1|IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 OS=Homo sapiens OX=9606 GN=IGDCC3 PE=1 SV=2,,,,,,
OG_09673,0.3078075320766861,OG_09673,FUN_041895-T1,Peve_00026172,Pocillopora_meandrina_HIv1___RNAseq.g15351.t1,three_way,68.37666666666668,FUN_041895-T1,Q505H7,,,,,49.0,392.0,1.3e-80,302.4,sp|Q505H7|IWS1_XENTR Protein IWS1 homolog OS=Xenopus tropicalis OX=8364 GN=iws1 PE=2 SV=1,,,,,,
OG_06110,0.3071182594013327,OG_06110,FUN_027815-T1,Peve_00036487,Pocillopora_meandrina_HIv1___RNAseq.g13889.t2,three_way,90.976,FUN_027815-T1,Q23356,MIG15_CAEEL,,Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15),Caenorhabditis elegans,44.9,1094.0,1.7e-240,833.9,sp|Q23356|MIG15_CAEEL Serine/threonine-protein kinase mig-15 OS=Caenorhabditis elegans OX=6239 GN=mig-15 PE=2 SV=3,GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0022414; GO:0030334; GO:0032228; GO:0033563; GO:0043408; GO:0048812; GO:0106310,"body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of MAPK cascade [GO:0043408]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproductive process [GO:0022414]",cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_01466,0.3064463734717321,OG_01466,FUN_006002-T1,Peve_00036060,Pocillopora_meandrina_HIv1___RNAseq.g19927.t1,three_way,76.86133333333333,FUN_006002-T1,A0A1U8QWA2,ATR12_EMENI,,Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)],Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans),38.2,1317.0,3.3e-237,823.5,sp|A0A1U8QWA2|ATR12_EMENI Glycine betaine reductase ATRR OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=ATRR PE=1 SV=1,GO:0009058; GO:0016491; GO:0031177,biosynthetic process [GO:0009058],,oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_01156,0.3059581963736363,OG_01156,FUN_004767-T1,Peve_00007781,Pocillopora_meandrina_HIv1___RNAseq.g6697.t1,three_way,76.52799999999999,FUN_004767-T1,O57457,,,,,44.1,474.0,3.5e-96,354.4,sp|O57457|E41LA_DANRE Band 4.1-like protein 4 OS=Danio rerio OX=7955 GN=epb41l4a PE=2 SV=1,,,,,,
OG_01747,0.3051106292488093,OG_01747,FUN_007073-T1,Peve_00019897,Pocillopora_meandrina_HIv1___RNAseq.g20081.t1,three_way,71.9425,FUN_007073-T1,Q9DER7,,,,,47.7,870.0,3e-256,886.3,sp|Q9DER7|TLL1_CHICK Tolloid-like protein 1 OS=Gallus gallus OX=9031 GN=TLL1 PE=2 SV=1,,,,,,
OG_07716,0.3042038596989,OG_07716,FUN_034870-T1,Peve_00005769,Pocillopora_meandrina_HIv1___RNAseq.g27159.t1,three_way,54.551,FUN_034870-T1,Q91Y77,,,,,29.8,423.0,2.3e-49,198.7,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_05007,0.3038429072402974,OG_05007,FUN_023157-T1,Peve_00017447,Pocillopora_meandrina_HIv1___RNAseq.g12682.t1,three_way,76.46433333333333,FUN_023157-T1,A7YWP4,HUTH_BOVIN,,Histidine ammonia-lyase (Histidase) (EC 4.3.1.3),Bos taurus (Bovine),62.6,642.0,4.4e-222,772.3,sp|A7YWP4|HUTH_BOVIN Histidine ammonia-lyase OS=Bos taurus OX=9913 GN=HAL PE=2 SV=1,GO:0004397; GO:0005737; GO:0006548; GO:0019556; GO:0019557,L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557],cytoplasm [GO:0005737],histidine ammonia-lyase activity [GO:0004397],GO:0003824; GO:0006520; GO:0016829,catalytic activity; amino acid metabolic process; lyase activity
OG_06089,0.303267573914621,OG_06089,FUN_027127-T1,Peve_00039622,Pocillopora_meandrina_HIv1___RNAseq.g15332.t1,three_way,58.584833333333336,FUN_027127-T1,Q8K245,UVRAG_MOUSE,,UV radiation resistance-associated protein,Mus musculus (Mouse),43.1,450.0,5.2e-84,313.9,sp|Q8K245|UVRAG_MOUSE UV radiation resistance-associated protein OS=Mus musculus OX=10090 GN=Uvrag PE=1 SV=2,GO:0000149; GO:0000421; GO:0000775; GO:0005764; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0007051; GO:0007059; GO:0007098; GO:0010506; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035032; GO:0035493; GO:0036092; GO:0045335; GO:0046718; GO:0051684; GO:0070418; GO:0097352; GO:0097680,"autophagosome maturation [GO:0097352]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; symbiont entry into host cell [GO:0046718]","autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; protein-containing complex [GO:0032991]",SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149],GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005815; GO:0006281; GO:0006629; GO:0007010; GO:0007059; GO:0016192; GO:0031410; GO:0043226; GO:0065003,lysosome; endosome; vacuole; endoplasmic reticulum; microtubule organizing center; DNA repair; lipid metabolic process; cytoskeleton organization; chromosome segregation; vesicle-mediated transport; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_09609,0.3031656659794645,OG_09609,FUN_041767-T1,Peve_00041572,Pocillopora_meandrina_HIv1___RNAseq.g15244.t1,three_way,57.924,FUN_041767-T1,Q6WRH9,,,,,29.6,406.0,5.6000000000000005e-28,128.6,sp|Q6WRH9|IGS10_RAT Immunoglobulin superfamily member 10 OS=Rattus norvegicus OX=10116 GN=Igsf10 PE=1 SV=1,,,,,,
OG_09760,0.3028393449681136,OG_09760,FUN_042034-T1,Peve_00035625,Pocillopora_meandrina_HIv1___RNAseq.g15181.t1,three_way,72.15583333333333,FUN_042034-T1,Q8C0W1,,,,,27.5,840.0,4.6e-70,268.1,sp|Q8C0W1|ANMY1_MOUSE Ankyrin repeat and MYND domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankmy1 PE=1 SV=1,,,,,,
OG_06527,0.301600583904882,OG_06527,FUN_029356-T1,Peve_00023383,Pocillopora_meandrina_HIv1___RNAseq.g17292.t1,three_way,73.16533333333334,FUN_029356-T1,Q15397,,,,,44.1,424.0,5.2e-92,339.7,sp|Q15397|PUM3_HUMAN Pumilio homolog 3 OS=Homo sapiens OX=9606 GN=PUM3 PE=1 SV=3,,,,,,
OG_07824,0.3010169095517114,OG_07824,FUN_035094-T1,Peve_00014774,Pocillopora_meandrina_HIv1___RNAseq.g27699.t1,three_way,62.495,FUN_035094-T1,Q92896,GSLG1_HUMAN,,Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1) (ESL-1) (Golgi sialoglycoprotein MG-160),Homo sapiens (Human),40.9,1085.0,6.1999999999999985e-251,869.0,sp|Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,GO:0000139; GO:0005102; GO:0005794; GO:0005815; GO:0005886; GO:0007179; GO:0010955; GO:0016020; GO:0016485; GO:0017134; GO:0030512; GO:0031012; GO:0032330; GO:0060349; GO:0070062,bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein processing [GO:0016485]; regulation of chondrocyte differentiation [GO:0032330]; transforming growth factor beta receptor signaling pathway [GO:0007179],extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886],fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102],GO:0005794; GO:0005815; GO:0005886; GO:0030312; GO:0031012; GO:0043226; GO:0051604,Golgi apparatus; microtubule organizing center; plasma membrane; external encapsulating structure; extracellular matrix; organelle; protein maturation
OG_04250,0.30030289580829,OG_04250,FUN_017780-T1,Peve_00029909,Pocillopora_meandrina_HIv1___RNAseq.g9514.t1,three_way,48.56066666666667,,,,,,,,,,,,,,,,,
OG_08313,0.2996696517273994,OG_08313,FUN_036513-T1,Peve_00031408,Pocillopora_meandrina_HIv1___RNAseq.g27052.t1,three_way,58.79833333333333,FUN_036513-T1,A0A8I3PDQ1,CASL_CANLF,,Enhancer of filamentation 1 (CRK-associated substrate-related protein) (CAS-L) (Neural precursor cell expressed developmentally down-regulated protein 9) (NEDD-9) (p105),Canis lupus familiaris (Dog) (Canis familiaris),22.2,968.0,2.6e-26,122.5,sp|A0A8I3PDQ1|CASL_CANLF Enhancer of filamentation 1 OS=Canis lupus familiaris OX=9615 GN=NEDD9 PE=1 SV=1,GO:0000922; GO:0001772; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0005938; GO:0007155; GO:0007169; GO:0007611; GO:0016323; GO:0016477; GO:0030027; GO:0030336; GO:0032956; GO:0036064; GO:0045672; GO:0051301; GO:0061523; GO:0072686; GO:0097021; GO:0140131; GO:1900026; GO:1902952; GO:1903829; GO:1990782; GO:2000522,cell adhesion [GO:0007155]; cell division [GO:0051301]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cilium disassembly [GO:0061523]; learning or memory [GO:0007611]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of lymphocyte chemotaxis [GO:0140131]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein localization [GO:1903829]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956],basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0007155; GO:0043226; GO:0044782; GO:0048870; GO:0050877,immune system process; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; cell adhesion; organelle; cilium organization; cell motility; nervous system process
OG_01177,0.2981422933775177,OG_01177,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_08623,0.2964332994761794,OG_08623,FUN_037778-T1,Peve_00040702,Pocillopora_meandrina_HIv1___RNAseq.g1514.t1,three_way,68.98816666666667,,,,,,,,,,,,,,,,,
OG_01991,0.2963954303692454,OG_01991,FUN_008099-T1,Peve_00038883,Pocillopora_meandrina_HIv1___RNAseq.g30140.t1,three_way,82.39933333333333,FUN_008099-T1,O94806,KPCD3_HUMAN,,Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu),Homo sapiens (Human),56.9,822.0,2.4e-263,909.8,sp|O94806|KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens OX=9606 GN=PRKD3 PE=1 SV=1,GO:0004674; GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006468; GO:0007200; GO:0008270; GO:0016301; GO:0030148; GO:0035556; GO:0036064; GO:0106310,intracellular signal transduction [GO:0035556]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148],ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0006629; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; microtubule organizing center; cytosol; plasma membrane; lipid metabolic process; transferase activity; catalytic activity, acting on a protein"
OG_08874,0.2951205810021651,OG_08874,FUN_038271-T1,Peve_00010406,Pocillopora_meandrina_HIv1___RNAseq.g28323.t1,three_way,64.48483333333333,FUN_038271-T1,Q7TN88,,,,,29.4,1654.0,3.4e-170,602.1,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_04109,0.2950780110544274,OG_04109,FUN_016475-T1,Peve_00040144,Pocillopora_meandrina_HIv1___RNAseq.g10194.t1,three_way,66.4755,FUN_016475-T1,P0C5Y8,ALS2_RAT,,Alsin (Amyotrophic lateral sclerosis 2 protein homolog),Rattus norvegicus (Rat),30.6,1765.0,3.8e-188,661.0,sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1,GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072,"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267],GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0016192; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,nucleus; endosome; microtubule organizing center; cytosol; vesicle-mediated transport; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_02202,0.2942715089914312,OG_02202,FUN_008577-T1,Peve_00028423,Pocillopora_meandrina_HIv1___RNAseq.g12779.t1,three_way,77.05433333333333,FUN_008577-T1,Q80Y56,,,,,37.4,505.0,3.3e-76,287.3,sp|Q80Y56|RBNS5_MOUSE Rabenosyn-5 OS=Mus musculus OX=10090 GN=Rbsn PE=1 SV=1,,,,,,
OG_06717,0.2942708195273608,OG_06717,FUN_031467-T1,Peve_00026558,Pocillopora_meandrina_HIv1___RNAseq.g5084.t2,three_way,78.09566666666667,FUN_031467-T1,Q5RDQ2,PALS1_PONAB,,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),46.4,576.0,2.3e-140,501.5,sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1,GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204,central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204],ATP binding [GO:0005524],GO:0005794; GO:0043226; GO:0048856,Golgi apparatus; organelle; anatomical structure development
OG_01641,0.2940901773962172,OG_01641,FUN_006778-T1,Peve_00042981,Pocillopora_meandrina_HIv1___TS.g29885.t1,three_way,45.0235,FUN_006778-T1,P16092,FGFR1_MOUSE,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Mus musculus (Mouse),33.7,784.0,2.6e-100,368.6,sp|P16092|FGFR1_MOUSE Fibroblast growth factor receptor 1 OS=Mus musculus OX=10090 GN=Fgfr1 PE=1 SV=2,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010966; GO:0010976; GO:0017134; GO:0021769; GO:0021847; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042803; GO:0043235; GO:0043536; GO:0043583; GO:0045666; GO:0045787; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cementum mineralization [GO:0071529]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_08722,0.2940494620237054,OG_08722,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),36.1,280.0,6.1e-42,174.9,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08722,0.2940494620237054,OG_08722,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),43.2,148.0,5.4e-22,108.6,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_00527,0.2936446866369367,OG_00527,FUN_001531-T1,Peve_00000632,Pocillopora_meandrina_HIv1___RNAseq.g2047.t1,three_way,79.239,FUN_001531-T1,A2RSQ0,,,,,43.6,1377.0,1.4e-312,1074.7,sp|A2RSQ0|DEN5B_MOUSE DENN domain-containing protein 5B OS=Mus musculus OX=10090 GN=Dennd5b PE=1 SV=2,,,,,,
OG_09346,0.2929023540501533,OG_09346,FUN_040329-T1,Peve_00014960,Pocillopora_meandrina_HIv1___TS.g20804.t1,three_way,59.10066666666667,FUN_040329-T1,Q96JI7,SPTCS_HUMAN,,Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein),Homo sapiens (Human),27.8,1418.0,1.1e-133,480.3,sp|Q96JI7|SPTCS_HUMAN Spatacsin OS=Homo sapiens OX=9606 GN=SPG11 PE=1 SV=3,GO:0005730; GO:0005737; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006606; GO:0007040; GO:0007268; GO:0007409; GO:0007528; GO:0007613; GO:0008088; GO:0019901; GO:0021957; GO:0030163; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0047496; GO:0048489; GO:0048675; GO:0048741; GO:0051668; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256,autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; localization within membrane [GO:0051668]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; walking behavior [GO:0090659],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202],protein kinase binding [GO:0019901],GO:0005730; GO:0005783; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0007018; GO:0007040; GO:0012501; GO:0023052; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0061024,nucleolus; endoplasmic reticulum; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; microtubule-based movement; lysosome organization; programmed cell death; signaling; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process; membrane organization
OG_03863,0.2911544998223825,OG_03863,FUN_015366-T1,Peve_00000210,Pocillopora_meandrina_HIv1___RNAseq.g21696.t1,three_way,87.96916666666667,FUN_015366-T1,Q9D8V0,SPP_MOUSE,,Signal peptide peptidase (EC 3.4.23.-) (Minor histocompatibility antigen H13) (Presenilin-like protein 3) (Signal peptide peptidase-like 1),Mus musculus (Mouse),64.6,350.0,7.2e-124,445.3,sp|Q9D8V0|SPP_MOUSE Signal peptide peptidase OS=Mus musculus OX=10090 GN=Hm13 PE=1 SV=1,GO:0001701; GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0008233; GO:0009986; GO:0031625; GO:0033619; GO:0036513; GO:0042500; GO:0042803; GO:0098553; GO:0098554; GO:1904211,"in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]",cell surface [GO:0009986]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005783; GO:0005886; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endoplasmic reticulum; plasma membrane; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00853,0.2904033492010607,OG_00853,FUN_004115-T1,Peve_00008071,Pocillopora_meandrina_HIv1___RNAseq.g11666.t1,three_way,69.32233333333333,FUN_004115-T1,O94632,EGT1_SCHPO,,Ergothioneine biosynthesis protein 1 (Meiotically up-regulated gene 158 protein) [Includes: L-histidine N(alpha)-methyltransferase (EC 2.1.1.44); Hercynylcysteine S-oxide synthase (EC 1.21.3.10)],Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),28.3,184.0,1.9e-09,66.2,sp|O94632|EGT1_SCHPO Ergothioneine biosynthesis protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt1 PE=1 SV=4,GO:0004497; GO:0005509; GO:0005634; GO:0005829; GO:0032259; GO:0051321; GO:0052699; GO:0052706; GO:0061686; GO:1903257,ergothioneine biosynthetic process [GO:0052699]; meiotic cell cycle [GO:0051321]; methylation [GO:0032259]; selenoneine biosynthetic process [GO:1903257],cytosol [GO:0005829]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; hercynylcysteine sulfoxide synthase activity [GO:0061686]; L-histidine N(alpha)-methyltransferase activity [GO:0052706]; monooxygenase activity [GO:0004497],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740; GO:0022414; GO:0043226,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity; reproductive process; organelle
OG_01792,0.290264959239904,OG_01792,FUN_007172-T1,Peve_00019754,Pocillopora_meandrina_HIv1___RNAseq.g19765.t1b,three_way,69.35266666666666,FUN_007172-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),43.9,1072.0,5.8e-264,912.1,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_04624,0.2900310494281585,OG_04624,FUN_022332-T1,Peve_00028602,Pocillopora_meandrina_HIv1___RNAseq.g4651.t2,three_way,52.3965,FUN_022332-T1,P26008,,,,,27.8,994.0,3.3000000000000003e-81,305.1,sp|P26008|ITAV_CHICK Integrin alpha-V OS=Gallus gallus OX=9031 GN=ITGAV PE=2 SV=1,,,,,,
OG_04042,0.2898204658505038,OG_04042,FUN_016351-T1,Peve_00004332,Pocillopora_meandrina_HIv1___RNAseq.g9676.t1,three_way,80.54966666666667,FUN_016351-T1,Q6ZMI0,PPR21_HUMAN,,Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (Ferry endosomal RAB5 effector complex subunit 2) (Fy-2) (KLRAQ motif-containing protein 1),Homo sapiens (Human),40.8,787.0,5.8e-136,486.5,sp|Q6ZMI0|PPR21_HUMAN Protein phosphatase 1 regulatory subunit 21 OS=Homo sapiens OX=9606 GN=PPP1R21 PE=1 SV=1,GO:0003723; GO:0005769; GO:0016020,,early endosome [GO:0005769]; membrane [GO:0016020],RNA binding [GO:0003723],GO:0003723; GO:0005768; GO:0031410; GO:0043226,RNA binding; endosome; cytoplasmic vesicle; organelle
OG_00135,0.289106345496129,OG_00135,FUN_000569-T1,Peve_00034755,Pocillopora_meandrina_HIv1___RNAseq.g2452.t1,three_way,73.191,FUN_000569-T1,Q9CXF4,,,,,39.4,632.0,6.3e-121,436.4,sp|Q9CXF4|TBC15_MOUSE TBC1 domain family member 15 OS=Mus musculus OX=10090 GN=Tbc1d15 PE=1 SV=1,,,,,,
OG_10078,0.2890398509174776,OG_10078,FUN_043387-T1,Peve_00024251,Pocillopora_meandrina_HIv1___RNAseq.g8999.t1,three_way,69.81466666666667,FUN_043387-T1,P02468,LAMC1_MOUSE,,Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma),Mus musculus (Mouse),41.9,1369.0,3.9000000000000004e-227,790.4,sp|P02468|LAMC1_MOUSE Laminin subunit gamma-1 OS=Mus musculus OX=10090 GN=Lamc1 PE=1 SV=2,GO:0005201; GO:0005576; GO:0005604; GO:0006325; GO:0007155; GO:0010467; GO:0016477; GO:0022617; GO:0031069; GO:0031175; GO:0031581; GO:0031594; GO:0035315; GO:0043083; GO:0043208; GO:0043259; GO:0045785; GO:0048729; GO:0051149; GO:0062023; GO:0065003; GO:0071335; GO:0098637; GO:0110011; GO:2001046,cell adhesion [GO:0007155]; cell migration [GO:0016477]; chromatin organization [GO:0006325]; extracellular matrix disassembly [GO:0022617]; gene expression [GO:0010467]; hair cell differentiation [GO:0035315]; hair follicle cell proliferation [GO:0071335]; hair follicle morphogenesis [GO:0031069]; hemidesmosome assembly [GO:0031581]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; tissue morphogenesis [GO:0048729],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin-10 complex [GO:0043259]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083],extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208],GO:0005198; GO:0005576; GO:0006325; GO:0007155; GO:0008289; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0034330; GO:0048870; GO:0065003,structural molecule activity; extracellular region; chromatin organization; cell adhesion; lipid binding; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; cell junction organization; cell motility; protein-containing complex assembly
OG_08406,0.2890364558518239,OG_08406,FUN_037057-T1,Peve_00018391,Pocillopora_meandrina_HIv1___RNAseq.g26784.t1,three_way,86.48433333333334,FUN_037057-T1,P43332,SNRPA_DROME,,U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A) (Sex determination protein snf),Drosophila melanogaster (Fruit fly),70.9,234.0,2.3999999999999996e-69,263.5,sp|P43332|SNRPA_DROME U1 small nuclear ribonucleoprotein A OS=Drosophila melanogaster OX=7227 GN=snf PE=1 SV=1,GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0005686; GO:0007539; GO:0008266; GO:0008380; GO:0019099; GO:0030532; GO:0030619; GO:0030620; GO:0032991; GO:0035614; GO:0042802; GO:0048477; GO:0071011; GO:0071013; GO:0097158; GO:1990904,"female germ-line sex determination [GO:0019099]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686],identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620],GO:0003723; GO:0005634; GO:0016071; GO:0022414; GO:0043226; GO:0048856,RNA binding; nucleus; mRNA metabolic process; reproductive process; organelle; anatomical structure development
OG_09797,0.2889254009554982,OG_09797,FUN_042605-T1,Peve_00034914,Pocillopora_meandrina_HIv1___RNAseq.g16849.t1a,three_way,81.68166666666667,FUN_042605-T1,Q9QUM7,,,,,46.1,798.0,1.1e-204,714.9,sp|Q9QUM7|MSH5_MOUSE MutS protein homolog 5 OS=Mus musculus OX=10090 GN=Msh5 PE=1 SV=1,,,,,,
OG_07628,0.288877492955816,OG_07628,FUN_034376-T1,Peve_00027168,Pocillopora_meandrina_HIv1___RNAseq.g26154.t1,three_way,68.84483333333333,FUN_034376-T1,E7FAG6,AMR1A_DANRE,,Activating molecule in BECN1-regulated autophagy protein 1A,Danio rerio (Zebrafish) (Brachydanio rerio),26.3,954.0,1.9e-61,238.8,sp|E7FAG6|AMR1A_DANRE Activating molecule in BECN1-regulated autophagy protein 1A OS=Danio rerio OX=7955 GN=ambra1a PE=2 SV=2,GO:0000045; GO:0000209; GO:0000423; GO:0005634; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0006914; GO:0007626; GO:0008406; GO:0031410; GO:0043009; GO:0043231; GO:0045591; GO:0048741; GO:0072542; GO:0080008; GO:1901526; GO:1904544; GO:1990756; GO:2000045,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; chordate embryonic development [GO:0043009]; gonad development [GO:0008406]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; skeletal muscle fiber development [GO:0048741],autophagosome [GO:0005776]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634],protein phosphatase activator activity [GO:0072542]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0005856; GO:0006914; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; mitochondrion; vacuole; endoplasmic reticulum; cytosol; cytoskeleton; autophagy; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_10208,0.2888379294863438,OG_10208,FUN_043643-T1,Peve_00004207,Pocillopora_meandrina_HIv1___RNAseq.g7409.t1,three_way,56.01,,,,,,,,,,,,,,,,,
OG_00691,0.2884244480942493,OG_00691,FUN_002378-T1,Peve_00034013,Pocillopora_meandrina_HIv1___RNAseq.g21.t1,three_way,75.79133333333333,FUN_002378-T1,Q8TCT0,CERK1_HUMAN,,Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4),Homo sapiens (Human),45.1,457.0,4.400000000000001e-111,403.3,sp|Q8TCT0|CERK1_HUMAN Ceramide kinase OS=Homo sapiens OX=9606 GN=CERK PE=1 SV=1,GO:0000287; GO:0001729; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006688; GO:0016020,ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; magnesium ion binding [GO:0000287],GO:0003824; GO:0005886; GO:0006629; GO:0016740; GO:1901135,catalytic activity; plasma membrane; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_04878,0.2870644677374388,OG_04878,FUN_022909-T1,Peve_00001833,Pocillopora_meandrina_HIv1___RNAseq.g3706.t1,three_way,71.17616666666667,FUN_022909-T1,A2RSY1,KANL3_MOUSE,,KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog),Mus musculus (Mouse),49.6,516.0,4.3000000000000004e-134,480.7,sp|A2RSY1|KANL3_MOUSE KAT8 regulatory NSL complex subunit 3 OS=Mus musculus OX=10090 GN=Kansl3 PE=1 SV=1,GO:0000123; GO:0000922; GO:0005654; GO:0005739; GO:0006325; GO:0044545; GO:0045893; GO:0051011; GO:0090307; GO:1903108,chromatin organization [GO:0006325]; mitotic spindle assembly [GO:0090307]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitochondrial transcription [GO:1903108],histone acetyltransferase complex [GO:0000123]; mitochondrion [GO:0005739]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],microtubule minus-end binding [GO:0051011],GO:0005654; GO:0005739; GO:0006325; GO:0006355; GO:0007010; GO:0008092; GO:0043226,nucleoplasm; mitochondrion; chromatin organization; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_07254,0.286650125683373,OG_07254,FUN_033020-T1,Peve_00020848,Pocillopora_meandrina_HIv1___RNAseq.g24458.t1,three_way,61.12266666666667,FUN_033020-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),32.5,271.0,1.0999999999999998e-24,116.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_08386,0.2861567070822807,OG_08386,FUN_036993-T1,Peve_00002136,Pocillopora_meandrina_HIv1___RNAseq.g26710.t1,three_way,55.684333333333335,FUN_036993-T1,Q6L8S8,,,,,31.9,990.0,7.700000000000001e-126,453.4,"sp|Q6L8S8|B4GN3_MOUSE Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Mus musculus OX=10090 GN=B4galnt3 PE=2 SV=1",,,,,,
OG_05871,0.2860200681518123,OG_05871,FUN_025986-T1,Peve_00002322,Pocillopora_meandrina_HIv1___TS.g13918.t1,three_way,61.095,FUN_025986-T1,Q8K2A1,,,,,50.5,186.0,1e-43,179.1,sp|Q8K2A1|GULP1_MOUSE PTB domain-containing engulfment adapter protein 1 OS=Mus musculus OX=10090 GN=Gulp1 PE=1 SV=1,,,,,,
OG_00635,0.2858407202533448,OG_00635,FUN_001860-T1,Peve_00032178,Pocillopora_meandrina_HIv1___RNAseq.g2600.t1,three_way,73.505,FUN_001860-T1,Q10741,ADA10_BOVIN,,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (Myelin-associated metalloproteinase) (CD antigen CD156c),Bos taurus (Bovine),45.6,754.0,1.3e-175,618.2,sp|Q10741|ADA10_BOVIN Disintegrin and metalloproteinase domain-containing protein 10 OS=Bos taurus OX=9913 GN=ADAM10 PE=1 SV=1,GO:0000139; GO:0001701; GO:0002315; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042803; GO:0042987; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:1901342; GO:1902945,adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; marginal zone B cell differentiation [GO:0002315]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612],adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124],GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005886; GO:0016787; GO:0030154; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0065003; GO:0140096,"immune system process; catalytic activity; nucleus; Golgi apparatus; plasma membrane; hydrolase activity; cell differentiation; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein maturation; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_01914,0.2855253951519991,OG_01914,FUN_007939-T1,Peve_00040694,Pocillopora_meandrina_HIv1___RNAseq.g18118.t1,three_way,57.98416666666667,FUN_007939-T1,Q5RET9,SDE2_PONAB,,Splicing regulator SDE2 (Replication stress response regulator SDE2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),34.2,415.0,1.7e-38,161.8,sp|Q5RET9|SDE2_PONAB Splicing regulator SDE2 OS=Pongo abelii OX=9601 GN=SDE2 PE=2 SV=1,GO:0000479; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0030515; GO:0045292; GO:0051301,"cell division [GO:0051301]; DNA replication [GO:0006260]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; mRNA cis splicing, via spliceosome [GO:0045292]",cytoplasm [GO:0005737]; nucleus [GO:0005634],DNA binding [GO:0003677]; snoRNA binding [GO:0030515],GO:0003677; GO:0003723; GO:0005634; GO:0006260; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; DNA replication; mRNA metabolic process; organelle
OG_01611,0.2848342940921384,OG_01611,FUN_006656-T1,Peve_00029042,Pocillopora_meandrina_HIv1___RNAseq.3492_t,three_way,56.7115,FUN_006656-T1,Q9HC56,,,,,32.8,704.0,2.2e-87,325.5,sp|Q9HC56|PCDH9_HUMAN Protocadherin-9 OS=Homo sapiens OX=9606 GN=PCDH9 PE=1 SV=2,,,,,,
OG_07344,0.2848237670744921,OG_07344,FUN_033751-T1,Peve_00004933,Pocillopora_meandrina_HIv1___TS.g8542.t1,three_way,79.90966666666667,FUN_033751-T1,O95461,,,,,60.2,689.0,6.4e-254,878.2,sp|O95461|LARG1_HUMAN Xylosyl- and glucuronyltransferase LARGE1 OS=Homo sapiens OX=9606 GN=LARGE1 PE=1 SV=1,,,,,,
OG_00338,0.2839862681853666,OG_00338,FUN_001160-T1,Peve_00043472,Pocillopora_meandrina_HIv1___RNAseq.g29219.t1,three_way,80.853,FUN_001160-T1,P50416,CPT1A_HUMAN,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Homo sapiens (Human),40.4,798.0,1.7e-154,548.1,"sp|P50416|CPT1A_HUMAN Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007584; GO:0009410; GO:0009437; GO:0010883; GO:0016020; GO:0030674; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0055085; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; transmembrane transport; molecular adaptor activity
OG_04715,0.2836581149609118,OG_04715,FUN_022527-T1,Peve_00020803,Pocillopora_meandrina_HIv1___RNAseq.g4524.t2,three_way,62.5415,FUN_022527-T1,Q9NYL2,M3K20_HUMAN,,Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase 7) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK),Homo sapiens (Human),50.5,533.0,3.2e-135,484.2,sp|Q9NYL2|M3K20_HUMAN Mitogen-activated protein kinase kinase kinase 20 OS=Homo sapiens OX=9606 GN=MAP3K20 PE=1 SV=3,GO:0000077; GO:0000165; GO:0000287; GO:0003723; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007010; GO:0007059; GO:0007254; GO:0008219; GO:0019887; GO:0030071; GO:0030154; GO:0030295; GO:0031098; GO:0038066; GO:0042733; GO:0043022; GO:0043065; GO:0043068; GO:0046777; GO:0051403; GO:0060173; GO:0070181; GO:0070269; GO:0070303; GO:0071480; GO:0071493; GO:0106310; GO:0140469; GO:0170011; GO:1902010; GO:1904291,cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV-B [GO:0071493]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; GCN2-mediated signaling [GO:0140469]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; limb development [GO:0060173]; MAPK cascade [GO:0000165]; negative regulation of stress-activated protein kinase signaling cascade [GO:0070303]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; positive regulation of programmed cell death [GO:0043068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; pyroptotic inflammatory response [GO:0070269]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activator activity [GO:0030295]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; stalled ribosome sensor activity [GO:0170011],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006954; GO:0007010; GO:0007059; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140096; GO:0140299,"RNA binding; catalytic activity; nucleus; cytosol; inflammatory response; cytoskeleton organization; chromosome segregation; transferase activity; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein; molecular sensor activity"
OG_00184,0.2828729518588484,OG_00184,FUN_000879-T1,Peve_00039669,Pocillopora_meandrina_HIv1___RNAseq.g29430.t1,three_way,82.648,FUN_000879-T1,Q5XK92,,,,,39.4,668.0,1.9000000000000002e-117,425.2,sp|Q5XK92|CIP2A_XENLA Protein CIP2A homolog L OS=Xenopus laevis OX=8355 GN=cip2a.L PE=2 SV=1,,,,,,
OG_09940,0.2828258004998704,OG_09940,FUN_043101-T1,Peve_00026301,Pocillopora_meandrina_HIv1___TS.g740.t1,three_way,67.05266666666667,FUN_043101-T1,Q8R4K8,PAPP1_MOUSE,,Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A),Mus musculus (Mouse),39.8,1552.0,3.3e-308,1059.7,sp|Q8R4K8|PAPP1_MOUSE Pappalysin-1 OS=Mus musculus OX=10090 GN=Pappa PE=2 SV=2,GO:0004175; GO:0005615; GO:0006508; GO:0008237; GO:0046872,proteolysis [GO:0006508],extracellular space [GO:0005615],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_08750,0.2827112413599631,OG_08750,FUN_038017-T1,Peve_00009818,Pocillopora_meandrina_HIv1___RNAseq.g26530.t2,three_way,84.67783333333334,FUN_038017-T1,A6NCI4,VWA3A_HUMAN,,von Willebrand factor A domain-containing protein 3A,Homo sapiens (Human),37.6,1172.0,1.8000000000000002e-227,791.2,sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3,GO:0005576,,extracellular region [GO:0005576],,GO:0005576,extracellular region
OG_08785,0.2823612000356431,OG_08785,FUN_038074-T1,Peve_00000950,Pocillopora_meandrina_HIv1___RNAseq.g801.t1,three_way,77.11666666666666,FUN_038074-T1,A7MBC2,,,,,36.1,660.0,2.4e-110,401.4,sp|A7MBC2|PDXD1_BOVIN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PDXDC1 PE=2 SV=1,,,,,,
OG_03261,0.2818732177022875,OG_03261,FUN_013085-T1,Peve_00027392,Pocillopora_meandrina_HIv1___RNAseq.g13092.t2,three_way,58.874,FUN_013085-T1,Q8IZH2,XRN1_HUMAN,,5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog),Homo sapiens (Human),45.9,1541.0,0.0,1238.8,sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:1905795,cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; rRNA catabolic process [GO:0016075],cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886],5'-3' RNA exonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; plasma membrane; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03939,0.2812392923794778,OG_03939,FUN_016071-T1,Peve_00021918,Pocillopora_meandrina_HIv1___RNAseq.g21619.t1,three_way,78.3115,FUN_016071-T1,Q8JHJ2,,,,,64.9,470.0,1.8e-177,624.0,sp|Q8JHJ2|DDX55_DANRE ATP-dependent RNA helicase DDX55 OS=Danio rerio OX=7955 GN=ddx55 PE=2 SV=2,,,,,,
OG_07039,0.281176931100581,OG_07039,FUN_032235-T1,Peve_00043486,Pocillopora_meandrina_HIv1___RNAseq.g24841.t1,three_way,59.83833333333334,,,,,,,,,,,,,,,,,
OG_04750,0.2810298841077656,OG_04750,FUN_022634-T1,Peve_00012928,Pocillopora_meandrina_HIv1___RNAseq.g9361.t1,three_way,87.668,FUN_022634-T1,Q7Z4L5,TT21B_HUMAN,,Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog),Homo sapiens (Human),54.7,1309.0,0.0,1412.5,sp|Q7Z4L5|TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens OX=9606 GN=TTC21B PE=1 SV=2,GO:0003682; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0060020; GO:0060271; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799,Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591],ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991],chromatin binding [GO:0003682],GO:0005856; GO:0005929; GO:0006355; GO:0007018; GO:0030154; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cilium; regulation of DNA-templated transcription; microtubule-based movement; cell differentiation; organelle; cilium organization; anatomical structure development
OG_02702,0.2808597746515671,OG_02702,FUN_010977-T1,Peve_00013380,Pocillopora_meandrina_HIv1___RNAseq.g22016.t2,three_way,61.6055,FUN_010977-T1,Q8VCM2,NOXO1_MOUSE,,NADPH oxidase organizer 1 (Nox organizer 1) (Sorting nexin-28),Mus musculus (Mouse),34.5,110.0,2e-12,76.3,sp|Q8VCM2|NOXO1_MOUSE NADPH oxidase organizer 1 OS=Mus musculus OX=10090 GN=Noxo1 PE=1 SV=2,GO:0005886; GO:0006801; GO:0016176; GO:0019899; GO:0022617; GO:0035091; GO:0043020,extracellular matrix disassembly [GO:0022617]; superoxide metabolic process [GO:0006801],NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; superoxide-generating NADPH oxidase activator activity [GO:0016176],GO:0005886; GO:0008289; GO:0030198; GO:0098772,plasma membrane; lipid binding; extracellular matrix organization; molecular function regulator activity
OG_07684,0.2804596098773879,OG_07684,FUN_034803-T1,Peve_00007553,Pocillopora_meandrina_HIv1___RNAseq.g12304.t1,three_way,77.09400000000001,FUN_034803-T1,Q4R4P4,FA2H_MACFA,,Fatty acid 2-hydroxylase (EC 1.14.18.-) (Fatty acid alpha-hydroxylase),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),45.3,364.0,2.4e-84,313.9,sp|Q4R4P4|FA2H_MACFA Fatty acid 2-hydroxylase OS=Macaca fascicularis OX=9541 GN=FA2H PE=2 SV=1,GO:0005506; GO:0005789; GO:0006633; GO:0006679; GO:0006682; GO:0016020; GO:0020037; GO:0044857; GO:0046513; GO:0061436; GO:0080132; GO:0120520,ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid biosynthetic process [GO:0006633]; galactosylceramide biosynthetic process [GO:0006682]; glucosylceramide biosynthetic process [GO:0006679]; plasma membrane raft organization [GO:0044857],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],fatty acid 2-hydroxylase activity [GO:0080132]; free fatty acid 2-hydroxylase activity [GO:0120520]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0048856; GO:0061024; GO:1901135,catalytic activity; lipid metabolic process; oxidoreductase activity; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_04746,0.2801270931038965,OG_04746,FUN_022627-T1,Peve_00012280,Pocillopora_meandrina_HIv1___RNAseq.g4385.t1,three_way,74.43166666666667,FUN_022627-T1,Q13485,SMAD4_HUMAN,,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),Homo sapiens (Human),52.7,220.0,2.4e-51,205.7,sp|Q13485|SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens OX=9606 GN=SMAD4 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001837; GO:0003148; GO:0003161; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006366; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007411; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048665; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0097191; GO:1901203; GO:1902895; GO:1905305,activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412],activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_01399,0.2798447721032288,OG_01399,FUN_005387-T1,Peve_00044223,Pocillopora_meandrina_HIv1___RNAseq.g6614.t1,three_way,86.572,FUN_005387-T1,Q32LQ4,,,,,68.3,262.0,1.9e-105,384.0,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_09280,0.2797049276574987,OG_09280,FUN_040095-T1,Peve_00037198,Pocillopora_meandrina_HIv1___RNAseq.g7609.t1,three_way,67.75166666666667,,,,,,,,,,,,,,,,,
OG_00802,0.279626321839954,OG_00802,FUN_004000-T1,Peve_00034331,Pocillopora_meandrina_HIv1___RNAseq.g11698.t1,three_way,63.14333333333333,FUN_004000-T1,Q8CJ12,AGRG2_MOUSE,,"Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Mouse epididymis-specific protein 6) (Me6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)]",Mus musculus (Mouse),34.0,379.0,1.9e-50,203.4,sp|Q8CJ12|AGRG2_MOUSE Adhesion G-protein coupled receptor G2 OS=Mus musculus OX=10090 GN=Adgrg2 PE=1 SV=1,GO:0004930; GO:0005829; GO:0007166; GO:0007189; GO:0007286; GO:0016324,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; spermatid development [GO:0007286],apical plasma membrane [GO:0016324]; cytosol [GO:0005829],G protein-coupled receptor activity [GO:0004930],GO:0005829; GO:0022414; GO:0048856; GO:0060089,cytosol; reproductive process; anatomical structure development; molecular transducer activity
OG_00952,0.2791616972669152,OG_00952,FUN_004312-T1,Peve_00033934,Pocillopora_meandrina_HIv1___RNAseq.g16986.t1,three_way,70.072,FUN_004312-T1,Q98864,,,,,42.5,1133.0,1.3999999999999999e-244,847.8,sp|Q98864|PTC1_DANRE Protein patched homolog 1 OS=Danio rerio OX=7955 GN=ptch1 PE=2 SV=1,,,,,,
OG_04160,0.2791551312676067,OG_04160,FUN_016638-T1,Peve_00026352,Pocillopora_meandrina_HIv1___RNAseq.g102.t1,three_way,61.59666666666666,FUN_016638-T1,Q62136,,,,,27.0,1183.0,6.699999999999999e-90,333.6,sp|Q62136|PTN21_MOUSE Tyrosine-protein phosphatase non-receptor type 21 OS=Mus musculus OX=10090 GN=Ptpn21 PE=1 SV=1,,,,,,
OG_09229,0.2790178844891351,OG_09229,FUN_039966-T1,Peve_00039035,Pocillopora_meandrina_HIv1___RNAseq.g7517.t1a,three_way,70.402,,,,,,,,,,,,,,,,,
OG_08707,0.2787647872549412,OG_08707,FUN_037957-T1,Peve_00040730,Pocillopora_meandrina_HIv1___TS.g19259.t1,three_way,88.39133333333334,FUN_037957-T1,Q96HU1,SGSM3_HUMAN,,Small G protein signaling modulator 3 (Merlin-associated protein) (RUN and TBC1 domain-containing protein 3) (Rab-GTPase-activating protein-like protein) (RabGAPLP),Homo sapiens (Human),61.7,798.0,1.2e-288,993.8,sp|Q96HU1|SGSM3_HUMAN Small G protein signaling modulator 3 OS=Homo sapiens OX=9606 GN=SGSM3 PE=1 SV=1,GO:0005096; GO:0005829; GO:0005921; GO:0031267; GO:0032483; GO:0032486; GO:0043547; GO:0045732; GO:0048227; GO:0051726,plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein catabolic process [GO:0045732]; Rap protein signal transduction [GO:0032486]; regulation of cell cycle [GO:0051726]; regulation of Rab protein signal transduction [GO:0032483],cytosol [GO:0005829]; gap junction [GO:0005921],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0016192; GO:0098772,cytosol; vesicle-mediated transport; molecular function regulator activity
OG_00007,0.2785163224970963,OG_00007,FUN_000194-T1,Peve_00038470,Pocillopora_meandrina_HIv1___RNAseq.g28898.t1,three_way,77.11833333333334,FUN_000194-T1,P70182,,,,,60.2,447.0,3.4e-147,523.5,sp|P70182|PI51A_MOUSE Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2,,,,,,
OG_03269,0.278476727200707,OG_03269,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_06485,0.2781700289108403,OG_06485,FUN_029259-T1,Peve_00024365,Pocillopora_meandrina_HIv1___RNAseq.g15031.t1b,three_way,71.01783333333333,FUN_029259-T1,Q6DN90,IQEC1_HUMAN,,IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2),Homo sapiens (Human),42.1,447.0,1.1e-74,283.1,sp|Q6DN90|IQEC1_HUMAN IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IQSEC1 PE=1 SV=1,GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0008021; GO:0008289; GO:0014069; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0051549; GO:0060996; GO:0120183,actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012],centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_03039,0.2778492013274173,OG_03039,FUN_012278-T1,Peve_00010528,Pocillopora_meandrina_HIv1___RNAseq.g23570.t1,three_way,80.52133333333333,FUN_012278-T1,Q9D5W4,,,,,40.4,708.0,7.8e-127,456.1,sp|Q9D5W4|CCD81_MOUSE Coiled-coil domain-containing protein 81 OS=Mus musculus OX=10090 GN=Ccdc81 PE=2 SV=1,,,,,,
OG_02112,0.2777807862796604,OG_02112,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_08588,0.2774854918878685,OG_08588,FUN_037697-T1,Peve_00044127,Pocillopora_meandrina_HIv1___RNAseq.g1357.t1,three_way,66.68333333333334,FUN_037697-T1,Q6NZQ2,DDX31_MOUSE,,ATP-dependent DNA helicase DDX31 (EC 5.6.2.-) (DEAD box protein 31) (Probable ATP-dependent RNA helicase DDX31) (EC 3.6.4.13),Mus musculus (Mouse),46.4,686.0,1.1999999999999999e-148,528.5,sp|Q6NZQ2|DDX31_MOUSE ATP-dependent DNA helicase DDX31 OS=Mus musculus OX=10090 GN=Ddx31 PE=2 SV=2,GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0005794; GO:0016887; GO:0042254,ribosome biogenesis [GO:0042254],Golgi apparatus [GO:0005794]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005730; GO:0005794; GO:0016787; GO:0016853; GO:0042254; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleolus; Golgi apparatus; hydrolase activity; isomerase activity; ribosome biogenesis; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_03716,0.2773416815659659,OG_03716,FUN_014991-T1,Peve_00032857,Pocillopora_meandrina_HIv1___RNAseq.g21154.t2,three_way,83.89333333333333,FUN_014991-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),30.0,621.0,3.3e-94,347.4,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_01021,0.2772327028956066,OG_01021,FUN_004453-T1,Peve_00024317,Pocillopora_meandrina_HIv1___RNAseq.g5040.t1,three_way,69.144,FUN_004453-T1,Q5GN48,DMD_PIG,,Dystrophin,Sus scrofa (Pig),36.3,557.0,9.2e-96,352.4,sp|Q5GN48|DMD_PIG Dystrophin OS=Sus scrofa OX=9823 GN=DMD PE=1 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0007519; GO:0008270; GO:0016010; GO:0042383; GO:0045211; GO:0048666; GO:0055001; GO:0090257; GO:0099536; GO:0120025,muscle cell development [GO:0055001]; neuron development [GO:0048666]; regulation of muscle system process [GO:0090257]; skeletal muscle tissue development [GO:0007519]; synaptic signaling [GO:0099536],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; plasma membrane bounded cell projection [GO:0120025]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383],actin binding [GO:0003779]; zinc ion binding [GO:0008270],GO:0005856; GO:0005886; GO:0008092; GO:0023052; GO:0043226; GO:0048856,cytoskeleton; plasma membrane; cytoskeletal protein binding; signaling; organelle; anatomical structure development
OG_07786,0.2767725201179995,OG_07786,FUN_035007-T1,Peve_00024588,Pocillopora_meandrina_HIv1___RNAseq.g12133.t1,three_way,76.595,FUN_035007-T1,O60268,,,,,33.6,110.0,4.3e-10,65.5,sp|O60268|K0513_HUMAN Uncharacterized protein KIAA0513 OS=Homo sapiens OX=9606 GN=KIAA0513 PE=1 SV=1,,,,,,
OG_05506,0.2767588636044116,OG_05506,FUN_024587-T1,Peve_00037917,Pocillopora_meandrina_HIv1___RNAseq.2717_t,three_way,63.268,,,,,,,,,,,,,,,,,
OG_08902,0.276535847098357,OG_08902,FUN_038330-T1,Peve_00023108,Pocillopora_meandrina_HIv1___RNAseq.g1119.t2,three_way,80.42033333333333,FUN_038330-T1,Q9EQY0,ERN1_MOUSE,,Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],Mus musculus (Mouse),44.5,954.0,2.3e-213,743.8,sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus OX=10090 GN=Ern1 PE=1 SV=1,GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005739; GO:0005789; GO:0006468; GO:0017148; GO:0019899; GO:0030544; GO:0030968; GO:0033120; GO:0035924; GO:0036498; GO:0042803; GO:0043507; GO:0043531; GO:0046777; GO:0051879; GO:0070054; GO:0070059; GO:0070301; GO:0071333; GO:0106310; GO:1900103; GO:1901142; GO:1904294; GO:1904707; GO:1990597; GO:1990604; GO:1990630,"cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; negative regulation of translation [GO:0017148]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]",AIP1-IRE1 complex [GO:1990597]; endoplasmic reticulum membrane [GO:0005789]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637],ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA endonuclease activity [GO:0004521],GO:0003824; GO:0005739; GO:0016071; GO:0016740; GO:0043226; GO:0140096; GO:0140098,"catalytic activity; mitochondrion; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_06571,0.2763435069124036,OG_06571,FUN_029484-T1,Peve_00017245,Pocillopora_meandrina_HIv1___RNAseq.g17128.t1,three_way,64.353,FUN_029484-T1,Q8NEA6,GLIS3_HUMAN,,Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515),Homo sapiens (Human),64.3,70.0,4.8e-23,110.9,sp|Q8NEA6|GLIS3_HUMAN Zinc finger protein GLIS3 OS=Homo sapiens OX=9606 GN=GLIS3 PE=1 SV=5,GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008270; GO:0045944,negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_01121,0.2762901185537627,OG_01121,FUN_004684-T1,Peve_00035122,Pocillopora_meandrina_HIv1___RNAseq.g8765.t1,three_way,65.35983333333333,FUN_004684-T1,Q07008,NOTC1_RAT,,Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Rattus norvegicus (Rat),42.2,628.0,7.7e-77,291.2,sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3,GO:0000122; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006915; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008283; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685],"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003677; GO:0005634; GO:0005783; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006954; GO:0012501; GO:0016192; GO:0022414; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; nucleus; endoplasmic reticulum; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; inflammatory response; programmed cell death; vesicle-mediated transport; reproductive process; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular transducer activity; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_06125,0.2757631001649288,OG_06125,FUN_027903-T1,Peve_00020107,Pocillopora_meandrina_HIv1___RNAseq.g13881.t1,three_way,48.315666666666665,FUN_027903-T1,O75487,GPC4_HUMAN,,Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4],Homo sapiens (Human),33.5,507.0,6.5e-73,276.6,sp|O75487|GPC4_HUMAN Glypican-4 OS=Homo sapiens OX=9606 GN=GPC4 PE=1 SV=4,GO:0005634; GO:0005796; GO:0005886; GO:0009897; GO:0009966; GO:0009986; GO:0015026; GO:0016055; GO:0016477; GO:0043202; GO:0045202; GO:0070062; GO:0098696; GO:0098978; GO:0099560; GO:1905606,cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],coreceptor activity [GO:0015026],GO:0005634; GO:0005886; GO:0007155; GO:0043226; GO:0048870; GO:0060089,nucleus; plasma membrane; cell adhesion; organelle; cell motility; molecular transducer activity
OG_01653,0.2757598926163061,OG_01653,FUN_006821-T1,Peve_00023763,Pocillopora_meandrina_HIv1___RNAseq.g20482.t1,three_way,90.73766666666668,FUN_006821-T1,Q9HD45,,,,,69.3,554.0,6.7e-206,718.4,sp|Q9HD45|TM9S3_HUMAN Transmembrane 9 superfamily member 3 OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=2,,,,,,
OG_01258,0.2755279849419701,OG_01258,FUN_004990-T1,Peve_00015881,Pocillopora_meandrina_HIv1___RNAseq.g8685.t1,three_way,78.06383333333333,FUN_004990-T1,Q7Z2Z2,EFL1_HUMAN,,Elongation factor-like GTPase 1 (EC 3.6.5.-) (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A),Homo sapiens (Human),53.6,1185.0,0.0,1171.8,sp|Q7Z2Z2|EFL1_HUMAN Elongation factor-like GTPase 1 OS=Homo sapiens OX=9606 GN=EFL1 PE=1 SV=2,GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0042256; GO:0043022; GO:0046039; GO:1990904,cytosolic ribosome assembly [GO:0042256]; GTP metabolic process [GO:0046039],cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; GTPase activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02904,0.275066550067406,OG_02904,FUN_011974-T1,Peve_00000999,Pocillopora_meandrina_HIv1___RNAseq.g23723.t1,three_way,49.84633333333333,FUN_011974-T1,Q9BQF6,SENP7_HUMAN,,Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7),Homo sapiens (Human),48.3,321.0,1.3e-68,263.1,sp|Q9BQF6|SENP7_HUMAN Sentrin-specific protease 7 OS=Homo sapiens OX=9606 GN=SENP7 PE=1 SV=4,GO:0005634; GO:0005737; GO:0006508; GO:0016926; GO:0070139; GO:0099523; GO:0099524; GO:0140374,antiviral innate immune response [GO:0140374]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523],SUMO-specific endopeptidase activity [GO:0070139],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; hydrolase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_07741,0.2745639772242991,OG_07741,FUN_034920-T1,Peve_00039139,Pocillopora_meandrina_HIv1___RNAseq.g12138.t1,three_way,54.01583333333333,FUN_034920-T1,Q8CGC6,,,,,34.2,929.0,3.6e-76,288.1,sp|Q8CGC6|RBM28_MOUSE RNA-binding protein 28 OS=Mus musculus OX=10090 GN=Rbm28 PE=1 SV=4,,,,,,
OG_02309,0.2744916501989813,OG_02309,FUN_008889-T1,Peve_00020945,Pocillopora_meandrina_HIv1___RNAseq.g4003.t1,three_way,51.47683333333334,FUN_008889-T1,D3Z8E6,CAMP1_RAT,,Calmodulin-regulated spectrin-associated protein 1,Rattus norvegicus (Rat),43.7,142.0,7.000000000000001e-32,142.1,sp|D3Z8E6|CAMP1_RAT Calmodulin-regulated spectrin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Camsap1 PE=1 SV=2,GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0036449; GO:0051011,cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule minus-end [GO:0036449],calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507],GO:0007010; GO:0008092,cytoskeleton organization; cytoskeletal protein binding
OG_09858,0.2743476628941991,OG_09858,FUN_042852-T1,Peve_00023270,Pocillopora_meandrina_HIv1___RNAseq.g7247.t1,three_way,60.656666666666666,FUN_042852-T1,Q15527,,,,,37.4,163.0,5.4e-20,99.8,sp|Q15527|SURF2_HUMAN Surfeit locus protein 2 OS=Homo sapiens OX=9606 GN=SURF2 PE=1 SV=4,,,,,,
OG_06347,0.2738866738026135,OG_06347,FUN_028913-T1,Peve_00028026,Pocillopora_meandrina_HIv1___RNAseq.g20741.t2a,three_way,84.06333333333333,FUN_028913-T1,Q8IV35,,,,,40.4,1045.0,5.2e-223,776.2,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_08639,0.2735460283330407,OG_08639,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_09079,0.2734288025383067,OG_09079,FUN_038808-T1,Peve_00007219,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1a,three_way,79.655,FUN_038808-T1,A4QNE0,,,,,50.2,297.0,3.1e-83,310.1,sp|A4QNE0|GET4_XENTR Golgi to ER traffic protein 4 homolog OS=Xenopus tropicalis OX=8364 GN=get4 PE=2 SV=1,,,,,,
OG_05749,0.2733058431962429,OG_05749,FUN_025681-T1,Peve_00000455,Pocillopora_meandrina_HIv1___RNAseq.g13115.t1,three_way,68.22683333333333,FUN_025681-T1,P98064,,,,,39.3,690.0,1.5999999999999999e-137,491.5,sp|P98064|MASP1_MOUSE Mannan-binding lectin serine protease 1 OS=Mus musculus OX=10090 GN=Masp1 PE=1 SV=2,,,,,,
OG_08693,0.2721665085016169,OG_08693,FUN_037937-T1,Peve_00015638,Pocillopora_meandrina_HIv1___RNAseq.g26202.t1,three_way,78.55583333333333,FUN_037937-T1,Q5M9B1,,,,,51.3,226.0,6.9e-63,242.3,sp|Q5M9B1|SPSB3_XENLA SPRY domain-containing SOCS box protein 3 OS=Xenopus laevis OX=8355 GN=spsb3 PE=2 SV=1,,,,,,
OG_06943,0.2720526407148063,OG_06943,FUN_032053-T1,Peve_00012451,Pocillopora_meandrina_HIv1___RNAseq.g6027.t1,three_way,65.46633333333334,FUN_032053-T1,Q68DK2,ZFY26_HUMAN,,Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein) (FYVE-CENT) (Spastizin),Homo sapiens (Human),31.7,1223.0,2.8e-168,595.9,sp|Q68DK2|ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ZFYVE26 PE=1 SV=4,GO:0000281; GO:0000724; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0008270; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:1905037,autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496],phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270],GO:0000910; GO:0005764; GO:0005768; GO:0005773; GO:0005815; GO:0006281; GO:0006310; GO:0007040; GO:0008289; GO:0031410; GO:0043226,cytokinesis; lysosome; endosome; vacuole; microtubule organizing center; DNA repair; DNA recombination; lysosome organization; lipid binding; cytoplasmic vesicle; organelle
OG_02457,0.272025359092228,OG_02457,FUN_009641-T1,Peve_00021801,Pocillopora_meandrina_HIv1___RNAseq.g24616.t1,three_way,92.12033333333332,FUN_009641-T1,A6N6J5,WDR35_RAT,,WD repeat-containing protein 35 (Naofen),Rattus norvegicus (Rat),68.2,1188.0,0.0,1680.6,sp|A6N6J5|WDR35_RAT WD repeat-containing protein 35 OS=Rattus norvegicus OX=10116 GN=Wdr35 PE=1 SV=1,GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0045019; GO:0045907; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0071466; GO:0090200; GO:0097421; GO:1990830; GO:2001238,cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vasoconstriction [GO:0045907]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; intraciliary transport particle A [GO:0030991],,GO:0003013; GO:0005815; GO:0007018; GO:0044782; GO:0048856,circulatory system process; microtubule organizing center; microtubule-based movement; cilium organization; anatomical structure development
OG_04724,0.2718712963756302,OG_04724,FUN_022589-T1,Peve_00020263,Pocillopora_meandrina_HIv1___RNAseq.g4431.t1,three_way,80.9065,FUN_022589-T1,O70172,,,,,50.9,450.0,7.000000000000003e-110,399.1,sp|O70172|PI42A_MOUSE Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha OS=Mus musculus OX=10090 GN=Pip4k2a PE=1 SV=1,,,,,,
OG_05428,0.2718359024975652,OG_05428,FUN_024373-T1,Peve_00020237,Pocillopora_meandrina_HIv1___RNAseq.g18595.t1,three_way,71.70833333333333,FUN_024373-T1,A0JMY5,,,,,42.7,560.0,4.799999999999999e-92,340.1,sp|A0JMY5|NFXL1_XENLA NF-X1-type zinc finger protein NFXL1 OS=Xenopus laevis OX=8355 GN=nfxl1 PE=2 SV=1,,,,,,
OG_02111,0.2717616808355489,OG_02111,FUN_008396-T1,Peve_00043608,Pocillopora_meandrina_HIv1___RNAseq.g6175.t1,three_way,71.88550000000001,FUN_008396-T1,Q9EQC5,SCYL1_MOUSE,,N-terminal kinase-like protein (105 kDa kinase-like protein) (Mitosis-associated kinase-like protein NTKL) (SCY1-like protein 1),Mus musculus (Mouse),51.4,675.0,2.1e-182,641.0,sp|Q9EQC5|SCYL1_MOUSE N-terminal kinase-like protein OS=Mus musculus OX=10090 GN=Scyl1 PE=1 SV=1,GO:0004672; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005813; GO:0005829; GO:0006890; GO:0006954; GO:0008104; GO:0021522; GO:0030126; GO:0048666,"inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]",centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; protein kinase activity [GO:0004672],GO:0003824; GO:0005794; GO:0005815; GO:0005829; GO:0006954; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; microtubule organizing center; cytosol; inflammatory response; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09509,0.2713373848094345,OG_09509,FUN_041557-T1,Peve_00033125,Pocillopora_meandrina_HIv1___RNAseq.g16079.t1,three_way,82.36866666666667,FUN_041557-T1,F1LP64,TRIPC_RAT,,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),Rattus norvegicus (Rat),52.2,1669.0,0.0,1587.8,sp|F1LP64|TRIPC_RAT E3 ubiquitin-protein ligase TRIP12 OS=Rattus norvegicus OX=10116 GN=Trip12 PE=1 SV=1,GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0033696; GO:0043161; GO:0045995; GO:0046966; GO:0061630; GO:0140861,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09177,0.2710389806598512,OG_09177,FUN_039853-T1,Peve_00020651,Pocillopora_meandrina_HIv1___RNAseq.g7295.t2,three_way,71.36883333333333,FUN_039853-T1,Q8QFV0,,,,,43.4,1143.0,3.4999999999999996e-251,869.8,sp|Q8QFV0|KCNT1_CHICK Potassium channel subfamily T member 1 OS=Gallus gallus OX=9031 GN=KCNT1 PE=1 SV=1,,,,,,
OG_06383,0.2710314611607486,OG_06383,FUN_029007-T1,Peve_00025770,Pocillopora_meandrina_HIv1___RNAseq.g25642.t1,three_way,63.09433333333333,FUN_029007-T1,Q8N4T0,CBPA6_HUMAN,,Carboxypeptidase A6 (EC 3.4.17.-),Homo sapiens (Human),33.4,404.0,1.7e-60,235.0,sp|Q8N4T0|CBPA6_HUMAN Carboxypeptidase A6 OS=Homo sapiens OX=9606 GN=CPA6 PE=1 SV=2,GO:0004181; GO:0005615; GO:0006508; GO:0008270,proteolysis [GO:0006508],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_01521,0.2707915772302304,OG_01521,FUN_006275-T1,Peve_00019725,Pocillopora_meandrina_HIv1___RNAseq.g20370.t1,three_way,75.4355,FUN_006275-T1,Q8R3S6,,,,,43.7,924.0,1.3e-200,701.4,sp|Q8R3S6|EXOC1_MOUSE Exocyst complex component 1 OS=Mus musculus OX=10090 GN=Exoc1 PE=1 SV=4,,,,,,
OG_05627,0.2699724598162819,OG_05627,FUN_025322-T1,Peve_00027091,Pocillopora_meandrina_HIv1___RNAseq.g13422.t1,three_way,87.86033333333333,FUN_025322-T1,Q6PAX2,,,,,62.0,574.0,2.0000000000000005e-165,583.9,sp|Q6PAX2|ATD3B_XENLA ATPase family AAA domain-containing protein 3-B OS=Xenopus laevis OX=8355 GN=atad3-b PE=2 SV=1,,,,,,
OG_04762,0.2696918607724223,OG_04762,FUN_022662-T1,Peve_00027940,Pocillopora_meandrina_HIv1___RNAseq.g3157.t1b,three_way,84.34933333333333,FUN_022662-T1,Q5ZLC8,,,,,47.4,137.0,1.4e-25,120.2,sp|Q5ZLC8|ANR52_CHICK Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Gallus gallus OX=9031 GN=ANKRD52 PE=2 SV=1,,,,,,
OG_02374,0.269648416775007,OG_02374,FUN_008984-T1,Peve_00029644,Pocillopora_meandrina_HIv1___RNAseq.g3905.t1,three_way,78.63966666666667,FUN_008984-T1,Q9NSN8,,,,,34.6,448.0,3e-69,264.2,sp|Q9NSN8|SNTG1_HUMAN Gamma-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTG1 PE=1 SV=1,,,,,,
OG_08490,0.2695692931628541,OG_08490,FUN_037327-T1,Peve_00006233,Pocillopora_meandrina_HIv1___RNAseq.g10694.t1,three_way,65.693,FUN_037327-T1,Q90YK3,,,,,49.0,437.0,2.1e-133,477.2,sp|Q90YK3|GGLO_SCYTO L-gulonolactone oxidase OS=Scyliorhinus torazame OX=75743 GN=GULO PE=2 SV=1,,,,,,
OG_00852,0.269444846902401,OG_00852,FUN_004114-T1,Peve_00015643,Pocillopora_meandrina_HIv1___RNAseq.g11665.t1,three_way,81.109,FUN_004114-T1,Q4R5E4,,,,,61.4,568.0,4.5e-207,722.2,sp|Q4R5E4|PGM1_MACFA Phosphoglucomutase-1 OS=Macaca fascicularis OX=9541 GN=PGM1 PE=2 SV=3,,,,,,
OG_08086,0.2692918944732717,OG_08086,FUN_035818-T1,Peve_00037796,Pocillopora_meandrina_HIv1___RNAseq.g11926.t1,three_way,85.777,FUN_035818-T1,Q6ZQ89,,,,,69.6,573.0,3.7e-215,749.2,sp|Q6ZQ89|MARH6_MOUSE E3 ubiquitin-protein ligase MARCHF6 OS=Mus musculus OX=10090 GN=Marchf6 PE=2 SV=2,,,,,,
OG_10062,0.2692014999319939,OG_10062,FUN_043362-T1,Peve_00016657,Pocillopora_meandrina_HIv1___RNAseq.g8969.t1,three_way,65.42666666666666,FUN_043362-T1,Q8STF6,DYC1_CAEEL,,Dystrophin-like protein 1 (Dyb-1-binding and CAPON-related protein),Caenorhabditis elegans,41.2,228.0,8.5e-40,166.4,sp|Q8STF6|DYC1_CAEEL Dystrophin-like protein 1 OS=Caenorhabditis elegans OX=6239 GN=dyc-1 PE=1 SV=1,GO:0007626; GO:0008307; GO:0016010; GO:0030235; GO:0030424; GO:0040017; GO:0045214; GO:0046662; GO:0046716; GO:0050998; GO:0055120,locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of locomotion [GO:0040017]; regulation of egg-laying behavior [GO:0046662]; sarcomere organization [GO:0045214],axon [GO:0030424]; dystrophin-associated glycoprotein complex [GO:0016010]; striated muscle dense body [GO:0055120],nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; structural constituent of muscle [GO:0008307],GO:0005198; GO:0007010; GO:0098772,structural molecule activity; cytoskeleton organization; molecular function regulator activity
OG_08249,0.2687565332841457,OG_08249,FUN_036158-T1,Peve_00039218,Pocillopora_meandrina_HIv1___RNAseq.g27493.t1,three_way,85.587,FUN_036158-T1,Q5PQY6,,,,,58.8,838.0,6.9e-268,924.9,"sp|Q5PQY6|LONP2_DANRE Lon protease homolog 2, peroxisomal OS=Danio rerio OX=7955 GN=lonp2 PE=2 SV=1",,,,,,
OG_06985,0.2687375831828255,OG_06985,FUN_032124-T1,Peve_00040714,Pocillopora_meandrina_HIv1___TS.g24079.t3,three_way,68.271,FUN_032124-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),24.2,715.0,4.2e-45,184.9,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_03623,0.2687030516450292,OG_03623,FUN_014810-T1,Peve_00022206,Pocillopora_meandrina_HIv1___RNAseq.g22405.t1,three_way,74.15333333333334,FUN_014810-T1,Q9NXZ2,,,,,46.8,577.0,2.1e-146,521.2,sp|Q9NXZ2|DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens OX=9606 GN=DDX43 PE=1 SV=2,,,,,,
OG_06707,0.2683538357235929,OG_06707,FUN_031287-T1,Peve_00036748,Pocillopora_meandrina_HIv1___RNAseq.g5172.t1,three_way,87.3345,FUN_031287-T1,Q8BFX3,,,,,64.2,653.0,1.1999999999999999e-235,817.4,sp|Q8BFX3|KCTD3_MOUSE BTB/POZ domain-containing protein KCTD3 OS=Mus musculus OX=10090 GN=Kctd3 PE=1 SV=1,,,,,,
OG_07149,0.2679484993631719,OG_07149,FUN_032502-T1,Peve_00042406,Pocillopora_meandrina_HIv1___RNAseq.g24323.t1,three_way,42.0895,,,,,,,,,,,,,,,,,
OG_05906,0.2677617081043894,OG_05906,FUN_026093-T1,Peve_00036299,Pocillopora_meandrina_HIv1___RNAseq.g10574.t1a,three_way,64.66183333333333,FUN_026093-T1,Q9Y6M1,IF2B2_HUMAN,,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),Homo sapiens (Human),30.0,474.0,8.6e-34,146.4,sp|Q9Y6M1|IF2B2_HUMAN Insulin-like growth factor 2 mRNA-binding protein 2 OS=Homo sapiens OX=9606 GN=IGF2BP2 PE=1 SV=2,GO:0000932; GO:0001817; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007399; GO:0009653; GO:0010494; GO:0017148; GO:0043489; GO:0045182; GO:0048027; GO:0051028; GO:0070934; GO:0097009; GO:0106106; GO:1990247,anatomical structure morphogenesis [GO:0009653]; cold-induced thermogenesis [GO:0106106]; CRD-mediated mRNA stabilization [GO:0070934]; energy homeostasis [GO:0097009]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; RNA stabilization [GO:0043489],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182],GO:0003723; GO:0005634; GO:0005829; GO:0005856; GO:0043226; GO:0045182; GO:0048856; GO:0060090,RNA binding; nucleus; cytosol; cytoskeleton; organelle; translation regulator activity; anatomical structure development; molecular adaptor activity
OG_03725,0.2673232961927861,OG_03725,FUN_015010-T1,Peve_00034686,Pocillopora_meandrina_HIv1___RNAseq.g21244.t1,three_way,58.71366666666667,FUN_015010-T1,Q86UW9,DTX2_HUMAN,,Probable E3 ubiquitin-protein ligase DTX2 (EC 2.3.2.27) (Protein deltex-2) (Deltex2) (hDTX2) (RING finger protein 58) (RING-type E3 ubiquitin transferase DTX2),Homo sapiens (Human),35.4,605.0,4.6000000000000003e-88,326.6,sp|Q86UW9|DTX2_HUMAN Probable E3 ubiquitin-protein ligase DTX2 OS=Homo sapiens OX=9606 GN=DTX2 PE=1 SV=3,GO:0005654; GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0031965; GO:0061630,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; transferase activity; catalytic activity, acting on a protein"
OG_10054,0.2670685177544946,OG_10054,FUN_043347-T1,Peve_00043038,Pocillopora_meandrina_HIv1___RNAseq.g8956.t1,three_way,86.98733333333334,FUN_043347-T1,Q5NVD0,,,,,55.9,288.0,4.3e-79,297.0,sp|Q5NVD0|PRP4_PONAB U4/U6 small nuclear ribonucleoprotein Prp4 OS=Pongo abelii OX=9601 GN=PRPF4 PE=2 SV=1,,,,,,
OG_05937,0.2665725969632408,OG_05937,FUN_026167-T1,Peve_00008134,Pocillopora_meandrina_HIv1___RNAseq.g3196.t1,three_way,63.132333333333335,,,,,,,,,,,,,,,,,
OG_07910,0.2665142461789356,OG_07910,FUN_035368-T1,Peve_00016220,Pocillopora_meandrina_HIv1___TS.g3560.t1,three_way,68.399,FUN_035368-T1,P10611,,,,,35.0,451.0,5.5e-78,293.1,sp|P10611|CP4A4_RABIT Cytochrome P450 4A4 OS=Oryctolagus cuniculus OX=9986 GN=CYP4A4 PE=1 SV=3,,,,,,
OG_04824,0.2663195203422068,OG_04824,FUN_022815-T1,Peve_00017628,Pocillopora_meandrina_HIv1___RNAseq.g3454.t1,three_way,55.73433333333333,,,,,,,,,,,,,,,,,
OG_10196,0.2662634209845831,OG_10196,FUN_043620-T1,Peve_00008227,Pocillopora_meandrina_HIv1___RNAseq.g6930.t1,three_way,51.489333333333335,,,,,,,,,,,,,,,,,
OG_07720,0.2658544440462685,OG_07720,FUN_034875-T1,Peve_00005784,Pocillopora_meandrina_HIv1___RNAseq.g27164.t1b,three_way,85.19866666666667,FUN_034875-T1,Q8QZR1,ATTY_MOUSE,,Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase),Mus musculus (Mouse),53.7,408.0,7.9e-140,498.4,sp|Q8QZR1|ATTY_MOUSE Tyrosine aminotransferase OS=Mus musculus OX=10090 GN=Tat PE=1 SV=1,GO:0004838; GO:0005739; GO:0006103; GO:0006536; GO:0006559; GO:0006572; GO:0006979; GO:0009058; GO:0016597; GO:0030170; GO:0042802; GO:0046689; GO:0071548,2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572],mitochondrion [GO:0005739],amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine-2-oxoglutarate transaminase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; organelle
OG_04521,0.2658340067898482,OG_04521,FUN_022055-T1,Peve_00014937,Pocillopora_meandrina_HIv1___RNAseq.g4606.t1,three_way,77.94066666666666,FUN_022055-T1,Q9BVL4,SELO_HUMAN,,"Protein adenylyltransferase SelO, mitochondrial (EC 2.7.7.-) (EC 2.7.7.108) (Selenoprotein O) (SelO)",Homo sapiens (Human),55.3,631.0,1.3999999999999999e-191,671.0,"sp|Q9BVL4|SELO_HUMAN Protein adenylyltransferase SelO, mitochondrial OS=Homo sapiens OX=9606 GN=SELENOO PE=1 SV=3",GO:0005524; GO:0005694; GO:0005739; GO:0018117; GO:0046872; GO:0070733,protein adenylylation [GO:0018117],chromosome [GO:0005694]; mitochondrion [GO:0005739],AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],GO:0003824; GO:0005694; GO:0005739; GO:0016740; GO:0043226,catalytic activity; chromosome; mitochondrion; transferase activity; organelle
OG_06635,0.2657636774333977,OG_06635,FUN_030183-T1,Peve_00004642,Pocillopora_meandrina_HIv1___RNAseq.g17361.t1,three_way,86.83633333333333,FUN_030183-T1,Q4ZIN3,MBRL_HUMAN,,Membralin (Transmembrane protein 259),Homo sapiens (Human),57.5,454.0,1.4999999999999998e-127,458.0,sp|Q4ZIN3|MBRL_HUMAN Membralin OS=Homo sapiens OX=9606 GN=TMEM259 PE=1 SV=1,GO:0005783; GO:0005789; GO:0034976; GO:1904294,positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0005783; GO:0043226,endoplasmic reticulum; organelle
OG_01444,0.2657262389655273,OG_01444,FUN_005890-T1,Peve_00015769,Pocillopora_meandrina_HIv1___RNAseq.g19679.t1,three_way,69.12316666666668,FUN_005890-T1,O94868,,,,,36.6,673.0,7.4e-94,346.7,sp|O94868|FCSD2_HUMAN F-BAR and double SH3 domains protein 2 OS=Homo sapiens OX=9606 GN=FCHSD2 PE=1 SV=3,,,,,,
OG_08586,0.26559002630131,OG_08586,FUN_037690-T1,Peve_00001242,Pocillopora_meandrina_HIv1___RNAseq.g1579.t1,three_way,69.16366666666667,FUN_037690-T1,Q8TEM1,PO210_HUMAN,,Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa),Homo sapiens (Human),34.5,1584.0,2.7e-254,880.9,sp|Q8TEM1|PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens OX=9606 GN=NUP210 PE=1 SV=3,GO:0005635; GO:0005643; GO:0005789; GO:0006913; GO:0015031; GO:0016020; GO:0031965; GO:0051028,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643],,GO:0005635; GO:0006913,nuclear envelope; nucleocytoplasmic transport
OG_02867,0.2654452333021624,OG_02867,FUN_011917-T1,Peve_00010930,Pocillopora_meandrina_HIv1___RNAseq.g23316.t1,three_way,66.30183333333333,FUN_011917-T1,Q80Y44,,,,,58.7,543.0,1.5e-178,627.9,sp|Q80Y44|DDX10_MOUSE Probable ATP-dependent RNA helicase DDX10 OS=Mus musculus OX=10090 GN=Ddx10 PE=1 SV=2,,,,,,
OG_03282,0.2653370037314546,OG_03282,FUN_013314-T1,Peve_00022437,Pocillopora_meandrina_HIv1___RNAseq.g12993.t1,three_way,71.73,FUN_013314-T1,Q5XF89,AT133_MOUSE,,Polyamine-transporting ATPase 13A3 (Putrescine transporting ATPase) (EC 7.6.2.16),Mus musculus (Mouse),47.0,1186.0,5.3999999999999995e-279,962.2,sp|Q5XF89|AT133_MOUSE Polyamine-transporting ATPase 13A3 OS=Mus musculus OX=10090 GN=Atp13a3 PE=1 SV=1,GO:0005524; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358,,early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038],ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358],GO:0003824; GO:0005215; GO:0016787; GO:0140657,catalytic activity; transporter activity; hydrolase activity; ATP-dependent activity
OG_01494,0.2653146332545942,OG_01494,FUN_006172-T1,Peve_00028675,Pocillopora_meandrina_HIv1___RNAseq.g20432.t1,three_way,61.756,FUN_006172-T1,Q9QXG2,,,,,42.3,684.0,1.2000000000000002e-124,448.7,sp|Q9QXG2|RAE1_MOUSE Rab proteins geranylgeranyltransferase component A 1 OS=Mus musculus OX=10090 GN=Chm PE=1 SV=1,,,,,,
OG_06863,0.2647956468147581,OG_06863,FUN_031856-T1,Peve_00011072,Pocillopora_meandrina_HIv1___RNAseq.g5630.t1,three_way,86.09033333333333,FUN_031856-T1,P13255,GNMT_RAT,,Glycine N-methyltransferase (EC 2.1.1.20) (Folate-binding protein),Rattus norvegicus (Rat),55.3,309.0,1.1e-88,328.2,sp|P13255|GNMT_RAT Glycine N-methyltransferase OS=Rattus norvegicus OX=10116 GN=Gnmt PE=1 SV=2,GO:0005542; GO:0005829; GO:0005977; GO:0006111; GO:0006544; GO:0006555; GO:0006730; GO:0008757; GO:0016594; GO:0017174; GO:0032259; GO:0034708; GO:0042802; GO:0046498; GO:0046500; GO:0051289; GO:0098603; GO:1901052; GO:1904047,glycine metabolic process [GO:0006544]; glycogen metabolic process [GO:0005977]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052],cytosol [GO:0005829]; methyltransferase complex [GO:0034708],folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; selenol Se-methyltransferase activity [GO:0098603],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0006520; GO:0006575; GO:0006790; GO:0016740; GO:0055086; GO:0065003; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_06113,0.2639049366197367,OG_06113,FUN_027830-T1,Peve_00020554,Pocillopora_meandrina_HIv1___RNAseq.g13867.t1,three_way,75.69233333333334,FUN_027830-T1,O00233,PSMD9_HUMAN,,26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27),Homo sapiens (Human),49.5,206.0,1.6999999999999996e-47,190.7,sp|O00233|PSMD9_HUMAN 26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens OX=9606 GN=PSMD9 PE=1 SV=3,GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0005838; GO:0006511; GO:0032024; GO:0043425; GO:0045893; GO:0046676; GO:0070682,negative regulation of insulin secretion [GO:0046676]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion [GO:0032024]; proteasome regulatory particle assembly [GO:0070682]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838],bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_08392,0.2636424743960288,OG_08392,FUN_037004-T1,Peve_00002158,Pocillopora_meandrina_HIv1___RNAseq.g26681.t1,three_way,58.53766666666667,FUN_037004-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),35.2,267.0,1.5999999999999998e-41,172.9,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03628,0.2633959795405592,OG_03628,FUN_014844-T1,Peve_00038815,Pocillopora_meandrina_HIv1___RNAseq.g22389.t1,three_way,69.21433333333333,FUN_014844-T1,C0HL13,LRP2_PIG,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Sus scrofa (Pig),31.5,305.0,4.3e-34,149.8,sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1,GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167,coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0016192; GO:0022414; GO:0048856; GO:0050877; GO:0055085,vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process; transmembrane transport
OG_06392,0.2633772657282262,OG_06392,FUN_029040-T1,Peve_00026015,Pocillopora_meandrina_HIv1___RNAseq.g20769.t1,three_way,90.76433333333334,FUN_029040-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),57.2,568.0,1.8000000000000004e-164,580.9,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_00552,0.2633729961252692,OG_00552,FUN_001595-T1,Peve_00004149,Pocillopora_meandrina_HIv1___TS.g4491.t1,three_way,73.311,FUN_001595-T1,Q9LMG7,PPA2_ARATH,,Probable inactive purple acid phosphatase 2,Arabidopsis thaliana (Mouse-ear cress),34.2,573.0,7.2e-83,309.7,sp|Q9LMG7|PPA2_ARATH Probable inactive purple acid phosphatase 2 OS=Arabidopsis thaliana OX=3702 GN=PAP2 PE=2 SV=1,GO:0003993; GO:0005576; GO:0005739; GO:0005740; GO:0005768; GO:0005794; GO:0005802; GO:0006109; GO:0006626; GO:0009507; GO:0009941; GO:0030943; GO:0045040; GO:0046872,protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; regulation of carbohydrate metabolic process [GO:0006109],chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; trans-Golgi network [GO:0005802],acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]; mitochondrion targeting sequence binding [GO:0030943],GO:0003824; GO:0005576; GO:0005739; GO:0005768; GO:0005794; GO:0007005; GO:0009536; GO:0016787; GO:0031410; GO:0043226; GO:0061024,catalytic activity; extracellular region; mitochondrion; endosome; Golgi apparatus; mitochondrion organization; plastid; hydrolase activity; cytoplasmic vesicle; organelle; membrane organization
OG_00519,0.263232297101376,OG_00519,FUN_001517-T1,Peve_00012127,Pocillopora_meandrina_HIv1___TS.g4391.t1,three_way,84.86149999999999,FUN_001517-T1,Q3SZ40,,,,,56.4,535.0,3.6000000000000003e-158,559.7,sp|Q3SZ40|DDX56_BOVIN Probable ATP-dependent RNA helicase DDX56 OS=Bos taurus OX=9913 GN=DDX56 PE=2 SV=1,,,,,,
OG_02572,0.2631665262876824,OG_02572,FUN_010675-T1,Peve_00044784,Pocillopora_meandrina_HIv1___RNAseq.g21349.t1,three_way,66.34933333333333,FUN_010675-T1,Q8K2L8,,,,,46.4,435.0,4.8e-112,407.1,sp|Q8K2L8|TPC12_MOUSE Trafficking protein particle complex subunit 12 OS=Mus musculus OX=10090 GN=Trappc12 PE=1 SV=2,,,,,,
OG_04395,0.2629783651376683,OG_04395,FUN_018398-T1,Peve_00032288,Pocillopora_meandrina_HIv1___TS.g23627.t2,three_way,73.27966666666667,FUN_018398-T1,P70168,IMB1_MOUSE,,Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG),Mus musculus (Mouse),64.6,878.0,0.0,1105.5,sp|P70168|IMB1_MOUSE Importin subunit beta-1 OS=Mus musculus OX=10090 GN=Kpnb1 PE=1 SV=2,GO:0005654; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0010494; GO:0019904; GO:0030953; GO:0031267; GO:0031965; GO:0032991; GO:0040001; GO:0042564; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307,astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; protein domain specific binding [GO:0019904]; small GTPase binding [GO:0031267],GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0007010; GO:0007018; GO:0043226; GO:0140104,nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; microtubule-based movement; organelle; molecular carrier activity
OG_00049,0.262894140554173,OG_00049,FUN_000289-T1,Peve_00033565,Pocillopora_meandrina_HIv1___TS.g6289.t1,three_way,56.049,FUN_000289-T1,Q9UPM8,,,,,26.1,743.0,7.4e-53,210.3,sp|Q9UPM8|AP4E1_HUMAN AP-4 complex subunit epsilon-1 OS=Homo sapiens OX=9606 GN=AP4E1 PE=1 SV=2,,,,,,
OG_03406,0.2628873001859563,OG_03406,FUN_014449-T1,Peve_00009606,Pocillopora_meandrina_HIv1___RNAseq.1985_t,three_way,77.316,FUN_014449-T1,Q54BU4,ABCB1_DICDI,,ABC transporter B family member 1 (ABC transporter ABCB.1),Dictyostelium discoideum (Social amoeba),51.9,620.0,1.3e-162,575.1,sp|Q54BU4|ABCB1_DICDI ABC transporter B family member 1 OS=Dictyostelium discoideum OX=44689 GN=abcB1 PE=3 SV=1,GO:0005524; GO:0006935; GO:0006972; GO:0016020; GO:0016887; GO:0031154; GO:0042626; GO:0055085; GO:0140359,chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085],membrane [GO:0016020],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626],GO:0003824; GO:0005215; GO:0016787; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_06242,0.2625954762948717,OG_06242,FUN_028232-T1,Peve_00018561,Pocillopora_meandrina_HIv1___RNAseq.g15526.t1,three_way,81.03166666666667,FUN_028232-T1,Q96KN3,,,,,45.9,407.0,1.1e-76,289.3,sp|Q96KN3|PKNX2_HUMAN Homeobox protein PKNOX2 OS=Homo sapiens OX=9606 GN=PKNOX2 PE=1 SV=2,,,,,,
OG_01622,0.2624401929669609,OG_01622,FUN_006731-T1,Peve_00039563,Pocillopora_meandrina_HIv1___RNAseq.g20017.t1,three_way,82.17733333333334,FUN_006731-T1,Q7ZVK4,,,,,55.0,387.0,1.3e-112,407.9,sp|Q7ZVK4|VPS36_DANRE Vacuolar protein-sorting-associated protein 36 OS=Danio rerio OX=7955 GN=vps36 PE=2 SV=1,,,,,,
OG_07703,0.2619491470185063,OG_07703,FUN_034837-T1,Peve_00010449,Pocillopora_meandrina_HIv1___RNAseq.g27187.t1,three_way,85.81433333333334,FUN_034837-T1,Q6IWL4,TRAF6_DANRE,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Danio rerio (Zebrafish) (Brachydanio rerio),29.9,157.0,1.4e-08,62.0,sp|Q6IWL4|TRAF6_DANRE TNF receptor-associated factor 6 OS=Danio rerio OX=7955 GN=traf6 PE=1 SV=2,GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0008270; GO:0009615; GO:0009617; GO:0009898; GO:0031663; GO:0035591; GO:0038061; GO:0042981; GO:0043122; GO:0045087; GO:0045893; GO:0061630; GO:0070534; GO:0098978,innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of DNA-templated transcription [GO:0045893]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; response to bacterium [GO:0009617]; response to virus [GO:0009615],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634],signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_04778,0.2619087530221539,OG_04778,FUN_022684-T1,Peve_00019690,Pocillopora_meandrina_HIv1___TS.g22251.t2,three_way,75.05633333333333,FUN_022684-T1,O94880,PHF14_HUMAN,,PHD finger protein 14,Homo sapiens (Human),48.8,291.0,4.8e-73,276.6,sp|O94880|PHF14_HUMAN PHD finger protein 14 OS=Homo sapiens OX=9606 GN=PHF14 PE=1 SV=3,GO:0000122; GO:0000785; GO:0002314; GO:0005634; GO:0005694; GO:0005737; GO:0008270; GO:0008285; GO:0010463; GO:0042393; GO:0048286; GO:0060916; GO:0072201; GO:0140566; GO:2000584; GO:2000791,germinal center B cell differentiation [GO:0002314]; lung alveolus development [GO:0048286]; mesenchymal cell proliferation [GO:0010463]; mesenchymal cell proliferation involved in lung development [GO:0060916]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122],chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634],histone binding [GO:0042393]; histone reader activity [GO:0140566]; zinc ion binding [GO:0008270],GO:0002376; GO:0005634; GO:0005694; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0048856; GO:0060090,immune system process; nucleus; chromosome; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; anatomical structure development; molecular adaptor activity
OG_01630,0.2613155683808695,OG_01630,FUN_006744-T1,Peve_00039581,Pocillopora_meandrina_HIv1___RNAseq.g20530.t1,three_way,63.90916666666666,FUN_006744-T1,Q8BNA6,FAT3_MOUSE,,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Mus musculus (Mouse),33.8,4122.0,0.0,2094.3,sp|Q8BNA6|FAT3_MOUSE Protocadherin Fat 3 OS=Mus musculus OX=10090 GN=Fat3 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:1904936; GO:2000171,cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],dendrite [GO:0030425]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0048856; GO:0048870,plasma membrane; cell adhesion; anatomical structure development; cell motility
OG_00843,0.2609423105558064,OG_00843,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_06899,0.2605141655256605,OG_06899,FUN_031942-T1,Peve_00031841,Pocillopora_meandrina_HIv1___RNAseq.g18206.t1,three_way,81.319,FUN_031942-T1,Q9UKY4,,,,,52.4,687.0,1.1e-208,728.0,sp|Q9UKY4|POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens OX=9606 GN=POMT2 PE=1 SV=2,,,,,,
OG_01593,0.2600403287278718,OG_01593,FUN_006634-T1,Peve_00040843,Pocillopora_meandrina_HIv1___TS.g29546.t1b,three_way,57.3695,FUN_006634-T1,Q9NY47,,,,,30.1,951.0,1.1e-87,326.2,sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2,,,,,,
OG_02454,0.2599794838177204,OG_02454,FUN_009532-T1,Peve_00009560,Pocillopora_meandrina_HIv1___RNAseq.g24493.t1,three_way,88.02533333333334,FUN_009532-T1,Q148N0,,,,,64.9,976.0,0.0,1304.7,sp|Q148N0|ODO1_BOVIN 2-oxoglutarate dehydrogenase complex component E1 OS=Bos taurus OX=9913 GN=OGDH PE=1 SV=1,,,,,,
OG_07727,0.259562746850746,OG_07727,FUN_034888-T1,Peve_00023804,Pocillopora_meandrina_HIv1___RNAseq.g27810.t1,three_way,82.89466666666667,FUN_034888-T1,A7RRG3,AKTIP_NEMVE,,Protein AKTIP homolog (Fused toes protein homolog),Nematostella vectensis (Starlet sea anemone),69.6,306.0,1e-120,434.5,sp|A7RRG3|AKTIP_NEMVE Protein AKTIP homolog OS=Nematostella vectensis OX=45351 GN=v1g232160 PE=3 SV=1,,,,,,
OG_06522,0.2595349401769329,OG_06522,FUN_029339-T1,Peve_00023361,Pocillopora_meandrina_HIv1___RNAseq.g17301.t1,three_way,61.434333333333335,FUN_029339-T1,Q01973,ROR1_HUMAN,,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",Homo sapiens (Human),31.6,773.0,1.1000000000000001e-118,429.1,sp|Q01973|ROR1_HUMAN Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens OX=9606 GN=ROR1 PE=1 SV=2,GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0015026; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092,astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0006355; GO:0016740; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_07121,0.2593640493095915,OG_07121,FUN_032420-T1,Peve_00041753,Pocillopora_meandrina_HIv1___RNAseq.g24395.t1,three_way,71.22583333333333,,,,,,,,,,,,,,,,,
OG_06067,0.2591824333532317,OG_06067,FUN_026913-T1,Peve_00021652,Pocillopora_meandrina_HIv1___TS.g19727.t2,three_way,92.013,FUN_026913-T1,Q5PPI9,TTLL1_RAT,,Polyglutamylase complex subunit TTLL1 (EC 6.3.2.-) (Tubulin polyglutamylase TTLL1) (Tubulin polyglutamylase complex subunit 3) (PGs3) (Tubulin--tyrosine ligase-like protein 1),Rattus norvegicus (Rat),71.4,420.0,5.1e-187,655.2,sp|Q5PPI9|TTLL1_RAT Polyglutamylase complex subunit TTLL1 OS=Rattus norvegicus OX=10116 GN=Ttll1 PE=2 SV=1,GO:0000226; GO:0002395; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0007288; GO:0015631; GO:0021702; GO:0030317; GO:0031514; GO:0035082; GO:0036064; GO:0036211; GO:0046872; GO:0070740; GO:0106438; GO:0120197; GO:0120222,axoneme assembly [GO:0035082]; cerebellar Purkinje cell differentiation [GO:0021702]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; microtubule cytoskeleton organization [GO:0000226]; mucociliary clearance [GO:0120197]; protein modification process [GO:0036211]; regulation of blastocyst development [GO:0120222]; sperm axoneme assembly [GO:0007288],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0002376; GO:0003016; GO:0003824; GO:0005576; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016874; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0140096,"immune system process; respiratory system process; catalytic activity; extracellular region; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; ligase activity; reproductive process; cell differentiation; organelle; cell motility; catalytic activity, acting on a protein"
OG_08402,0.2590618038172563,OG_08402,FUN_037053-T1,Peve_00032337,Pocillopora_meandrina_HIv1___RNAseq.g26788.t1,three_way,70.36133333333333,FUN_037053-T1,O88622,PARG_MOUSE,,Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143),Mus musculus (Mouse),54.2,524.0,3.1000000000000004e-157,557.0,sp|O88622|PARG_MOUSE Poly(ADP-ribose) glycohydrolase OS=Mus musculus OX=10090 GN=Parg PE=1 SV=2,GO:0004649; GO:0005634; GO:0005829; GO:0005975; GO:0006282; GO:0006974; GO:0016045; GO:1990966,ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; detection of bacterium [GO:0016045]; DNA damage response [GO:0006974]; regulation of DNA repair [GO:0006282],cytosol [GO:0005829]; nucleus [GO:0005634],poly(ADP-ribose) glycohydrolase activity [GO:0004649],GO:0003824; GO:0005634; GO:0005829; GO:0005975; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; cytosol; carbohydrate metabolic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09336,0.259013342694829,OG_09336,FUN_040299-T1,Peve_00038649,Pocillopora_meandrina_HIv1___TS.g20792.t1,three_way,42.627833333333335,FUN_040299-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),24.5,4769.0,0.0,1096.6,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_08478,0.2589120788030399,OG_08478,FUN_037305-T1,Peve_00045269,Pocillopora_meandrina_HIv1___RNAseq.g10723.t1,three_way,44.54433333333333,,,,,,,,,,,,,,,,,
OG_00538,0.2589054795965091,OG_00538,FUN_001554-T1,Peve_00027305,Pocillopora_meandrina_HIv1___RNAseq.g2001.t1,three_way,66.06466666666667,FUN_001554-T1,Q924H0,,,,,27.7,303.0,2.2e-23,113.2,sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2,,,,,,
OG_00479,0.2588186610499834,OG_00479,FUN_001418-T1,Peve_00008742,Pocillopora_meandrina_HIv1___RNAseq.g2097.t1,three_way,81.65133333333334,FUN_001418-T1,P32198,CPT1A_RAT,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Rattus norvegicus (Rat),49.2,765.0,3.5e-218,759.6,"sp|P32198|CPT1A_RAT Carnitine O-palmitoyltransferase 1, liver isoform OS=Rattus norvegicus OX=10116 GN=Cpt1a PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0007584; GO:0009410; GO:0009437; GO:0030674; GO:0030855; GO:0031667; GO:0031998; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0046320; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity
OG_09339,0.2582852135621883,OG_09339,FUN_040302-T1,Peve_00038640,Pocillopora_meandrina_HIv1___TS.g20795.t2,three_way,55.475,,,,,,,,,,,,,,,,,
OG_02407,0.258058468727524,OG_02407,FUN_009056-T1,Peve_00032033,Pocillopora_meandrina_HIv1___RNAseq.g14479.t1,three_way,51.15833333333333,,,,,,,,,,,,,,,,,
OG_05316,0.2579802022579636,OG_05316,FUN_024001-T1,Peve_00034187,Pocillopora_meandrina_HIv1___RNAseq.g19350.t1,three_way,77.74116666666666,FUN_024001-T1,P15056,BRAF_HUMAN,,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),Homo sapiens (Human),47.0,743.0,1.8999999999999998e-173,610.9,sp|P15056|BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens OX=9606 GN=BRAF PE=1 SV=4,GO:0000165; GO:0002318; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006468; GO:0007173; GO:0008270; GO:0008542; GO:0009887; GO:0010628; GO:0010764; GO:0010828; GO:0016079; GO:0030878; GO:0033077; GO:0033138; GO:0034446; GO:0034451; GO:0035019; GO:0036064; GO:0042127; GO:0042802; GO:0043005; GO:0043066; GO:0043149; GO:0043231; GO:0043367; GO:0043369; GO:0043524; GO:0044297; GO:0045580; GO:0048538; GO:0048680; GO:0050772; GO:0050852; GO:0051496; GO:0060291; GO:0060323; GO:0060324; GO:0070371; GO:0070374; GO:0071277; GO:0071466; GO:0072577; GO:0090150; GO:0097110; GO:0098793; GO:0098794; GO:0098978; GO:0099170; GO:0106310; GO:1900026; GO:2000301; GO:2000352,"animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; visual learning [GO:0008542]",cell body [GO:0044297]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0007155; GO:0012501; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; cell adhesion; programmed cell death; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_09938,0.2579705276226832,OG_09938,FUN_043098-T1,Peve_00033761,Pocillopora_meandrina_HIv1___RNAseq.g7006.t1,three_way,61.962,FUN_043098-T1,Q08BM0,,,,,41.0,266.0,4.4e-45,184.1,sp|Q08BM0|TM10B_DANRE tRNA methyltransferase 10 homolog B OS=Danio rerio OX=7955 GN=trmt10b PE=2 SV=1,,,,,,
OG_07411,0.2579349529086869,OG_07411,FUN_033864-T1,Peve_00043326,Pocillopora_meandrina_HIv1___RNAseq.g28413.t1,three_way,80.2635,FUN_033864-T1,Q86YS7,C2CD5_HUMAN,,C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa),Homo sapiens (Human),45.1,1041.0,6.3e-250,865.5,sp|Q86YS7|C2CD5_HUMAN C2 domain-containing protein 5 OS=Homo sapiens OX=9606 GN=C2CD5 PE=1 SV=1,GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0008286; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0034451; GO:0065002; GO:0072659; GO:0090314,insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659],cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544],GO:0005829; GO:0005886; GO:0006886; GO:0008289; GO:0055085; GO:0072659,cytosol; plasma membrane; intracellular protein transport; lipid binding; transmembrane transport; protein localization to plasma membrane
OG_06071,0.2578360417601293,OG_06071,FUN_026976-T1,Peve_00013247,Pocillopora_meandrina_HIv1___TS.g17924.t2,three_way,66.8675,FUN_026976-T1,Q9NZ56,FMN2_HUMAN,,Formin-2,Homo sapiens (Human),40.8,449.0,2e-89,331.6,sp|Q9NZ56|FMN2_HUMAN Formin-2 OS=Homo sapiens OX=9606 GN=FMN2 PE=1 SV=4,GO:0003779; GO:0005634; GO:0005730; GO:0005783; GO:0005789; GO:0005819; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0015031; GO:0015629; GO:0016192; GO:0016477; GO:0030036; GO:0030659; GO:0035556; GO:0040038; GO:0042177; GO:0043066; GO:0046907; GO:0048471; GO:0048477; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781,actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0005730; GO:0005783; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0022414; GO:0043226; GO:0048856; GO:0048870,cytokinesis; nucleus; nucleolus; endoplasmic reticulum; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; reproductive process; organelle; anatomical structure development; cell motility
OG_09267,0.257741107230594,OG_09267,FUN_040072-T1,Peve_00021005,Pocillopora_meandrina_HIv1___RNAseq.g7692.t2,three_way,86.87233333333333,FUN_040072-T1,Q6PB70,,,,,38.3,838.0,5e-155,549.7,sp|Q6PB70|ANO8_MOUSE Anoctamin-8 OS=Mus musculus OX=10090 GN=Ano8 PE=1 SV=3,,,,,,
OG_09906,0.2577095758569076,OG_09906,FUN_043003-T1,Peve_00017777,Pocillopora_meandrina_HIv1___RNAseq.g7027.t1,three_way,86.71766666666667,FUN_043003-T1,Q66L49,SCMC1_DANRE,,Mitochondrial adenyl nucleotide antiporter SLC25A24 (Small calcium-binding mitochondrial carrier protein 1) (SCaMC-1) (Solute carrier family 25 member 24),Danio rerio (Zebrafish) (Brachydanio rerio),54.6,467.0,1e-146,521.5,sp|Q66L49|SCMC1_DANRE Mitochondrial adenyl nucleotide antiporter SLC25A24 OS=Danio rerio OX=7955 GN=slc25a24 PE=2 SV=1,GO:0000295; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0015866; GO:0015867; GO:0016020; GO:0051503; GO:0071277; GO:0140987; GO:0140988; GO:1990544,adenine nucleotide transport [GO:0051503]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; mitochondrial ATP transmembrane transport [GO:1990544],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP:phosphate antiporter activity [GO:0140988]; ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_03129,0.2576731218298787,OG_03129,FUN_012488-T1,Peve_00010911,Pocillopora_meandrina_HIv1___RNAseq.g24002.t1,three_way,66.74766666666667,FUN_012488-T1,Q2T9Y1,,,,,38.2,288.0,2e-35,151.0,sp|Q2T9Y1|CC026_BOVIN Uncharacterized protein C3orf26 homolog OS=Bos taurus OX=9913 PE=2 SV=1,,,,,,
OG_07710,0.257602070569655,OG_07710,FUN_034856-T1,Peve_00008083,Pocillopora_meandrina_HIv1___TS.g3494.t2,three_way,93.22233333333334,FUN_034856-T1,Q6DJE4,CPSF5_XENLA,,Cleavage and polyadenylation specificity factor subunit 5 (Nudix hydrolase 21),Xenopus laevis (African clawed frog),83.1,195.0,4e-94,345.5,sp|Q6DJE4|CPSF5_XENLA Cleavage and polyadenylation specificity factor subunit 5 OS=Xenopus laevis OX=8355 GN=nudt21 PE=2 SV=1,GO:0003729; GO:0005634; GO:0005737; GO:0005849; GO:0006397; GO:0010608; GO:0030154; GO:0031124; GO:0035925; GO:0042382; GO:0042802; GO:0051290; GO:0110104; GO:0180010; GO:2000738; GO:2000975,"cell differentiation [GO:0030154]; co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; post-transcriptional regulation of gene expression [GO:0010608]; protein heterotetramerization [GO:0051290]",cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382],identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729],GO:0003723; GO:0005634; GO:0016071; GO:0030154; GO:0043226; GO:0065003,RNA binding; nucleus; mRNA metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_03236,0.2574287695897801,OG_03236,FUN_012786-T1,Peve_00018304,Pocillopora_meandrina_HIv1___RNAseq.g12888.t1,three_way,86.545,FUN_012786-T1,Q6IWH7,ANO7_HUMAN,,Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G),Homo sapiens (Human),45.7,879.0,2.2e-213,743.8,sp|Q6IWH7|ANO7_HUMAN Anoctamin-7 OS=Homo sapiens OX=9606 GN=ANO7 PE=1 SV=2,GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0034220; GO:0046983; GO:0061588; GO:0070161; GO:1902476,calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220],anchoring junction [GO:0070161]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; organelle; transmembrane transport; membrane organization
OG_07183,0.2574155849502468,OG_07183,FUN_032641-T1,Peve_00015953,Pocillopora_meandrina_HIv1___RNAseq.g24113.t1,three_way,69.64766666666667,FUN_032641-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),31.4,2239.0,9.5e-255,882.9,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_00999,0.2573899206573234,OG_00999,FUN_004409-T1,Peve_00024220,Pocillopora_meandrina_HIv1___TS.g8710.t1,three_way,72.84100000000001,FUN_004409-T1,Q92889,,,,,53.6,928.0,4.8000000000000004e-267,922.2,sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3,,,,,,
OG_04334,0.2573480712783728,OG_04334,FUN_017946-T1,Peve_00001582,Pocillopora_meandrina_HIv1___TS.g6988.t2,three_way,85.60566666666666,FUN_017946-T1,A7SGZ5,,,,,70.4,216.0,1.4e-84,313.9,sp|A7SGZ5|EIF3K_NEMVE Eukaryotic translation initiation factor 3 subunit K OS=Nematostella vectensis OX=45351 GN=v1g170558 PE=3 SV=1,,,,,,
OG_04568,0.2570772199789584,OG_04568,FUN_022212-T1,Peve_00008597,Pocillopora_meandrina_HIv1___RNAseq.g4763.t1,three_way,72.44316666666667,FUN_022212-T1,Q14554,PDIA5_HUMAN,,Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein),Homo sapiens (Human),38.8,405.0,1.2e-71,272.7,sp|Q14554|PDIA5_HUMAN Protein disulfide-isomerase A5 OS=Homo sapiens OX=9606 GN=PDIA5 PE=1 SV=1,GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0015035; GO:0016491; GO:0022900,electron transport chain [GO:0022900]; protein folding [GO:0006457],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],oxidoreductase activity [GO:0016491]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],GO:0003824; GO:0005783; GO:0006091; GO:0006457; GO:0016491; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; generation of precursor metabolites and energy; protein folding; oxidoreductase activity; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_00236,0.256655587613578,OG_00236,FUN_000990-T1,Peve_00022152,Pocillopora_meandrina_HIv1___RNAseq.g29207.t1,three_way,69.63933333333333,,,,,,,,,,,,,,,,,
OG_02580,0.256336020223103,OG_02580,FUN_010696-T1,Peve_00040382,Pocillopora_meandrina_HIv1___RNAseq.g6938.t1,three_way,55.94833333333333,FUN_010696-T1,F4JTS8,NOV_ARATH,,Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597),Arabidopsis thaliana (Mouse-ear cress),26.4,2000.0,7.3e-152,541.2,sp|F4JTS8|NOV_ARATH Protein NO VEIN OS=Arabidopsis thaliana OX=3702 GN=NOV PE=1 SV=1,GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364,auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827],nucleus [GO:0005634],,GO:0005634; GO:0022414; GO:0043226; GO:0048856,nucleus; reproductive process; organelle; anatomical structure development
OG_06585,0.2560085130973173,OG_06585,FUN_029557-T1,Peve_00044890,Pocillopora_meandrina_HIv1___RNAseq.g17260.t1,three_way,94.77716666666667,FUN_029557-T1,Q8BFY9,,,,,75.1,897.0,0.0,1327.4,sp|Q8BFY9|TNPO1_MOUSE Transportin-1 OS=Mus musculus OX=10090 GN=Tnpo1 PE=1 SV=2,,,,,,
OG_08930,0.2560013455039517,OG_08930,FUN_038392-T1,Peve_00000048,Pocillopora_meandrina_HIv1___RNAseq.g28264.t1,three_way,76.04899999999999,FUN_038392-T1,P16065,,,,,36.6,998.0,4.3999999999999996e-160,567.0,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_04299,0.2554210025697003,OG_04299,FUN_017868-T1,Peve_00020409,Pocillopora_meandrina_HIv1___RNAseq.g9556.t1,three_way,92.76516666666666,FUN_017868-T1,Q6DKN2,,,,,73.3,86.0,6.7e-28,125.6,sp|Q6DKN2|OTX2B_XENLA Homeobox protein OTX2-B OS=Xenopus laevis OX=8355 GN=otx2-b PE=2 SV=1,,,,,,
OG_09369,0.2553790364931214,OG_09369,FUN_040493-T1,Peve_00015398,Pocillopora_meandrina_HIv1___RNAseq.g6529.t1,three_way,81.2965,FUN_040493-T1,Q69ZF3,GBA2_MOUSE,,Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase) (EC 3.2.1.46) (Non-lysosomal glycosylceramidase),Mus musculus (Mouse),52.7,827.0,2.4e-249,863.2,sp|Q69ZF3|GBA2_MOUSE Non-lysosomal glucosylceramidase OS=Mus musculus OX=10090 GN=Gba2 PE=1 SV=2,GO:0000139; GO:0004336; GO:0004348; GO:0005789; GO:0005829; GO:0005975; GO:0006680; GO:0008203; GO:0008422; GO:0016139; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0046527; GO:0050295; GO:0097035,carbohydrate metabolic process [GO:0005975]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295],GO:0003824; GO:0005829; GO:0005975; GO:0006629; GO:0016740; GO:0016787; GO:0048856; GO:0061024; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; lipid metabolic process; transferase activity; hydrolase activity; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_10182,0.2551458131126686,OG_10182,FUN_043597-T1,Peve_00007614,Pocillopora_meandrina_HIv1___RNAseq.g6953.t1,three_way,44.255,FUN_043597-T1,Q80T79,CSMD3_MOUSE,,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),Mus musculus (Mouse),31.6,730.0,4.6e-97,357.5,sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3,GO:0005886; GO:0050773,regulation of dendrite development [GO:0050773],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_00073,0.2550173596090658,OG_00073,FUN_000397-T1,Peve_00033585,Pocillopora_meandrina_HIv1___RNAseq.g2533.t1a,three_way,50.99,FUN_000397-T1,Q9H792,PEAK1_HUMAN,,Inactive tyrosine-protein kinase PEAK1 (Pseudopodium-enriched atypical kinase 1) (Sugen kinase 269) (Tyrosine-protein kinase SgK269),Homo sapiens (Human),25.8,512.0,3.1e-32,142.9,sp|Q9H792|PEAK1_HUMAN Inactive tyrosine-protein kinase PEAK1 OS=Homo sapiens OX=9606 GN=PEAK1 PE=1 SV=4,GO:0004672; GO:0004715; GO:0005829; GO:0005925; GO:0015629; GO:0016477; GO:0034446; GO:0042802; GO:0046777; GO:0048041; GO:0051893; GO:2000145,cell migration [GO:0016477]; focal adhesion assembly [GO:0048041]; protein autophosphorylation [GO:0046777]; regulation of cell motility [GO:2000145]; regulation of focal adhesion assembly [GO:0051893]; substrate adhesion-dependent cell spreading [GO:0034446],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925],identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672],GO:0003824; GO:0005829; GO:0005856; GO:0007155; GO:0016740; GO:0034330; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; cytosol; cytoskeleton; cell adhesion; transferase activity; cell junction organization; organelle; cell motility; catalytic activity, acting on a protein"
OG_03284,0.2546542124132339,OG_03284,FUN_013321-T1,Peve_00022436,Pocillopora_meandrina_HIv1___RNAseq.g12987.t1,three_way,43.632333333333335,,,,,,,,,,,,,,,,,
OG_03643,0.2544629964640492,OG_03643,FUN_014871-T1,Peve_00012980,Pocillopora_meandrina_HIv1___RNAseq.g21043.t2a,three_way,72.989,FUN_014871-T1,Q05B54,,,,,27.7,213.0,3.2e-12,73.6,sp|Q05B54|TM134_BOVIN Transmembrane protein 134 OS=Bos taurus OX=9913 GN=TMEM134 PE=2 SV=2,,,,,,
OG_05173,0.2544265704506258,OG_05173,FUN_023501-T1,Peve_00017454,Pocillopora_meandrina_HIv1___RNAseq.g534.t1,three_way,56.98533333333334,,,,,,,,,,,,,,,,,
OG_04101,0.2542901334582102,OG_04101,FUN_016452-T1,Peve_00016427,Pocillopora_meandrina_HIv1___RNAseq.g9832.t1,three_way,79.55466666666666,FUN_016452-T1,Q8TD10,MIPO1_HUMAN,,Mirror-image polydactyly gene 1 protein,Homo sapiens (Human),26.7,322.0,5.4e-17,90.5,sp|Q8TD10|MIPO1_HUMAN Mirror-image polydactyly gene 1 protein OS=Homo sapiens OX=9606 GN=MIPOL1 PE=1 SV=1,GO:0005634; GO:0042802,,nucleus [GO:0005634],identical protein binding [GO:0042802],GO:0005634; GO:0043226,nucleus; organelle
OG_04735,0.2539793606982026,OG_04735,FUN_022604-T1,Peve_00012247,Pocillopora_meandrina_HIv1___RNAseq.g4419.t1,three_way,56.8415,FUN_022604-T1,Q8VCH8,,,,,36.6,514.0,1.1e-42,176.0,sp|Q8VCH8|UBXN4_MOUSE UBX domain-containing protein 4 OS=Mus musculus OX=10090 GN=Ubxn4 PE=1 SV=1,,,,,,
OG_08326,0.2539787717125745,OG_08326,FUN_036756-T1,Peve_00001059,Pocillopora_meandrina_HIv1___RNAseq.g27066.t1,three_way,84.369,FUN_036756-T1,Q08CH8,,,,,50.0,340.0,3.7e-95,349.7,sp|Q08CH8|ZTRF1_DANRE Zinc finger TRAF-type-containing protein 1 OS=Danio rerio OX=7955 GN=zftraf1 PE=2 SV=2,,,,,,
OG_01476,0.2538592279403863,OG_01476,FUN_006039-T1,Peve_00040858,Pocillopora_meandrina_HIv1___RNAseq.g20511.t1,three_way,58.39266666666667,FUN_006039-T1,Q5F457,,,,,34.4,209.0,2.5e-24,114.4,sp|Q5F457|WBP4_CHICK WW domain-binding protein 4 OS=Gallus gallus OX=9031 GN=WBP4 PE=2 SV=1,,,,,,
OG_02707,0.2536781126058571,OG_02707,FUN_010984-T1,Peve_00013386,Pocillopora_meandrina_HIv1___RNAseq.g22009.t1,three_way,79.6975,FUN_010984-T1,Q7Z3V4,UBE3B_HUMAN,,Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B),Homo sapiens (Human),50.4,1075.0,3.1e-310,1065.8,sp|Q7Z3V4|UBE3B_HUMAN Ubiquitin-protein ligase E3B OS=Homo sapiens OX=9606 GN=UBE3B PE=1 SV=3,GO:0000209; GO:0005739; GO:0006511; GO:0014069; GO:0061630; GO:0098978; GO:0150052,protein polyubiquitination [GO:0000209]; regulation of postsynapse assembly [GO:0150052]; ubiquitin-dependent protein catabolic process [GO:0006511],glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; postsynaptic density [GO:0014069],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00356,0.2536708441351376,OG_00356,FUN_001188-T1,Peve_00009673,Pocillopora_meandrina_HIv1___TS.g6724.t2,three_way,43.03966666666667,,,,,,,,,,,,,,,,,
OG_07586,0.2535384158301623,OG_07586,FUN_034282-T1,Peve_00013944,Pocillopora_meandrina_HIv1___RNAseq.g28519.t1,three_way,57.317,,,,,,,,,,,,,,,,,
OG_01533,0.253151576703053,OG_01533,FUN_006336-T1,Peve_00026066,Pocillopora_meandrina_HIv1___TS.g29722.t1,three_way,94.48533333333332,FUN_006336-T1,Q3ZC01,CNOT7_BOVIN,,CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1),Bos taurus (Bovine),73.1,208.0,6.8000000000000015e-87,321.6,sp|Q3ZC01|CNOT7_BOVIN CCR4-NOT transcription complex subunit 7 OS=Bos taurus OX=9913 GN=CNOT7 PE=2 SV=1,GO:0000175; GO:0000288; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0004532; GO:0004535; GO:0006417; GO:0008284; GO:0008285; GO:0016607; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0034584; GO:0035279; GO:0045070; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0140297; GO:0140991; GO:1900153,"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]",CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nuclear speck [GO:0016607]; P-body [GO:0000932],3'-5'-RNA exonuclease activity [GO:0000175]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA exonuclease activity [GO:0004532]; transcription corepressor activity [GO:0003714],GO:0003723; GO:0003824; GO:0006355; GO:0016071; GO:0016787; GO:0031047; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_07534,0.2528388613549949,OG_07534,FUN_034110-T1,Peve_00034861,Pocillopora_meandrina_HIv1___RNAseq.g25961.t1,three_way,65.22083333333333,,,,,,,,,,,,,,,,,
OG_09247,0.25254243853498,OG_09247,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08945,0.2525191155883034,OG_08945,FUN_038418-T1,Peve_00000006,Pocillopora_meandrina_HIv1___RNAseq.g1186.t1,three_way,79.584,FUN_038418-T1,P17844,DDX5_HUMAN,,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),Homo sapiens (Human),68.1,470.0,2.1999999999999997e-192,673.7,sp|P17844|DDX5_HUMAN Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens OX=9606 GN=DDX5 PE=1 SV=1,GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003729; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0009299; GO:0016020; GO:0016607; GO:0016887; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0031053; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0046332; GO:0048306; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1990841; GO:1990904; GO:2001014,"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; primary miRNA processing [GO:0031053]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01740,0.2523345131739798,OG_01740,FUN_007062-T1,Peve_00025326,Pocillopora_meandrina_HIv1___RNAseq.g20109.t1,three_way,70.79983333333334,FUN_007062-T1,Q8IX03,KIBRA_HUMAN,,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),Homo sapiens (Human),29.0,1136.0,8.3e-51,204.1,sp|Q8IX03|KIBRA_HUMAN Protein KIBRA OS=Homo sapiens OX=9606 GN=WWC1 PE=1 SV=1,GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0035329; GO:0035330; GO:0035331; GO:0035591; GO:0043410; GO:0046621; GO:0048471; GO:0060090,cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587],kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0007163; GO:0043226; GO:0048870; GO:0060090; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_08665,0.2522425676443805,OG_08665,FUN_037899-T1,Peve_00028724,Pocillopora_meandrina_HIv1___RNAseq.g28680.t1,three_way,74.81033333333333,FUN_037899-T1,F5H4B4,,,,,26.1,502.0,3.7e-37,157.9,sp|F5H4B4|F227A_HUMAN Protein FAM227A OS=Homo sapiens OX=9606 GN=FAM227A PE=1 SV=1,,,,,,
OG_00566,0.2521971890934951,OG_00566,FUN_001622-T1,Peve_00012530,Pocillopora_meandrina_HIv1___TS.g4457.t1,three_way,69.43533333333333,FUN_001622-T1,Q9EPK6,SIL1_MOUSE,,Nucleotide exchange factor SIL1,Mus musculus (Mouse),37.6,457.0,7.6e-72,272.7,sp|Q9EPK6|SIL1_MOUSE Nucleotide exchange factor SIL1 OS=Mus musculus OX=10090 GN=Sil1 PE=1 SV=2,GO:0000774; GO:0005783; GO:0005788; GO:0015031; GO:0042802,protein transport [GO:0015031],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802],GO:0005783; GO:0043226; GO:0098772,endoplasmic reticulum; organelle; molecular function regulator activity
OG_03272,0.2519789703656612,OG_03272,FUN_013145-T1,Peve_00027383,Pocillopora_meandrina_HIv1___RNAseq.g13822.t1,three_way,65.41383333333333,FUN_013145-T1,Q01780,EXOSX_HUMAN,,Exosome complex component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2),Homo sapiens (Human),45.4,707.0,2.4e-159,564.3,sp|Q01780|EXOSX_HUMAN Exosome complex component 10 OS=Homo sapiens OX=9606 GN=EXOSC10 PE=1 SV=2,GO:0000166; GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000791; GO:0000956; GO:0003723; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0032040; GO:0032211; GO:0042274; GO:0046872; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071051; GO:0101019; GO:1904872; GO:1905746,"CUT catabolic process [GO:0071034]; DNA repair [GO:0006281]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; ribosomal small subunit biogenesis [GO:0042274]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]",cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006399; GO:0016071; GO:0016073; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; tRNA metabolic process; mRNA metabolic process; snRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_00202,0.2519510938720041,OG_00202,FUN_000916-T1,Peve_00044970,Pocillopora_meandrina_HIv1___TS.g6672.t1,three_way,89.06833333333333,FUN_000916-T1,Q9R0N7,SYT7_MOUSE,,Synaptotagmin-7 (Synaptotagmin VII) (SytVII),Mus musculus (Mouse),54.8,270.0,1.4e-85,318.2,sp|Q9R0N7|SYT7_MOUSE Synaptotagmin-7 OS=Mus musculus OX=10090 GN=Syt7 PE=1 SV=1,GO:0000149; GO:0001778; GO:0001786; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0006909; GO:0008021; GO:0014059; GO:0017158; GO:0030425; GO:0030670; GO:0030672; GO:0032009; GO:0036465; GO:0042734; GO:0043025; GO:0043679; GO:0046850; GO:0046872; GO:0048791; GO:0050764; GO:0050796; GO:0070092; GO:0090119; GO:0090385; GO:0098978; GO:0098982; GO:0099502; GO:1990926; GO:1990927,calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119],axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; early phagosome [GO:0032009]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],"calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]",GO:0005764; GO:0005773; GO:0005777; GO:0005829; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,lysosome; vacuole; peroxisome; cytosol; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_04262,0.2519463246529688,OG_04262,FUN_017808-T1,Peve_00023910,Pocillopora_meandrina_HIv1___RNAseq.g9554.t1,three_way,86.70083333333334,FUN_017808-T1,Q8WUB8,,,,,40.8,473.0,2.2e-89,331.3,sp|Q8WUB8|PHF10_HUMAN PHD finger protein 10 OS=Homo sapiens OX=9606 GN=PHF10 PE=1 SV=3,,,,,,
OG_09146,0.2515730792663204,OG_09146,FUN_039798-T1,Peve_00017577,Pocillopora_meandrina_HIv1___RNAseq.g7474.t1,three_way,69.27600000000001,,,,,,,,,,,,,,,,,
OG_04295,0.2514452542269084,OG_04295,FUN_017861-T1,Peve_00016056,Pocillopora_meandrina_HIv1___RNAseq.g9572.t1,three_way,71.73,FUN_017861-T1,Q803R5,,,,,50.6,778.0,7.900000000000001e-224,778.5,sp|Q803R5|CMTR1_DANRE Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 OS=Danio rerio OX=7955 GN=cmtr1 PE=2 SV=1,,,,,,
OG_09118,0.2510578639009339,OG_09118,FUN_039264-T1,Peve_00019986,Pocillopora_meandrina_HIv1___RNAseq.g13571.t1,three_way,41.18666666666667,,,,,,,,,,,,,,,,,
OG_04388,0.2510491577890876,OG_04388,FUN_018139-T1,Peve_00020505,Pocillopora_meandrina_HIv1___RNAseq.g25311.t1,three_way,78.628,FUN_018139-T1,O88597,BECN1_MOUSE,,Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) [Cleaved into: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa],Mus musculus (Mouse),66.1,348.0,2.6e-72,273.9,sp|O88597|BECN1_MOUSE Beclin-1 OS=Mus musculus OX=10090 GN=Becn1 PE=1 SV=3,GO:0000045; GO:0000423; GO:0001525; GO:0001666; GO:0002753; GO:0005737; GO:0005776; GO:0005789; GO:0005802; GO:0005829; GO:0005856; GO:0006622; GO:0006914; GO:0006915; GO:0007040; GO:0007080; GO:0007254; GO:0007623; GO:0008285; GO:0009410; GO:0010008; GO:0010040; GO:0010288; GO:0010506; GO:0010507; GO:0010508; GO:0010613; GO:0016020; GO:0016236; GO:0016241; GO:0016604; GO:0019901; GO:0030425; GO:0030674; GO:0031410; GO:0031625; GO:0032465; GO:0032473; GO:0032801; GO:0032991; GO:0033197; GO:0034198; GO:0035032; GO:0036092; GO:0038066; GO:0042149; GO:0042802; GO:0043066; GO:0043069; GO:0043548; GO:0043652; GO:0045022; GO:0045335; GO:0048666; GO:0050435; GO:0051020; GO:0051301; GO:0051607; GO:0051707; GO:0060395; GO:0062029; GO:0065003; GO:0070301; GO:0071275; GO:0071280; GO:0071364; GO:0090650; GO:0097352; GO:0098780; GO:1902425; GO:1902902; GO:1905672; GO:2000786; GO:2001244,amyloid-beta metabolic process [GO:0050435]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular response to aluminum ion [GO:0071275]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian rhythm [GO:0007623]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; engulfment of apoptotic cell [GO:0043652]; JNK cascade [GO:0007254]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of lysosome organization [GO:1905672]; negative regulation of programmed cell death [GO:0043069]; neuron development [GO:0048666]; p38MAPK cascade [GO:0038066]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of stress granule assembly [GO:0062029]; protein targeting to lysosome [GO:0006622]; protein-containing complex assembly [GO:0065003]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to mitochondrial depolarisation [GO:0098780]; response to other organism [GO:0051707]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; SMAD protein signal transduction [GO:0060395],"autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; membrane [GO:0016020]; nuclear body [GO:0016604]; phagocytic vesicle [GO:0045335]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]",GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625],GO:0002376; GO:0005773; GO:0005829; GO:0005856; GO:0006629; GO:0006886; GO:0006914; GO:0007040; GO:0012501; GO:0016192; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003,immune system process; vacuole; cytosol; cytoskeleton; lipid metabolic process; intracellular protein transport; autophagy; lysosome organization; programmed cell death; vesicle-mediated transport; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly
OG_04478,0.2507930638223187,OG_04478,FUN_021108-T1,Peve_00008861,Pocillopora_meandrina_HIv1___RNAseq.g4371.t1,three_way,84.41233333333334,FUN_021108-T1,Q15119,PDK2_HUMAN,,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)",Homo sapiens (Human),50.9,385.0,7.8e-108,392.1,"sp|Q15119|PDK2_HUMAN [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial OS=Homo sapiens OX=9606 GN=PDK2 PE=1 SV=2",GO:0004672; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0045254; GO:0050848; GO:0072332,cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of ketone metabolic process [GO:0010565]; regulation of pH [GO:0006885],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254],ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0005975; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; mitochondrion; cytosol; carbohydrate metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04426,0.2503416511429041,OG_04426,FUN_018540-T1,Peve_00006702,Pocillopora_meandrina_HIv1___RNAseq.g9993.t1,three_way,69.65,FUN_018540-T1,O57460,TLL1_DANRE,,Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein),Danio rerio (Zebrafish) (Brachydanio rerio),37.6,109.0,4.2e-11,71.6,sp|O57460|TLL1_DANRE Dorsal-ventral patterning tolloid-like protein 1 OS=Danio rerio OX=7955 GN=tll1 PE=2 SV=1,GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264,blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular region [GO:0005576]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_04955,0.2499915033366253,OG_04955,FUN_023045-T1,Peve_00008511,Pocillopora_meandrina_HIv1___TS.g10042.t2c,three_way,82.148,FUN_023045-T1,P45954,ACDSB_HUMAN,,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)",Homo sapiens (Human),63.8,376.0,7.7e-143,508.4,"sp|P45954|ACDSB_HUMAN Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADSB PE=1 SV=1",GO:0003853; GO:0003995; GO:0005739; GO:0005759; GO:0006550; GO:0006631; GO:0016937; GO:0042802; GO:0050660,fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; short-chain 2-methyl fatty acyl-CoA dehydrogenase activity [GO:0003853]; short-chain fatty acyl-CoA dehydrogenase activity [GO:0016937],GO:0003824; GO:0005739; GO:0006520; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; lipid metabolic process; oxidoreductase activity; organelle
OG_09963,0.2499328736966456,OG_09963,FUN_043144-T1,Peve_00034957,Pocillopora_meandrina_HIv1___RNAseq.g6886.t1,three_way,84.25150000000001,FUN_043144-T1,Q26481,,,,,73.1,279.0,2e-116,420.2,sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3,,,,,,
OG_03669,0.2498538775719344,OG_03669,FUN_014909-T1,Peve_00003534,Pocillopora_meandrina_HIv1___RNAseq.g21074.t1,three_way,64.27283333333332,,,,,,,,,,,,,,,,,
OG_08909,0.2496286400180407,OG_08909,FUN_038340-T1,Peve_00000096,Pocillopora_meandrina_HIv1___RNAseq.g1108.t1,three_way,79.30233333333334,FUN_038340-T1,Q17770,,,,,56.6,431.0,9.2e-145,515.0,sp|Q17770|PDI2_CAEEL Protein disulfide-isomerase 2 OS=Caenorhabditis elegans OX=6239 GN=pdi-2 PE=1 SV=1,,,,,,
OG_01875,0.2495074214321865,OG_01875,FUN_007848-T1,Peve_00039903,Pocillopora_meandrina_HIv1___RNAseq.g18285.t1,three_way,77.36716666666668,FUN_007848-T1,B1ANS9,,,,,38.4,690.0,2.5999999999999997e-135,485.0,sp|B1ANS9|WDR64_HUMAN WD repeat-containing protein 64 OS=Homo sapiens OX=9606 GN=WDR64 PE=1 SV=1,,,,,,
OG_02890,0.2494218170782984,OG_02890,FUN_011945-T1,Peve_00016921,Pocillopora_meandrina_HIv1___RNAseq.g9189.t2,three_way,87.27733333333333,FUN_011945-T1,Q9YH18,,,,,42.9,324.0,4.7e-59,229.6,sp|Q9YH18|QKI_CHICK KH domain-containing RNA-binding protein QKI OS=Gallus gallus OX=9031 GN=QKI PE=2 SV=2,,,,,,
OG_05049,0.2493288074871836,OG_05049,FUN_023239-T1,Peve_00029850,Pocillopora_meandrina_HIv1___RNAseq.g17390.t1,three_way,93.638,FUN_023239-T1,Q6DCT2,,,,,58.7,688.0,2e-218,760.4,sp|Q6DCT2|ARMD3_XENLA Armadillo-like helical domain-containing protein 3 OS=Xenopus laevis OX=8355 GN=armh3 PE=2 SV=2,,,,,,
OG_01161,0.2490262236451531,OG_01161,FUN_004780-T1,Peve_00037744,Pocillopora_meandrina_HIv1___RNAseq.g6689.t1,three_way,84.39833333333334,FUN_004780-T1,Q6P3J5,EF2_DANRE,,Elongation factor 2b (EF-2) (EC 3.6.5.-),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,858.0,0.0,1342.8,sp|Q6P3J5|EF2_DANRE Elongation factor 2b OS=Danio rerio OX=7955 GN=eef2b PE=1 SV=1,GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0006414; GO:0043009; GO:0043022; GO:0071466; GO:1990904,cellular response to xenobiotic stimulus [GO:0071466]; chordate embryonic development [GO:0043009]; translational elongation [GO:0006414],cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development
OG_07698,0.2489176818856246,OG_07698,FUN_034832-T1,Peve_00006740,Pocillopora_meandrina_HIv1___TS.g14528.t1,three_way,88.521,FUN_034832-T1,O35242,,,,,46.1,921.0,1.3e-227,791.2,sp|O35242|FAN_MOUSE Protein FAN OS=Mus musculus OX=10090 GN=Nsmaf PE=1 SV=2,,,,,,
OG_06517,0.2489093630355523,OG_06517,FUN_029319-T1,Peve_00038249,Pocillopora_meandrina_HIv1___RNAseq.g11687.t1,three_way,77.53966666666666,FUN_029319-T1,Q8AVP1,,,,,58.6,297.0,7.8e-97,355.1,sp|Q8AVP1|RPF1_XENLA Ribosome production factor 1 OS=Xenopus laevis OX=8355 GN=rpf1 PE=2 SV=1,,,,,,
OG_08761,0.2487603958602297,OG_08761,FUN_038034-T1,Peve_00016941,Pocillopora_meandrina_HIv1___RNAseq.g26545.t1,three_way,84.4425,FUN_038034-T1,O55173,PDPK1_RAT,,3-phosphoinositide-dependent protein kinase 1 (EC 2.7.11.1) (Protein kinase B kinase) (PkB kinase),Rattus norvegicus (Rat),63.1,474.0,4.8e-168,592.4,sp|O55173|PDPK1_RAT 3-phosphoinositide-dependent protein kinase 1 OS=Rattus norvegicus OX=10116 GN=Pdpk1 PE=1 SV=2,GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005925; GO:0006972; GO:0007173; GO:0008286; GO:0010594; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0019722; GO:0019901; GO:0030512; GO:0031410; GO:0032869; GO:0034122; GO:0035556; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043491; GO:0043524; GO:0043536; GO:0045766; GO:0048009; GO:0048041; GO:0051281; GO:0051897; GO:0071364; GO:0097191; GO:0106310; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352,calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of endothelial cell migration [GO:0010594]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005886; GO:0016740; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0098772; GO:0140096,"catalytic activity; nucleus; plasma membrane; transferase activity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03415,0.2487412807618242,OG_03415,FUN_014463-T1,Peve_00034300,Pocillopora_meandrina_HIv1___RNAseq.g22648.t1,three_way,67.13816666666666,FUN_014463-T1,O75976,,,,,41.7,1280.0,2.4e-275,950.7,sp|O75976|CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2,,,,,,
OG_03308,0.2487309065712397,OG_03308,FUN_013381-T1,Peve_00015988,Pocillopora_meandrina_HIv1___RNAseq.g22983.t2b,three_way,81.351,FUN_013381-T1,Q4FZX7,,,,,53.0,183.0,8.099999999999997e-41,168.3,sp|Q4FZX7|SRPRB_RAT Signal recognition particle receptor subunit beta OS=Rattus norvegicus OX=10116 GN=Srprb PE=2 SV=1,,,,,,
OG_03424,0.2486476642291512,OG_03424,FUN_014478-T1,Peve_00037305,Pocillopora_meandrina_HIv1___RNAseq.g22816.t2,three_way,65.88550000000001,,,,,,,,,,,,,,,,,
OG_07351,0.2486288310574951,OG_07351,FUN_033759-T1,Peve_00009253,Pocillopora_meandrina_HIv1___RNAseq.g28744.t1,three_way,61.443,FUN_033759-T1,Q28005,LSHR_BOVIN,,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Bos taurus (Bovine),36.1,498.0,3.2000000000000003e-80,301.6,sp|Q28005|LSHR_BOVIN Lutropin-choriogonadotropic hormone receptor OS=Bos taurus OX=9913 GN=LHCGR PE=2 SV=1,GO:0001541; GO:0004964; GO:0005886; GO:0007189; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_02646,0.2484415882120679,OG_02646,FUN_010827-T1,Peve_00006524,Pocillopora_meandrina_HIv1___RNAseq.g20910.t1,three_way,77.81533333333333,FUN_010827-T1,Q80UK8,,,,,45.5,1277.0,4.8e-286,985.7,sp|Q80UK8|INT2_MOUSE Integrator complex subunit 2 OS=Mus musculus OX=10090 GN=Ints2 PE=1 SV=2,,,,,,
OG_04298,0.2483776362322027,OG_04298,FUN_017867-T1,Peve_00020408,Pocillopora_meandrina_HIv1___RNAseq.g9557.t1,three_way,69.84466666666667,FUN_017867-T1,P80205,OTX1_MOUSE,,Homeobox protein OTX1 (Orthodenticle homolog 1),Mus musculus (Mouse),68.5,89.0,1.4e-26,121.3,sp|P80205|OTX1_MOUSE Homeobox protein OTX1 OS=Mus musculus OX=10090 GN=Otx1 PE=2 SV=1,GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0009952; GO:0022037; GO:0030900; GO:0030901; GO:0042472; GO:0048852,anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; forebrain development [GO:0030900]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_04814,0.2482856858480828,OG_04814,FUN_022778-T1,Peve_00021168,Pocillopora_meandrina_HIv1___RNAseq.g4772.t1,three_way,76.42866666666667,,,,,,,,,,,,,,,,,
OG_04533,0.248233128861161,OG_04533,FUN_022079-T1,Peve_00038279,Pocillopora_meandrina_HIv1___TS.g19620.t1,three_way,56.668,FUN_022079-T1,Q3TZ87,MARH9_MOUSE,,E3 ubiquitin-protein ligase MARCHF9 (EC 2.3.2.27) (Membrane-associated RING finger protein 9) (Membrane-associated RING-CH protein IX) (MARCH-IX) (RING-type E3 ubiquitin transferase MARCHF9),Mus musculus (Mouse),33.2,187.0,1.4e-21,105.5,sp|Q3TZ87|MARH9_MOUSE E3 ubiquitin-protein ligase MARCHF9 OS=Mus musculus OX=10090 GN=Marchf9 PE=2 SV=1,GO:0000139; GO:0004842; GO:0005765; GO:0005795; GO:0005802; GO:0008270; GO:0016567,protein ubiquitination [GO:0016567],Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; trans-Golgi network [GO:0005802],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04021,0.2481194259252814,OG_04021,FUN_016326-T1,Peve_00032379,Pocillopora_meandrina_HIv1___RNAseq.g9683.t1,three_way,81.121,FUN_016326-T1,Q9I9N1,,,,,45.5,112.0,1.4e-14,80.5,sp|Q9I9N1|DAP1A_DANRE Death-associated protein 1 homolog OS=Danio rerio OX=7955 GN=dap PE=1 SV=1,,,,,,
OG_00576,0.2479479315708558,OG_00576,FUN_001638-T1,Peve_00009933,Pocillopora_meandrina_HIv1___TS.g14306.t1,three_way,61.513666666666666,FUN_001638-T1,Q9UGK8,SRGEF_HUMAN,,Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor) (DelGEF) (Guanine nucleotide exchange factor-related protein),Homo sapiens (Human),41.6,401.0,2.7000000000000003e-73,277.3,sp|Q9UGK8|SRGEF_HUMAN Secretion-regulating guanine nucleotide exchange factor OS=Homo sapiens OX=9606 GN=SERGEF PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0050709,negative regulation of protein secretion [GO:0050709]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005634; GO:0005654; GO:0005829; GO:0043226; GO:0098772,nucleus; nucleoplasm; cytosol; organelle; molecular function regulator activity
OG_01580,0.2478353026161712,OG_01580,FUN_006614-T1,Peve_00040860,Pocillopora_meandrina_HIv1___RNAseq.g20509.t1,three_way,66.381,FUN_006614-T1,Q5SSI6,,,,,41.4,493.0,2.2e-97,357.8,sp|Q5SSI6|UTP18_MOUSE U3 small nucleolar RNA-associated protein 18 homolog OS=Mus musculus OX=10090 GN=Utp18 PE=1 SV=1,,,,,,
OG_07962,0.2478304176755293,OG_07962,FUN_035522-T1,Peve_00007931,Pocillopora_meandrina_HIv1___TS.g14310.t1,three_way,48.43233333333333,FUN_035522-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),35.3,363.0,1.6000000000000002e-48,195.7,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_02225,0.2476927787520729,OG_02225,FUN_008629-T1,Peve_00035603,Pocillopora_meandrina_HIv1___RNAseq.g14909.t1,three_way,89.81700000000001,FUN_008629-T1,Q96G21,IMP4_HUMAN,,U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4) (Brix domain-containing protein 4),Homo sapiens (Human),67.2,290.0,3.4e-110,399.4,sp|Q96G21|IMP4_HUMAN U3 small nucleolar ribonucleoprotein protein IMP4 OS=Homo sapiens OX=9606 GN=IMP4 PE=1 SV=1,GO:0001650; GO:0005654; GO:0005730; GO:0006364; GO:0030490; GO:0030515; GO:0030684; GO:0032040; GO:0034457; GO:0042134; GO:0042274,maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040],rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515],GO:0003723; GO:0005654; GO:0005730; GO:0043226,RNA binding; nucleoplasm; nucleolus; organelle
OG_09808,0.2475085298447779,OG_09808,FUN_042630-T1,Peve_00033746,Pocillopora_meandrina_HIv1___RNAseq.g11507.t1,three_way,66.90383333333334,FUN_042630-T1,Q8TEK3,DOT1L_HUMAN,,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",Homo sapiens (Human),42.8,636.0,2.0999999999999998e-129,465.7,"sp|Q8TEK3|DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 specific OS=Homo sapiens OX=9606 GN=DOT1L PE=1 SV=3",GO:0000077; GO:0000781; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0010467; GO:0031151; GO:0031509; GO:0032200; GO:0032259; GO:0032991; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:0140938; GO:0140956; GO:2000677,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K79 methyltransferase activity [GO:0031151]; histone H3K79 trimethyltransferase activity [GO:0140956]; histone methyltransferase activity [GO:0042054]; nucleic acid binding [GO:0003676]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0032200; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; telomere organization; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_09008,0.2472472259959623,OG_09008,FUN_038565-T1,Peve_00020185,Pocillopora_meandrina_HIv1___RNAseq.g1021.t1,three_way,72.52799999999999,FUN_038565-T1,Q8C5H1,ANO4_MOUSE,,Anoctamin-4 (Transmembrane protein 16D),Mus musculus (Mouse),36.6,846.0,1.5e-148,528.5,sp|Q8C5H1|ANO4_MOUSE Anoctamin-4 OS=Mus musculus OX=10090 GN=Ano4 PE=1 SV=2,GO:0005886; GO:0017128; GO:0046983; GO:0051649; GO:0061589; GO:0061590; GO:0061591; GO:1902476,calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; establishment of localization in cell [GO:0051649],plasma membrane [GO:0005886],phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0055085; GO:0061024,transporter activity; plasma membrane; transmembrane transport; membrane organization
OG_06700,0.2470622536346693,OG_06700,FUN_031267-T1,Peve_00036736,Pocillopora_meandrina_HIv1___RNAseq.11406_t,three_way,69.776,FUN_031267-T1,P20072,,,,,40.6,313.0,1.1000000000000001e-60,237.3,sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2,,,,,,
OG_09410,0.2468715274920408,OG_09410,FUN_040878-T1,Peve_00002288,Pocillopora_meandrina_HIv1___RNAseq.g6534.t1,three_way,77.77733333333333,FUN_040878-T1,A0A250YGJ5,SIR6_CASCN,,NAD-dependent protein deacylase sirtuin-6 (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-6) (EC 2.3.1.286) (Protein mono-ADP-ribosyltransferase sirtuin-6) (EC 2.4.2.-),Castor canadensis (American beaver),63.8,246.0,2.9e-92,339.7,sp|A0A250YGJ5|SIR6_CASCN NAD-dependent protein deacylase sirtuin-6 OS=Castor canadensis OX=51338 GN=SIRT6 PE=1 SV=1,GO:0000122; GO:0000781; GO:0000785; GO:0003684; GO:0003714; GO:0003723; GO:0005634; GO:0005783; GO:0006302; GO:0008340; GO:0010526; GO:0010569; GO:0016779; GO:0016787; GO:0019216; GO:0031490; GO:0031491; GO:0031508; GO:0031648; GO:0032024; GO:0032922; GO:0034244; GO:0034979; GO:0042181; GO:0042308; GO:0042752; GO:0042803; GO:0045600; GO:0045721; GO:0045820; GO:0046827; GO:0046872; GO:0046969; GO:0050994; GO:0051697; GO:0055007; GO:0070403; GO:0097372; GO:0106274; GO:0120162; GO:0120187; GO:0140612; GO:0140765; GO:0140773; GO:0140774; GO:1904841; GO:2000738; GO:2000781,cardiac muscle cell differentiation [GO:0055007]; circadian regulation of gene expression [GO:0032922]; determination of adult lifespan [GO:0008340]; double-strand break repair [GO:0006302]; ketone biosynthetic process [GO:0042181]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of glycolytic process [GO:0045820]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of stem cell differentiation [GO:2000738]; protein delipidation [GO:0051697]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of lipid catabolic process [GO:0050994]; regulation of lipid metabolic process [GO:0019216]; transposable element silencing [GO:0010526],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]","chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; histone H3K18 deacetylase activity, NAD-dependent [GO:0097372]; histone H3K56 deacetylase activity, NAD-dependent [GO:0140765]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; TORC2 complex binding [GO:1904841]; transcription corepressor activity [GO:0003714]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005783; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0030154; GO:0043226; GO:0060090; GO:0098772; GO:0140096; GO:0140110; GO:0140299,"DNA binding; RNA binding; catalytic activity; nucleus; endoplasmic reticulum; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; cell differentiation; organelle; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein; transcription regulator activity; molecular sensor activity"
OG_00368,0.2464600613558265,OG_00368,FUN_001209-T1,Peve_00033820,Pocillopora_meandrina_HIv1___RNAseq.g29516.t1,three_way,79.10166666666666,FUN_001209-T1,Q1JQD2,GRWD1_BOVIN,,Glutamate-rich WD repeat-containing protein 1,Bos taurus (Bovine),50.0,416.0,2.6000000000000002e-110,400.6,sp|Q1JQD2|GRWD1_BOVIN Glutamate-rich WD repeat-containing protein 1 OS=Bos taurus OX=9913 GN=GRWD1 PE=2 SV=1,GO:0003682; GO:0003688; GO:0005634; GO:0005694; GO:0005730; GO:0006260; GO:0006334; GO:0006337; GO:0042254; GO:0042393,DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; ribosome biogenesis [GO:0042254],chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393],GO:0003677; GO:0005634; GO:0005694; GO:0005730; GO:0006260; GO:0006325; GO:0042254; GO:0042393; GO:0043226; GO:0065003,DNA binding; nucleus; chromosome; nucleolus; DNA replication; chromatin organization; ribosome biogenesis; histone binding; organelle; protein-containing complex assembly
OG_04662,0.2463337338074841,OG_04662,FUN_022408-T1,Peve_00037583,Pocillopora_meandrina_HIv1___RNAseq.g4541.t1,three_way,68.21366666666667,FUN_022408-T1,F1QJX5,UBR3_DANRE,,E3 ubiquitin-protein ligase ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase ubr3),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,844.0,4.4000000000000004e-125,451.1,sp|F1QJX5|UBR3_DANRE E3 ubiquitin-protein ligase ubr3 OS=Danio rerio OX=7955 GN=ubr3 PE=2 SV=2,GO:0000151; GO:0005737; GO:0008270; GO:0016567; GO:0048592; GO:0061630; GO:0071596,eye morphogenesis [GO:0048592]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_02117,0.2463078252556156,OG_02117,FUN_008402-T1,Peve_00001054,Pocillopora_meandrina_HIv1___RNAseq.g18036.t1,three_way,81.348,FUN_008402-T1,Q9U518,,,,,45.7,552.0,1.3e-134,481.5,sp|Q9U518|ASPG_DIRIM L-asparaginase OS=Dirofilaria immitis OX=6287 PE=1 SV=1,,,,,,
OG_01632,0.2462829013087494,OG_01632,FUN_006750-T1,Peve_00029281,Pocillopora_meandrina_HIv1___RNAseq.g20533.t1,three_way,80.3975,FUN_006750-T1,Q9H3E2,,,,,37.7,871.0,3.8e-161,570.5,sp|Q9H3E2|SNX25_HUMAN Sorting nexin-25 OS=Homo sapiens OX=9606 GN=SNX25 PE=1 SV=2,,,,,,
OG_10052,0.2462710151264672,OG_10052,FUN_043326-T1,Peve_00043041,Pocillopora_meandrina_HIv1___RNAseq.g8953.t1,three_way,56.76033333333333,FUN_043326-T1,D3ZAZ5,BCAR3_RAT,,"Breast cancer anti-estrogen resistance protein 3 homolog (BCAR3 adapter protein, NSP family member) (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) (p130Cas-binding protein AND-34)",Rattus norvegicus (Rat),23.4,785.0,4.2e-25,118.2,sp|D3ZAZ5|BCAR3_RAT Breast cancer anti-estrogen resistance protein 3 homolog OS=Rattus norvegicus OX=10116 GN=Bcar3 PE=1 SV=1,GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007173; GO:0007264; GO:0008284; GO:0008286; GO:0016020; GO:0019900; GO:0043410; GO:0043547; GO:0086100,endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020],guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784],GO:0098772,molecular function regulator activity
OG_07965,0.2462530750412266,OG_07965,FUN_035527-T1,Peve_00021385,Pocillopora_meandrina_HIv1___RNAseq.g27994.t1,three_way,69.53316666666666,FUN_035527-T1,Q28IV8,,,,,39.9,298.0,1.5e-44,181.4,sp|Q28IV8|NGDN_XENTR Neuroguidin OS=Xenopus tropicalis OX=8364 GN=ngdn PE=2 SV=1,,,,,,
OG_08822,0.2462427071234993,OG_08822,FUN_038153-T1,Peve_00038320,Pocillopora_meandrina_HIv1___RNAseq.g1149.t1,three_way,68.13433333333333,FUN_038153-T1,Q7Z020,,,,,26.1,898.0,5e-40,168.3,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_07370,0.2461329714512617,OG_07370,FUN_033787-T1,Peve_00014255,Pocillopora_meandrina_HIv1___RNAseq.g26644.t1,three_way,95.845,FUN_033787-T1,Q9DE27,,,,,85.8,466.0,1.3e-223,776.9,sp|Q9DE27|RUVB2_XENLA RuvB-like 2 OS=Xenopus laevis OX=8355 GN=ruvbl2 PE=2 SV=1,,,,,,
OG_09093,0.2461114912248588,OG_09093,FUN_038891-T1,Peve_00028706,Pocillopora_meandrina_HIv1___RNAseq.g28660.t1,three_way,59.693333333333335,FUN_038891-T1,Q8CBY3,,,,,44.1,488.0,6.699999999999999e-90,333.6,sp|Q8CBY3|LENG8_MOUSE Leukocyte receptor cluster member 8 homolog OS=Mus musculus OX=10090 GN=Leng8 PE=1 SV=1,,,,,,
OG_03825,0.2460740819985756,OG_03825,FUN_015245-T1,Peve_00003467,Pocillopora_meandrina_HIv1___RNAseq.g22163.t1,three_way,72.38283333333334,FUN_015245-T1,Q6VAB6,KSR2_HUMAN,,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),Homo sapiens (Human),33.3,953.0,6.5e-104,380.2,sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2,GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162,calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; cytosol; plasma membrane; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_00162,0.2460404434204243,OG_00162,FUN_000620-T1,Peve_00017114,Pocillopora_meandrina_HIv1___RNAseq.g1866.t1,three_way,76.233,FUN_000620-T1,O95427,PIGN_HUMAN,,GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (GPI-ethanolamine transferase I) (GPI-ETI) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N),Homo sapiens (Human),53.5,939.0,5.199999999999999e-264,912.1,sp|O95427|PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens OX=9606 GN=PIGN PE=1 SV=1,GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016020; GO:0051377,GPI anchor biosynthetic process [GO:0006506],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],mannose-ethanolamine phosphotransferase activity [GO:0051377],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016740; GO:1901135,catalytic activity; cytosol; plasma membrane; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_05038,0.2460281685306062,OG_05038,FUN_023220-T1,Peve_00029814,Pocillopora_meandrina_HIv1___RNAseq.g696.t1,three_way,81.45,FUN_023220-T1,Q8K2C8,GPAT4_MOUSE,,Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7),Mus musculus (Mouse),50.9,432.0,5.8e-122,439.1,sp|Q8K2C8|GPAT4_MOUSE Glycerol-3-phosphate acyltransferase 4 OS=Mus musculus OX=10090 GN=Gpat4 PE=1 SV=1,GO:0002071; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016024; GO:0019432; GO:0030879; GO:0040014; GO:0046339,acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],glycerol-3-phosphate O-acyltransferase activity [GO:0004366],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0048856; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_06706,0.2459895968104013,OG_06706,FUN_031286-T1,Peve_00036747,Pocillopora_meandrina_HIv1___RNAseq.g5173.t1,three_way,73.2735,FUN_031286-T1,Q8CHB8,TTLL5_MOUSE,,Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 5),Mus musculus (Mouse),44.1,870.0,1.4999999999999998e-189,665.2,sp|Q8CHB8|TTLL5_MOUSE Tubulin polyglutamylase TTLL5 OS=Mus musculus OX=10090 GN=Ttll5 PE=1 SV=3,GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0030317; GO:0036064; GO:0036211; GO:0046872; GO:0060041; GO:0070740; GO:0097731; GO:0106437; GO:0106438,fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283],9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005634; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0016874; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; ligase activity; reproductive process; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_10122,0.2459805107748854,OG_10122,FUN_043500-T1,Peve_00024905,Pocillopora_meandrina_HIv1___RNAseq.g7966.t1,three_way,90.83083333333332,FUN_043500-T1,Q9DCD2,,,,,62.9,852.0,2e-304,1046.2,sp|Q9DCD2|SYF1_MOUSE Pre-mRNA-splicing factor SYF1 OS=Mus musculus OX=10090 GN=Xab2 PE=1 SV=1,,,,,,
OG_00795,0.2456599833219608,OG_00795,FUN_003978-T1,Peve_00009042,Pocillopora_meandrina_HIv1___RNAseq.g11761.t1,three_way,85.38833333333334,FUN_003978-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),67.5,40.0,1.8e-06,54.7,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_07816,0.2455094468576751,OG_07816,FUN_035068-T1,Peve_00026040,Pocillopora_meandrina_HIv1___RNAseq.g27722.t1,three_way,68.704,FUN_035068-T1,Q5U403,MVD1_DANRE,,Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase),Danio rerio (Zebrafish) (Brachydanio rerio),54.7,391.0,7.4e-119,428.7,sp|Q5U403|MVD1_DANRE Diphosphomevalonate decarboxylase OS=Danio rerio OX=7955 GN=mvd PE=2 SV=1,GO:0003334; GO:0004163; GO:0005524; GO:0005829; GO:0006695; GO:0019287; GO:0045765,"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; keratinocyte development [GO:0003334]; regulation of angiogenesis [GO:0045765]",cytosol [GO:0005829],ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163],GO:0003824; GO:0005829; GO:0006629; GO:0006790; GO:0016829; GO:0048856; GO:0055086,catalytic activity; cytosol; lipid metabolic process; sulfur compound metabolic process; lyase activity; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_07980,0.2451876231508344,OG_07980,FUN_035602-T1,Peve_00027478,Pocillopora_meandrina_HIv1___RNAseq.g28040.t1,three_way,92.946,FUN_035602-T1,O60762,DPM1_HUMAN,,Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1),Homo sapiens (Human),81.5,238.0,3.2999999999999996e-114,412.5,sp|O60762|DPM1_HUMAN Dolichol-phosphate mannosyltransferase subunit 1 OS=Homo sapiens OX=9606 GN=DPM1 PE=1 SV=1,GO:0004169; GO:0004582; GO:0005537; GO:0005634; GO:0005783; GO:0005789; GO:0006488; GO:0006506; GO:0016020; GO:0018279; GO:0019348; GO:0019673; GO:0033185; GO:0035268; GO:0035269; GO:0043178; GO:0046872; GO:0070482; GO:0180047,dolichol metabolic process [GO:0019348]; dolichol phosphate mannose biosynthetic process [GO:0180047]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269]; response to oxygen levels [GO:0070482],dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634],alcohol binding [GO:0043178]; D-mannose binding [GO:0005537]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0005783; GO:0006629; GO:0009101; GO:0016740; GO:0043226; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; nucleus; endoplasmic reticulum; lipid metabolic process; glycoprotein biosynthetic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_08417,0.2450038141203869,OG_08417,FUN_037075-T1,Peve_00004732,Pocillopora_meandrina_HIv1___RNAseq.g26676.t1,three_way,77.25566666666667,FUN_037075-T1,Q6ZT07,,,,,45.3,1328.0,2.4e-304,1046.6,sp|Q6ZT07|TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens OX=9606 GN=TBC1D9 PE=1 SV=2,,,,,,
OG_05789,0.2449675901327478,OG_05789,FUN_025767-T1,Peve_00021328,Pocillopora_meandrina_HIv1___RNAseq.g10372.t1,three_way,75.75,FUN_025767-T1,P31508,,,,,64.9,37.0,9.2e-06,52.4,sp|P31508|ESCA_APIME Escargot/snail protein homolog (Fragment) OS=Apis mellifera OX=7460 PE=3 SV=1,,,,,,
OG_03333,0.2449259985013223,OG_03333,FUN_013553-T1,Peve_00024215,Pocillopora_meandrina_HIv1___RNAseq.g22958.t1,three_way,59.68833333333333,FUN_013553-T1,Q5R5W2,TADBP_PONAB,,TAR DNA-binding protein 43 (TDP-43),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),49.7,145.0,3.1e-32,140.6,sp|Q5R5W2|TADBP_PONAB TAR DNA-binding protein 43 OS=Pongo abelii OX=9601 GN=TARDBP PE=2 SV=1,GO:0000785; GO:0003677; GO:0003723; GO:0005730; GO:0005739; GO:0006397; GO:0008380; GO:0010468; GO:0016607; GO:0031647; GO:0042752,mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; RNA splicing [GO:0008380],chromatin [GO:0000785]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730],DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005730; GO:0005739; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleolus; mitochondrion; mRNA metabolic process; organelle
OG_05540,0.2447771902779433,OG_05540,FUN_024742-T1,Peve_00005934,Pocillopora_meandrina_HIv1___TS.g28230.t1,three_way,61.432,FUN_024742-T1,Q865W2,,,,,26.7,217.0,2e-10,69.3,sp|Q865W2|TRI50_PIG E3 ubiquitin-protein ligase TRIM50 OS=Sus scrofa OX=9823 GN=TRIM50 PE=2 SV=1,,,,,,
OG_02364,0.2447232439056235,OG_02364,FUN_008969-T1,Peve_00007346,Pocillopora_meandrina_HIv1___RNAseq.g14271.t1,three_way,68.706,FUN_008969-T1,Q9NWM8,FKB14_HUMAN,,Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (22 kDa FK506-binding protein) (22 kDa FKBP) (FKBP-22) (FK506-binding protein 14) (FKBP-14) (Rotamase),Homo sapiens (Human),43.3,194.0,6.7e-38,159.5,sp|Q9NWM8|FKB14_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP14 OS=Homo sapiens OX=9606 GN=FKBP14 PE=1 SV=1,GO:0003755; GO:0005509; GO:0005788,,endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0016853; GO:0140096,"catalytic activity; isomerase activity; catalytic activity, acting on a protein"
OG_04826,0.2446588118765049,OG_04826,FUN_022818-T1,Peve_00031617,Pocillopora_meandrina_HIv1___RNAseq.g3463.t1,three_way,77.29366666666667,FUN_022818-T1,Q8CDU6,,,,,63.1,640.0,1.2000000000000001e-238,827.8,sp|Q8CDU6|HECD2_MOUSE Probable E3 ubiquitin-protein ligase HECTD2 OS=Mus musculus OX=10090 GN=Hectd2 PE=1 SV=2,,,,,,
OG_09075,0.2446533185298648,OG_09075,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_05306,0.2446457593448,OG_05306,FUN_023979-T1,Peve_00020872,Pocillopora_meandrina_HIv1___RNAseq.g19434.t1,three_way,54.052166666666665,,,,,,,,,,,,,,,,,
OG_08143,0.2446328738956447,OG_08143,FUN_035908-T1,Peve_00006733,Pocillopora_meandrina_HIv1___TS.g3371.t1,three_way,92.83516666666668,,,,,,,,,,,,,,,,,
OG_07590,0.2445019718436435,OG_07590,FUN_034294-T1,Peve_00013952,Pocillopora_meandrina_HIv1___RNAseq.g28509.t1,three_way,53.21816666666667,,,,,,,,,,,,,,,,,
OG_06612,0.2444591448179507,OG_06612,FUN_029763-T1,Peve_00019504,Pocillopora_meandrina_HIv1___RNAseq.g17323.t1,three_way,61.1925,FUN_029763-T1,Q6PCS4,,,,,36.2,716.0,2.9e-92,342.0,sp|Q6PCS4|RHG29_DANRE Rho GTPase-activating protein 29 OS=Danio rerio OX=7955 GN=arhgap29 PE=2 SV=1,,,,,,
OG_03955,0.2443308849175991,OG_03955,FUN_016100-T1,Peve_00010771,Pocillopora_meandrina_HIv1___RNAseq.g21590.t1,three_way,83.7185,FUN_016100-T1,Q13948,,,,,48.2,676.0,4.2e-151,536.6,sp|Q13948|CASP_HUMAN Protein CASP OS=Homo sapiens OX=9606 GN=CUX1 PE=1 SV=2,,,,,,
OG_09082,0.2442537686580089,OG_09082,FUN_038816-T1,Peve_00007229,Pocillopora_meandrina_HIv1___RNAseq.g28534.t1,three_way,57.37033333333333,,,,,,,,,,,,,,,,,
OG_04542,0.2441884928747731,OG_04542,FUN_022103-T1,Peve_00009716,Pocillopora_meandrina_HIv1___RNAseq.g4105.t1,three_way,85.40766666666667,FUN_022103-T1,A6H779,FBXL2_BOVIN,,F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2),Bos taurus (Bovine),69.6,102.0,2.1e-37,158.3,sp|A6H779|FBXL2_BOVIN F-box/LRR-repeat protein 2 OS=Bos taurus OX=9913 GN=FBXL2 PE=2 SV=1,GO:0005516; GO:0006513; GO:0010506; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830; GO:0050727; GO:0051896; GO:1900226; GO:1990756,modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005],calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_05989,0.2439649241810557,OG_05989,FUN_026475-T1,Peve_00002335,Pocillopora_meandrina_HIv1___RNAseq.g4182.t1,three_way,75.23366666666666,FUN_026475-T1,Q802U2,MIOS_DANRE,,GATOR2 complex protein MIOS,Danio rerio (Zebrafish) (Brachydanio rerio),45.1,443.0,7.2e-107,389.0,sp|Q802U2|MIOS_DANRE GATOR2 complex protein MIOS OS=Danio rerio OX=7955 GN=mios PE=2 SV=1,GO:0005737; GO:0005765; GO:0008270; GO:0031669; GO:0034198; GO:0060047; GO:0060841; GO:0061700; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; heart contraction [GO:0060047]; positive regulation of TORC1 signaling [GO:1904263]; venous blood vessel development [GO:0060841],cytoplasm [GO:0005737]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765],zinc ion binding [GO:0008270],GO:0003013; GO:0048856,circulatory system process; anatomical structure development
OG_04237,0.243938090893077,OG_04237,FUN_017758-T1,Peve_00040794,Pocillopora_meandrina_HIv1___RNAseq.g432.t3,three_way,65.21266666666666,FUN_017758-T1,Q9I8C7,,,,,33.0,485.0,1e-67,259.2,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_00033,0.2438026357284287,OG_00033,FUN_000239-T1,Peve_00033353,Pocillopora_meandrina_HIv1___RNAseq.g28955.t1,three_way,97.61933333333332,FUN_000239-T1,Q2KHT7,,,,,89.3,84.0,1.7e-38,159.5,sp|Q2KHT7|RS27_BOVIN Small ribosomal subunit protein eS27 OS=Bos taurus OX=9913 GN=RPS27 PE=1 SV=3,,,,,,
OG_00640,0.243556901682707,OG_00640,FUN_001879-T1,Peve_00030499,Pocillopora_meandrina_HIv1___RNAseq.g2593.t1,three_way,62.20333333333333,FUN_001879-T1,Q6NTR1,,,,,38.1,691.0,1.8e-112,408.3,sp|Q6NTR1|EFNMT_XENLA eEF1A lysine and N-terminal methyltransferase OS=Xenopus laevis OX=8355 GN=mettl13 PE=2 SV=1,,,,,,
OG_04343,0.2434847861254218,OG_04343,FUN_017964-T1,Peve_00000391,Pocillopora_meandrina_HIv1___TS.g25524.t1,three_way,75.0295,FUN_017964-T1,O00409,FOXN3_HUMAN,,Forkhead box protein N3 (Checkpoint suppressor 1),Homo sapiens (Human),44.8,281.0,4.799999999999999e-53,210.3,sp|O00409|FOXN3_HUMAN Forkhead box protein N3 OS=Homo sapiens OX=9606 GN=FOXN3 PE=1 SV=1,GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0006355; GO:0007095; GO:0045892; GO:0097094,craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],chromatin [GO:0000785]; nucleus [GO:0005634],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_01728,0.2434442798760986,OG_01728,FUN_007020-T1,Peve_00037180,Pocillopora_meandrina_HIv1___RNAseq.g20542.t1,three_way,63.67233333333333,FUN_007020-T1,Q6ZZY0,,,,,46.9,497.0,1.3e-139,499.6,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_06001,0.2433930313755319,OG_06001,FUN_026490-T1,Peve_00002095,Pocillopora_meandrina_HIv1___RNAseq.g4192.t1,three_way,88.14433333333334,FUN_026490-T1,O57683,,,,,77.7,1266.0,0.0,1677.9,sp|O57683|SF3B1_XENLA Splicing factor 3B subunit 1 OS=Xenopus laevis OX=8355 GN=sf3b1 PE=2 SV=1,,,,,,
OG_05770,0.2433323786206044,OG_05770,FUN_025730-T1,Peve_00035630,Pocillopora_meandrina_HIv1___RNAseq.g10436.t1,three_way,81.93766666666667,FUN_025730-T1,A5D8W1,CFA69_HUMAN,,Cilia- and flagella-associated protein 69,Homo sapiens (Human),40.2,895.0,9.3e-194,678.7,sp|A5D8W1|CFA69_HUMAN Cilia- and flagella-associated protein 69 OS=Homo sapiens OX=9606 GN=CFAP69 PE=1 SV=3,GO:0005737; GO:0007288; GO:0007608; GO:0030317; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834,flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288],cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225],,GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_08072,0.2432935661932067,OG_08072,FUN_035777-T1,Peve_00017722,Pocillopora_meandrina_HIv1___RNAseq.g11902.t1,three_way,56.0365,FUN_035777-T1,Q68ED3,PAPD5_MOUSE,,Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2),Mus musculus (Mouse),56.3,332.0,8.300000000000001e-100,366.3,sp|Q68ED3|PAPD5_MOUSE Terminal nucleotidyltransferase 4B OS=Mus musculus OX=10090 GN=Tent4b PE=1 SV=2,GO:0003677; GO:0003887; GO:0005524; GO:0005730; GO:0005737; GO:0006364; GO:0010587; GO:0031124; GO:0033500; GO:0046872; GO:0051301; GO:0060212; GO:0070568; GO:0071044; GO:0071051; GO:1905870; GO:1990817,carbohydrate homeostasis [GO:0033500]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA 3'-end processing [GO:0031124]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003677; GO:0003824; GO:0005730; GO:0016071; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleolus; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on DNA"
OG_06625,0.2432503821713246,OG_06625,FUN_030048-T1,Peve_00008446,Pocillopora_meandrina_HIv1___RNAseq.g17347.t1,three_way,81.524,FUN_030048-T1,Q5RBL0,,,,,58.5,229.0,6.200000000000001e-73,275.8,sp|Q5RBL0|YIPF1_PONAB Protein YIPF1 OS=Pongo abelii OX=9601 GN=YIPF1 PE=2 SV=1,,,,,,
OG_02235,0.2432344123084404,OG_02235,FUN_008646-T1,Peve_00021172,Pocillopora_meandrina_HIv1___RNAseq.g13.t1,three_way,77.26433333333333,FUN_008646-T1,Q8IVJ1,S41A1_HUMAN,,Solute carrier family 41 member 1,Homo sapiens (Human),59.2,448.0,1.0999999999999999e-141,505.0,sp|Q8IVJ1|S41A1_HUMAN Solute carrier family 41 member 1 OS=Homo sapiens OX=9606 GN=SLC41A1 PE=1 SV=2,GO:0005886; GO:0010961; GO:0015095; GO:0015693; GO:0016323; GO:0022857; GO:0022890; GO:0030001; GO:0032991; GO:0061768; GO:0071286; GO:1903830,cellular response to magnesium ion [GO:0071286]; intracellular magnesium ion homeostasis [GO:0010961]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; metal ion transport [GO:0030001],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_09869,0.2432058318623156,OG_09869,FUN_042878-T1,Peve_00015664,Pocillopora_meandrina_HIv1___RNAseq.g7228.t1,three_way,78.19666666666667,FUN_042878-T1,Q9UHB4,,,,,54.6,599.0,1.2e-192,674.5,sp|Q9UHB4|NDOR1_HUMAN NADPH-dependent diflavin oxidoreductase 1 OS=Homo sapiens OX=9606 GN=NDOR1 PE=1 SV=1,,,,,,
OG_08885,0.2431831472224706,OG_08885,FUN_038290-T1,Peve_00041725,Pocillopora_meandrina_HIv1___RNAseq.g28307.t1,three_way,85.748,FUN_038290-T1,A7SE07,,,,,77.1,253.0,1.4e-121,437.2,sp|A7SE07|NUBP2_NEMVE Cytosolic Fe-S cluster assembly factor NUBP2 homolog OS=Nematostella vectensis OX=45351 GN=v1g229988 PE=3 SV=1,,,,,,
OG_05718,0.2429235954991519,OG_05718,FUN_025610-T1,Peve_00009537,Pocillopora_meandrina_HIv1___RNAseq.g23128.t1,three_way,58.688833333333335,FUN_025610-T1,Q07497,,,,,34.9,935.0,3.6999999999999996e-147,523.9,sp|Q07497|EPHB5_CHICK Ephrin type-B receptor 5 OS=Gallus gallus OX=9031 GN=EPHB5 PE=2 SV=1,,,,,,
OG_09695,0.2426517104787894,OG_09695,FUN_041924-T1,Peve_00007863,Pocillopora_meandrina_HIv1___TS.g10650.t1,three_way,81.45066666666666,FUN_041924-T1,Q9H8V3,,,,,44.9,864.0,3.6e-184,646.7,sp|Q9H8V3|ECT2_HUMAN Protein ECT2 OS=Homo sapiens OX=9606 GN=ECT2 PE=1 SV=4,,,,,,
OG_09161,0.2423322091363839,OG_09161,FUN_039820-T1,Peve_00009577,Pocillopora_meandrina_HIv1___RNAseq.g7314.t2,three_way,67.855,FUN_039820-T1,Q3U0J8,,,,,31.8,406.0,2.6e-50,202.6,sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2,,,,,,
OG_00231,0.2423162338845778,OG_00231,FUN_000977-T1,Peve_00007809,Pocillopora_meandrina_HIv1___RNAseq.g29137.t1,three_way,71.25866666666667,FUN_000977-T1,P70451,,,,,38.0,843.0,1.8999999999999998e-153,544.7,sp|P70451|FER_MOUSE Tyrosine-protein kinase Fer OS=Mus musculus OX=10090 GN=Fer PE=1 SV=2,,,,,,
OG_03070,0.2422398158300756,OG_03070,FUN_012340-T1,Peve_00042542,Pocillopora_meandrina_HIv1___RNAseq.g23343.t1,three_way,61.76633333333333,FUN_012340-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),30.7,205.0,2.5e-17,91.7,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_01180,0.2422194016417269,OG_01180,FUN_004829-T1,Peve_00021957,Pocillopora_meandrina_HIv1___RNAseq.g8582.t1,three_way,65.48383333333334,,,,,,,,,,,,,,,,,
OG_01547,0.2422024878905887,OG_01547,FUN_006422-T1,Peve_00043549,Pocillopora_meandrina_HIv1___RNAseq.g20281.t1,three_way,93.65066666666668,FUN_006422-T1,Q9UKJ5,,,,,60.1,168.0,6.999999999999999e-55,214.9,sp|Q9UKJ5|CHIC2_HUMAN Cysteine-rich hydrophobic domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CHIC2 PE=1 SV=1,,,,,,
OG_02857,0.242076731280352,OG_02857,FUN_011899-T1,Peve_00010113,Pocillopora_meandrina_HIv1___RNAseq.g23787.t1,three_way,67.8275,FUN_011899-T1,Q5R9B8,DCAF6_PONAB,,DDB1- and CUL4-associated factor 6 (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),39.1,843.0,7.8e-144,512.7,sp|Q5R9B8|DCAF6_PONAB DDB1- and CUL4-associated factor 6 OS=Pongo abelii OX=9601 GN=DCAF6 PE=2 SV=2,GO:0005634; GO:0005737; GO:0016567; GO:0045944; GO:0080008,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_05142,0.2420128358846481,OG_05142,FUN_023418-T1,Peve_00019270,Pocillopora_meandrina_HIv1___RNAseq.g579.t1,three_way,56.60016666666667,FUN_023418-T1,Q5ZJR9,,,,,27.2,383.0,7.6e-21,103.6,sp|Q5ZJR9|TAF1B_CHICK TATA box-binding protein-associated factor RNA polymerase I subunit B OS=Gallus gallus OX=9031 GN=TAF1B PE=2 SV=2,,,,,,
OG_00022,0.2420056254950205,OG_00022,FUN_000219-T1,Peve_00019412,Pocillopora_meandrina_HIv1___RNAseq.g28928.t1,three_way,64.90866666666666,,,,,,,,,,,,,,,,,
OG_08175,0.2419804670959957,OG_08175,FUN_035986-T1,Peve_00038193,Pocillopora_meandrina_HIv1___RNAseq.g12345.t1,three_way,50.869166666666665,,,,,,,,,,,,,,,,,
OG_07827,0.2419613090861799,OG_07827,FUN_035129-T1,Peve_00005904,Pocillopora_meandrina_HIv1___RNAseq.g27641.t1,three_way,89.21533333333333,,,,,,,,,,,,,,,,,
OG_03793,0.2418339191998287,OG_03793,FUN_015164-T1,Peve_00001860,Pocillopora_meandrina_HIv1___TS.g25730.t1,three_way,68.88416666666667,FUN_015164-T1,Q14667,,,,,30.3,2363.0,1.9999999999999998e-285,984.6,sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3,,,,,,
OG_06630,0.2418338745664739,OG_06630,FUN_030078-T1,Peve_00018131,Pocillopora_meandrina_HIv1___RNAseq.g20156.t1,three_way,75.601,,,,,,,,,,,,,,,,,
OG_08324,0.2417640483231096,OG_08324,FUN_036753-T1,Peve_00001060,Pocillopora_meandrina_HIv1___RNAseq.g12113.t1,three_way,78.39483333333332,FUN_036753-T1,Q2V2M9,FHOD3_HUMAN,,FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2),Homo sapiens (Human),42.2,1460.0,2.6000000000000004e-214,747.7,sp|Q2V2M9|FHOD3_HUMAN FH1/FH2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FHOD3 PE=1 SV=2,GO:0005737; GO:0005856; GO:0030018; GO:0030866; GO:0045214; GO:0051015; GO:0055003,cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; sarcomere organization [GO:0045214],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018],actin filament binding [GO:0051015],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_00626,0.2417522697395324,OG_00626,FUN_001842-T1,Peve_00006790,Pocillopora_meandrina_HIv1___RNAseq.g2620.t1,three_way,88.205,FUN_001842-T1,Q9GKQ9,,,,,60.2,558.0,1.9e-172,607.1,sp|Q9GKQ9|SMAD4_PIG Mothers against decapentaplegic homolog 4 OS=Sus scrofa OX=9823 GN=SMAD4 PE=2 SV=1,,,,,,
OG_01677,0.2414008095666744,OG_01677,FUN_006885-T1,Peve_00009911,Pocillopora_meandrina_HIv1___RNAseq.g19833.t1,three_way,60.03416666666667,FUN_006885-T1,O94966,,,,,42.5,738.0,3.1999999999999995e-151,537.7,sp|O94966|UBP19_HUMAN Ubiquitin carboxyl-terminal hydrolase 19 OS=Homo sapiens OX=9606 GN=USP19 PE=1 SV=2,,,,,,
OG_04468,0.2413259633013792,OG_04468,FUN_019560-T1,Peve_00032909,Pocillopora_meandrina_HIv1___RNAseq.g20816.t1,three_way,74.66783333333333,FUN_019560-T1,Q90941,,,,,38.3,1523.0,1.2e-280,968.4,sp|Q90941|PB1_CHICK Protein polybromo-1 OS=Gallus gallus OX=9031 GN=PBRM1 PE=1 SV=1,,,,,,
OG_08936,0.2411865905121762,OG_08936,FUN_038400-T1,Peve_00000036,Pocillopora_meandrina_HIv1___RNAseq.g28274.t1,three_way,75.47866666666667,FUN_038400-T1,Q6P5D8,SMHD1_MOUSE,,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-),Mus musculus (Mouse),23.5,2075.0,6.200000000000001e-86,321.6,sp|Q6P5D8|SMHD1_MOUSE Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Mus musculus OX=10090 GN=Smchd1 PE=1 SV=2,GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0016604; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060818; GO:2000042; GO:2001034,chromosome organization [GO:0051276]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],"Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006325; GO:0016787; GO:0043226; GO:0048856,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; chromatin organization; hydrolase activity; organelle; anatomical structure development
OG_09023,0.2411718217356298,OG_09023,FUN_038613-T1,Peve_00002805,Pocillopora_meandrina_HIv1___RNAseq.g973.t1b,three_way,59.701,FUN_038613-T1,Q6ICB0,DESI1_HUMAN,,Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2) (Palmitoyl protein thioesterase DESI1) (EC 3.1.2.22) (Polyubiquitinated substrate transporter) (POST) (S-depalmitoylase DESI1),Homo sapiens (Human),63.3,150.0,1e-55,219.2,sp|Q6ICB0|DESI1_HUMAN Desumoylating isopeptidase 1 OS=Homo sapiens OX=9606 GN=DESI1 PE=1 SV=1,GO:0005634; GO:0005829; GO:0006508; GO:0006611; GO:0008474; GO:0016926; GO:0016929; GO:0032434; GO:0032991; GO:0042802; GO:0052816; GO:0061676,protein desumoylation [GO:0016926]; protein export from nucleus [GO:0006611]; proteolysis [GO:0006508]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],deSUMOylase activity [GO:0016929]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; palmitoyl-(protein) hydrolase activity [GO:0008474],GO:0003824; GO:0005634; GO:0005829; GO:0006886; GO:0006913; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08165,0.2409679267542941,OG_08165,FUN_035962-T1,Peve_00006624,Pocillopora_meandrina_HIv1___RNAseq.g12329.t1,three_way,87.42883333333333,FUN_035962-T1,Q9GYZ0,,,,,39.5,1065.0,2e-180,634.8,sp|Q9GYZ0|KIF15_STRPU Kinesin-like protein KIF15 OS=Strongylocentrotus purpuratus OX=7668 GN=KIF15 PE=1 SV=1,,,,,,
OG_06981,0.2408743117703384,OG_06981,FUN_032118-T1,Peve_00030238,Pocillopora_meandrina_HIv1___RNAseq.g5380.t1,three_way,76.23633333333333,FUN_032118-T1,Q5ZL91,INT7_CHICK,,Integrator complex subunit 7 (Int7),Gallus gallus (Chicken),45.5,927.0,3.2e-212,740.3,sp|Q5ZL91|INT7_CHICK Integrator complex subunit 7 OS=Gallus gallus OX=9031 GN=INTS7 PE=2 SV=1,GO:0005634; GO:0005694; GO:0005737; GO:0006974; GO:0032039; GO:0034472; GO:0160232; GO:0160240,DNA damage response [GO:0006974]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472],chromosome [GO:0005694]; cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634],,GO:0005634; GO:0005694; GO:0016073; GO:0043226,nucleus; chromosome; snRNA metabolic process; organelle
OG_09691,0.2408536995031359,OG_09691,FUN_041920-T1,Peve_00007875,Pocillopora_meandrina_HIv1___RNAseq.g15622.t1,three_way,92.08833333333334,FUN_041920-T1,A6QQ21,,,,,59.4,266.0,1.6999999999999996e-75,284.3,sp|A6QQ21|CSN6_BOVIN COP9 signalosome complex subunit 6 OS=Bos taurus OX=9913 GN=COPS6 PE=2 SV=1,,,,,,
OG_01408,0.2408044447063118,OG_01408,FUN_005479-T1,Peve_00001976,Pocillopora_meandrina_HIv1___RNAseq.g6643.t1,three_way,83.39633333333333,FUN_005479-T1,P50904,,,,,47.7,900.0,1.4e-237,824.3,sp|P50904|RASA1_RAT Ras GTPase-activating protein 1 OS=Rattus norvegicus OX=10116 GN=Rasa1 PE=1 SV=1,,,,,,
OG_02442,0.2408006434496168,OG_02442,FUN_009488-T1,Peve_00016361,Pocillopora_meandrina_HIv1___RNAseq.g28392.t1,three_way,82.25866666666667,FUN_009488-T1,Q95J75,,,,,55.1,207.0,2.0000000000000002e-60,233.8,sp|Q95J75|S2532_MACFA Solute carrier family 25 member 32 OS=Macaca fascicularis OX=9541 GN=SLC25A32 PE=2 SV=1,,,,,,
OG_02250,0.2407304380464242,OG_02250,FUN_008694-T1,Peve_00040327,Pocillopora_meandrina_HIv1___RNAseq.g6276.t1,three_way,91.75133333333332,FUN_008694-T1,A7RKF6,RTCB_NEMVE,,RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase),Nematostella vectensis (Starlet sea anemone),88.7,468.0,5.5e-247,854.7,sp|A7RKF6|RTCB_NEMVE RNA-splicing ligase RtcB homolog OS=Nematostella vectensis OX=45351 GN=v1g198406 PE=3 SV=1,GO:0005525; GO:0005634; GO:0006388; GO:0046872; GO:0072669; GO:0170057,"tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]",nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669],GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (GTP) activity [GO:0170057],GO:0003824; GO:0005634; GO:0006399; GO:0016874; GO:0043226; GO:0140098,"catalytic activity; nucleus; tRNA metabolic process; ligase activity; organelle; catalytic activity, acting on RNA"
OG_05884,0.2405894412767822,OG_05884,FUN_026037-T1,Peve_00025183,Pocillopora_meandrina_HIv1___RNAseq.g10550.t1,three_way,71.07133333333333,FUN_026037-T1,P47727,CBR1_RAT,,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)",Rattus norvegicus (Rat),45.3,278.0,2.3e-66,253.8,sp|P47727|CBR1_RAT Carbonyl reductase [NADPH] 1 OS=Rattus norvegicus OX=10116 GN=Cbr1 PE=1 SV=2,GO:0001542; GO:0004090; GO:0005737; GO:0005902; GO:0006706; GO:0006805; GO:0008211; GO:0016616; GO:0016655; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0047020; GO:0047021; GO:0050221; GO:0160163; GO:1905344; GO:2000379,epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; microvillus [GO:0005902],"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E2 9-reductase activity [GO:0050221]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163]",GO:0003824; GO:0006629; GO:0006766; GO:0016491; GO:0022414; GO:0030154,catalytic activity; lipid metabolic process; vitamin metabolic process; oxidoreductase activity; reproductive process; cell differentiation
OG_02046,0.2405653882373792,OG_02046,FUN_008253-T1,Peve_00009137,Pocillopora_meandrina_HIv1___RNAseq.g17956.t1,three_way,98.44433333333332,FUN_008253-T1,Q5E9B8,RPB7_BOVIN,,DNA-directed RNA polymerase II subunit RPB7 (RNA polymerase II subunit B7) (DNA-directed RNA polymerase II subunit G),Bos taurus (Bovine),92.6,95.0,3.7e-46,185.3,sp|Q5E9B8|RPB7_BOVIN DNA-directed RNA polymerase II subunit RPB7 OS=Bos taurus OX=9913 GN=POLR2G PE=1 SV=1,GO:0000932; GO:0000956; GO:0003697; GO:0003727; GO:0005634; GO:0005665; GO:0006366; GO:0006367; GO:0031369; GO:0045948; GO:0060213,nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],"nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]",single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369],GO:0003677; GO:0003723; GO:0005634; GO:0006351; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; DNA-templated transcription; mRNA metabolic process; organelle
OG_07572,0.2405505798464921,OG_07572,FUN_034244-T1,Peve_00036914,Pocillopora_meandrina_HIv1___TS.g19363.t1,three_way,41.717333333333336,,,,,,,,,,,,,,,,,
OG_09608,0.2404662180871251,OG_09608,FUN_041762-T1,Peve_00041571,Pocillopora_meandrina_HIv1___RNAseq.g15243.t1,three_way,78.552,FUN_041762-T1,Q9NXL6,,,,,58.9,280.0,1.1e-89,331.3,sp|Q9NXL6|SIDT1_HUMAN SID1 transmembrane family member 1 OS=Homo sapiens OX=9606 GN=SIDT1 PE=1 SV=2,,,,,,
OG_00449,0.240446699745354,OG_00449,FUN_001369-T1,Peve_00035683,Pocillopora_meandrina_HIv1___RNAseq.g2141.t1,three_way,82.50766666666667,FUN_001369-T1,A0A1L8F5J9,NMDZ1_XENLA,,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",Xenopus laevis (African clawed frog),50.5,876.0,2.8e-243,843.2,"sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1",GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839,calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725],neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_03516,0.2404032161557921,OG_03516,FUN_014627-T1,Peve_00002415,Pocillopora_meandrina_HIv1___TS.g27554.t1,three_way,87.76583333333333,FUN_014627-T1,Q5ZML3,,,,,65.0,200.0,3.2e-57,223.4,sp|Q5ZML3|SRSF1_CHICK Serine/arginine-rich splicing factor 1 OS=Gallus gallus OX=9031 GN=SRSF1 PE=1 SV=3,,,,,,
OG_00972,0.2402985567097946,OG_00972,FUN_004346-T1,Peve_00016493,Pocillopora_meandrina_HIv1___RNAseq.g16896.t1,three_way,82.173,FUN_004346-T1,Q8BRK8,AAPK2_MOUSE,,5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31),Mus musculus (Mouse),58.6,561.0,3.1e-179,629.8,sp|Q8BRK8|AAPK2_MOUSE 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Mus musculus OX=10090 GN=Prkaa2 PE=1 SV=3,GO:0003682; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010468; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0036064; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:0140823; GO:1903829; GO:1903944; GO:1904262; GO:1904428; GO:1905691; GO:1990044,autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634],[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone H2BS36 kinase activity [GO:0140823]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712],GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; lipid metabolic process; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08254,0.2402402228436725,OG_08254,FUN_036164-T1,Peve_00027211,Pocillopora_meandrina_HIv1___RNAseq.g27499.t1,three_way,89.75383333333333,FUN_036164-T1,Q5RC80,RBM39_PONAB,,RNA-binding protein 39 (RNA-binding motif protein 39),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),58.2,385.0,3.1e-117,423.7,sp|Q5RC80|RBM39_PONAB RNA-binding protein 39 OS=Pongo abelii OX=9601 GN=RBM39 PE=2 SV=1,GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733,"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]",centriolar satellite [GO:0034451]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; RS domain binding [GO:0050733],GO:0003723; GO:0016071; GO:0043226,RNA binding; mRNA metabolic process; organelle
OG_02428,0.2402292107669276,OG_02428,FUN_009369-T1,Peve_00011042,Pocillopora_meandrina_HIv1___RNAseq.g14409.t1,three_way,62.123666666666665,FUN_009369-T1,A8KBE0,,,,,31.3,823.0,3.5e-86,321.2,sp|A8KBE0|OXR1_XENTR Oxidation resistance protein 1 OS=Xenopus tropicalis OX=8364 GN=oxr1 PE=2 SV=2,,,,,,
OG_08575,0.2401581677132194,OG_08575,FUN_037586-T1,Peve_00035294,Pocillopora_meandrina_HIv1___RNAseq.g1594.t1,three_way,57.32,FUN_037586-T1,Q2TBA3,MALT1_MOUSE,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase),Mus musculus (Mouse),30.2,394.0,3.9e-35,151.4,sp|Q2TBA3|MALT1_MOUSE Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog OS=Mus musculus OX=10090 GN=Malt1 PE=1 SV=2,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005829; GO:0006508; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051168; GO:0051603; GO:0061133; GO:0071222; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; cellular response to lipopolysaccharide [GO:0071222]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; protease binding [GO:0002020]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06372,0.2400291695664075,OG_06372,FUN_028977-T1,Peve_00014804,Pocillopora_meandrina_HIv1___RNAseq.g25607.t1,three_way,64.57616666666667,FUN_028977-T1,Q3UG20,KMT2E_MOUSE,,Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog),Mus musculus (Mouse),30.4,460.0,1e-47,194.1,sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2,GO:0000791; GO:0002446; GO:0003713; GO:0005737; GO:0005813; GO:0008270; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0035064; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:1900087,epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; retinoic acid receptor signaling pathway [GO:0048384],centrosome [GO:0005813]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005815; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"immune system process; catalytic activity; microtubule organizing center; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_10051,0.2400216111214298,OG_10051,FUN_043325-T1,Peve_00043035,Pocillopora_meandrina_HIv1___RNAseq.g8952.t1,three_way,72.11733333333333,FUN_043325-T1,Q2HWF0,FBP1L_RAT,,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),Rattus norvegicus (Rat),31.6,604.0,1.9000000000000002e-74,281.6,sp|Q2HWF0|FBP1L_RAT Formin-binding protein 1-like OS=Rattus norvegicus OX=10116 GN=Fnbp1l PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0007399; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0030154; GO:0031410; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320,autophagy [GO:0006914]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; nervous system development [GO:0007399]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886],GTPase binding [GO:0051020]; lipid binding [GO:0008289],GO:0005829; GO:0005856; GO:0005886; GO:0006914; GO:0008289; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0061024,cytosol; cytoskeleton; plasma membrane; autophagy; lipid binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; membrane organization
OG_01354,0.2398942933944865,OG_01354,FUN_005267-T1,Peve_00003352,Pocillopora_meandrina_HIv1___RNAseq.g8154.t1,three_way,58.39033333333333,FUN_005267-T1,B5X4E0,,,,,38.4,289.0,2.6000000000000003e-44,180.6,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_04758,0.2398618456704748,OG_04758,FUN_022647-T1,Peve_00036577,Pocillopora_meandrina_HIv1___RNAseq.g4454.t1,three_way,72.587,FUN_022647-T1,Q15434,,,,,61.2,232.0,9.8e-69,262.7,"sp|Q15434|RBMS2_HUMAN RNA-binding motif, single-stranded-interacting protein 2 OS=Homo sapiens OX=9606 GN=RBMS2 PE=1 SV=1",,,,,,
OG_07649,0.239822145405444,OG_07649,FUN_034481-T1,Peve_00010882,Pocillopora_meandrina_HIv1___RNAseq.g28844.t1,three_way,80.02866666666667,FUN_034481-T1,P80147,GABT_PIG,,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)",Sus scrofa (Pig),53.6,459.0,4.2e-148,526.2,"sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2",GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537,gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877],4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016740; GO:0043226; GO:0050877,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; transferase activity; organelle; nervous system process
OG_04010,0.2398217101615352,OG_04010,FUN_016311-T1,Peve_00032324,Pocillopora_meandrina_HIv1___RNAseq.g10035.t1,three_way,78.09949999999999,FUN_016311-T1,Q76L87,,,,,37.8,259.0,3.8e-27,124.0,sp|Q76L87|DMTA2_ORYLA Doublesex- and mab-3-related transcription factor A2 OS=Oryzias latipes OX=8090 GN=dmrta2 PE=3 SV=1,,,,,,
OG_02982,0.2395484781021195,OG_02982,FUN_012152-T1,Peve_00035458,Pocillopora_meandrina_HIv1___TS.g16648.t1,three_way,75.35416666666667,FUN_012152-T1,Q8NEN0,,,,,32.3,885.0,5.2000000000000004e-117,423.7,sp|Q8NEN0|ARMC2_HUMAN Armadillo repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=ARMC2 PE=1 SV=4,,,,,,
OG_00402,0.2395391711778506,OG_00402,FUN_001289-T1,Peve_00037015,Pocillopora_meandrina_HIv1___TS.g4708.t1a,three_way,81.49916666666667,FUN_001289-T1,Q9ULJ6,,,,,45.5,1166.0,3.5e-155,550.8,sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3,,,,,,
OG_04037,0.2395192730698484,OG_04037,FUN_016345-T1,Peve_00004334,Pocillopora_meandrina_HIv1___TS.g23380.t1,three_way,66.87283333333333,FUN_016345-T1,P63252,KCNJ2_HUMAN,,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",Homo sapiens (Human),42.7,328.0,8.2e-70,265.8,sp|P63252|KCNJ2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens OX=9606 GN=KCNJ2 PE=1 SV=1,GO:0005242; GO:0005546; GO:0005886; GO:0006813; GO:0008076; GO:0014704; GO:0014861; GO:0015693; GO:0016020; GO:0030007; GO:0030315; GO:0034765; GO:0042802; GO:0043025; GO:0043197; GO:0045211; GO:0051289; GO:0055119; GO:0060075; GO:0060306; GO:0071260; GO:0071805; GO:0086002; GO:0086004; GO:0086008; GO:0086011; GO:0086012; GO:0086013; GO:0086091; GO:0090076; GO:0098978; GO:1901381; GO:1990573,cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to mechanical stimulus [GO:0071260]; intracellular potassium ion homeostasis [GO:0030007]; magnesium ion transport [GO:0015693]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076],dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076],"identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]",GO:0003012; GO:0005215; GO:0005886; GO:0008289; GO:0055085; GO:0065003,muscle system process; transporter activity; plasma membrane; lipid binding; transmembrane transport; protein-containing complex assembly
OG_00847,0.2395038669822921,OG_00847,FUN_004098-T1,Peve_00028980,Pocillopora_meandrina_HIv1___RNAseq.g11565.t1,three_way,82.82433333333333,FUN_004098-T1,A7RQM5,ASNA_NEMVE,,ATPase ASNA1 homolog (EC 3.6.-.-) (Arsenical pump-driving ATPase homolog) (Arsenite-stimulated ATPase),Nematostella vectensis (Starlet sea anemone),80.4,327.0,1.3e-153,543.9,sp|A7RQM5|ASNA_NEMVE ATPase ASNA1 homolog OS=Nematostella vectensis OX=45351 GN=v1g161623 PE=3 SV=1,GO:0005524; GO:0016887; GO:0043529; GO:0046872; GO:0071816,tail-anchored membrane protein insertion into ER membrane [GO:0071816],GET complex [GO:0043529],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872],GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_00650,0.2394973490954432,OG_00650,FUN_001905-T1,Peve_00013092,Pocillopora_meandrina_HIv1___RNAseq.g2568.t1,three_way,52.91466666666667,FUN_001905-T1,Q9TVU5,,,,,34.3,166.0,1e-20,101.7,sp|Q9TVU5|RAB1_THEPA Ras-related protein Rab-1 OS=Theileria parva OX=5875 GN=rab1 PE=1 SV=1,,,,,,
OG_03402,0.2394391606841368,OG_03402,FUN_014441-T1,Peve_00009614,Pocillopora_meandrina_HIv1___RNAseq.g22836.t1,three_way,66.44333333333333,FUN_014441-T1,Q6PDY2,AEDO_MOUSE,,2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase),Mus musculus (Mouse),34.8,264.0,2.0000000000000002e-29,131.0,sp|Q6PDY2|AEDO_MOUSE 2-aminoethanethiol dioxygenase OS=Mus musculus OX=10090 GN=Ado PE=1 SV=2,GO:0005506; GO:0005739; GO:0047800; GO:0071456,cellular response to hypoxia [GO:0071456],mitochondrion [GO:0005739],cysteamine dioxygenase activity [GO:0047800]; iron ion binding [GO:0005506],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_01556,0.2394209187159211,OG_01556,FUN_006436-T1,Peve_00024930,Pocillopora_meandrina_HIv1___RNAseq.g20293.t1,three_way,69.03933333333335,FUN_006436-T1,Q8BW70,,,,,34.7,1038.0,8.4e-156,552.7,sp|Q8BW70|UBP38_MOUSE Ubiquitin carboxyl-terminal hydrolase 38 OS=Mus musculus OX=10090 GN=Usp38 PE=1 SV=2,,,,,,
OG_01440,0.2393738411478195,OG_01440,FUN_005878-T1,Peve_00015762,Pocillopora_meandrina_HIv1___RNAseq.g19674.t1,three_way,82.214,FUN_005878-T1,Q9Y619,ORNT1_HUMAN,,Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15),Homo sapiens (Human),54.9,288.0,1.4e-85,317.8,sp|Q9Y619|ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens OX=9606 GN=SLC25A15 PE=1 SV=1,GO:0000050; GO:0000064; GO:0005739; GO:0005743; GO:0015189; GO:0015297; GO:0016020; GO:0061459; GO:1903401; GO:1903826; GO:1990575,L-arginine transmembrane transport [GO:1903826]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],antiporter activity [GO:0015297]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],GO:0005215; GO:0005739; GO:0043226; GO:0055085; GO:0071941,transporter activity; mitochondrion; organelle; transmembrane transport; nitrogen cycle metabolic process
OG_05687,0.2393584227078086,OG_05687,FUN_025538-T1,Peve_00013052,Pocillopora_meandrina_HIv1___RNAseq.g13802.t1,three_way,63.76133333333333,FUN_025538-T1,Q3SYU1,NOC2L_BOVIN,,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),Bos taurus (Bovine),39.7,491.0,3.2e-107,391.0,sp|Q3SYU1|NOC2L_BOVIN Nucleolar complex protein 2 homolog OS=Bos taurus OX=9913 GN=NOC2L PE=2 SV=1,GO:0000122; GO:0003714; GO:0005654; GO:0005730; GO:0006915; GO:0030690; GO:0030691; GO:0042273; GO:0042393,apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273],Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005654; GO:0005730; GO:0006355; GO:0012501; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleoplasm; nucleolus; regulation of DNA-templated transcription; programmed cell death; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_05266,0.2392527562469502,OG_05266,FUN_023798-T1,Peve_00039438,Pocillopora_meandrina_HIv1___RNAseq.g3305.t1,three_way,83.62333333333333,FUN_023798-T1,P54886,P5CS_HUMAN,,Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)],Homo sapiens (Human),59.2,777.0,1e-249,864.4,sp|P54886|P5CS_HUMAN Delta-1-pyrroline-5-carboxylate synthase OS=Homo sapiens OX=9606 GN=ALDH18A1 PE=1 SV=2,GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006536; GO:0006561; GO:0006592; GO:0009266; GO:0019240; GO:0042802; GO:0055129,citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]; response to temperature stimulus [GO:0009266],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0016740; GO:0043226,RNA binding; catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; transferase activity; organelle
OG_02119,0.2391908447270255,OG_02119,FUN_008404-T1,Peve_00031485,Pocillopora_meandrina_HIv1___RNAseq.g18034.t1,three_way,63.198,,,,,,,,,,,,,,,,,
OG_06957,0.2391704700160603,OG_06957,FUN_032082-T1,Peve_00039909,Pocillopora_meandrina_HIv1___RNAseq.g5228.t1,three_way,70.91216666666666,FUN_032082-T1,Q6UWX4,,,,,47.1,605.0,4.7e-163,576.2,sp|Q6UWX4|HIPL2_HUMAN HHIP-like protein 2 OS=Homo sapiens OX=9606 GN=HHIPL2 PE=1 SV=1,,,,,,
OG_06170,0.2391092632191478,OG_06170,FUN_028023-T1,Peve_00010826,Pocillopora_meandrina_HIv1___RNAseq.g13914.t1,three_way,48.07233333333333,,,,,,,,,,,,,,,,,
OG_07566,0.2388683943850041,OG_07566,FUN_034216-T1,Peve_00027530,Pocillopora_meandrina_HIv1___RNAseq.g26161.t1,three_way,74.85666666666667,,,,,,,,,,,,,,,,,
OG_08298,0.2386920134246958,OG_08298,FUN_036247-T1,Peve_00042155,Pocillopora_meandrina_HIv1___RNAseq.g27593.t1,three_way,84.28566666666666,FUN_036247-T1,Q8NDZ6,,,,,42.0,505.0,3.1e-103,377.1,sp|Q8NDZ6|T161B_HUMAN Transmembrane protein 161B OS=Homo sapiens OX=9606 GN=TMEM161B PE=1 SV=1,,,,,,
OG_02819,0.2386580350899473,OG_02819,FUN_011806-T1,Peve_00013013,Pocillopora_meandrina_HIv1___RNAseq.g23247.t1,three_way,51.883,FUN_011806-T1,O60287,,,,,28.8,1032.0,1.1999999999999999e-91,340.9,sp|O60287|NPA1P_HUMAN Nucleolar pre-ribosomal-associated protein 1 OS=Homo sapiens OX=9606 GN=URB1 PE=1 SV=4,,,,,,
OG_05538,0.2386351614458419,OG_05538,FUN_024740-T1,Peve_00026310,Pocillopora_meandrina_HIv1___RNAseq.g18838.t1,three_way,80.97633333333333,FUN_024740-T1,O15067,PUR4_HUMAN,,Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase) (Phosphoribosylformylglycineamide amidotransferase),Homo sapiens (Human),58.8,1323.0,0.0,1520.8,sp|O15067|PUR4_HUMAN Phosphoribosylformylglycinamidine synthase OS=Homo sapiens OX=9606 GN=PFAS PE=1 SV=4,GO:0004642; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006541; GO:0009168; GO:0009410; GO:0044208; GO:0046872; GO:0070062; GO:0097065; GO:0097294,'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to xenobiotic stimulus [GO:0009410],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642],GO:0003824; GO:0005829; GO:0006520; GO:0016874; GO:0043226; GO:0048856; GO:0055086; GO:1901135,catalytic activity; cytosol; amino acid metabolic process; ligase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05729,0.2385080329648625,OG_05729,FUN_025654-T1,Peve_00002534,Pocillopora_meandrina_HIv1___RNAseq.g23083.t1,three_way,64.02466666666666,FUN_025654-T1,A4IH36,,,,,33.0,203.0,3.6e-23,110.5,sp|A4IH36|ADIPL_XENTR Adipolin OS=Xenopus tropicalis OX=8364 GN=c1qtnf12 PE=2 SV=1,,,,,,
OG_00577,0.2384747149327979,OG_00577,FUN_001639-T1,Peve_00020138,Pocillopora_meandrina_HIv1___RNAseq.g29422.t1,three_way,78.42066666666666,FUN_001639-T1,Q5ZIH2,,,,,53.5,445.0,6.7e-134,479.2,sp|Q5ZIH2|MON1A_CHICK Vacuolar fusion protein MON1 homolog A OS=Gallus gallus OX=9031 GN=MON1A PE=2 SV=1,,,,,,
OG_01098,0.2384092466734336,OG_01098,FUN_004598-T1,Peve_00012407,Pocillopora_meandrina_HIv1___RNAseq.g6588.t1,three_way,65.93233333333333,,,,,,,,,,,,,,,,,
OG_03274,0.2383796283538073,OG_03274,FUN_013153-T1,Peve_00022450,Pocillopora_meandrina_HIv1___RNAseq.g12978.t1,three_way,39.60333333333333,,,,,,,,,,,,,,,,,
OG_01808,0.238080053786942,OG_01808,FUN_007607-T1,Peve_00034273,Pocillopora_meandrina_HIv1___RNAseq.g5809.t1,three_way,55.49466666666667,FUN_007607-T1,Q8R2S1,,,,,31.8,525.0,3.5e-63,245.0,sp|Q8R2S1|RPKL1_MOUSE Ribosomal protein S6 kinase-like 1 OS=Mus musculus OX=10090 GN=Rps6kl1 PE=1 SV=1,,,,,,
OG_03689,0.2379797525585592,OG_03689,FUN_014951-T1,Peve_00006245,Pocillopora_meandrina_HIv1___RNAseq.g21118.t1,three_way,71.575,FUN_014951-T1,A8WGF7,,,,,52.3,459.0,5e-126,453.0,sp|A8WGF7|SPNS1_XENTR Protein spinster homolog 1 OS=Xenopus tropicalis OX=8364 GN=spns1 PE=2 SV=2,,,,,,
OG_00369,0.2378936477977517,OG_00369,FUN_001210-T1,Peve_00033819,Pocillopora_meandrina_HIv1___RNAseq.g29515.t1,three_way,72.2315,FUN_001210-T1,O74362,,,,,37.0,243.0,2.2e-35,150.6,sp|O74362|ESF2_SCHPO Pre-rRNA-processing protein esf2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=esf2 PE=1 SV=1,,,,,,
OG_10013,0.2378359041474755,OG_10013,FUN_043250-T1,Peve_00028667,Pocillopora_meandrina_HIv1___RNAseq.g8852.t1,three_way,78.99966666666667,FUN_043250-T1,Q9PUB8,S39A7_DANRE,,"Zinc transporter Slc39a7 (Histidine-rich membrane protein Ke4) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7)",Danio rerio (Zebrafish) (Brachydanio rerio),64.0,342.0,3.0999999999999997e-85,317.4,sp|Q9PUB8|S39A7_DANRE Zinc transporter Slc39a7 OS=Danio rerio OX=7955 GN=slc39a7 PE=2 SV=2,GO:0005385; GO:0005789; GO:0005794; GO:0006829; GO:0006882; GO:0030183; GO:0071577; GO:0098773; GO:0110075,B cell differentiation [GO:0030183]; intracellular zinc ion homeostasis [GO:0006882]; regulation of ferroptosis [GO:0110075]; skin epidermis development [GO:0098773]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],zinc ion transmembrane transporter activity [GO:0005385],GO:0002376; GO:0005215; GO:0005794; GO:0030154; GO:0043226; GO:0048856; GO:0055085,immune system process; transporter activity; Golgi apparatus; cell differentiation; organelle; anatomical structure development; transmembrane transport
OG_00750,0.237559953153523,OG_00750,FUN_002807-T1,Peve_00044270,Pocillopora_meandrina_HIv1___RNAseq.g14969.t1,three_way,74.78366666666668,FUN_002807-T1,Q8BX57,PXK_MOUSE,,"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)",Mus musculus (Mouse),47.6,435.0,3.4e-114,413.7,sp|Q8BX57|PXK_MOUSE PX domain-containing protein kinase-like protein OS=Mus musculus OX=10090 GN=Pxk PE=1 SV=2,GO:0003779; GO:0004672; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0043271; GO:0050804,inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of monoatomic ion transport [GO:0043271],centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein kinase activity [GO:0004672],GO:0003824; GO:0005829; GO:0005886; GO:0006954; GO:0008092; GO:0008289; GO:0016740; GO:0140096,"catalytic activity; cytosol; plasma membrane; inflammatory response; cytoskeletal protein binding; lipid binding; transferase activity; catalytic activity, acting on a protein"
OG_03154,0.2375200697925251,OG_03154,FUN_012545-T1,Peve_00030392,Pocillopora_meandrina_HIv1___RNAseq.g23621.t1,three_way,90.88266666666668,FUN_012545-T1,Q9DC48,,,,,66.9,550.0,4.299999999999998e-229,795.4,sp|Q9DC48|PRP17_MOUSE Pre-mRNA-processing factor 17 OS=Mus musculus OX=10090 GN=Cdc40 PE=1 SV=1,,,,,,
OG_06133,0.237356334867259,OG_06133,FUN_027939-T1,Peve_00023148,Pocillopora_meandrina_HIv1___RNAseq.g14031.t1,three_way,77.95766666666667,FUN_027939-T1,Q18120,TWK18_CAEEL,,TWiK family of potassium channels protein 18,Caenorhabditis elegans,35.9,192.0,7.4e-23,109.8,sp|Q18120|TWK18_CAEEL TWiK family of potassium channels protein 18 OS=Caenorhabditis elegans OX=6239 GN=twk-18 PE=1 SV=2,GO:0005886; GO:0006813; GO:0006936; GO:0015271; GO:0016020; GO:0022841; GO:0040011; GO:0071805,locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813],membrane [GO:0016020]; plasma membrane [GO:0005886],outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841],GO:0003012; GO:0005215; GO:0005886; GO:0055085,muscle system process; transporter activity; plasma membrane; transmembrane transport
OG_08646,0.2373532966684239,OG_08646,FUN_037837-T1,Peve_00000568,Pocillopora_meandrina_HIv1___RNAseq.g1461.t1,three_way,77.83033333333334,FUN_037837-T1,F6QV99,,,,,62.9,345.0,2.2e-119,430.3,sp|F6QV99|ATAD1_BOVIN Outer mitochondrial transmembrane helix translocase OS=Bos taurus OX=9913 GN=ATAD1 PE=2 SV=2,,,,,,
OG_03137,0.237143340600548,OG_03137,FUN_012518-T1,Peve_00022370,Pocillopora_meandrina_HIv1___RNAseq.g23957.t1,three_way,84.53366666666666,FUN_012518-T1,Q8CHX6,MBTP2_MOUSE,,Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P),Mus musculus (Mouse),40.6,508.0,4.7e-104,379.8,sp|Q8CHX6|MBTP2_MOUSE Membrane-bound transcription factor site-2 protease OS=Mus musculus OX=10090 GN=Mbtps2 PE=2 SV=1,GO:0000139; GO:0004222; GO:0005737; GO:0005789; GO:0007095; GO:0008203; GO:0031293; GO:0034976; GO:0045542; GO:0045944; GO:0046872; GO:0051604; GO:0070977; GO:0140537,bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein maturation [GO:0051604]; response to endoplasmic reticulum stress [GO:0034976],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; transcription regulator activator activity [GO:0140537],GO:0003824; GO:0006355; GO:0006629; GO:0016787; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; regulation of DNA-templated transcription; lipid metabolic process; hydrolase activity; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06641,0.237061413806664,OG_06641,FUN_030202-T1,Peve_00017913,Pocillopora_meandrina_HIv1___RNAseq.g17365.t1,three_way,75.41716666666666,FUN_030202-T1,Q96SU4,OSBL9_HUMAN,,Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9),Homo sapiens (Human),43.4,491.0,4.6e-91,336.7,sp|Q96SU4|OSBL9_HUMAN Oxysterol-binding protein-related protein 9 OS=Homo sapiens OX=9606 GN=OSBPL9 PE=1 SV=2,GO:0005794; GO:0005829; GO:0006699; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0120015,bile acid biosynthetic process [GO:0006699],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020],sterol binding [GO:0032934]; sterol transfer activity [GO:0120015],GO:0005215; GO:0005794; GO:0005829; GO:0006629; GO:0008289; GO:0043226,transporter activity; Golgi apparatus; cytosol; lipid metabolic process; lipid binding; organelle
OG_03330,0.2369650860685003,OG_03330,FUN_013421-T1,Peve_00038575,Pocillopora_meandrina_HIv1___TS.g15837.t1,three_way,55.18933333333333,FUN_013421-T1,P42893,,,,,35.5,707.0,1.3000000000000002e-124,448.7,sp|P42893|ECE1_RAT Endothelin-converting enzyme 1 OS=Rattus norvegicus OX=10116 GN=Ece1 PE=1 SV=2,,,,,,
OG_03660,0.2369237694689545,OG_03660,FUN_014897-T1,Peve_00003545,Pocillopora_meandrina_HIv1___RNAseq.g21065.t1,three_way,70.15983333333334,FUN_014897-T1,Q9Y4D8,,,,,34.5,4127.0,0.0,2025.4,sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5,,,,,,
OG_02356,0.2368912181413771,OG_02356,FUN_008959-T1,Peve_00021629,Pocillopora_meandrina_HIv1___RNAseq.g4044.t1,three_way,87.273,FUN_008959-T1,Q9UKD2,,,,,61.5,218.0,1.2e-78,294.3,sp|Q9UKD2|MRT4_HUMAN mRNA turnover protein 4 homolog OS=Homo sapiens OX=9606 GN=MRTO4 PE=1 SV=2,,,,,,
OG_09463,0.2361536467744507,OG_09463,FUN_041486-T1,Peve_00004078,Pocillopora_meandrina_HIv1___RNAseq.g15672.t2,three_way,56.60683333333333,FUN_041486-T1,D3ZZL9,,,,,35.3,388.0,1.7e-30,137.9,sp|D3ZZL9|GCC2_RAT GRIP and coiled-coil domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Gcc2 PE=1 SV=1,,,,,,
OG_00602,0.2360093483140835,OG_00602,FUN_001750-T1,Peve_00019399,Pocillopora_meandrina_HIv1___RNAseq.g2655.t1,three_way,82.17433333333334,,,,,,,,,,,,,,,,,
OG_04016,0.2359943347213512,OG_04016,FUN_016320-T1,Peve_00000581,Pocillopora_meandrina_HIv1___RNAseq.g9711.t1,three_way,50.35866666666666,FUN_016320-T1,E7F6T8,UBP37_DANRE,,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),Danio rerio (Zebrafish) (Brachydanio rerio),36.6,361.0,7e-47,191.0,sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1,GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0021551; GO:0031647; GO:0035871; GO:0051301; GO:0071108; GO:1904888,cell division [GO:0051301]; central nervous system morphogenesis [GO:0021551]; cranial skeletal system development [GO:1904888]; G1/S transition of mitotic cell cycle [GO:0000082]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04016,0.2359943347213512,OG_04016,FUN_016320-T1,Peve_00000581,Pocillopora_meandrina_HIv1___RNAseq.g9711.t1,three_way,50.35866666666666,FUN_016320-T1,E7F6T8,UBP37_DANRE,,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),Danio rerio (Zebrafish) (Brachydanio rerio),47.1,70.0,3e-13,79.3,sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1,GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0021551; GO:0031647; GO:0035871; GO:0051301; GO:0071108; GO:1904888,cell division [GO:0051301]; central nervous system morphogenesis [GO:0021551]; cranial skeletal system development [GO:1904888]; G1/S transition of mitotic cell cycle [GO:0000082]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08924,0.2359873797070335,OG_08924,FUN_038381-T1,Peve_00000068,Pocillopora_meandrina_HIv1___RNAseq.g28294.t2,three_way,78.44800000000001,FUN_038381-T1,Q9UNK0,STX8_HUMAN,,Syntaxin-8,Homo sapiens (Human),41.1,224.0,7.199999999999997e-35,149.1,sp|Q9UNK0|STX8_HUMAN Syntaxin-8 OS=Homo sapiens OX=9606 GN=STX8 PE=1 SV=2,GO:0000149; GO:0005484; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005802; GO:0005886; GO:0006886; GO:0006906; GO:0012505; GO:0019869; GO:0019905; GO:0031201; GO:0031625; GO:0031982; GO:0045022; GO:0045335; GO:0048278; GO:0048471; GO:0055037; GO:0071346; GO:1903076,cellular response to type II interferon [GO:0071346]; early endosome to late endosome transport [GO:0045022]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982],chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625],GO:0005768; GO:0005783; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0098772,endosome; endoplasmic reticulum; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; molecular function regulator activity
OG_01940,0.2359481403087956,OG_01940,FUN_007990-T1,Peve_00040190,Pocillopora_meandrina_HIv1___RNAseq.g18166.t1,three_way,74.74333333333333,FUN_007990-T1,Q61103,REQU_MOUSE,,"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)",Mus musculus (Mouse),41.2,391.0,2.7e-74,280.8,sp|Q61103|REQU_MOUSE Zinc finger protein ubi-d4 OS=Mus musculus OX=10090 GN=Dpf2 PE=1 SV=1,GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006338; GO:0006357; GO:0006915; GO:0008270; GO:0016514; GO:0030071; GO:0070316; GO:0140015; GO:0140046; GO:1902459; GO:1905454; GO:2000045; GO:2000781; GO:2000819,apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],histone H3K14ac reader activity [GO:0140015]; histone H4K16ac reader activity [GO:0140046]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006325; GO:0006355; GO:0012501; GO:0043226; GO:0060090,nucleus; nucleoplasm; microtubule organizing center; cytosol; chromatin organization; regulation of DNA-templated transcription; programmed cell death; organelle; molecular adaptor activity
OG_07422,0.2358751929470902,OG_07422,FUN_033884-T1,Peve_00043305,Pocillopora_meandrina_HIv1___RNAseq.g28393.t1,three_way,52.554,,,,,,,,,,,,,,,,,
OG_04199,0.2358380221162853,OG_04199,FUN_016732-T1,Peve_00014684,Pocillopora_meandrina_HIv1___RNAseq.g234.t1,three_way,56.1385,,,,,,,,,,,,,,,,,
OG_04464,0.2357568352321573,OG_04464,FUN_019346-T1,Peve_00032914,Pocillopora_meandrina_HIv1___RNAseq.g20864.t1,three_way,58.6805,FUN_019346-T1,Q80XP9,WNK3_MOUSE,,Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3),Mus musculus (Mouse),68.5,378.0,6e-143,510.8,sp|Q80XP9|WNK3_MOUSE Serine/threonine-protein kinase WNK3 OS=Mus musculus OX=10090 GN=Wnk3 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005912; GO:0005923; GO:0006884; GO:0007231; GO:0010765; GO:0010800; GO:0035633; GO:0043066; GO:0044325; GO:0050801; GO:0051928; GO:0070294; GO:0071474; GO:0072659; GO:0090188; GO:0090279; GO:0106310; GO:0140693; GO:0140694; GO:0141109; GO:1903077; GO:1903078; GO:1904062; GO:2000651,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; maintenance of blood-brain barrier [GO:0035633]; membraneless organelle assembly [GO:0140694]; monoatomic ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; osmosensory signaling pathway [GO:0007231]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of calcium ion import [GO:0090279]; regulation of monoatomic cation transmembrane transport [GO:1904062]; renal sodium ion absorption [GO:0070294],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transmembrane transporter binding [GO:0044325]; transporter activator activity [GO:0141109],GO:0003014; GO:0003824; GO:0016740; GO:0060090; GO:0072659; GO:0098772; GO:0140096,"renal system process; catalytic activity; transferase activity; molecular adaptor activity; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04165,0.2357019509383807,OG_04165,FUN_016646-T1,Peve_00042745,Pocillopora_meandrina_HIv1___RNAseq.g199.t1,three_way,51.387166666666666,FUN_016646-T1,P30173,,,,,42.1,378.0,2.2e-80,302.4,sp|P30173|ACT13_SOLTU Actin-101 OS=Solanum tuberosum OX=4113 GN=AC101 PE=3 SV=1,,,,,,
OG_03562,0.2356542637017522,OG_03562,FUN_014710-T1,Peve_00004185,Pocillopora_meandrina_HIv1___TS.g27294.t1,three_way,91.096,FUN_014710-T1,Q5SPC5,OTOF_DANRE,,Otoferlin (Fer-1-like protein 2),Danio rerio (Zebrafish) (Brachydanio rerio),49.8,2026.0,0.0,1855.5,sp|Q5SPC5|OTOF_DANRE Otoferlin OS=Danio rerio OX=7955 GN=otof PE=3 SV=1,GO:0000139; GO:0001964; GO:0005509; GO:0005789; GO:0007009; GO:0007605; GO:0010996; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0036465; GO:0042995; GO:0048787; GO:0050885,neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle recycling [GO:0036465],basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672],AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509],GO:0016192; GO:0050877; GO:0061024; GO:0065003,vesicle-mediated transport; nervous system process; membrane organization; protein-containing complex assembly
OG_07865,0.2356167063496122,OG_07865,FUN_035222-T1,Peve_00035887,Pocillopora_meandrina_HIv1___RNAseq.g27609.t1,three_way,55.40566666666666,FUN_035222-T1,Q501V0,KPSH1_DANRE,,Serine/threonine-protein kinase H1 homolog (EC 2.7.11.1),Danio rerio (Zebrafish) (Brachydanio rerio),66.9,323.0,4.8e-116,419.9,sp|Q501V0|KPSH1_DANRE Serine/threonine-protein kinase H1 homolog OS=Danio rerio OX=7955 GN=pskh1 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005737; GO:0106310,,cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_01636,0.2356094580640244,OG_01636,FUN_006769-T1,Peve_00027411,Pocillopora_meandrina_HIv1___RNAseq.g20028.t1,three_way,57.7305,FUN_006769-T1,Q9Y2U8,MAN1_HUMAN,,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),Homo sapiens (Human),42.9,317.0,7.4e-55,216.9,sp|Q9Y2U8|MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2,GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446,negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446],GO:0003677,DNA binding
OG_06314,0.2355958217406775,OG_06314,FUN_028554-T1,Peve_00002501,Pocillopora_meandrina_HIv1___RNAseq.g20706.t2,three_way,70.67833333333333,FUN_028554-T1,A8MWY0,ELAP2_HUMAN,,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L),Homo sapiens (Human),35.5,1029.0,1.2e-176,622.1,sp|A8MWY0|ELAP2_HUMAN Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Homo sapiens OX=9606 GN=ELAPOR2 PE=1 SV=2,GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700,negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684],membrane [GO:0016020]; plasma membrane [GO:0005886],BMP receptor binding [GO:0070700],GO:0005886,plasma membrane
OG_08394,0.2355911021767766,OG_08394,FUN_037006-T1,Peve_00032341,Pocillopora_meandrina_HIv1___RNAseq.g26695.t1,three_way,75.10066666666667,FUN_037006-T1,Q8GX78,ANTR2_ARATH,,"Ascorbate transporter, chloroplastic (Phosphate transporter PHT4;4) (AtPHT4;4) (Probable anion transporter 2)",Arabidopsis thaliana (Mouse-ear cress),32.4,435.0,1.8000000000000001e-65,251.5,"sp|Q8GX78|ANTR2_ARATH Ascorbate transporter, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=PHT4;4 PE=1 SV=1",GO:0005315; GO:0009507; GO:0009536; GO:0009706; GO:0009941; GO:0010028; GO:0015229; GO:0015882,L-ascorbic acid transmembrane transport [GO:0015882]; xanthophyll cycle [GO:0010028],chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast inner membrane [GO:0009706]; plastid [GO:0009536],L-ascorbic acid transmembrane transporter activity [GO:0015229]; phosphate transmembrane transporter activity [GO:0005315],GO:0005215; GO:0006629; GO:0009536; GO:0043226; GO:0055085,transporter activity; lipid metabolic process; plastid; organelle; transmembrane transport
OG_03364,0.2355134212635976,OG_03364,FUN_013606-T1,Peve_00002653,Pocillopora_meandrina_HIv1___RNAseq.g13526.t1,three_way,79.673,FUN_013606-T1,Q60HE5,,,,,52.4,614.0,6.400000000000001e-186,652.1,sp|Q60HE5|MTHR_MACFA Methylenetetrahydrofolate reductase (NADPH) OS=Macaca fascicularis OX=9541 GN=MTHFR PE=2 SV=1,,,,,,
OG_06541,0.2354864714864628,OG_06541,FUN_029405-T1,Peve_00035059,Pocillopora_meandrina_HIv1___RNAseq.g17144.t1,three_way,85.84700000000001,FUN_029405-T1,Q3MHG1,SPTC1_BOVIN,,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),Bos taurus (Bovine),57.5,463.0,4.2e-156,552.7,sp|Q3MHG1|SPTC1_BOVIN Serine palmitoyltransferase 1 OS=Bos taurus OX=9913 GN=SPTLC1 PE=2 SV=1,GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0017059; GO:0030170; GO:0046512; GO:0046513; GO:1904649,ceramide biosynthetic process [GO:0046513]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059],pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_04595,0.2354841674057098,OG_04595,FUN_022279-T1,Peve_00022093,Pocillopora_meandrina_HIv1___RNAseq.g4703.t2,three_way,75.602,FUN_022279-T1,Q7ZWS1,DUS3L_XENLA,,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like),Xenopus laevis (African clawed frog),54.4,634.0,7.399999999999997e-190,665.2,sp|Q7ZWS1|DUS3L_XENLA tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Xenopus laevis OX=8355 GN=dus3l PE=2 SV=1,GO:0002943; GO:0003723; GO:0006397; GO:0006417; GO:0008270; GO:0017150; GO:0050660; GO:0102265; GO:0106414,mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943],,flavin adenine dinucleotide binding [GO:0050660]; mRNA dihydrouridine synthase activity [GO:0106414]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine47 synthase activity [GO:0102265]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0006399; GO:0016071; GO:0016491; GO:0140098,"RNA binding; catalytic activity; tRNA metabolic process; mRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA"
OG_08878,0.2353419137118953,OG_08878,FUN_038277-T1,Peve_00041700,Pocillopora_meandrina_HIv1___TS.g8098.t1,three_way,74.06316666666667,FUN_038277-T1,Q0V8S9,,,,,34.8,135.0,1.4e-13,84.7,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_02481,0.2353205476858331,OG_02481,FUN_009771-T1,Peve_00002097,Pocillopora_meandrina_HIv1___RNAseq.g24559.t1,three_way,79.394,FUN_009771-T1,Q9WVK7,HCDH_RAT,,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)",Rattus norvegicus (Rat),65.4,286.0,9.4e-104,378.3,"sp|Q9WVK7|HCDH_RAT Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Hadh PE=2 SV=1",GO:0003857; GO:0005654; GO:0005739; GO:0005759; GO:0006635; GO:0007283; GO:0009410; GO:0009725; GO:0014823; GO:0030154; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162,cell differentiation [GO:0030154]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403],GO:0003824; GO:0005654; GO:0005739; GO:0006629; GO:0016491; GO:0022414; GO:0030154; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; lipid metabolic process; oxidoreductase activity; reproductive process; cell differentiation; organelle
OG_01130,0.2351724569178516,OG_01130,FUN_004700-T1,Peve_00044679,Pocillopora_meandrina_HIv1___RNAseq.g8781.t1,three_way,89.18666666666667,FUN_004700-T1,Q2YDN4,,,,,29.7,357.0,5.1e-35,150.2,sp|Q2YDN4|TEKL1_BOVIN Tektin-like protein 1 OS=Bos taurus OX=9913 GN=TEKTL1 PE=1 SV=1,,,,,,
OG_08824,0.2351649266784633,OG_08824,FUN_038161-T1,Peve_00033052,Pocillopora_meandrina_HIv1___RNAseq.g1154.t1,three_way,72.33833333333334,FUN_038161-T1,Q8BHY8,SNX14_MOUSE,,Sorting nexin-14,Mus musculus (Mouse),35.9,892.0,3e-144,514.2,sp|Q8BHY8|SNX14_MOUSE Sorting nexin-14 OS=Mus musculus OX=10090 GN=Snx14 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0030425; GO:0031902; GO:0045202; GO:0080025; GO:0097352; GO:0098794; GO:0099170,autophagosome maturation [GO:0097352]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein transport [GO:0015031],cytosol [GO:0005829]; dendrite [GO:0030425]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; postsynapse [GO:0098794]; synapse [GO:0045202],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]",GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0008289; GO:0031410; GO:0043226,lysosome; endosome; vacuole; cytosol; lipid binding; cytoplasmic vesicle; organelle
OG_01957,0.2349841080037517,OG_01957,FUN_008025-T1,Peve_00011341,Pocillopora_meandrina_HIv1___RNAseq.g30350.t1,three_way,62.04266666666667,,,,,,,,,,,,,,,,,
OG_02647,0.2349179624144738,OG_02647,FUN_010829-T1,Peve_00017534,Pocillopora_meandrina_HIv1___RNAseq.g20912.t1,three_way,43.3975,,,,,,,,,,,,,,,,,
OG_06366,0.2348396040685869,OG_06366,FUN_028970-T1,Peve_00006113,Pocillopora_meandrina_HIv1___RNAseq.g25636.t1,three_way,82.70400000000001,FUN_028970-T1,P13195,HEM1_RAT,,"5-aminolevulinate synthase, non-specific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)",Rattus norvegicus (Rat),52.0,611.0,1.8e-169,597.4,"sp|P13195|HEM1_RAT 5-aminolevulinate synthase, non-specific, mitochondrial OS=Rattus norvegicus OX=10116 GN=Alas1 PE=2 SV=2",GO:0001666; GO:0003870; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0009410; GO:0009635; GO:0010045; GO:0030170; GO:0031667; GO:0032025; GO:0032869; GO:0034698; GO:0042541; GO:0042802; GO:0045471; GO:0048034; GO:0048821; GO:0051591; GO:0070541; GO:1903412,cellular response to insulin stimulus [GO:0032869]; erythrocyte development [GO:0048821]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412]; response to cAMP [GO:0051591]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to nickel cation [GO:0010045]; response to nutrient levels [GO:0031667]; response to platinum ion [GO:0070541]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleoplasm; mitochondrion; cytosol; transferase activity; organelle; anatomical structure development
OG_04286,0.2348386978860047,OG_04286,FUN_017849-T1,Peve_00013266,Pocillopora_meandrina_HIv1___RNAseq.g9583.t1,three_way,76.97,FUN_017849-T1,P57788,,,,,32.0,419.0,1.8e-52,208.4,sp|P57788|MOT4_CHICK Monocarboxylate transporter 4 OS=Gallus gallus OX=9031 GN=SLC16A3 PE=2 SV=2,,,,,,
OG_03042,0.2345337383079936,OG_03042,FUN_012281-T1,Peve_00024232,Pocillopora_meandrina_HIv1___RNAseq.g23579.t1,three_way,65.3465,FUN_012281-T1,Q5TB80,CE162_HUMAN,,Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog),Homo sapiens (Human),31.5,791.0,2.9e-91,339.0,sp|Q5TB80|CE162_HUMAN Centrosomal protein of 162 kDa OS=Homo sapiens OX=9606 GN=CEP162 PE=1 SV=2,GO:0005654; GO:0005794; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005879; GO:0034451; GO:0036064; GO:0043231; GO:0060271,cilium assembly [GO:0060271],axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; spindle [GO:0005819],,GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0043226; GO:0044782,nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; organelle; cilium organization
OG_07681,0.2344767252294624,OG_07681,FUN_034799-T1,Peve_00007557,Pocillopora_meandrina_HIv1___RNAseq.g12300.t1,three_way,88.019,FUN_034799-T1,O14744,,,,,58.5,626.0,8.5e-215,748.0,sp|O14744|ANM5_HUMAN Protein arginine N-methyltransferase 5 OS=Homo sapiens OX=9606 GN=PRMT5 PE=1 SV=4,,,,,,
OG_02131,0.2344549022986726,OG_02131,FUN_008435-T1,Peve_00003897,Pocillopora_meandrina_HIv1___RNAseq.g18054.t1,three_way,72.38416666666667,FUN_008435-T1,Q2KIU0,VTI1B_BOVIN,,Vesicle transport through interaction with t-SNAREs homolog 1B,Bos taurus (Bovine),37.8,225.0,9.900000000000001e-33,141.7,sp|Q2KIU0|VTI1B_BOVIN Vesicle transport through interaction with t-SNAREs homolog 1B OS=Bos taurus OX=9913 GN=VTI1B PE=2 SV=1,GO:0000149; GO:0005484; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006891; GO:0006896; GO:0012507; GO:0016236; GO:0031201; GO:0031901; GO:0031902; GO:0042147; GO:0048280; GO:0055038; GO:1903076,"Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]",cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201],SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0016192; GO:0043226; GO:0060090; GO:0061024,Golgi apparatus; cytosol; intracellular protein transport; autophagy; vesicle-mediated transport; organelle; molecular adaptor activity; membrane organization
OG_06539,0.2344521089014353,OG_06539,FUN_029401-T1,Peve_00044530,Pocillopora_meandrina_HIv1___RNAseq.g17142.t1,three_way,73.958,,,,,,,,,,,,,,,,,
OG_06126,0.2342894783764254,OG_06126,FUN_027923-T1,Peve_00020108,Pocillopora_meandrina_HIv1___RNAseq.g13880.t1,three_way,62.48633333333333,FUN_027923-T1,Q2KHV4,,,,,42.6,298.0,1.4999999999999999e-61,238.0,"sp|Q2KHV4|PARL_BOVIN Presenilin-associated rhomboid-like protein, mitochondrial OS=Bos taurus OX=9913 GN=PARL PE=2 SV=1",,,,,,
OG_04506,0.2342882915071625,OG_04506,FUN_022030-T1,Peve_00036252,Pocillopora_meandrina_HIv1___RNAseq.g3188.t1,three_way,85.19900000000001,FUN_022030-T1,Q9Z1G4,VPP1_MOUSE,,V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1),Mus musculus (Mouse),63.4,855.0,9.9e-307,1053.9,sp|Q9Z1G4|VPP1_MOUSE V-type proton ATPase 116 kDa subunit a 1 OS=Mus musculus OX=10090 GN=Atp6v0a1 PE=1 SV=3,GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0016241; GO:0016607; GO:0030665; GO:0030672; GO:0042470; GO:0046961; GO:0048471; GO:0051117; GO:0097401,regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401],"clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]","ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0005794; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0055085; GO:0140657,transporter activity; Golgi apparatus; cytosol; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_04857,0.2341539353704001,OG_04857,FUN_022871-T1,Peve_00012299,Pocillopora_meandrina_HIv1___RNAseq.g3616.t1,three_way,89.286,FUN_022871-T1,Q90788,NKX25_CHICK,,Homeobox protein Nkx-2.5 (cNKx-2.5) (Homeobox protein NK-2 homolog E),Gallus gallus (Chicken),52.2,159.0,1.2e-33,145.2,sp|Q90788|NKX25_CHICK Homeobox protein Nkx-2.5 OS=Gallus gallus OX=9031 GN=NKX-2.5 PE=2 SV=1,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001947; GO:0003148; GO:0003166; GO:0003168; GO:0003211; GO:0003221; GO:0003222; GO:0003228; GO:0003278; GO:0003285; GO:0003342; GO:0003350; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007512; GO:0010628; GO:0010667; GO:0010765; GO:0010832; GO:0030097; GO:0030154; GO:0030855; GO:0030878; GO:0032991; GO:0032993; GO:0042803; GO:0045666; GO:0045823; GO:0048536; GO:0050673; GO:0050679; GO:0051891; GO:0055005; GO:0055117; GO:0060037; GO:0060038; GO:0060043; GO:0060048; GO:0060261; GO:0060347; GO:0060412; GO:0060413; GO:0060928; GO:0060929; GO:0060971; GO:0061629; GO:0071772; GO:0090090; GO:1903779; GO:1904019; GO:1904036; GO:1990664,adult heart development [GO:0007512]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial cardiac muscle tissue development [GO:0003228]; atrial septum morphogenesis [GO:0060413]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; bundle of His development [GO:0003166]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle contraction [GO:0060048]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; embryonic heart tube left/right pattern formation [GO:0060971]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of heart contraction [GO:0045823]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; proepicardium development [GO:0003342]; pulmonary myocardium development [GO:0003350]; Purkinje myocyte differentiation [GO:0003168]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cardiac muscle contraction [GO:0055117]; regulation of transcription by RNA polymerase II [GO:0006357]; response to BMP [GO:0071772]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; septum secundum development [GO:0003285]; spleen development [GO:0048536]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],cytosol [GO:0005829]; Nkx-2.5 complex [GO:1990664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0007010; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_01780,0.2341255829531134,OG_01780,FUN_007152-T1,Peve_00028248,Pocillopora_meandrina_HIv1___RNAseq.g19716.t1,three_way,58.192,,,,,,,,,,,,,,,,,
OG_05502,0.234118021337476,OG_05502,FUN_024566-T1,Peve_00009964,Pocillopora_meandrina_HIv1___RNAseq.g19087.t1,three_way,94.32233333333332,FUN_024566-T1,P81436,OGT1_RABIT,,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT),Oryctolagus cuniculus (Rabbit),77.1,1013.0,5.3000000000000025e-211,736.1,sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2,GO:0000123; GO:0005547; GO:0005634; GO:0005737; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0017122; GO:0031397; GO:0032922; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263,apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122],"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0006355; GO:0008289; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; nucleus; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid binding; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03583,0.2340755475674319,OG_03583,FUN_014738-T1,Peve_00010439,Pocillopora_meandrina_HIv1___TS.g27242.t1,three_way,73.03666666666666,FUN_014738-T1,Q08AX9,,,,,40.9,648.0,2.6999999999999998e-121,437.6,sp|Q08AX9|SANBR_XENLA SANT and BTB domain regulator of class switch recombination OS=Xenopus laevis OX=8355 GN=sanbr PE=2 SV=1,,,,,,
OG_03729,0.2339269089257959,OG_03729,FUN_015022-T1,Peve_00004790,Pocillopora_meandrina_HIv1___TS.g25933.t1,three_way,69.6595,FUN_015022-T1,Q9Z0J4,,,,,46.8,1462.0,0.0,1275.0,sp|Q9Z0J4|NOS1_MOUSE Nitric oxide synthase 1 OS=Mus musculus OX=10090 GN=Nos1 PE=1 SV=1,,,,,,
OG_07692,0.2339235369826145,OG_07692,FUN_034819-T1,Peve_00041509,Pocillopora_meandrina_HIv1___RNAseq.g27216.t1,three_way,74.395,FUN_034819-T1,Q9R088,,,,,47.5,204.0,1.1e-52,208.4,"sp|Q9R088|KITM_MOUSE Thymidine kinase 2, mitochondrial OS=Mus musculus OX=10090 GN=Tk2 PE=1 SV=2",,,,,,
OG_06516,0.2338413921034507,OG_06516,FUN_029317-T1,Peve_00038259,Pocillopora_meandrina_HIv1___RNAseq.g12575.t1,three_way,56.52,FUN_029317-T1,Q8IY67,,,,,37.9,269.0,1.4e-40,169.9,sp|Q8IY67|RAVR1_HUMAN Ribonucleoprotein PTB-binding 1 OS=Homo sapiens OX=9606 GN=RAVER1 PE=1 SV=1,,,,,,
OG_02940,0.2337273757855766,OG_02940,FUN_012049-T1,Peve_00004088,Pocillopora_meandrina_HIv1___RNAseq.g23650.t3,three_way,68.88266666666667,FUN_012049-T1,E7EZG2,MY9AA_DANRE,,Unconventional myosin-IXAa (Myosin IXAa),Danio rerio (Zebrafish) (Brachydanio rerio),33.3,2215.0,4.1e-257,890.2,sp|E7EZG2|MY9AA_DANRE Unconventional myosin-IXAa OS=Danio rerio OX=7955 GN=myo9aa PE=3 SV=1,GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0007626; GO:0008270; GO:0016020; GO:0016459; GO:0035556; GO:0036269; GO:0044295; GO:0045198; GO:0045202; GO:0048675; GO:0051015; GO:0061564; GO:0098529,"axon development [GO:0061564]; axon extension [GO:0048675]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; swimming behavior [GO:0036269]",actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; membrane [GO:0016020]; myosin complex [GO:0016459]; synapse [GO:0045202],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270],GO:0003774; GO:0003824; GO:0007163; GO:0008092; GO:0016853; GO:0030154; GO:0034330; GO:0098772; GO:0140657,cytoskeletal motor activity; catalytic activity; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; cell differentiation; cell junction organization; molecular function regulator activity; ATP-dependent activity
OG_03206,0.2335685187977918,OG_03206,FUN_012698-T1,Peve_00016828,Pocillopora_meandrina_HIv1___RNAseq.g22855.t1,three_way,79.2805,FUN_012698-T1,Q62901,RERE_RAT,,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-related protein),Rattus norvegicus (Rat),46.5,514.0,8.900000000000001e-124,446.4,sp|Q62901|RERE_RAT Arginine-glutamic acid dipeptide repeats protein OS=Rattus norvegicus OX=10116 GN=Rere PE=1 SV=2,GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0008270; GO:0016605; GO:0021549; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813,branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942],histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605],chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; chromatin organization; organelle; anatomical structure development; cell motility; molecular adaptor activity; transcription regulator activity
OG_06004,0.2334661723302921,OG_06004,FUN_026494-T1,Peve_00004180,Pocillopora_meandrina_HIv1___RNAseq.g4199.t1,three_way,63.488,FUN_026494-T1,Q71M21,,,,,28.2,1343.0,2.3000000000000001e-88,329.7,sp|Q71M21|RH21B_XENLA Rho GTPase-activating protein 21-B OS=Xenopus laevis OX=8355 GN=arhgap21-b PE=2 SV=1,,,,,,
OG_06312,0.2333411780305225,OG_06312,FUN_028552-T1,Peve_00000749,Pocillopora_meandrina_HIv1___RNAseq.g9164.t1,three_way,47.18,,,,,,,,,,,,,,,,,
OG_09452,0.2333178428315238,OG_09452,FUN_041460-T1,Peve_00007409,Pocillopora_meandrina_HIv1___RNAseq.g15692.t1,three_way,85.84066666666666,FUN_041460-T1,Q68FP9,,,,,56.8,628.0,1e-207,724.5,sp|Q68FP9|COG6_RAT Conserved oligomeric Golgi complex subunit 6 OS=Rattus norvegicus OX=10116 GN=Cog6 PE=2 SV=1,,,,,,
OG_07457,0.2330920753299435,OG_07457,FUN_033958-T1,Peve_00022633,Pocillopora_meandrina_HIv1___RNAseq.g26600.t1,three_way,70.71616666666667,FUN_033958-T1,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),32.6,972.0,1.4e-144,516.2,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_05589,0.2330715625194979,OG_05589,FUN_025035-T1,Peve_00038379,Pocillopora_meandrina_HIv1___RNAseq.g19423.t1,three_way,84.7295,FUN_025035-T1,Q6DCE3,ZNT9_XENLA,,"Proton-coupled zinc antiporter SLC30A9, mitochondrial (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9)",Xenopus laevis (African clawed frog),48.4,517.0,2.8e-121,437.2,"sp|Q6DCE3|ZNT9_XENLA Proton-coupled zinc antiporter SLC30A9, mitochondrial OS=Xenopus laevis OX=8355 GN=slc30a9 PE=2 SV=1",GO:0005385; GO:0005634; GO:0005783; GO:0006829; GO:0006882; GO:0010821; GO:0015297; GO:0031410; GO:0031966,intracellular zinc ion homeostasis [GO:0006882]; regulation of mitochondrion organization [GO:0010821]; zinc ion transport [GO:0006829],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634],antiporter activity [GO:0015297]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005634; GO:0005783; GO:0031410; GO:0043226,transporter activity; nucleus; endoplasmic reticulum; cytoplasmic vesicle; organelle
OG_09573,0.232947947201653,OG_09573,FUN_041705-T1,Peve_00001480,Pocillopora_meandrina_HIv1___RNAseq.g13973.t1,three_way,45.37833333333334,FUN_041705-T1,Q95VY2,,,,,43.7,174.0,1.7000000000000002e-32,140.6,sp|Q95VY2|TCTP_BRABE Translationally-controlled tumor protein homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1,,,,,,
OG_00390,0.2329185083656021,OG_00390,FUN_001246-T1,Peve_00037027,Pocillopora_meandrina_HIv1___RNAseq.g2298.t1,three_way,69.81466666666667,FUN_001246-T1,Q7LL04,,,,,34.3,297.0,3.9e-30,133.7,sp|Q7LL04|YQK1_SCHPO UPF0676 protein C1494.01 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPCC1494.01 PE=3 SV=2,,,,,,
OG_04786,0.2329182926171631,OG_04786,FUN_022700-T1,Peve_00018683,Pocillopora_meandrina_HIv1___RNAseq.g4826.t1,three_way,70.454,FUN_022700-T1,Q9NS86,LANC2_HUMAN,,LanC-like protein 2 (Testis-specific adriamycin sensitivity protein),Homo sapiens (Human),49.2,386.0,2.1e-89,330.9,sp|Q9NS86|LANC2_HUMAN LanC-like protein 2 OS=Homo sapiens OX=9606 GN=LANCL2 PE=1 SV=1,GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0009789; GO:0010314; GO:0030864; GO:0031179; GO:0032266; GO:0045892; GO:0070273,carbohydrate metabolic process [GO:0005975]; negative regulation of DNA-templated transcription [GO:0045892]; peptide modification [GO:0031179]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789],cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314],GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005975; GO:0006355; GO:0008289; GO:0043226,nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; carbohydrate metabolic process; regulation of DNA-templated transcription; lipid binding; organelle
OG_01002,0.2328366896524729,OG_01002,FUN_004421-T1,Peve_00026932,Pocillopora_meandrina_HIv1___RNAseq.g16665.t1,three_way,58.136,FUN_004421-T1,F1NWE3,,,,,29.1,1542.0,2.5e-170,601.7,sp|F1NWE3|PTPRS_CHICK Receptor-type tyrosine-protein phosphatase S OS=Gallus gallus OX=9031 GN=PTPRS PE=1 SV=3,,,,,,
OG_08345,0.2328036532291532,OG_08345,FUN_036872-T1,Peve_00039758,Pocillopora_meandrina_HIv1___TS.g13142.t1,three_way,53.678333333333335,FUN_036872-T1,O08710,THYG_MOUSE,,Thyroglobulin (Tg),Mus musculus (Mouse),21.6,1359.0,7.8e-40,168.7,sp|O08710|THYG_MOUSE Thyroglobulin OS=Mus musculus OX=10090 GN=Tg PE=1 SV=3,GO:0005179; GO:0005615; GO:0006590; GO:0015705; GO:0030878; GO:0031641; GO:0042403; GO:0042446; GO:0042802,hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403],extracellular space [GO:0005615],hormone activity [GO:0005179]; identical protein binding [GO:0042802],GO:0005615; GO:0006575; GO:0048018; GO:0048856; GO:0098772,extracellular space; modified amino acid metabolic process; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_00784,0.2327461204875007,OG_00784,FUN_003894-T1,Peve_00015142,Pocillopora_meandrina_HIv1___RNAseq.g11707.t1,three_way,79.82766666666667,FUN_003894-T1,P35574,,,,,51.0,1345.0,0.0,1379.0,sp|P35574|GDE_RABIT Glycogen debranching enzyme OS=Oryctolagus cuniculus OX=9986 GN=AGL PE=1 SV=1,,,,,,
OG_10190,0.232726737140288,OG_10190,FUN_043609-T1,Peve_00040374,Pocillopora_meandrina_HIv1___TS.g684.t1,three_way,52.197833333333335,FUN_043609-T1,P0C6B8,,,,,28.0,1915.0,1.8e-253,879.0,"sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1",,,,,,
OG_02088,0.2327053627497471,OG_02088,FUN_008314-T1,Peve_00026747,Pocillopora_meandrina_HIv1___RNAseq.g5785.t1,three_way,57.846,,,,,,,,,,,,,,,,,
OG_05063,0.232690679426324,OG_05063,FUN_023260-T1,Peve_00019268,Pocillopora_meandrina_HIv1___RNAseq.g578.t1,three_way,89.18833333333333,FUN_023260-T1,Q9W676,,,,,61.8,382.0,2.4e-114,413.7,sp|Q9W676|LDB2_CHICK LIM domain-binding protein 2 OS=Gallus gallus OX=9031 GN=LDB2 PE=2 SV=1,,,,,,
OG_03925,0.232649680671266,OG_03925,FUN_016037-T1,Peve_00011810,Pocillopora_meandrina_HIv1___RNAseq.g21651.t1,three_way,74.29166666666667,FUN_016037-T1,F6ZDS4,TPR_MOUSE,,Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein),Mus musculus (Mouse),40.7,1012.0,4.0000000000000014e-74,282.7,sp|F6ZDS4|TPR_MOUSE Nucleoprotein TPR OS=Mus musculus OX=10090 GN=Tpr PE=1 SV=1,GO:0000122; GO:0000775; GO:0003682; GO:0003729; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006913; GO:0007094; GO:0010965; GO:0015031; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein transport [GO:0015031]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056],GO:0003723; GO:0005198; GO:0005635; GO:0006355; GO:0006913; GO:0043226,RNA binding; structural molecule activity; nuclear envelope; regulation of DNA-templated transcription; nucleocytoplasmic transport; organelle
OG_03925,0.232649680671266,OG_03925,FUN_016037-T1,Peve_00011810,Pocillopora_meandrina_HIv1___RNAseq.g21651.t1,three_way,74.29166666666667,FUN_016037-T1,F6ZDS4,TPR_MOUSE,,Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein),Mus musculus (Mouse),34.5,145.0,1.9e-07,61.2,sp|F6ZDS4|TPR_MOUSE Nucleoprotein TPR OS=Mus musculus OX=10090 GN=Tpr PE=1 SV=1,GO:0000122; GO:0000775; GO:0003682; GO:0003729; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006913; GO:0007094; GO:0010965; GO:0015031; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein transport [GO:0015031]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056],GO:0003723; GO:0005198; GO:0005635; GO:0006355; GO:0006913; GO:0043226,RNA binding; structural molecule activity; nuclear envelope; regulation of DNA-templated transcription; nucleocytoplasmic transport; organelle
OG_02730,0.232511322531541,OG_02730,FUN_011258-T1,Peve_00030534,Pocillopora_meandrina_HIv1___RNAseq.g22312.t1,three_way,68.89616666666667,FUN_011258-T1,A7MBS7,THS7A_DANRE,,Thrombospondin type-1 domain-containing protein 7A,Danio rerio (Zebrafish) (Brachydanio rerio),37.6,85.0,3.7e-08,60.5,sp|A7MBS7|THS7A_DANRE Thrombospondin type-1 domain-containing protein 7A OS=Danio rerio OX=7955 GN=thsd7aa PE=1 SV=2,GO:0001525; GO:0002040; GO:0003094; GO:0005886; GO:0008593; GO:0030036; GO:0032835; GO:0042995; GO:0043534; GO:0048675; GO:0072015,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; blood vessel endothelial cell migration [GO:0043534]; glomerular filtration [GO:0003094]; glomerulus development [GO:0032835]; podocyte development [GO:0072015]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040],cell projection [GO:0042995]; plasma membrane [GO:0005886],,GO:0003014; GO:0005886; GO:0007010; GO:0048856; GO:0048870,renal system process; plasma membrane; cytoskeleton organization; anatomical structure development; cell motility
OG_00554,0.2324844274642128,OG_00554,FUN_001599-T1,Peve_00004146,Pocillopora_meandrina_HIv1___RNAseq.g1982.t1,three_way,81.72066666666667,FUN_001599-T1,Q9Y2D4,EXC6B_HUMAN,,Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2),Homo sapiens (Human),50.0,800.0,4.7e-223,775.8,sp|Q9Y2D4|EXC6B_HUMAN Exocyst complex component 6B OS=Homo sapiens OX=9606 GN=EXOC6B PE=1 SV=3,GO:0000145; GO:0000281; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522],exocyst [GO:0000145],,GO:0000910; GO:0006886; GO:0016192; GO:0061024,cytokinesis; intracellular protein transport; vesicle-mediated transport; membrane organization
OG_06701,0.2324676206805269,OG_06701,FUN_031268-T1,Peve_00036751,Pocillopora_meandrina_HIv1___RNAseq.g5181.t2,three_way,67.62816666666666,FUN_031268-T1,Q9UBV2,SE1L1_HUMAN,,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),Homo sapiens (Human),62.3,579.0,1.3e-73,279.6,sp|Q9UBV2|SE1L1_HUMAN Protein sel-1 homolog 1 OS=Homo sapiens OX=9606 GN=SEL1L PE=1 SV=3,GO:0000836; GO:0000839; GO:0005783; GO:0005789; GO:0006641; GO:0007219; GO:0009306; GO:0030970; GO:0036503; GO:0036513; GO:0050821,"ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]",Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839],,GO:0005783; GO:0006629; GO:0006886; GO:0030163; GO:0043226,endoplasmic reticulum; lipid metabolic process; intracellular protein transport; protein catabolic process; organelle
OG_07959,0.2324491183344879,OG_07959,FUN_035511-T1,Peve_00039974,Pocillopora_meandrina_HIv1___RNAseq.g26971.t1,three_way,78.77533333333332,FUN_035511-T1,Q99747,SNAG_HUMAN,,Gamma-soluble NSF attachment protein (SNAP-gamma) (N-ethylmaleimide-sensitive factor attachment protein gamma),Homo sapiens (Human),32.3,331.0,8.6e-28,125.9,sp|Q99747|SNAG_HUMAN Gamma-soluble NSF attachment protein OS=Homo sapiens OX=9606 GN=NAPG PE=1 SV=1,GO:0005483; GO:0005739; GO:0005765; GO:0005794; GO:0006886; GO:0006891; GO:0019905; GO:0031201; GO:0050821; GO:0061025; GO:0065003; GO:0070062,intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; SNARE complex [GO:0031201],soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905],GO:0005739; GO:0005794; GO:0006886; GO:0016192; GO:0043226; GO:0060090; GO:0061024; GO:0065003,mitochondrion; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity; membrane organization; protein-containing complex assembly
OG_02331,0.2324047839001786,OG_02331,FUN_008924-T1,Peve_00028630,Pocillopora_meandrina_HIv1___RNAseq.g14267.t1,three_way,80.87533333333333,FUN_008924-T1,O76756,,,,,75.1,209.0,9.500000000000001e-86,317.8,sp|O76756|RS8_APIME Small ribosomal subunit protein eS8 OS=Apis mellifera OX=7460 GN=RpS8 PE=2 SV=2,,,,,,
OG_01942,0.2321139928722939,OG_01942,FUN_007995-T1,Peve_00018055,Pocillopora_meandrina_HIv1___RNAseq.g18162.t1,three_way,60.7,FUN_007995-T1,Q13308,,,,,32.5,1058.0,5.8e-147,523.5,sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,,,,,,
OG_00414,0.2320362493255297,OG_00414,FUN_001316-T1,Peve_00036964,Pocillopora_meandrina_HIv1___RNAseq.g2261.t1,three_way,53.97383333333333,FUN_001316-T1,Q8IVL1,,,,,36.1,388.0,7.2e-66,255.0,sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3,,,,,,
OG_03657,0.2319467929425142,OG_03657,FUN_014893-T1,Peve_00003548,Pocillopora_meandrina_HIv1___RNAseq.g21106.t1,three_way,54.15466666666666,,,,,,,,,,,,,,,,,
OG_06188,0.2318544005958056,OG_06188,FUN_028103-T1,Peve_00032588,Pocillopora_meandrina_HIv1___RNAseq.g15573.t1,three_way,47.289,,,,,,,,,,,,,,,,,
OG_05366,0.2318105989616507,OG_05366,FUN_024155-T1,Peve_00034622,Pocillopora_meandrina_HIv1___RNAseq.g19853.t1,three_way,62.59933333333333,FUN_024155-T1,Q5U405,TMPSD_MOUSE,,Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease),Mus musculus (Mouse),26.8,272.0,2.7e-21,104.8,sp|Q5U405|TMPSD_MOUSE Transmembrane protease serine 13 OS=Mus musculus OX=10090 GN=Tmprss13 PE=2 SV=2,GO:0004252; GO:0005576; GO:0005737; GO:0005886; GO:0006508; GO:0061436,establishment of skin barrier [GO:0061436]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0048856; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_01923,0.2317395499653387,OG_01923,FUN_007957-T1,Peve_00039189,Pocillopora_meandrina_HIv1___RNAseq.g30070.t1,three_way,65.248,FUN_007957-T1,P25703,,,,,42.9,403.0,6.099999999999999e-75,282.7,sp|P25703|BMP2A_XENLA Bone morphogenetic protein 2-A OS=Xenopus laevis OX=8355 GN=bmp2-a PE=2 SV=1,,,,,,
OG_03208,0.2315907418343311,OG_03208,FUN_012700-T1,Peve_00016832,Pocillopora_meandrina_HIv1___RNAseq.g12826.t1,three_way,67.51966666666667,FUN_012700-T1,Q12794,,,,,39.9,353.0,2.5000000000000002e-73,278.1,sp|Q12794|HYAL1_HUMAN Hyaluronidase-1 OS=Homo sapiens OX=9606 GN=HYAL1 PE=1 SV=2,,,,,,
OG_02007,0.2315770084096296,OG_02007,FUN_008122-T1,Peve_00022348,Pocillopora_meandrina_HIv1___RNAseq.g17883.t1,three_way,77.1465,FUN_008122-T1,Q8R4P9,MRP7_MOUSE,,ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7),Mus musculus (Mouse),49.7,1236.0,0.0,1107.0,sp|Q8R4P9|MRP7_MOUSE ATP-binding cassette sub-family C member 10 OS=Mus musculus OX=10090 GN=Abcc10 PE=1 SV=1,GO:0005524; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0016323; GO:0016887; GO:0071716; GO:0140359,leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869],basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323],ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005215; GO:0016787; GO:0140657,catalytic activity; transporter activity; hydrolase activity; ATP-dependent activity
OG_06778,0.2315044372145479,OG_06778,FUN_031644-T1,Peve_00043582,Pocillopora_meandrina_HIv1___RNAseq.g5685.t1,three_way,76.86,FUN_031644-T1,Q3EBF7,SLD2_ARATH,,Delta(8)-fatty-acid desaturase 2 (EC 1.14.19.29) (Delta(8)-sphingolipid desaturase 2) (Sphingoid long-chain base desaturase 2) (Sphingoid LCB desaturase 2) (Sphingolipid 8-(E/Z)-desaturase 2),Arabidopsis thaliana (Mouse-ear cress),41.9,451.0,8.5e-100,365.5,sp|Q3EBF7|SLD2_ARATH Delta(8)-fatty-acid desaturase 2 OS=Arabidopsis thaliana OX=3702 GN=SLD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0030148; GO:0046872; GO:0052631; GO:0070417,cellular response to cold [GO:0070417]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; sphingolipid 8-(E/Z)-desaturase activity [GO:0052631],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle
OG_05931,0.2314677920975011,OG_05931,FUN_026158-T1,Peve_00023048,Pocillopora_meandrina_HIv1___RNAseq.g3210.t2,three_way,71.991,FUN_026158-T1,Q12999,,,,,41.4,215.0,1.4e-37,157.9,sp|Q12999|TSN31_HUMAN Tetraspanin-31 OS=Homo sapiens OX=9606 GN=TSPAN31 PE=1 SV=1,,,,,,
OG_00280,0.2314673862584424,OG_00280,FUN_001066-T1,Peve_00018849,Pocillopora_meandrina_HIv1___RNAseq.g29655.t1,three_way,63.10516666666666,FUN_001066-T1,P22758,,,,,39.4,695.0,3.2e-132,474.2,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_04850,0.2314162455062774,OG_04850,FUN_022862-T1,Peve_00025610,Pocillopora_meandrina_HIv1___RNAseq.g3606.t1,three_way,84.90033333333334,FUN_022862-T1,Q5EA43,SFXN2_BOVIN,,Sideroflexin-2,Bos taurus (Bovine),60.2,314.0,9.8e-106,384.8,sp|Q5EA43|SFXN2_BOVIN Sideroflexin-2 OS=Bos taurus OX=9913 GN=SFXN2 PE=2 SV=2,GO:0005739; GO:0005741; GO:0005743; GO:0015075; GO:0022857; GO:0140300; GO:1990542,mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300],mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],monoatomic ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_06491,0.23138484328919,OG_06491,FUN_029269-T1,Peve_00002504,Pocillopora_meandrina_HIv1___RNAseq.g25417.t1,three_way,91.27916666666668,FUN_029269-T1,P08110,,,,,69.4,779.0,1.7e-282,973.4,sp|P08110|ENPL_CHICK Endoplasmin OS=Gallus gallus OX=9031 GN=HSP90B1 PE=1 SV=1,,,,,,
OG_01555,0.2313060516572206,OG_01555,FUN_006435-T1,Peve_00024931,Pocillopora_meandrina_HIv1___RNAseq.g20292.t1,three_way,81.35366666666667,FUN_006435-T1,Q9ULJ7,,,,,44.8,542.0,4.500000000000001e-130,467.6,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_04505,0.2312588271019007,OG_04505,FUN_022017-T1,Peve_00030675,Pocillopora_meandrina_HIv1___RNAseq.g3183.t1,three_way,89.45066666666666,FUN_022017-T1,Q0II68,,,,,67.9,336.0,3.7e-151,535.8,sp|Q0II68|ACMSD_BOVIN 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase OS=Bos taurus OX=9913 GN=ACMSD PE=2 SV=1,,,,,,
OG_06410,0.2312477075044771,OG_06410,FUN_029093-T1,Peve_00007821,Pocillopora_meandrina_HIv1___TS.g9197.t1,three_way,87.07566666666666,FUN_029093-T1,Q6GNL7,AL1L1_XENLA,,Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1),Xenopus laevis (African clawed frog),64.4,634.0,9.2e-244,844.3,sp|Q6GNL7|AL1L1_XENLA Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Xenopus laevis OX=8355 GN=aldh1l1 PE=2 SV=1,GO:0004029; GO:0005829; GO:0006730; GO:0006740; GO:0009058; GO:0009258; GO:0016155,10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730],cytosol [GO:0005829],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155],GO:0003824; GO:0005829; GO:0006091; GO:0006575; GO:0016491; GO:0055086,catalytic activity; cytosol; generation of precursor metabolites and energy; modified amino acid metabolic process; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_07473,0.2311978443605075,OG_07473,FUN_033988-T1,Peve_00031324,Pocillopora_meandrina_HIv1___RNAseq.g26103.t1,three_way,92.09933333333332,FUN_033988-T1,Q9BV81,EMC6_HUMAN,,ER membrane protein complex subunit 6 (Transmembrane protein 93),Homo sapiens (Human),60.7,89.0,1.0000000000000001e-23,110.5,sp|Q9BV81|EMC6_HUMAN ER membrane protein complex subunit 6 OS=Homo sapiens OX=9606 GN=EMC6 PE=1 SV=1,GO:0000045; GO:0005789; GO:0016020; GO:0045050; GO:0071816; GO:0072546; GO:1903349,autophagosome assembly [GO:0000045]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; omegasome membrane [GO:1903349],,,
OG_04797,0.2311716057617773,OG_04797,FUN_022716-T1,Peve_00016561,Pocillopora_meandrina_HIv1___RNAseq.g3161.t1,three_way,88.14033333333333,FUN_022716-T1,A7RG82,,,,,77.2,338.0,3.5e-154,545.8,sp|A7RG82|CLP1_NEMVE Protein CLP1 homolog OS=Nematostella vectensis OX=45351 GN=v1g236308 PE=3 SV=1,,,,,,
OG_03678,0.2311651085243142,OG_03678,FUN_014932-T1,Peve_00037144,Pocillopora_meandrina_HIv1___RNAseq.g21090.t2,three_way,93.364,FUN_014932-T1,P26818,,,,,66.9,680.0,9.099999999999999e-271,934.1,sp|P26818|ARBK2_BOVIN G protein-coupled receptor kinase 3 OS=Bos taurus OX=9913 GN=GRK3 PE=2 SV=1,,,,,,
OG_00487,0.2310567074818024,OG_00487,FUN_001453-T1,Peve_00018442,Pocillopora_meandrina_HIv1___RNAseq.g1954.t1,three_way,80.51,FUN_001453-T1,Q9UBR2,CATZ_HUMAN,,Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X),Homo sapiens (Human),61.6,297.0,1.4000000000000005e-111,404.1,sp|Q9UBR2|CATZ_HUMAN Cathepsin Z OS=Homo sapiens OX=9606 GN=CTSZ PE=1 SV=1,GO:0002003; GO:0004180; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0005886; GO:0005938; GO:0006508; GO:0008234; GO:0009986; GO:0010757; GO:0016807; GO:0030134; GO:0030426; GO:0031410; GO:0033116; GO:0035580; GO:0043231; GO:0051603; GO:0060441; GO:0062023; GO:0070062; GO:1904813,angiotensin maturation [GO:0002003]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580],carboxypeptidase activity [GO:0004180]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234],GO:0003824; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; lysosome; vacuole; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_01532,0.2310231170559118,OG_01532,FUN_006331-T1,Peve_00012580,Pocillopora_meandrina_HIv1___RNAseq.g20347.t1,three_way,69.86616666666667,FUN_006331-T1,Q92545,TM131_HUMAN,,Transmembrane protein 131 (Protein RW1),Homo sapiens (Human),41.2,1098.0,1.3000000000000002e-218,762.3,sp|Q92545|TM131_HUMAN Transmembrane protein 131 OS=Homo sapiens OX=9606 GN=TMEM131 PE=1 SV=3,GO:0005518; GO:0016020; GO:0032964,collagen biosynthetic process [GO:0032964],membrane [GO:0016020],collagen binding [GO:0005518],,
OG_01271,0.2309645506397326,OG_01271,FUN_005040-T1,Peve_00016737,Pocillopora_meandrina_HIv1___RNAseq.g20176.t1,three_way,50.495333333333335,FUN_005040-T1,A2RU49,HYKK_HUMAN,,Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1),Homo sapiens (Human),29.6,412.0,1e-38,162.5,sp|A2RU49|HYKK_HUMAN Hydroxylysine kinase OS=Homo sapiens OX=9606 GN=HYKK PE=1 SV=2,GO:0005759; GO:0006554; GO:0019202; GO:0047992,lysine catabolic process [GO:0006554],mitochondrial matrix [GO:0005759],amino acid kinase activity [GO:0019202]; hydroxylysine kinase activity [GO:0047992],GO:0003824; GO:0006520; GO:0016740,catalytic activity; amino acid metabolic process; transferase activity
OG_05067,0.2309597327336981,OG_05067,FUN_023270-T1,Peve_00019480,Pocillopora_meandrina_HIv1___RNAseq.g17805.t1,three_way,80.59366666666666,FUN_023270-T1,Q63ZH8,,,,,32.8,137.0,1.2e-18,94.4,sp|Q63ZH8|F136A_XENLA Protein FAM136A OS=Xenopus laevis OX=8355 GN=fam136a PE=2 SV=1,,,,,,
OG_06965,0.2308433507053323,OG_06965,FUN_032097-T1,Peve_00035672,Pocillopora_meandrina_HIv1___RNAseq.g5267.t1,three_way,74.00183333333334,,,,,,,,,,,,,,,,,
OG_09076,0.2308416468913604,OG_09076,FUN_038805-T1,Peve_00007221,Pocillopora_meandrina_HIv1___RNAseq.g28540.t1,three_way,72.57433333333333,FUN_038805-T1,Q6GMF8,RHDF1_DANRE,,Inactive rhomboid protein 1 (iRhom1) (Rhomboid family member 1),Danio rerio (Zebrafish) (Brachydanio rerio),43.3,716.0,4.9999999999999995e-142,506.5,sp|Q6GMF8|RHDF1_DANRE Inactive rhomboid protein 1 OS=Danio rerio OX=7955 GN=rhbdf1 PE=2 SV=1,GO:0000139; GO:0005789; GO:0008283; GO:0015031; GO:0016477; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0061136,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],growth factor binding [GO:0019838],GO:0048870,cell motility
OG_02036,0.230569716918835,OG_02036,FUN_008238-T1,Peve_00003880,Pocillopora_meandrina_HIv1___RNAseq.g17929.t1,three_way,69.81566666666667,FUN_008238-T1,Q8R2K4,TAF6L_MOUSE,,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha),Mus musculus (Mouse),43.2,472.0,5.600000000000001e-89,330.1,sp|Q8R2K4|TAF6L_MOUSE TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L OS=Mus musculus OX=10090 GN=Taf6l PE=1 SV=1,GO:0000124; GO:0005634; GO:0005669; GO:0006282; GO:0006355; GO:0006367; GO:0016251; GO:0043484; GO:0045893; GO:0046695; GO:0046982; GO:1904672,positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; transcription initiation at RNA polymerase II promoter [GO:0006367],nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669],protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0005634; GO:0006355; GO:0043226; GO:0140223,nucleus; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_09481,0.2305385110833183,OG_09481,FUN_041509-T1,Peve_00025395,Pocillopora_meandrina_HIv1___RNAseq.g16082.t1,three_way,78.44016666666667,FUN_041509-T1,P13773,,,,,23.2,228.0,1.4e-12,75.5,sp|P13773|CAR1_DICDI Cyclic AMP receptor 1 OS=Dictyostelium discoideum OX=44689 GN=carA-1 PE=1 SV=1,,,,,,
OG_01616,0.230499074441747,OG_01616,FUN_006723-T1,Peve_00039552,Pocillopora_meandrina_HIv1___TS.g29394.t1,three_way,61.66466666666667,,,,,,,,,,,,,,,,,
OG_00154,0.230457012266215,OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),47.8,912.0,6.499999999999998e-229,796.2,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_00154,0.230457012266215,OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),37.4,286.0,1.3e-27,127.5,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_02593,0.2304330569710534,OG_02593,FUN_010713-T1,Peve_00022566,Pocillopora_meandrina_HIv1___RNAseq.g20958.t1,three_way,82.25733333333334,FUN_010713-T1,Q8R3G1,PP1R8_MOUSE,,Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8),Mus musculus (Mouse),53.2,365.0,6.9e-92,339.0,sp|Q8R3G1|PP1R8_MOUSE Nuclear inhibitor of protein phosphatase 1 OS=Mus musculus OX=10090 GN=Ppp1r8 PE=1 SV=1,GO:0003677; GO:0003723; GO:0004864; GO:0005681; GO:0006397; GO:0008283; GO:0008380; GO:0016607; GO:0019888,cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0016071; GO:0043226; GO:0098772,DNA binding; RNA binding; mRNA metabolic process; organelle; molecular function regulator activity
OG_07006,0.2303459055185581,OG_07006,FUN_032158-T1,Peve_00013926,Pocillopora_meandrina_HIv1___RNAseq.g5321.t1,three_way,75.96416666666667,FUN_032158-T1,Q9EPI9,KCNH5_RAT,,Voltage-gated delayed rectifier potassium channel KCNH5 (Ether-a-go-go potassium channel 2) (rEAG2) (Potassium voltage-gated channel subfamily H member 5) (Voltage-gated potassium channel subunit Kv10.2),Rattus norvegicus (Rat),44.8,757.0,1.3e-182,641.7,sp|Q9EPI9|KCNH5_RAT Voltage-gated delayed rectifier potassium channel KCNH5 OS=Rattus norvegicus OX=10116 GN=Kcnh5 PE=2 SV=1,GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0006813; GO:0008076; GO:0009986; GO:0010389; GO:0042391; GO:0044325; GO:0044877; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of membrane potential [GO:0042391],cell surface [GO:0009986]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076],calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_02045,0.2303063901691781,OG_02045,FUN_008250-T1,Peve_00025019,Pocillopora_meandrina_HIv1___RNAseq.21440_t,three_way,71.38866666666667,FUN_008250-T1,Q9DCU6,,,,,44.4,216.0,2.7999999999999997e-41,170.6,sp|Q9DCU6|RM04_MOUSE Large ribosomal subunit protein uL4m OS=Mus musculus OX=10090 GN=Mrpl4 PE=1 SV=1,,,,,,
OG_10201,0.2302388057170938,OG_10201,FUN_043629-T1,Peve_00008240,Pocillopora_meandrina_HIv1___RNAseq.g6901.t1,three_way,72.333,FUN_043629-T1,B2GUY0,MA1B1_RAT,,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Mannosidase alpha class 1B member 1)",Rattus norvegicus (Rat),48.4,674.0,2.1e-163,577.4,"sp|B2GUY0|MA1B1_RAT Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase OS=Rattus norvegicus OX=10116 GN=Man1b1 PE=2 SV=2",GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0006058; GO:0006486; GO:0016020; GO:0031410; GO:0036503; GO:0044322,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; mannoprotein catabolic process [GO:0006058]; protein glycosylation [GO:0006486],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005975; GO:0006486; GO:0016787; GO:0030163; GO:0031410; GO:0043226,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; protein glycosylation; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle
OG_07181,0.2301244605826839,OG_07181,FUN_032636-T1,Peve_00033699,Pocillopora_meandrina_HIv1___TS.g12060.t1,three_way,41.117,,,,,,,,,,,,,,,,,
OG_01905,0.2300481738761639,OG_01905,FUN_007919-T1,Peve_00040675,Pocillopora_meandrina_HIv1___RNAseq.g30121.t1,three_way,90.73183333333331,FUN_007919-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),63.3,608.0,1.6e-207,724.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_05323,0.229956138453237,OG_05323,FUN_024015-T1,Peve_00040419,Pocillopora_meandrina_HIv1___RNAseq.g19286.t1,three_way,70.89716666666666,FUN_024015-T1,Q6ZR37,PKHG7_HUMAN,,Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7),Homo sapiens (Human),35.4,540.0,1.8e-73,279.3,sp|Q6ZR37|PKHG7_HUMAN Pleckstrin homology domain-containing family G member 7 OS=Homo sapiens OX=9606 GN=PLEKHG7 PE=1 SV=2,GO:0005085; GO:0007266,Rho protein signal transduction [GO:0007266],,guanyl-nucleotide exchange factor activity [GO:0005085],GO:0098772,molecular function regulator activity
OG_03302,0.2297940440167938,OG_03302,FUN_013373-T1,Peve_00001201,Pocillopora_meandrina_HIv1___RNAseq.g22996.t1,three_way,81.58533333333334,FUN_013373-T1,P56399,,,,,54.9,856.0,3.2999999999999997e-275,949.1,sp|P56399|UBP5_MOUSE Ubiquitin carboxyl-terminal hydrolase 5 OS=Mus musculus OX=10090 GN=Usp5 PE=1 SV=1,,,,,,
OG_02741,0.2296828666540404,OG_02741,FUN_011284-T1,Peve_00033625,Pocillopora_meandrina_HIv1___RNAseq.g22145.t2,three_way,53.47266666666667,FUN_011284-T1,Q5M775,CYTSB_HUMAN,,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),Homo sapiens (Human),46.2,106.0,1.9e-21,106.3,sp|Q5M775|CYTSB_HUMAN Cytospin-B OS=Homo sapiens OX=9606 GN=SPECC1 PE=1 SV=1,GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177,actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824],apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0048856; GO:0050877,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; organelle; anatomical structure development; nervous system process
OG_08809,0.2296347318684167,OG_08809,FUN_038132-T1,Peve_00043373,Pocillopora_meandrina_HIv1___RNAseq.g766.t1,three_way,72.71566666666666,FUN_038132-T1,Q9JL56,GDE1_MOUSE,,Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16),Mus musculus (Mouse),37.6,295.0,5.9e-47,189.5,sp|Q9JL56|GDE1_MOUSE Glycerophosphodiester phosphodiesterase 1 OS=Mus musculus OX=10090 GN=Gde1 PE=1 SV=1,GO:0004622; GO:0005886; GO:0006580; GO:0006644; GO:0007186; GO:0008081; GO:0008889; GO:0016020; GO:0030659; GO:0046872; GO:0047395; GO:0070291,ethanolamine metabolic process [GO:0006580]; G protein-coupled receptor signaling pathway [GO:0007186]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644],cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; plasma membrane [GO:0005886],glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol glycerophosphodiesterase activity [GO:0047395]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081],GO:0003824; GO:0005886; GO:0006629; GO:0016787,catalytic activity; plasma membrane; lipid metabolic process; hydrolase activity
OG_08796,0.2295405919900427,OG_08796,FUN_038092-T1,Peve_00007110,Pocillopora_meandrina_HIv1___RNAseq.g820.t1,three_way,74.33033333333333,FUN_038092-T1,Q9FPH3,,,,,49.0,361.0,4.0999999999999997e-91,336.7,sp|Q9FPH3|THA2_ARATH Probable low-specificity L-threonine aldolase 2 OS=Arabidopsis thaliana OX=3702 GN=THA2 PE=1 SV=1,,,,,,
OG_05501,0.2294397769198527,OG_05501,FUN_024564-T1,Peve_00009968,Pocillopora_meandrina_HIv1___RNAseq.g18662.t1,three_way,88.02933333333334,,,,,,,,,,,,,,,,,
OG_03884,0.2292740577940867,OG_03884,FUN_015429-T1,Peve_00033649,Pocillopora_meandrina_HIv1___RNAseq.g22262.t1,three_way,84.209,FUN_015429-T1,Q5ZI89,,,,,48.9,1121.0,0.0,1077.0,sp|Q5ZI89|TPC11_CHICK Trafficking protein particle complex subunit 11 OS=Gallus gallus OX=9031 GN=TRAPPC11 PE=2 SV=1,,,,,,
OG_02777,0.2292283105056128,OG_02777,FUN_011725-T1,Peve_00039709,Pocillopora_meandrina_HIv1___RNAseq.g23849.t1,three_way,80.71566666666666,FUN_011725-T1,Q4R918,KIF25_MACFA,,Kinesin-like protein KIF25,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),41.1,604.0,4.1000000000000004e-111,403.7,sp|Q4R918|KIF25_MACFA Kinesin-like protein KIF25 OS=Macaca fascicularis OX=9541 GN=KIF25 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647,establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; protein-containing complex assembly; ATP-dependent activity
OG_01584,0.229156271540514,OG_01584,FUN_006621-T1,Peve_00040867,Pocillopora_meandrina_HIv1___RNAseq.g20504.t1,three_way,51.0425,FUN_006621-T1,Q8WWI1,LMO7_HUMAN,,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),Homo sapiens (Human),43.5,131.0,4.7e-23,112.8,sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005635; GO:0005739; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nuclear envelope; mitochondrion; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03674,0.2291022026344337,OG_03674,FUN_014925-T1,Peve_00006270,Pocillopora_meandrina_HIv1___RNAseq.g21082.t1,three_way,77.86116666666666,FUN_014925-T1,Q9I9E0,,,,,43.7,581.0,9.9e-52,206.5,sp|Q9I9E0|TAOK3_CHICK Serine/threonine-protein kinase TAO3 OS=Gallus gallus OX=9031 GN=TAOK3 PE=2 SV=2,,,,,,
OG_04008,0.2290739454491062,OG_04008,FUN_016308-T1,Peve_00032290,Pocillopora_meandrina_HIv1___RNAseq.g10037.t1,three_way,81.12333333333333,,,,,,,,,,,,,,,,,
OG_08589,0.2290072652830774,OG_08589,FUN_037698-T1,Peve_00044125,Pocillopora_meandrina_HIv1___TS.g22767.t1b,three_way,68.75333333333333,FUN_037698-T1,F1QC45,XRP2_DANRE,,Protein XRP2,Danio rerio (Zebrafish) (Brachydanio rerio),56.6,325.0,8.6e-84,312.0,sp|F1QC45|XRP2_DANRE Protein XRP2 OS=Danio rerio OX=7955 GN=rp2 PE=1 SV=1,GO:0001947; GO:0005096; GO:0005525; GO:0005929; GO:0006892; GO:0010842; GO:0015031; GO:0035845; GO:0042461; GO:0045494; GO:0048793; GO:0060041; GO:0061371; GO:1990075,determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; post-Golgi vesicle-mediated transport [GO:0006892]; pronephros development [GO:0048793]; protein transport [GO:0015031]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842],cilium [GO:0005929]; periciliary membrane compartment [GO:1990075],GTP binding [GO:0005525]; GTPase activator activity [GO:0005096],GO:0005929; GO:0016192; GO:0043226; GO:0048856; GO:0098772,cilium; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_02734,0.2286262812837481,OG_02734,FUN_011264-T1,Peve_00030536,Pocillopora_meandrina_HIv1___RNAseq.g22310.t1,three_way,79.29683333333332,FUN_011264-T1,P02401,,,,,70.6,68.0,7.3e-19,94.7,sp|P02401|RLA2_RAT Large ribosomal subunit protein P2 OS=Rattus norvegicus OX=10116 GN=Rplp2 PE=1 SV=2,,,,,,
OG_05980,0.2284933004760988,OG_05980,FUN_026411-T1,Peve_00006098,Pocillopora_meandrina_HIv1___RNAseq.g2984.t1,three_way,76.715,,,,,,,,,,,,,,,,,
OG_03188,0.2284478451959642,OG_03188,FUN_012659-T1,Peve_00020498,Pocillopora_meandrina_HIv1___RNAseq.8480_t,three_way,56.535,FUN_012659-T1,Q6P1S2,CC033_HUMAN,,Protein C3orf33 (Protein AC3-33),Homo sapiens (Human),30.2,215.0,1.4000000000000002e-22,108.2,sp|Q6P1S2|CC033_HUMAN Protein C3orf33 OS=Homo sapiens OX=9606 GN=C3orf33 PE=1 SV=2,GO:0005615; GO:0005739; GO:0016020; GO:0051090; GO:0070373,negative regulation of ERK1 and ERK2 cascade [GO:0070373]; regulation of DNA-binding transcription factor activity [GO:0051090],extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739],,GO:0005615; GO:0005739; GO:0006355; GO:0043226,extracellular space; mitochondrion; regulation of DNA-templated transcription; organelle
OG_08817,0.2284250273074707,OG_08817,FUN_038145-T1,Peve_00026423,Pocillopora_meandrina_HIv1___RNAseq.g753.t1,three_way,57.66566666666667,FUN_038145-T1,Q4V9P9,,,,,22.8,762.0,2.6999999999999997e-31,138.7,sp|Q4V9P9|NOL11_DANRE Nucleolar protein 11-like OS=Danio rerio OX=7955 GN=nol11 PE=2 SV=1,,,,,,
OG_10191,0.2283898680636965,OG_10191,FUN_043611-T1,Peve_00040373,Pocillopora_meandrina_HIv1___RNAseq.g6942.t1,three_way,43.37433333333333,FUN_043611-T1,P0C6B8,,,,,43.6,117.0,2.6999999999999997e-25,117.9,"sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1",,,,,,
OG_07644,0.2283634054321191,OG_07644,FUN_034423-T1,Peve_00010896,Pocillopora_meandrina_HIv1___RNAseq.g28847.t1,three_way,41.70183333333333,FUN_034423-T1,Q10057,PDI1_SCHPO,,Putative protein disulfide-isomerase C1F5.02 (EC 5.3.4.1),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),32.3,195.0,3.4e-18,95.5,sp|Q10057|PDI1_SCHPO Putative protein disulfide-isomerase C1F5.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC1F5.02 PE=3 SV=1,GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0015035; GO:0034975; GO:0034976,protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],GO:0003824; GO:0005783; GO:0006457; GO:0016491; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; protein folding; oxidoreductase activity; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_09652,0.2283183809006248,OG_09652,FUN_041852-T1,Peve_00030440,Pocillopora_meandrina_HIv1___TS.g10103.t1,three_way,49.88133333333333,FUN_041852-T1,P05300,,,,,25.1,211.0,3.6e-07,57.0,sp|P05300|LAMP1_CHICK Lysosome-associated membrane glycoprotein 1 OS=Gallus gallus OX=9031 GN=LAMP1 PE=2 SV=1,,,,,,
OG_09670,0.2282788844056208,OG_09670,FUN_041888-T1,Peve_00033407,Pocillopora_meandrina_HIv1___RNAseq.g15416.t1,three_way,83.91333333333334,FUN_041888-T1,Q3SZ65,,,,,83.1,397.0,6.8999999999999995e-189,661.4,sp|Q3SZ65|IF4A2_BOVIN Eukaryotic initiation factor 4A-II OS=Bos taurus OX=9913 GN=EIF4A2 PE=2 SV=1,,,,,,
OG_07669,0.2282400572542865,OG_07669,FUN_034724-T1,Peve_00033264,Pocillopora_meandrina_HIv1___RNAseq.g28719.t1,three_way,89.57333333333334,FUN_034724-T1,P39023,RL3_HUMAN,,Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (HIV-1 TAR RNA-binding protein B) (TARBP-B),Homo sapiens (Human),72.8,397.0,2.4e-170,599.7,sp|P39023|RL3_HUMAN Large ribosomal subunit protein uL3 OS=Homo sapiens OX=9606 GN=RPL3 PE=1 SV=2,GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0022625; GO:0022626; GO:0032991; GO:0070062; GO:0071353,cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198; GO:0005634; GO:0005730; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; RNA binding; structural molecule activity; nucleus; nucleolus; cytosol; ribosome; organelle
OG_08661,0.2282256754948625,OG_08661,FUN_037877-T1,Peve_00027466,Pocillopora_meandrina_HIv1___TS.g13174.t1,three_way,47.705333333333336,FUN_037877-T1,P86733,,,,,41.8,110.0,7.4e-27,125.6,sp|P86733|KCP_HALAI BPTI/Kunitz domain-containing protein (Fragment) OS=Haliotis asinina OX=109174 PE=1 SV=1,,,,,,
OG_00289,0.2280732217290517,OG_00289,FUN_001079-T1,Peve_00037394,Pocillopora_meandrina_HIv1___RNAseq.g2713.t1,three_way,65.095,FUN_001079-T1,P19440,GGT1_HUMAN,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Homo sapiens (Human),38.9,542.0,5.2e-92,340.1,sp|P19440|GGT1_HUMAN Glutathione hydrolase 1 proenzyme OS=Homo sapiens OX=9606 GN=GGT1 PE=1 SV=2,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0019344; GO:0031179; GO:0031638; GO:0036374; GO:0050727; GO:0070062; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; organelle; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_03228,0.2280516073457123,OG_03228,FUN_012770-T1,Peve_00007595,Pocillopora_meandrina_HIv1___RNAseq.g13655.t1,three_way,69.76033333333334,FUN_012770-T1,P14755,,,,,48.1,310.0,5.4e-80,299.3,sp|P14755|CRYL1_RABIT Lambda-crystallin OS=Oryctolagus cuniculus OX=9986 GN=CRYL1 PE=1 SV=3,,,,,,
OG_08713,0.2280088044908407,OG_08713,FUN_037965-T1,Peve_00009707,Pocillopora_meandrina_HIv1___RNAseq.g26234.t1,three_way,48.86333333333334,,,,,,,,,,,,,,,,,
OG_09116,0.2279545037224666,OG_09116,FUN_039091-T1,Peve_00028752,Pocillopora_meandrina_HIv1___RNAseq.g28707.t1,three_way,75.19333333333334,FUN_039091-T1,A0A571BF63,ANKF1_MOUSE,,Ankyrin-repeat and fibronectin type III domain-containing 1,Mus musculus (Mouse),35.6,824.0,9.6e-135,483.0,sp|A0A571BF63|ANKF1_MOUSE Ankyrin-repeat and fibronectin type III domain-containing 1 OS=Mus musculus OX=10090 GN=Ankfn1 PE=1 SV=1,GO:0001662; GO:0045475; GO:0050957,behavioral fear response [GO:0001662]; equilibrioception [GO:0050957]; locomotor rhythm [GO:0045475],,,GO:0050877,nervous system process
OG_07319,0.2278740180731239,OG_07319,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),34.7,404.0,4.399999999999997e-47,191.8,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07319,0.2278740180731239,OG_07319,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),36.6,243.0,1.1e-37,160.6,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_02591,0.2278089899304988,OG_02591,FUN_010711-T1,Peve_00022576,Pocillopora_meandrina_HIv1___RNAseq.g20960.t1,three_way,81.52633333333333,FUN_010711-T1,Q9UHY1,NRBP_HUMAN,,Nuclear receptor-binding protein,Homo sapiens (Human),54.0,470.0,1.6e-136,487.6,sp|Q9UHY1|NRBP_HUMAN Nuclear receptor-binding protein OS=Homo sapiens OX=9606 GN=NRBP1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005938; GO:0006888; GO:0006974; GO:0012505; GO:0016020; GO:0030027; GO:0042803,DNA damage response [GO:0006974]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005654; GO:0016192; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_00695,0.2277755722447532,OG_00695,FUN_002406-T1,Peve_00034029,Pocillopora_meandrina_HIv1___RNAseq.g14842.t1,three_way,82.38833333333334,FUN_002406-T1,Q86TL2,STIMA_HUMAN,,Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110),Homo sapiens (Human),50.2,259.0,2.8000000000000002e-59,230.3,sp|Q86TL2|STIMA_HUMAN Store-operated calcium entry regulator STIMATE OS=Homo sapiens OX=9606 GN=STIMATE PE=1 SV=1,GO:0002115; GO:0005246; GO:0005789; GO:0016020; GO:0032237; GO:0032541; GO:0140268,activation of store-operated calcium channel activity [GO:0032237]; store-operated calcium entry [GO:0002115],cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020],calcium channel regulator activity [GO:0005246],GO:0098772,molecular function regulator activity
OG_06424,0.2277489565939008,OG_06424,FUN_029113-T1,Peve_00013129,Pocillopora_meandrina_HIv1___RNAseq.g25757.t1,three_way,79.15533333333333,FUN_029113-T1,A7RK30,,,,,66.5,364.0,2.7e-136,486.5,sp|A7RK30|QORL2_NEMVE Quinone oxidoreductase-like protein 2 homolog OS=Nematostella vectensis OX=45351 GN=v1g238856 PE=3 SV=1,,,,,,
OG_04142,0.2277356806333662,OG_04142,FUN_016599-T1,Peve_00003402,Pocillopora_meandrina_HIv1___RNAseq.g414.t2,three_way,67.56366666666666,,,,,,,,,,,,,,,,,
OG_09630,0.2277047554430655,OG_09630,FUN_041815-T1,Peve_00025189,Pocillopora_meandrina_HIv1___RNAseq.g15799.t1,three_way,65.50633333333333,FUN_041815-T1,Q92551,IP6K1_HUMAN,,Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1),Homo sapiens (Human),42.7,433.0,1.4e-86,321.6,sp|Q92551|IP6K1_HUMAN Inositol hexakisphosphate kinase 1 OS=Homo sapiens OX=9606 GN=IP6K1 PE=1 SV=3,GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032958; GO:0043647; GO:0046854; GO:0052836; GO:0052839; GO:0120163,inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ATP binding [GO:0005524]; diphosphoinositol pentakisphosphate kinase activity [GO:0000829]; diphosphoinositol tetrakisphosphate kinase activity [GO:0052839]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]",GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; nucleus; nucleoplasm; cytosol; lipid metabolic process; transferase activity; organelle
OG_04541,0.2276165786892761,OG_04541,FUN_022098-T1,Peve_00038678,Pocillopora_meandrina_HIv1___RNAseq.g4106.t1,three_way,67.46583333333334,FUN_022098-T1,Q9IA31,,,,,31.5,523.0,6.9e-32,141.4,sp|Q9IA31|GLI3_CHICK Transcriptional activator GLI3 (Fragment) OS=Gallus gallus OX=9031 GN=GLI3 PE=1 SV=1,,,,,,
OG_07599,0.2275940817509739,OG_07599,FUN_034313-T1,Peve_00011307,Pocillopora_meandrina_HIv1___RNAseq.g28492.t1,three_way,82.53633333333333,FUN_034313-T1,A7SLW1,BCAT_NEMVE,,Branched-chain-amino-acid aminotransferase (EC 2.6.1.42),Nematostella vectensis (Starlet sea anemone),65.7,385.0,5.8e-156,552.0,sp|A7SLW1|BCAT_NEMVE Branched-chain-amino-acid aminotransferase OS=Nematostella vectensis OX=45351 GN=v1g246094 PE=3 SV=1,GO:0004084; GO:0005739; GO:0009098; GO:0009099; GO:0052654; GO:0052655; GO:0052656,L-leucine biosynthetic process [GO:0009098]; L-valine biosynthetic process [GO:0009099],mitochondrion [GO:0005739],branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine-2-oxoglutarate transaminase activity [GO:0052656]; L-leucine-2-oxoglutarate transaminase activity [GO:0052654]; L-valine-2-oxoglutarate transaminase activity [GO:0052655],GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; organelle
OG_00353,0.2275644693143954,OG_00353,FUN_001181-T1,Peve_00018945,Pocillopora_meandrina_HIv1___RNAseq.g29543.t1,three_way,82.81166666666667,FUN_001181-T1,A8WH18,,,,,63.5,482.0,5e-176,619.0,sp|A8WH18|NARFL_XENTR Cytosolic Fe-S cluster assembly factor narfl OS=Xenopus tropicalis OX=8364 GN=narfl PE=2 SV=1,,,,,,
OG_05456,0.2275628798987146,OG_05456,FUN_024414-T1,Peve_00027663,Pocillopora_meandrina_HIv1___RNAseq.g18703.t1,three_way,84.054,FUN_024414-T1,O02691,HCD2_BOVIN,,3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-estradiol 17-dehydrogenase) (EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))) (EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase) (EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH),Bos taurus (Bovine),64.1,256.0,7.3e-88,325.1,sp|O02691|HCD2_BOVIN 3-hydroxyacyl-CoA dehydrogenase type-2 OS=Bos taurus OX=9913 GN=HSD17B10 PE=1 SV=3,GO:0000049; GO:0003857; GO:0004303; GO:0005739; GO:0006550; GO:0006631; GO:0006635; GO:0006699; GO:0008207; GO:0008209; GO:0008210; GO:0008709; GO:0030283; GO:0030678; GO:0042645; GO:0044594; GO:0047015; GO:0047035; GO:0047044; GO:0051289; GO:0062173; GO:0070901; GO:0097745; GO:0106281; GO:0106282; GO:0106283; GO:1990180,androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; protein homotetramerization [GO:0051289],mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739],"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity [GO:0106281]; cholate 7-alpha-dehydrogenase (NAD+) activity [GO:0008709]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)+] activity [GO:0030283]; tRNA binding [GO:0000049]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283]",GO:0003723; GO:0003824; GO:0005739; GO:0006399; GO:0006520; GO:0006629; GO:0016491; GO:0043226; GO:0065003; GO:0140053,RNA binding; catalytic activity; mitochondrion; tRNA metabolic process; amino acid metabolic process; lipid metabolic process; oxidoreductase activity; organelle; protein-containing complex assembly; mitochondrial gene expression
OG_05734,0.2275334171513199,OG_05734,FUN_025660-T1,Peve_00042171,Pocillopora_meandrina_HIv1___RNAseq.g23068.t1,three_way,78.61866666666667,FUN_025660-T1,B0DOB4,NPHP4_XENLA,,Nephrocystin-4,Xenopus laevis (African clawed frog),41.9,1048.0,1.8e-222,774.2,sp|B0DOB4|NPHP4_XENLA Nephrocystin-4 OS=Xenopus laevis OX=8355 GN=nphp4 PE=2 SV=1,GO:0005737; GO:0035869; GO:0036064; GO:0090090; GO:0097546; GO:0097730; GO:1904491,negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein localization to ciliary transition zone [GO:1904491],ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_09134,0.2274619429083501,OG_09134,FUN_039701-T1,Peve_00008100,Pocillopora_meandrina_HIv1___RNAseq.g14123.t1,three_way,57.217333333333336,,,,,,,,,,,,,,,,,
OG_05556,0.2274125079859383,OG_05556,FUN_024770-T1,Peve_00003488,Pocillopora_meandrina_HIv1___RNAseq.g18819.t1,three_way,69.99166666666666,FUN_024770-T1,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),33.2,918.0,1.8e-116,422.9,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_02899,0.2273873865223256,OG_02899,FUN_011957-T1,Peve_00027894,Pocillopora_meandrina_HIv1___RNAseq.g23735.t1,three_way,62.81966666666667,FUN_011957-T1,Q92734,TFG_HUMAN,,Protein TFG (TRK-fused gene protein),Homo sapiens (Human),46.5,243.0,5.1e-40,166.8,sp|Q92734|TFG_HUMAN Protein TFG OS=Homo sapiens OX=9606 GN=TFG PE=1 SV=2,GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0043231; GO:0048208; GO:0070971,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; intracellular membrane-bounded organelle [GO:0043231],identical protein binding [GO:0042802],GO:0005829; GO:0016192; GO:0043226; GO:0065003,cytosol; vesicle-mediated transport; organelle; protein-containing complex assembly
OG_04363,0.2273589685791543,OG_04363,FUN_018014-T1,Peve_00000399,Pocillopora_meandrina_HIv1___RNAseq.g25260.t2,three_way,70.6505,FUN_018014-T1,Q5QM84,TPC1_ORYSJ,,Two pore calcium channel protein 1 (OsTPC1) (Voltage-dependent calcium channel protein TPC1),Oryza sativa subsp. japonica (Rice),24.1,439.0,2.1e-22,110.2,sp|Q5QM84|TPC1_ORYSJ Two pore calcium channel protein 1 OS=Oryza sativa subsp. japonica OX=39947 GN=TPC1 PE=1 SV=2,GO:0000325; GO:0005245; GO:0005509; GO:0005774; GO:0006816; GO:0006952; GO:0034702,calcium ion transport [GO:0006816]; defense response [GO:0006952],monoatomic ion channel complex [GO:0034702]; plant-type vacuole [GO:0000325]; vacuolar membrane [GO:0005774],calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005773; GO:0043226,transporter activity; vacuole; organelle
OG_08442,0.227218816420588,OG_08442,FUN_037204-T1,Peve_00019442,Pocillopora_meandrina_HIv1___RNAseq.g11069.t1a,three_way,78.51766666666667,FUN_037204-T1,O35623,,,,,49.0,96.0,3.9e-17,89.0,sp|O35623|BET1_MOUSE BET1 homolog OS=Mus musculus OX=10090 GN=Bet1 PE=1 SV=1,,,,,,
OG_08071,0.2272110954613538,OG_08071,FUN_035776-T1,Peve_00017723,Pocillopora_meandrina_HIv1___RNAseq.g11903.t1,three_way,63.2255,FUN_035776-T1,Q7TSG2,CTDP1_MOUSE,,RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),Mus musculus (Mouse),33.5,714.0,1.6e-88,328.9,sp|Q7TSG2|CTDP1_MOUSE RNA polymerase II subunit A C-terminal domain phosphatase OS=Mus musculus OX=10090 GN=Ctdp1 PE=1 SV=1,GO:0000922; GO:0001096; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006470; GO:0008420; GO:0010458; GO:0030496; GO:0030957; GO:0032991; GO:0043923; GO:0051233; GO:0051301; GO:0061052,cell division [GO:0051301]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096],GO:0003824; GO:0005654; GO:0005815; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; microtubule organizing center; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02771,0.2271126699702257,OG_02771,FUN_011710-T1,Peve_00025140,Pocillopora_meandrina_HIv1___RNAseq.g23816.t1,three_way,86.54816666666667,FUN_011710-T1,Q9JJ31,CUL5_RAT,,Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1),Rattus norvegicus (Rat),71.6,784.0,0.0,1121.3,sp|Q9JJ31|CUL5_RAT Cullin-5 OS=Rattus norvegicus OX=10116 GN=Cul5 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005000; GO:0005634; GO:0016567; GO:0019005; GO:0021799; GO:0021942; GO:0030674; GO:0031146; GO:0031466; GO:0031625; GO:0038026; GO:0043161; GO:0051480; GO:0070979; GO:0090734; GO:0160072; GO:2001222,cerebral cortex radially oriented cell migration [GO:0021799]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942]; reelin-mediated signaling pathway [GO:0038026]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of neuron migration [GO:2001222]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul5-RING ubiquitin ligase complex [GO:0031466]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734],protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; vasopressin receptor activity [GO:0005000],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0048870; GO:0060089; GO:0060090; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; cell motility; molecular transducer activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_02955,0.2271055513165877,OG_02955,FUN_012100-T1,Peve_00007424,Pocillopora_meandrina_HIv1___RNAseq.g23948.t1,three_way,81.48233333333333,FUN_012100-T1,B4F7A7,CEP57_RAT,,Centrosomal protein of 57 kDa (Cep57) (Translokin),Rattus norvegicus (Rat),36.2,447.0,2.8e-56,221.1,sp|B4F7A7|CEP57_RAT Centrosomal protein of 57 kDa OS=Rattus norvegicus OX=10116 GN=Cep57 PE=1 SV=2,GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034451; GO:0042803; GO:0043015; GO:0051260,fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634],fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0005794; GO:0005815; GO:0005829; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0065003,nucleus; Golgi apparatus; microtubule organizing center; cytosol; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; protein-containing complex assembly
OG_09218,0.2268850585808956,OG_09218,FUN_039938-T1,Peve_00004407,Pocillopora_meandrina_HIv1___TS.g1076.t1,three_way,66.03833333333333,FUN_039938-T1,Q28DX0,QTRT2_XENTR,,Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),42.0,257.0,1.2e-51,204.9,sp|Q28DX0|QTRT2_XENTR Queuine tRNA-ribosyltransferase accessory subunit 2 OS=Xenopus tropicalis OX=8364 GN=qtrt2 PE=2 SV=1,GO:0000049; GO:0005737; GO:0005739; GO:0005741; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0101030,tRNA-guanine transglycosylation [GO:0101030],cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA-guanosine(34) queuine transglycosylase activity [GO:0008479],GO:0003723; GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on RNA"
OG_06662,0.2268474833123446,OG_06662,FUN_030881-T1,Peve_00043611,Pocillopora_meandrina_HIv1___RNAseq.g30297.t1,three_way,90.43266666666666,FUN_030881-T1,A6H7B5,,,,,59.6,413.0,1.8e-139,497.3,sp|A6H7B5|CSN3_BOVIN COP9 signalosome complex subunit 3 OS=Bos taurus OX=9913 GN=COPS3 PE=2 SV=1,,,,,,
OG_06103,0.2267739749627627,OG_06103,FUN_027804-T1,Peve_00036486,Pocillopora_meandrina_HIv1___RNAseq.g13899.t1,three_way,84.46000000000001,FUN_027804-T1,Q9U9L2,,,,,82.8,250.0,9.3e-123,441.0,sp|Q9U9L2|RL8_ANOGA Large ribosomal subunit protein uL2 OS=Anopheles gambiae OX=7165 GN=RpL8 PE=2 SV=2,,,,,,
OG_05754,0.2267708638926453,OG_05754,FUN_025689-T1,Peve_00005582,Pocillopora_meandrina_HIv1___RNAseq.g13163.t2a,three_way,81.69233333333334,FUN_025689-T1,P58058,,,,,53.0,389.0,1.3999999999999999e-112,407.9,sp|P58058|NADK_MOUSE NAD kinase OS=Mus musculus OX=10090 GN=Nadk PE=1 SV=2,,,,,,
OG_03033,0.2267213447156983,OG_03033,FUN_012271-T1,Peve_00023574,Pocillopora_meandrina_HIv1___RNAseq.g23875.t1,three_way,82.19366666666667,FUN_012271-T1,Q9JJ80,,,,,58.3,259.0,1.8e-85,317.4,sp|Q9JJ80|RPF2_MOUSE Ribosome production factor 2 homolog OS=Mus musculus OX=10090 GN=Rpf2 PE=2 SV=2,,,,,,
OG_05169,0.2266827437662436,OG_05169,FUN_023497-T1,Peve_00017459,Pocillopora_meandrina_HIv1___RNAseq.g539.t1,three_way,83.72433333333333,FUN_023497-T1,Q7T292,,,,,56.8,301.0,4.9e-98,359.4,sp|Q7T292|MFRN2_DANRE Mitoferrin-2 OS=Danio rerio OX=7955 GN=slc25a28 PE=2 SV=1,,,,,,
OG_02762,0.2265524537437728,OG_02762,FUN_011699-T1,Peve_00018060,Pocillopora_meandrina_HIv1___RNAseq.g23827.t1,three_way,86.615,FUN_011699-T1,P47836,,,,,73.9,241.0,3.3e-106,386.0,sp|P47836|RS4_CHICK Small ribosomal subunit protein eS4 OS=Gallus gallus OX=9031 GN=RPS4 PE=1 SV=2,,,,,,
OG_01597,0.2265230964870144,OG_01597,FUN_006639-T1,Peve_00033034,Pocillopora_meandrina_HIv1___RNAseq.g20239.t1,three_way,79.87783333333333,FUN_006639-T1,P53992,SC24C_HUMAN,,Protein transport protein Sec24C (SEC24-related protein C),Homo sapiens (Human),58.8,770.0,3.3e-276,953.0,sp|P53992|SC24C_HUMAN Protein transport protein Sec24C OS=Homo sapiens OX=9606 GN=SEC24C PE=1 SV=3,GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0070971; GO:0090110,COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507],SNARE binding [GO:0000149]; zinc ion binding [GO:0008270],GO:0005829; GO:0006886; GO:0016192; GO:0048856,cytosol; intracellular protein transport; vesicle-mediated transport; anatomical structure development
OG_08757,0.2263606815627934,OG_08757,FUN_038028-T1,Peve_00002131,Pocillopora_meandrina_HIv1___TS.g19287.t1a,three_way,79.5965,FUN_038028-T1,Q80U30,CL16A_MOUSE,,Protein CLEC16A,Mus musculus (Mouse),42.5,1092.0,9.9e-206,718.8,sp|Q80U30|CL16A_MOUSE Protein CLEC16A OS=Mus musculus OX=10090 GN=Clec16a PE=1 SV=2,GO:0006914; GO:0031648; GO:0032434; GO:0032435; GO:0036020; GO:0043161; GO:1901098; GO:1901525,autophagy [GO:0006914]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],endolysosome membrane [GO:0036020],,GO:0006914; GO:0030163,autophagy; protein catabolic process
OG_07730,0.2263500422238157,OG_07730,FUN_034891-T1,Peve_00037339,Pocillopora_meandrina_HIv1___TS.g15151.t2,three_way,94.67133333333334,FUN_034891-T1,Q13951,,,,,57.1,170.0,1.1e-48,194.5,sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2,,,,,,
OG_04023,0.2262664037962748,OG_04023,FUN_016329-T1,Peve_00032382,Pocillopora_meandrina_HIv1___RNAseq.g9858.t1b,three_way,87.74166666666666,FUN_016329-T1,Q96EZ8,MCRS1_HUMAN,,Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2),Homo sapiens (Human),53.9,410.0,8.7e-113,408.7,sp|Q96EZ8|MCRS1_HUMAN Microspherule protein 1 OS=Homo sapiens OX=9606 GN=MCRS1 PE=1 SV=1,GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0008266; GO:0010521; GO:0016604; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0036211; GO:0043204; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051726; GO:0060382; GO:0071339; GO:1904357; GO:1904507; GO:1904751,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204],G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226; GO:0098772,RNA binding; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle; molecular function regulator activity
OG_07515,0.2261845610601916,OG_07515,FUN_034083-T1,Peve_00037081,Pocillopora_meandrina_HIv1___RNAseq.g26053.t1,three_way,67.07933333333332,,,,,,,,,,,,,,,,,
OG_01778,0.2261155049092069,OG_01778,FUN_007150-T1,Peve_00028250,Pocillopora_meandrina_HIv1___RNAseq.g19714.t1,three_way,81.34100000000001,FUN_007150-T1,Q96DB2,HDA11_HUMAN,,Histone deacetylase 11 (HD11) (EC 3.5.1.98),Homo sapiens (Human),63.6,319.0,6.7e-119,428.7,sp|Q96DB2|HDA11_HUMAN Histone deacetylase 11 OS=Homo sapiens OX=9606 GN=HDAC11 PE=1 SV=1,GO:0000118; GO:0004407; GO:0005634; GO:0005886; GO:0006325; GO:0040029; GO:0140297; GO:0141221,chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029],histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; chromatin organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01979,0.2260826867326526,OG_01979,FUN_008086-T1,Peve_00041202,Pocillopora_meandrina_HIv1___RNAseq.g18086.t1a,three_way,72.75416666666666,FUN_008086-T1,Q5ZMM1,,,,,55.5,443.0,4.7e-146,519.6,sp|Q5ZMM1|RIOX1_CHICK Ribosomal oxygenase 1 OS=Gallus gallus OX=9031 GN=RIOX1 PE=2 SV=1,,,,,,
OG_00115,0.226061642506036,OG_00115,FUN_000533-T1,Peve_00039811,Pocillopora_meandrina_HIv1___RNAseq.g2384.t1,three_way,81.9405,FUN_000533-T1,P20693,,,,,34.0,147.0,3.6e-17,94.0,sp|P20693|FCER2_MOUSE Low affinity immunoglobulin epsilon Fc receptor OS=Mus musculus OX=10090 GN=Fcer2 PE=1 SV=1,,,,,,
OG_04303,0.2260537100829762,OG_04303,FUN_017881-T1,Peve_00001915,Pocillopora_meandrina_HIv1___RNAseq.g9851.t1,three_way,79.504,,,,,,,,,,,,,,,,,
OG_06537,0.2260064047714171,OG_06537,FUN_029397-T1,Peve_00044519,Pocillopora_meandrina_HIv1___RNAseq.g17139.t1,three_way,75.86833333333334,FUN_029397-T1,Q5ZL00,EMC1_CHICK,,ER membrane protein complex subunit 1,Gallus gallus (Chicken),39.0,1036.0,1e-185,652.1,sp|Q5ZL00|EMC1_CHICK ER membrane protein complex subunit 1 OS=Gallus gallus OX=9031 GN=EMC1 PE=2 SV=1,GO:0005789; GO:0016020; GO:0045050; GO:0071816; GO:0072546,protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],,,
OG_02240,0.225996927996736,OG_02240,FUN_008652-T1,Peve_00032562,Pocillopora_meandrina_HIv1___RNAseq.g18.t1,three_way,57.517,FUN_008652-T1,Q9Y3I1,,,,,31.2,478.0,3.6e-46,187.6,sp|Q9Y3I1|FBX7_HUMAN F-box only protein 7 OS=Homo sapiens OX=9606 GN=FBXO7 PE=1 SV=1,,,,,,
OG_08916,0.2259907946837581,OG_08916,FUN_038372-T1,Peve_00000082,Pocillopora_meandrina_HIv1___TS.g5627.t2,three_way,66.95883333333333,FUN_038372-T1,Q8VCY6,,,,,37.0,332.0,1.1e-48,195.3,sp|Q8VCY6|UTP6_MOUSE U3 small nucleolar RNA-associated protein 6 homolog OS=Mus musculus OX=10090 GN=Utp6 PE=2 SV=1,,,,,,
OG_03094,0.2259539997249479,OG_03094,FUN_012379-T1,Peve_00042533,Pocillopora_meandrina_HIv1___TS.g16234.t1b,three_way,77.48716666666667,FUN_012379-T1,P91620,SIF2_DROME,,"Protein still life, isoforms C/SIF type 2",Drosophila melanogaster (Fruit fly),32.8,1044.0,4.7e-133,477.6,"sp|P91620|SIF2_DROME Protein still life, isoforms C/SIF type 2 OS=Drosophila melanogaster OX=7227 GN=sif PE=2 SV=2",GO:0005085; GO:0007264; GO:0016020; GO:0030036; GO:0045202; GO:0050770; GO:0050772; GO:0050803; GO:0051491,actin cytoskeleton organization [GO:0030036]; positive regulation of axonogenesis [GO:0050772]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; small GTPase-mediated signal transduction [GO:0007264],membrane [GO:0016020]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0007010; GO:0098772,cytoskeleton organization; molecular function regulator activity
OG_04052,0.2258404377051881,OG_04052,FUN_016371-T1,Peve_00022927,Pocillopora_meandrina_HIv1___RNAseq.g9747.t1,three_way,64.89166666666667,FUN_016371-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),56.4,133.0,4.6e-27,123.2,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_06289,0.2258355738101522,OG_06289,FUN_028484-T1,Peve_00023662,Pocillopora_meandrina_HIv1___RNAseq.g16115.t1,three_way,73.85666666666667,FUN_028484-T1,Q9NYR8,,,,,33.7,264.0,2.2e-31,137.9,sp|Q9NYR8|RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens OX=9606 GN=RDH8 PE=1 SV=1,,,,,,
OG_00622,0.2258333191317808,OG_00622,FUN_001793-T1,Peve_00008718,Pocillopora_meandrina_HIv1___RNAseq.g2635.t1a,three_way,54.11416666666666,FUN_001793-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.2,112.0,1.9e-13,79.3,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_03882,0.2258232490066505,OG_03882,FUN_015424-T1,Peve_00011815,Pocillopora_meandrina_HIv1___RNAseq.g21656.t1,three_way,94.874,FUN_015424-T1,Q6PC30,CSN5_DANRE,,COP9 signalosome complex subunit 5 (Signalosome subunit 5) (EC 3.4.-.-),Danio rerio (Zebrafish) (Brachydanio rerio),84.4,327.0,2.1e-159,563.1,sp|Q6PC30|CSN5_DANRE COP9 signalosome complex subunit 5 OS=Danio rerio OX=7955 GN=cops5 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008021; GO:0008180; GO:0008237; GO:0019784; GO:0043066; GO:0046872; GO:0048471; GO:0051091; GO:0051726; GO:0060118,negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; vestibular receptor cell development [GO:0060118],COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021],deNEDDylase activity [GO:0019784]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04582,0.2258223177351989,OG_04582,FUN_022245-T1,Peve_00037428,Pocillopora_meandrina_HIv1___RNAseq.g4760.t1,three_way,54.247166666666665,FUN_022245-T1,Q96DN6,MBD6_HUMAN,,Methyl-CpG-binding domain protein 6 (Methyl-CpG-binding protein MBD6),Homo sapiens (Human),41.4,99.0,6.5e-16,88.6,sp|Q96DN6|MBD6_HUMAN Methyl-CpG-binding domain protein 6 OS=Homo sapiens OX=9606 GN=MBD6 PE=1 SV=2,GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0010369,,chromocenter [GO:0010369]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005654; GO:0005694; GO:0043226,nucleus; nucleoplasm; chromosome; organelle
OG_04359,0.2257939341453917,OG_04359,FUN_018010-T1,Peve_00000404,Pocillopora_meandrina_HIv1___RNAseq.g25255.t4,three_way,81.14033333333334,FUN_018010-T1,A2CG49,,,,,35.3,3036.0,0.0,1707.6,sp|A2CG49|KALRN_MOUSE Kalirin OS=Mus musculus OX=10090 GN=Kalrn PE=1 SV=1,,,,,,
OG_05557,0.2257830178252529,OG_05557,FUN_024775-T1,Peve_00033053,Pocillopora_meandrina_HIv1___RNAseq.g18815.t1,three_way,70.15433333333333,FUN_024775-T1,Q92629,,,,,40.8,265.0,5.6999999999999996e-49,196.1,sp|Q92629|SGCD_HUMAN Delta-sarcoglycan OS=Homo sapiens OX=9606 GN=SGCD PE=1 SV=2,,,,,,
OG_09616,0.225692652021559,OG_09616,FUN_041776-T1,Peve_00010497,Pocillopora_meandrina_HIv1___RNAseq.g15888.t1,three_way,68.81383333333333,FUN_041776-T1,Q6DRG1,,,,,67.6,142.0,2e-50,201.1,sp|Q6DRG1|RBM42_DANRE RNA-binding protein 42 OS=Danio rerio OX=7955 GN=rbm42 PE=2 SV=2,,,,,,
OG_04571,0.2255945176959945,OG_04571,FUN_022218-T1,Peve_00028321,Pocillopora_meandrina_HIv1___RNAseq.g4733.t1c,three_way,83.12133333333334,FUN_022218-T1,Q6QN10,,,,,66.3,181.0,2.999999999999999e-47,189.9,sp|Q6QN10|NACA_CHILA Nascent polypeptide-associated complex subunit alpha OS=Chinchilla lanigera OX=34839 PE=2 SV=1,,,,,,
OG_08747,0.2255462033821661,OG_08747,FUN_038011-T1,Peve_00013509,Pocillopora_meandrina_HIv1___RNAseq.g26524.t1,three_way,63.710166666666666,FUN_038011-T1,Q8CGS5,,,,,36.2,804.0,2e-131,471.5,sp|Q8CGS5|RNZ2_RAT Zinc phosphodiesterase ELAC protein 2 OS=Rattus norvegicus OX=10116 GN=Elac2 PE=1 SV=1,,,,,,
OG_07081,0.22539450780116,OG_07081,FUN_032323-T1,Peve_00017288,Pocillopora_meandrina_HIv1___RNAseq.g24797.t1,three_way,83.84383333333334,FUN_032323-T1,O60763,USO1_HUMAN,,General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein),Homo sapiens (Human),57.8,765.0,2.2e-236,820.5,sp|O60763|USO1_HUMAN General vesicular transport factor p115 OS=Homo sapiens OX=9606 GN=USO1 PE=1 SV=2,GO:0000139; GO:0001650; GO:0003723; GO:0005783; GO:0005794; GO:0005795; GO:0005815; GO:0005829; GO:0006886; GO:0006888; GO:0007264; GO:0012507; GO:0016020; GO:0030133; GO:0032252; GO:0045056; GO:0045296; GO:0048211; GO:0048280; GO:0048471; GO:0061025; GO:1900076,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase-mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133],cadherin binding [GO:0045296]; RNA binding [GO:0003723],GO:0003723; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0061024,RNA binding; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_03427,0.2253658742946742,OG_03427,FUN_014483-T1,Peve_00037300,Pocillopora_meandrina_HIv1___RNAseq.g22813.t2,three_way,92.40566666666666,FUN_014483-T1,Q6NVL5,ELP3_XENTR,,Elongator complex protein 3 (EC 2.3.1.311) (tRNA uridine(34) acetyltransferase),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),81.4,532.0,7.4e-262,904.0,sp|Q6NVL5|ELP3_XENTR Elongator complex protein 3 OS=Xenopus tropicalis OX=8364 GN=elp3 PE=2 SV=1,GO:0000049; GO:0001755; GO:0002098; GO:0005634; GO:0005737; GO:0006357; GO:0008607; GO:0031397; GO:0046872; GO:0050821; GO:0051539; GO:0106261,negative regulation of protein ubiquitination [GO:0031397]; neural crest cell migration [GO:0001755]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]",GO:0003723; GO:0003824; GO:0005634; GO:0006355; GO:0006399; GO:0016740; GO:0043226; GO:0048870; GO:0098772; GO:0140098,"RNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; tRNA metabolic process; transferase activity; organelle; cell motility; molecular function regulator activity; catalytic activity, acting on RNA"
OG_07462,0.2252952594893172,OG_07462,FUN_033966-T1,Peve_00015215,Pocillopora_meandrina_HIv1___RNAseq.g28551.t1,three_way,59.46483333333333,FUN_033966-T1,P48547,KCNC1_HUMAN,,Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4),Homo sapiens (Human),50.1,467.0,2.5e-111,405.6,sp|P48547|KCNC1_HUMAN Voltage-gated potassium channel KCNC1 OS=Homo sapiens OX=9606 GN=KCNC1 PE=1 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030673; GO:0032590; GO:0032809; GO:0035864; GO:0042734; GO:0043679; GO:0044305; GO:0044325; GO:0045211; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1901381; GO:1990089,action potential [GO:0001508]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636],axolemma [GO:0030673]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0008092; GO:0048856; GO:0055085; GO:0065003,transporter activity; plasma membrane; cytoskeletal protein binding; anatomical structure development; transmembrane transport; protein-containing complex assembly
OG_00060,0.2250953697597694,OG_00060,FUN_000352-T1,Peve_00033531,Pocillopora_meandrina_HIv1___RNAseq.g29116.t1,three_way,77.85483333333333,FUN_000352-T1,P18395,,,,,46.0,817.0,5.600000000000001e-180,632.9,sp|P18395|CSDE1_RAT Cold shock domain-containing protein E1 OS=Rattus norvegicus OX=10116 GN=Csde1 PE=2 SV=1,,,,,,
OG_04054,0.2250682054881572,OG_04054,FUN_016373-T1,Peve_00022923,Pocillopora_meandrina_HIv1___RNAseq.g9745.t1,three_way,73.565,FUN_016373-T1,P42587,,,,,58.7,75.0,4.2e-17,89.7,sp|P42587|HNK2_XENLA Homeobox protein XENK-2 OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_06766,0.2250095331299946,OG_06766,FUN_031605-T1,Peve_00012514,Pocillopora_meandrina_HIv1___RNAseq.g5989.t1,three_way,84.85766666666667,FUN_031605-T1,Q6PB93,GALT2_MOUSE,,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],Mus musculus (Mouse),62.1,493.0,2.2999999999999998e-192,673.3,sp|Q6PB93|GALT2_MOUSE Polypeptide N-acetylgalactosaminyltransferase 2 OS=Mus musculus OX=10090 GN=Galnt2 PE=1 SV=1,GO:0002639; GO:0004653; GO:0005576; GO:0005796; GO:0006493; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0051604,O-glycan processing [GO:0016266]; positive regulation of immunoglobulin production [GO:0002639]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005576; GO:0009101; GO:0016740; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; extracellular region; glycoprotein biosynthetic process; transferase activity; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_07918,0.2249391222235895,OG_07918,FUN_035403-T1,Peve_00002640,Pocillopora_meandrina_HIv1___TS.g3526.t1,three_way,88.887,,,,,,,,,,,,,,,,,
OG_09466,0.2249254757667995,OG_09466,FUN_041490-T1,Peve_00004073,Pocillopora_meandrina_HIv1___RNAseq.g15669.t1,three_way,79.144,FUN_041490-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),33.6,420.0,1.3e-68,262.3,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_05526,0.2248689517745224,OG_05526,FUN_024661-T1,Peve_00012719,Pocillopora_meandrina_HIv1___RNAseq.g18964.t1,three_way,69.191,FUN_024661-T1,Q74GW7,,,,,36.1,249.0,1.3e-35,153.7,sp|Q74GW7|TTCA_GEOSL tRNA-cytidine(32) 2-sulfurtransferase OS=Geobacter sulfurreducens (strain ATCC 51573 / DSM 12127 / PCA) OX=243231 GN=ttcA PE=3 SV=2,,,,,,
OG_00006,0.2248443534858438,OG_00006,FUN_000193-T1,Peve_00038467,Pocillopora_meandrina_HIv1___RNAseq.g28894.t1,three_way,70.21933333333334,FUN_000193-T1,Q5I0K7,,,,,53.2,158.0,3.4e-41,169.5,sp|Q5I0K7|ALG13_RAT UDP-N-acetylglucosamine transferase subunit ALG13 OS=Rattus norvegicus OX=10116 GN=Alg13 PE=1 SV=1,,,,,,
OG_09852,0.2248106152366753,OG_09852,FUN_042843-T1,Peve_00023281,Pocillopora_meandrina_HIv1___RNAseq.g7256.t1,three_way,66.93900000000001,FUN_042843-T1,Q6ZZY0,,,,,56.5,483.0,1.4e-176,620.9,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_03063,0.2246481460806949,OG_03063,FUN_012329-T1,Peve_00023485,Pocillopora_meandrina_HIv1___RNAseq.g23753.t1,three_way,67.88033333333334,FUN_012329-T1,Q6GMR7,FAAH2_HUMAN,,Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2),Homo sapiens (Human),47.5,495.0,4e-120,433.3,sp|Q6GMR7|FAAH2_HUMAN Fatty-acid amide hydrolase 2 OS=Homo sapiens OX=9606 GN=FAAH2 PE=1 SV=1,GO:0005811; GO:0016020; GO:0016042; GO:0017064; GO:0019369,arachidonate metabolic process [GO:0019369]; lipid catabolic process [GO:0016042],lipid droplet [GO:0005811]; membrane [GO:0016020],fatty acid amide hydrolase activity [GO:0017064],GO:0003824; GO:0005811; GO:0006629; GO:0016787; GO:0043226,catalytic activity; lipid droplet; lipid metabolic process; hydrolase activity; organelle
OG_04907,0.2245665537903547,OG_04907,FUN_022957-T1,Peve_00001411,Pocillopora_meandrina_HIv1___RNAseq.g3772.t1,three_way,78.32566666666666,FUN_022957-T1,Q28BS5,,,,,41.9,148.0,1.9e-25,117.9,sp|Q28BS5|FOXF1_XENTR Forkhead box protein F1 OS=Xenopus tropicalis OX=8364 GN=foxf1 PE=2 SV=1,,,,,,
OG_09399,0.224430457140041,OG_09399,FUN_040713-T1,Peve_00002272,Pocillopora_meandrina_HIv1___TS.g280.t1,three_way,81.17566666666667,FUN_040713-T1,Q9Z2E1,,,,,43.9,255.0,6.899999999999999e-49,195.7,sp|Q9Z2E1|MBD2_MOUSE Methyl-CpG-binding domain protein 2 OS=Mus musculus OX=10090 GN=Mbd2 PE=1 SV=2,,,,,,
OG_09795,0.2244156505461708,OG_09795,FUN_042602-T1,Peve_00034908,Pocillopora_meandrina_HIv1___RNAseq.g16851.t1,three_way,67.051,FUN_042602-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),26.5,701.0,3.2999999999999996e-62,241.9,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_04776,0.2243904369897043,OG_04776,FUN_022682-T1,Peve_00018005,Pocillopora_meandrina_HIv1___RNAseq.g4839.t1,three_way,89.59733333333334,FUN_022682-T1,Q9WUD8,,,,,67.6,176.0,4.5e-68,258.8,sp|Q9WUD8|FAIM1_MOUSE Fas apoptotic inhibitory molecule 1 OS=Mus musculus OX=10090 GN=Faim PE=1 SV=1,,,,,,
OG_00351,0.2242695278082703,OG_00351,FUN_001178-T1,Peve_00027159,Pocillopora_meandrina_HIv1___RNAseq.g29546.t1,three_way,73.34033333333333,FUN_001178-T1,Q9NUJ3,T11L1_HUMAN,,T-complex protein 11-like protein 1,Homo sapiens (Human),39.4,447.0,1.8e-84,314.7,sp|Q9NUJ3|T11L1_HUMAN T-complex protein 11-like protein 1 OS=Homo sapiens OX=9606 GN=TCP11L1 PE=1 SV=1,GO:0005874; GO:0007165,signal transduction [GO:0007165],microtubule [GO:0005874],,,
OG_06124,0.224237680335316,OG_06124,FUN_027902-T1,Peve_00020105,Pocillopora_meandrina_HIv1___RNAseq.g13882.t1,three_way,48.062,,,,,,,,,,,,,,,,,
OG_03433,0.2241839406244715,OG_03433,FUN_014490-T1,Peve_00013878,Pocillopora_meandrina_HIv1___RNAseq.g22518.t4,three_way,79.35166666666667,FUN_014490-T1,Q0V8A3,CAST1_BOVIN,,Cytosolic arginine sensor for mTORC1 subunit 1 (GATS-like protein 3),Bos taurus (Bovine),42.6,329.0,7.499999999999999e-69,262.3,sp|Q0V8A3|CAST1_BOVIN Cytosolic arginine sensor for mTORC1 subunit 1 OS=Bos taurus OX=9913 GN=CASTOR1 PE=2 SV=1,GO:0005829; GO:0034618; GO:0140311; GO:1903577; GO:1904262,cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262],cytosol [GO:0005829],arginine binding [GO:0034618]; protein sequestering activity [GO:0140311],GO:0005829; GO:0140313,cytosol; molecular sequestering activity
OG_09837,0.2241724184143515,OG_09837,FUN_042817-T1,Peve_00019562,Pocillopora_meandrina_HIv1___RNAseq.g7434.t3,three_way,67.52316666666667,FUN_042817-T1,Q8N1W1,ARG28_HUMAN,,Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor) (p190-RhoGEF) (p190RhoGEF) (Rho guanine nucleotide exchange factor),Homo sapiens (Human),26.8,1282.0,1.1e-79,300.4,sp|Q8N1W1|ARG28_HUMAN Rho guanine nucleotide exchange factor 28 OS=Homo sapiens OX=9606 GN=ARHGEF28 PE=1 SV=3,GO:0000902; GO:0003723; GO:0005085; GO:0005829; GO:0005886; GO:0008270; GO:0021955; GO:0035023; GO:0048013; GO:0051056; GO:0060052,cell morphogenesis [GO:0000902]; central nervous system neuron axonogenesis [GO:0021955]; ephrin receptor signaling pathway [GO:0048013]; neurofilament cytoskeleton organization [GO:0060052]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],cytosol [GO:0005829]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005829; GO:0005886; GO:0007010; GO:0098772,RNA binding; cytosol; plasma membrane; cytoskeleton organization; molecular function regulator activity
OG_02571,0.2240840114426751,OG_02571,FUN_010674-T1,Peve_00044786,Pocillopora_meandrina_HIv1___RNAseq.g21350.t1,three_way,81.68766666666667,FUN_010674-T1,O75116,ROCK2_HUMAN,,"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)",Homo sapiens (Human),50.3,445.0,8.199999999999999e-109,396.7,sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=4,GO:0000281; GO:0001837; GO:0001934; GO:0002020; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007266; GO:0008270; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0036464; GO:0042752; GO:0043410; GO:0044788; GO:0045019; GO:0045616; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061133; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; mitotic cytokinesis [GO:0000281]; modulation by host of viral process [GO:0044788]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; zinc ion binding [GO:0008270],GO:0000910; GO:0003012; GO:0003013; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0030154; GO:0043226; GO:0072659; GO:0098772; GO:0140096,"cytokinesis; muscle system process; circulatory system process; RNA binding; catalytic activity; structural molecule activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; cell differentiation; organelle; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01782,0.2240092033999775,OG_01782,FUN_007155-T1,Peve_00028244,Pocillopora_meandrina_HIv1___TS.g29111.t1,three_way,72.6365,FUN_007155-T1,Q9PT84,,,,,43.9,471.0,5.1e-99,363.6,sp|Q9PT84|KCNH6_CHICK Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Gallus gallus OX=9031 GN=KCNH6 PE=2 SV=2,,,,,,
OG_06864,0.2239968998669711,OG_06864,FUN_031860-T1,Peve_00011073,Pocillopora_meandrina_HIv1___RNAseq.g5631.t4,three_way,80.47416666666668,FUN_031860-T1,Q86UA1,,,,,44.6,579.0,9.1e-144,512.3,sp|Q86UA1|PRP39_HUMAN Pre-mRNA-processing factor 39 OS=Homo sapiens OX=9606 GN=PRPF39 PE=1 SV=3,,,,,,
OG_06199,0.2239783662040996,OG_06199,FUN_028133-T1,Peve_00004264,Pocillopora_meandrina_HIv1___RNAseq.g15555.t1,three_way,47.007000000000005,FUN_028133-T1,A2AJ76,HMCN2_MOUSE,,Hemicentin-2,Mus musculus (Mouse),22.6,495.0,5.8e-18,94.4,sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0030054; GO:0032154; GO:0062023,,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],calcium ion binding [GO:0005509],GO:0005576; GO:0030312; GO:0031012,extracellular region; external encapsulating structure; extracellular matrix
OG_00591,0.22384029699264,OG_00591,FUN_001725-T1,Peve_00041636,Pocillopora_meandrina_HIv1___RNAseq.g2701.t1,three_way,76.361,FUN_001725-T1,Q9I8C7,,,,,35.9,337.0,9e-52,205.7,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_09902,0.2238393031471305,OG_09902,FUN_042998-T1,Peve_00015176,Pocillopora_meandrina_HIv1___RNAseq.g7022.t1,three_way,83.66866666666667,FUN_042998-T1,Q6ZWV7,RL35_MOUSE,,Large ribosomal subunit protein uL29 (60S ribosomal protein L35),Mus musculus (Mouse),78.7,122.0,6.5e-42,171.4,sp|Q6ZWV7|RL35_MOUSE Large ribosomal subunit protein uL29 OS=Mus musculus OX=10090 GN=Rpl35 PE=1 SV=1,GO:0000463; GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; cytosol; ribosome; organelle
OG_09896,0.2238310705695161,OG_09896,FUN_042991-T1,Peve_00031067,Pocillopora_meandrina_HIv1___RNAseq.g7016.t1,three_way,70.472,FUN_042991-T1,Q28BT4,,,,,38.4,307.0,9.8e-50,198.7,sp|Q28BT4|CALU_XENTR Calumenin OS=Xenopus tropicalis OX=8364 GN=calu PE=2 SV=1,,,,,,
OG_08049,0.22381993531037,OG_08049,FUN_035737-T1,Peve_00044088,Pocillopora_meandrina_HIv1___RNAseq.g11864.t1,three_way,77.52216666666666,FUN_035737-T1,Q8BYH8,CHD9_MOUSE,,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.-) (ATP-dependent helicase CHD9) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),Mus musculus (Mouse),43.2,2161.0,0.0,1496.1,sp|Q8BYH8|CHD9_MOUSE Chromodomain-helicase-DNA-binding protein 9 OS=Mus musculus OX=10090 GN=Chd9 PE=1 SV=2,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005829; GO:0006325; GO:0016887,chromatin organization [GO:0006325],cytosol [GO:0005829]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0140657,DNA binding; catalytic activity; nucleoplasm; cytosol; chromatin organization; hydrolase activity; isomerase activity; ATP-dependent activity
OG_02928,0.2237939701655248,OG_02928,FUN_012021-T1,Peve_00030378,Pocillopora_meandrina_HIv1___RNAseq.g24048.t1,three_way,70.96433333333333,FUN_012021-T1,A7S5D9,IYD_NEMVE,,Iodotyrosine deiodinase (EC 1.21.1.1) (Halotyrosine dehalogenase),Nematostella vectensis (Starlet sea anemone),62.6,195.0,1.6999999999999999e-68,260.8,sp|A7S5D9|IYD_NEMVE Iodotyrosine deiodinase OS=Nematostella vectensis OX=45351 GN=v1g105379 PE=1 SV=1,GO:0005886; GO:0006570; GO:0010181; GO:0016491; GO:0140616,tyrosine metabolic process [GO:0006570],plasma membrane [GO:0005886],FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005886; GO:0006520; GO:0016491,catalytic activity; plasma membrane; amino acid metabolic process; oxidoreductase activity
OG_07768,0.2237719986620126,OG_07768,FUN_034963-T1,Peve_00028350,Pocillopora_meandrina_HIv1___TS.g3511.t1,three_way,62.328,FUN_034963-T1,Q9D5D8,,,,,27.8,503.0,6.9e-36,153.3,sp|Q9D5D8|CDYL2_MOUSE Chromodomain Y-like protein 2 OS=Mus musculus OX=10090 GN=Cdyl2 PE=1 SV=1,,,,,,
OG_09461,0.2237268967827932,OG_09461,FUN_041480-T1,Peve_00028683,Pocillopora_meandrina_HIv1___TS.g10702.t1,three_way,66.502,FUN_041480-T1,P33277,,,,,29.5,499.0,4.1e-42,174.1,sp|P33277|GAP1_SCHPO GTPase-activating protein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=gap1 PE=4 SV=1,,,,,,
OG_04271,0.2236945040382965,OG_04271,FUN_017829-T1,Peve_00029495,Pocillopora_meandrina_HIv1___RNAseq.g9642.t1,three_way,83.37966666666667,FUN_017829-T1,Q9NES8,,,,,59.1,477.0,9.1e-164,578.2,sp|Q9NES8|PPP5_CAEEL Serine/threonine-protein phosphatase 5 OS=Caenorhabditis elegans OX=6239 GN=pph-5 PE=1 SV=2,,,,,,
OG_03488,0.2235740778914147,OG_03488,FUN_014594-T1,Peve_00030566,Pocillopora_meandrina_HIv1___RNAseq.g22733.t1b,three_way,79.34916666666666,,,,,,,,,,,,,,,,,
OG_03083,0.2235361893273434,OG_03083,FUN_012356-T1,Peve_00042559,Pocillopora_meandrina_HIv1___RNAseq.g23275.t1,three_way,61.93366666666667,,,,,,,,,,,,,,,,,
OG_02963,0.2234092036134898,OG_02963,FUN_012113-T1,Peve_00045239,Pocillopora_meandrina_HIv1___RNAseq.g23944.t1,three_way,73.61,FUN_012113-T1,Q86U90,YRDC_HUMAN,,Threonylcarbamoyl-AMP synthase (EC 2.7.7.87) (Dopamine receptor-interacting protein 3) (Ischemia/reperfusion-inducible protein homolog) (hIRIP),Homo sapiens (Human),53.8,212.0,6.100000000000001e-57,222.2,sp|Q86U90|YRDC_HUMAN Threonylcarbamoyl-AMP synthase OS=Homo sapiens OX=9606 GN=YRDC PE=1 SV=1,GO:0000049; GO:0002949; GO:0003725; GO:0005737; GO:0005739; GO:0005886; GO:0006450; GO:0016779; GO:0051051; GO:0061710,negative regulation of transport [GO:0051051]; regulation of translational fidelity [GO:0006450]; tRNA threonylcarbamoyladenosine modification [GO:0002949],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],double-stranded RNA binding [GO:0003725]; L-threonylcarbamoyladenylate synthase [GO:0061710]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005739; GO:0005886; GO:0006399; GO:0016740; GO:0043226,RNA binding; catalytic activity; mitochondrion; plasma membrane; tRNA metabolic process; transferase activity; organelle
OG_09589,0.2233886381931171,OG_09589,FUN_041731-T1,Peve_00023310,Pocillopora_meandrina_HIv1___TS.g10511.t2,three_way,73.30466666666666,FUN_041731-T1,Q5ZLS8,,,,,29.0,758.0,8e-95,349.7,sp|Q5ZLS8|INT10_CHICK Integrator complex subunit 10 OS=Gallus gallus OX=9031 GN=INTS10 PE=2 SV=1,,,,,,
OG_08846,0.2233306519157919,OG_08846,FUN_038204-T1,Peve_00006771,Pocillopora_meandrina_HIv1___RNAseq.g930.t1,three_way,91.27933333333333,FUN_038204-T1,P26368,U2AF2_HUMAN,,Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit),Homo sapiens (Human),67.7,387.0,2.5e-142,506.9,sp|P26368|U2AF2_HUMAN Splicing factor U2AF 65 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF2 PE=1 SV=4,GO:0000243; GO:0000245; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008187; GO:0016607; GO:0019899; GO:0030628; GO:0031397; GO:0033120; GO:0048025; GO:0070742; GO:0071004; GO:0089701; GO:0140678,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]; spliceosomal complex assembly [GO:0000245]",commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701],C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; molecular function inhibitor activity [GO:0140678]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003; GO:0098772,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly; molecular function regulator activity
OG_05093,0.2232652459595638,OG_05093,FUN_023339-T1,Peve_00001913,Pocillopora_meandrina_HIv1___RNAseq.g17420.t1,three_way,51.641666666666666,FUN_023339-T1,Q91ZV2,,,,,33.3,168.0,2.7e-14,82.0,"sp|Q91ZV2|DCBD2_RAT Discoidin, CUB and LCCL domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Dcbld2 PE=2 SV=1",,,,,,
OG_09155,0.2232171417184748,OG_09155,FUN_039814-T1,Peve_00039067,Pocillopora_meandrina_HIv1___RNAseq.g7502.t1,three_way,68.30133333333333,,,,,,,,,,,,,,,,,
OG_09886,0.2232003942830268,OG_09886,FUN_042959-T1,Peve_00039053,Pocillopora_meandrina_HIv1___RNAseq.g7120.t1,three_way,63.528,FUN_042959-T1,B8PYG1,NSMF_DANRE,,NMDA receptor synaptonuclear signaling and neuronal migration factor (Nasal embryonic luteinizing hormone-releasing hormone factor) (Nasal embryonic LHRH factor),Danio rerio (Zebrafish) (Brachydanio rerio),33.0,221.0,3.7e-32,141.0,sp|B8PYG1|NSMF_DANRE NMDA receptor synaptonuclear signaling and neuronal migration factor OS=Danio rerio OX=7955 GN=nsmf PE=2 SV=1,GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0014069; GO:0016363; GO:0030425; GO:0031965; GO:0045773; GO:0048168; GO:2001224,positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; regulation of neuronal synaptic plasticity [GO:0048168],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],,GO:0005634; GO:0005856; GO:0005886; GO:0043226,nucleus; cytoskeleton; plasma membrane; organelle
OG_07791,0.2231845428481257,OG_07791,FUN_035012-T1,Peve_00024655,Pocillopora_meandrina_HIv1___RNAseq.g27783.t1,three_way,78.43166666666667,FUN_035012-T1,Q8BXA5,,,,,50.3,537.0,6.9e-157,555.4,sp|Q8BXA5|CLP1L_MOUSE Lipid scramblase CLPTM1L OS=Mus musculus OX=10090 GN=Clptm1l PE=1 SV=1,,,,,,
OG_01839,0.2231508956836616,OG_01839,FUN_007785-T1,Peve_00032269,Pocillopora_meandrina_HIv1___RNAseq.g5904.t3,three_way,77.73566666666667,FUN_007785-T1,Q7ZZC8,NEK9_XENLA,,Serine/threonine-protein kinase Nek9 (xNek9) (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9),Xenopus laevis (African clawed frog),45.7,637.0,6e-157,556.2,sp|Q7ZZC8|NEK9_XENLA Serine/threonine-protein kinase Nek9 OS=Xenopus laevis OX=8355 GN=nek9 PE=2 SV=1,GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0019901; GO:0030295; GO:0046872; GO:0051301; GO:0106310,cell division [GO:0051301]; mitotic cell cycle [GO:0000278],centrosome [GO:0005813]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000278; GO:0003824; GO:0005815; GO:0016740; GO:0098772; GO:0140096,"mitotic cell cycle; catalytic activity; microtubule organizing center; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03941,0.2230843184942332,OG_03941,FUN_016076-T1,Peve_00021921,Pocillopora_meandrina_HIv1___RNAseq.g21616.t1,three_way,70.497,FUN_016076-T1,Q9C9C6,,,,,49.4,180.0,1.2e-34,147.9,sp|Q9C9C6|RL62_ARATH Large ribosomal subunit protein eL6y OS=Arabidopsis thaliana OX=3702 GN=RPL6B PE=2 SV=1,,,,,,
OG_02073,0.2230467987587955,OG_02073,FUN_008289-T1,Peve_00018506,Pocillopora_meandrina_HIv1___RNAseq.g18019.t1,three_way,82.752,FUN_008289-T1,Q19980,GCH1_CAEEL,,GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I),Caenorhabditis elegans,72.6,186.0,1.3e-74,280.8,sp|Q19980|GCH1_CAEEL GTP cyclohydrolase 1 OS=Caenorhabditis elegans OX=6239 GN=cat-4 PE=1 SV=1,GO:0003934; GO:0005525; GO:0005737; GO:0006585; GO:0006729; GO:0008270; GO:0042438; GO:0046654,dopamine biosynthetic process from tyrosine [GO:0006585]; melanin biosynthetic process [GO:0042438]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654],cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270],GO:0003824; GO:0006520; GO:0006575; GO:0016787,catalytic activity; amino acid metabolic process; modified amino acid metabolic process; hydrolase activity
OG_04457,0.223000074516343,OG_04457,FUN_019141-T1,Peve_00024881,Pocillopora_meandrina_HIv1___RNAseq.g25378.t1,three_way,55.14266666666666,FUN_019141-T1,P15535,,,,,44.9,294.0,1.3000000000000001e-67,258.5,"sp|P15535|B4GT1_MOUSE Beta-1,4-galactosyltransferase 1 OS=Mus musculus OX=10090 GN=B4galt1 PE=1 SV=1",,,,,,
OG_06815,0.2229180321549281,OG_06815,FUN_031715-T1,Peve_00039096,Pocillopora_meandrina_HIv1___RNAseq.g5460.t1,three_way,86.92166666666667,FUN_031715-T1,Q4V8K5,BROX_RAT,,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),Rattus norvegicus (Rat),49.5,384.0,5.9e-103,375.9,sp|Q4V8K5|BROX_RAT BRO1 domain-containing protein BROX OS=Rattus norvegicus OX=10116 GN=Brox PE=2 SV=1,GO:0005635; GO:0007084; GO:0031965,mitotic nuclear membrane reassembly [GO:0007084],nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965],,GO:0005635; GO:0061024,nuclear envelope; membrane organization
OG_02320,0.2228943862519883,OG_02320,FUN_008912-T1,Peve_00033001,Pocillopora_meandrina_HIv1___RNAseq.g3977.t1,three_way,63.34133333333334,,,,,,,,,,,,,,,,,
OG_01090,0.222739200518907,OG_01090,FUN_004583-T1,Peve_00012403,Pocillopora_meandrina_HIv1___RNAseq.g6603.t1,three_way,58.695,,,,,,,,,,,,,,,,,
OG_03231,0.2226447164105085,OG_03231,FUN_012774-T1,Peve_00007593,Pocillopora_meandrina_HIv1___RNAseq.g13651.t1,three_way,88.069,FUN_012774-T1,O43741,,,,,45.0,280.0,3.1e-60,233.4,sp|O43741|AAKB2_HUMAN 5'-AMP-activated protein kinase subunit beta-2 OS=Homo sapiens OX=9606 GN=PRKAB2 PE=1 SV=1,,,,,,
OG_09849,0.2226291332194036,OG_09849,FUN_042840-T1,Peve_00007266,Pocillopora_meandrina_HIv1___RNAseq.g7261.t1,three_way,47.549,,,,,,,,,,,,,,,,,
OG_06164,0.2226254028985806,OG_06164,FUN_028015-T1,Peve_00036494,Pocillopora_meandrina_HIv1___RNAseq.g13906.t1,three_way,79.2535,FUN_028015-T1,Q13217,DNJC3_HUMAN,,"DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)",Homo sapiens (Human),37.9,472.0,1e-77,292.4,sp|Q13217|DNJC3_HUMAN DnaJ homolog subfamily C member 3 OS=Homo sapiens OX=9606 GN=DNAJC3 PE=1 SV=1,GO:0004860; GO:0005576; GO:0005737; GO:0005783; GO:0005788; GO:0005829; GO:0006986; GO:0016020; GO:0019901; GO:0034975; GO:0035578; GO:0036494; GO:0043066; GO:0051087; GO:0051603; GO:0051607; GO:0051787; GO:0070062; GO:0070417; GO:1902010; GO:1903561; GO:1903912,cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020],misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein-folding chaperone binding [GO:0051087],GO:0005576; GO:0005783; GO:0005829; GO:0006457; GO:0043226; GO:0098772,extracellular region; endoplasmic reticulum; cytosol; protein folding; organelle; molecular function regulator activity
OG_02847,0.2225828233608437,OG_02847,FUN_011874-T1,Peve_00018842,Pocillopora_meandrina_HIv1___RNAseq.g23398.t1,three_way,40.03266666666667,FUN_011874-T1,O08863,BIRC3_MOUSE,,Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 2) (C-IAP2) (Inhibitor of apoptosis protein 1) (mIAP1) (RING-type E3 ubiquitin transferase BIRC3),Mus musculus (Mouse),25.2,397.0,2.7e-15,85.9,sp|O08863|BIRC3_MOUSE Baculoviral IAP repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Birc3 PE=1 SV=2,GO:0005634; GO:0005737; GO:0006915; GO:0008270; GO:0016740; GO:0042326; GO:0042981; GO:0060546; GO:0070266; GO:0071356; GO:1901222; GO:1902916; GO:2000378,apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; necroptotic process [GO:0070266]; negative regulation of necroptotic process [GO:0060546]; negative regulation of phosphorylation [GO:0042326]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of protein polyubiquitination [GO:1902916]; regulation of apoptotic process [GO:0042981]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222],cytoplasm [GO:0005737]; nucleus [GO:0005634],transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0012501; GO:0016740; GO:0043226,catalytic activity; nucleus; programmed cell death; transferase activity; organelle
OG_05672,0.2225562463899893,OG_05672,FUN_025466-T1,Peve_00043837,Pocillopora_meandrina_HIv1___RNAseq.g13240.t1,three_way,86.86633333333333,FUN_025466-T1,Q8VDJ3,,,,,52.2,1291.0,0.0,1320.8,sp|Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus OX=10090 GN=Hdlbp PE=1 SV=1,,,,,,
OG_10166,0.2225284387251268,OG_10166,FUN_043565-T1,Peve_00008972,Pocillopora_meandrina_HIv1___RNAseq.g8053.t1a,three_way,82.33433333333333,FUN_043565-T1,Q6MG08,ABCF1_RAT,,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50),Rattus norvegicus (Rat),63.4,565.0,7.8e-198,691.8,sp|Q6MG08|ABCF1_RAT ATP-binding cassette sub-family F member 1 OS=Rattus norvegicus OX=10116 GN=Abcf1 PE=1 SV=1,GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005840; GO:0006412; GO:0006413; GO:0008494; GO:0016887; GO:0043022; GO:0045727,positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; ribosome [GO:0005840],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494],GO:0003824; GO:0005635; GO:0005654; GO:0005840; GO:0016787; GO:0043226; GO:0045182,catalytic activity; nuclear envelope; nucleoplasm; ribosome; hydrolase activity; organelle; translation regulator activity
OG_04780,0.2224922445872949,OG_04780,FUN_022689-T1,Peve_00045106,Pocillopora_meandrina_HIv1___RNAseq.g4835.t1,three_way,78.04266666666666,FUN_022689-T1,Q8NKE2,,,,,44.2,278.0,4.999999999999999e-62,239.6,"sp|Q8NKE2|AOX_CRYNH Alternative oxidase, mitochondrial OS=Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) OX=235443 GN=AOX1 PE=3 SV=2",,,,,,
OG_05387,0.2224430489756758,OG_05387,FUN_024208-T1,Peve_00031873,Pocillopora_meandrina_HIv1___RNAseq.g18905.t1b,three_way,71.887,FUN_024208-T1,O09167,RL21_MOUSE,,Large ribosomal subunit protein eL21 (60S ribosomal protein L21),Mus musculus (Mouse),65.0,160.0,4.7e-52,206.1,sp|O09167|RL21_MOUSE Large ribosomal subunit protein eL21 OS=Mus musculus OX=10090 GN=Rpl21 PE=1 SV=4,GO:0002181; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098794,cytoplasmic translation [GO:0002181],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; postsynapse [GO:0098794]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005783; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; endoplasmic reticulum; cytosol; ribosome; organelle
OG_06171,0.2223090723082635,OG_06171,FUN_028024-T1,Peve_00010827,Pocillopora_meandrina_HIv1___RNAseq.g13915.t1,three_way,86.50533333333333,,,,,,,,,,,,,,,,,
OG_02152,0.2222927496563948,OG_02152,FUN_008479-T1,Peve_00028798,Pocillopora_meandrina_HIv1___RNAseq.g30398.t1,three_way,78.626,FUN_008479-T1,Q21279,,,,,37.7,459.0,7.099999999999999e-90,332.8,sp|Q21279|TTL15_CAEEL Probable tubulin polyglutamylase ttll-15 OS=Caenorhabditis elegans OX=6239 GN=ttll-15 PE=2 SV=3,,,,,,
OG_00617,0.2221160713758276,OG_00617,FUN_001783-T1,Peve_00011612,Pocillopora_meandrina_HIv1___RNAseq.g2641.t1,three_way,49.378166666666665,,,,,,,,,,,,,,,,,
OG_06653,0.2218879652232708,OG_06653,FUN_030678-T1,Peve_00028161,Pocillopora_meandrina_HIv1___RNAseq.g6203.t1,three_way,43.779,,,,,,,,,,,,,,,,,
OG_05593,0.2218482523200402,OG_05593,FUN_025100-T1,Peve_00038383,Pocillopora_meandrina_HIv1___RNAseq.g19443.t1,three_way,68.198,FUN_025100-T1,Q8C8U0,,,,,33.6,961.0,3.5e-107,391.0,sp|Q8C8U0|LIPB1_MOUSE Liprin-beta-1 OS=Mus musculus OX=10090 GN=Ppfibp1 PE=1 SV=3,,,,,,
OG_09944,0.221834317763179,OG_09944,FUN_043111-T1,Peve_00014954,Pocillopora_meandrina_HIv1___RNAseq.g7894.t1,three_way,96.616,FUN_043111-T1,Q8JGS9,,,,,89.1,101.0,5.5e-47,188.0,sp|Q8JGS9|RS18_DANRE Small ribosomal subunit protein uS13 OS=Danio rerio OX=7955 GN=rps18 PE=1 SV=1,,,,,,
OG_04138,0.2217117353720087,OG_04138,FUN_016592-T1,Peve_00005996,Pocillopora_meandrina_HIv1___RNAseq.g475.t1,three_way,82.95,FUN_016592-T1,D3ZY60,PKHA8_RAT,,Pleckstrin homology domain-containing family A member 8 (PH domain-containing family A member 8) (Phosphatidylinositol-four-phosphate adapter protein 2) (FAPP-2) (Phosphoinositol 4-phosphate adapter protein 2),Rattus norvegicus (Rat),39.0,546.0,2.3999999999999998e-96,354.4,sp|D3ZY60|PKHA8_RAT Pleckstrin homology domain-containing family A member 8 OS=Rattus norvegicus OX=10116 GN=Plekha8 PE=1 SV=1,GO:0005654; GO:0005802; GO:0005829; GO:0006869; GO:0015031; GO:0016020; GO:0017089; GO:0035621; GO:0035627; GO:0042802; GO:0051861; GO:0070273; GO:0097001; GO:0120009; GO:1902387; GO:1902388,ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031],cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802],ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; identical protein binding [GO:0042802]; phosphatidylinositol-4-phosphate binding [GO:0070273],GO:0005215; GO:0005654; GO:0005829; GO:0008289; GO:0061024,transporter activity; nucleoplasm; cytosol; lipid binding; membrane organization
OG_00508,0.221515171004507,OG_00508,FUN_001484-T1,Peve_00029347,Pocillopora_meandrina_HIv1___RNAseq.g1910.t1,three_way,71.71783333333333,FUN_001484-T1,Q6NRH3,,,,,43.7,268.0,5.1999999999999996e-46,187.2,sp|Q6NRH3|CC149_XENLA Coiled-coil domain-containing protein 149 OS=Xenopus laevis OX=8355 GN=ccdc149 PE=2 SV=1,,,,,,
OG_02531,0.2214267369378142,OG_02531,FUN_010606-T1,Peve_00032719,Pocillopora_meandrina_HIv1___RNAseq.g21491.t1,three_way,76.36316666666666,FUN_010606-T1,Q5SSZ7,ZNRF3_MOUSE,,E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3),Mus musculus (Mouse),50.3,302.0,2.7e-80,300.8,sp|Q5SSZ7|ZNRF3_MOUSE E3 ubiquitin-protein ligase ZNRF3 OS=Mus musculus OX=10090 GN=Znrf3 PE=1 SV=1,GO:0004842; GO:0005109; GO:0005886; GO:0006511; GO:0008270; GO:0016055; GO:0016567; GO:0030178; GO:0038018; GO:0060173; GO:0060828; GO:0072089; GO:0090090; GO:2000051; GO:2000095,"limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]",plasma membrane [GO:0005886],frizzled binding [GO:0005109]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_07687,0.221364631945629,OG_07687,FUN_034808-T1,Peve_00034936,Pocillopora_meandrina_HIv1___RNAseq.g12307.t1,three_way,87.922,FUN_034808-T1,Q5R4A0,UBA3_PONAB,,NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),68.8,432.0,2.3e-185,649.8,sp|Q5R4A0|UBA3_PONAB NEDD8-activating enzyme E1 catalytic subunit OS=Pongo abelii OX=9601 GN=UBA3 PE=2 SV=2,GO:0005524; GO:0005634; GO:0005737; GO:0007113; GO:0019781; GO:0032991; GO:0042802; GO:0045116; GO:0046982; GO:0051726,endomitotic cell cycle [GO:0007113]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726],cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982],GO:0000278; GO:0003824; GO:0005634; GO:0016874; GO:0043226; GO:0140096; GO:0140657,"mitotic cell cycle; catalytic activity; nucleus; ligase activity; organelle; catalytic activity, acting on a protein; ATP-dependent activity"
OG_03945,0.221277386807487,OG_03945,FUN_016082-T1,Peve_00021929,Pocillopora_meandrina_HIv1___RNAseq.g21611.t1,three_way,89.665,FUN_016082-T1,Q8CCB4,,,,,60.6,830.0,1.8000000000000002e-273,943.3,sp|Q8CCB4|VPS53_MOUSE Vacuolar protein sorting-associated protein 53 homolog OS=Mus musculus OX=10090 GN=Vps53 PE=1 SV=1,,,,,,
OG_03491,0.2210838016122295,OG_03491,FUN_014598-T1,Peve_00010088,Pocillopora_meandrina_HIv1___RNAseq.g22739.t1,three_way,60.3855,FUN_014598-T1,Q8VIP2,,,,,36.9,279.0,3.8e-32,142.1,sp|Q8VIP2|MLXPL_RAT Carbohydrate-responsive element-binding protein OS=Rattus norvegicus OX=10116 GN=Mlxipl PE=1 SV=1,,,,,,
OG_09867,0.2210720747623936,OG_09867,FUN_042876-T1,Peve_00040153,Pocillopora_meandrina_HIv1___TS.g977.t1,three_way,68.58266666666667,,,,,,,,,,,,,,,,,
OG_08436,0.2210485782528177,OG_08436,FUN_037171-T1,Peve_00003251,Pocillopora_meandrina_HIv1___TS.g13578.t1c,three_way,49.90583333333333,FUN_037171-T1,O94481,,,,,26.0,435.0,8.6e-12,73.6,sp|O94481|TFC5_SCHPO Transcription factor TFIIIB component B'' OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=bdp1 PE=3 SV=2,,,,,,
OG_02861,0.221038750894448,OG_02861,FUN_011906-T1,Peve_00026367,Pocillopora_meandrina_HIv1___RNAseq.g23365.t1,three_way,91.1335,FUN_011906-T1,Q61371,,,,,70.8,718.0,5.900000000000001e-170,599.4,sp|Q61371|IFT88_MOUSE Intraflagellar transport protein 88 homolog OS=Mus musculus OX=10090 GN=Ift88 PE=1 SV=2,,,,,,
OG_06770,0.2208910915468355,OG_06770,FUN_031633-T1,Peve_00012499,Pocillopora_meandrina_HIv1___RNAseq.g5960.t1,three_way,82.72833333333334,FUN_031633-T1,A0A3Q7ZPG5,S39A9_MICUN,,Zinc transporter ZIP9 (ZIP-9) (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9),Micropogonias undulatus (Atlantic croaker),59.5,316.0,4.9000000000000004e-86,319.3,sp|A0A3Q7ZPG5|S39A9_MICUN Zinc transporter ZIP9 OS=Micropogonias undulatus OX=29154 GN=slc39a9 PE=1 SV=1,GO:0004930; GO:0005385; GO:0005497; GO:0005634; GO:0005739; GO:0005794; GO:0005886; GO:0006882; GO:0048471; GO:0071577,intracellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577],Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],androgen binding [GO:0005497]; G protein-coupled receptor activity [GO:0004930]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005634; GO:0005739; GO:0005794; GO:0005886; GO:0043226; GO:0055085; GO:0060089,transporter activity; nucleus; mitochondrion; Golgi apparatus; plasma membrane; organelle; transmembrane transport; molecular transducer activity
OG_10171,0.2208171298286744,OG_10171,FUN_043574-T1,Peve_00011699,Pocillopora_meandrina_HIv1___RNAseq.g7870.t2,three_way,82.55833333333334,FUN_043574-T1,Q5ZKK5,,,,,31.7,703.0,1.4e-15,86.7,sp|Q5ZKK5|ODFP2_CHICK Outer dense fiber protein 2 OS=Gallus gallus OX=9031 GN=ODF2 PE=2 SV=1,,,,,,
OG_03915,0.2208114610336865,OG_03915,FUN_016001-T1,Peve_00004543,Pocillopora_meandrina_HIv1___RNAseq.g21372.t1,three_way,70.03,FUN_016001-T1,Q8N6T3,ARFG1_HUMAN,,ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 1) (ADP-ribosylation factor 1 GTPase-activating protein) (ARF1 GAP) (ARF1-directed GTPase-activating protein),Homo sapiens (Human),47.5,318.0,2.6000000000000004e-57,224.6,sp|Q8N6T3|ARFG1_HUMAN ADP-ribosylation factor GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=ARFGAP1 PE=1 SV=2,GO:0000139; GO:0005096; GO:0005829; GO:0008270; GO:0015031; GO:0016192; GO:0030100; GO:0032012; GO:0045202,protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; Golgi membrane [GO:0000139]; synapse [GO:0045202],GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005829; GO:0016192; GO:0098772,cytosol; vesicle-mediated transport; molecular function regulator activity
OG_09445,0.2207709607038229,OG_09445,FUN_041437-T1,Peve_00007743,Pocillopora_meandrina_HIv1___RNAseq.g15744.t2,three_way,80.71600000000001,FUN_041437-T1,Q96MT8,,,,,30.8,240.0,5.7e-19,97.1,sp|Q96MT8|CEP63_HUMAN Centrosomal protein of 63 kDa OS=Homo sapiens OX=9606 GN=CEP63 PE=1 SV=1,,,,,,
OG_03343,0.2206438186257127,OG_03343,FUN_013573-T1,Peve_00026650,Pocillopora_meandrina_HIv1___RNAseq.g13522.t1,three_way,62.46266666666667,FUN_013573-T1,Q9NXK6,,,,,31.4,328.0,2.7000000000000004e-32,141.0,sp|Q9NXK6|PAQR5_HUMAN Membrane progestin receptor gamma OS=Homo sapiens OX=9606 GN=PAQR5 PE=1 SV=2,,,,,,
OG_06405,0.2206306925854742,OG_06405,FUN_029079-T1,Peve_00012859,Pocillopora_meandrina_HIv1___RNAseq.g25850.t1,three_way,44.321333333333335,,,,,,,,,,,,,,,,,
OG_04578,0.2204871749490052,OG_04578,FUN_022241-T1,Peve_00037422,Pocillopora_meandrina_HIv1___RNAseq.g4756.t1,three_way,81.13533333333334,FUN_022241-T1,B8JKD7,RPA2_DANRE,,DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6),Danio rerio (Zebrafish) (Brachydanio rerio),56.1,1131.0,0.0,1315.1,sp|B8JKD7|RPA2_DANRE DNA-directed RNA polymerase I subunit RPA2 OS=Danio rerio OX=7955 GN=polr1b PE=3 SV=1,GO:0000428; GO:0003677; GO:0003899; GO:0005694; GO:0005730; GO:0005739; GO:0006351; GO:0008270; GO:0014029; GO:0032549,DNA-templated transcription [GO:0006351]; neural crest formation [GO:0014029],chromosome [GO:0005694]; DNA-directed RNA polymerase complex [GO:0000428]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; ribonucleoside binding [GO:0032549]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005694; GO:0005730; GO:0005739; GO:0006351; GO:0016740; GO:0030154; GO:0043226; GO:0140098,"DNA binding; catalytic activity; chromosome; nucleolus; mitochondrion; DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_02929,0.2203416168653009,OG_02929,FUN_012028-T1,Peve_00030379,Pocillopora_meandrina_HIv1___RNAseq.g24047.t2,three_way,77.09433333333334,FUN_012028-T1,Q14192,FHL2_HUMAN,,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),Homo sapiens (Human),42.1,273.0,1.7000000000000002e-74,282.0,sp|Q14192|FHL2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3,GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885,atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018],bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06140,0.2202467822739646,OG_06140,FUN_027962-T1,Peve_00031346,Pocillopora_meandrina_HIv1___RNAseq.g14048.t1,three_way,72.3915,FUN_027962-T1,Q8NBM4,UBAC2_HUMAN,,Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1),Homo sapiens (Human),32.7,367.0,5.2e-39,163.3,sp|Q8NBM4|UBAC2_HUMAN Ubiquitin-associated domain-containing protein 2 OS=Homo sapiens OX=9606 GN=UBAC2 PE=1 SV=1,GO:0004252; GO:0005783; GO:0005789; GO:0016055; GO:0070972; GO:0090090; GO:1904153,"negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005783; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07521,0.220219202110827,OG_07521,FUN_034091-T1,Peve_00037069,Pocillopora_meandrina_HIv1___RNAseq.g26062.t1,three_way,83.5495,FUN_034091-T1,Q9VWG3,,,,,62.3,154.0,1.1e-44,181.0,sp|Q9VWG3|RS10B_DROME Small ribosomal subunit protein eS10B OS=Drosophila melanogaster OX=7227 GN=RpS10b PE=1 SV=2,,,,,,
OG_03537,0.2201284761669147,OG_03537,FUN_014656-T1,Peve_00014509,Pocillopora_meandrina_HIv1___RNAseq.g22582.t1,three_way,63.82566666666667,FUN_014656-T1,Q6GQD5,RN146_XENLA,,E3 ubiquitin-protein ligase rnf146 (EC 2.3.2.27) (RING finger protein 146) (RING-type E3 ubiquitin transferase rnf146),Xenopus laevis (African clawed frog),42.9,254.0,2.1000000000000002e-48,194.1,sp|Q6GQD5|RN146_XENLA E3 ubiquitin-protein ligase rnf146 OS=Xenopus laevis OX=8355 GN=rnf146 PE=2 SV=1,GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263,positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09565,0.2200196211065598,OG_09565,FUN_041675-T1,Peve_00009958,Pocillopora_meandrina_HIv1___RNAseq.g14004.t1,three_way,61.77533333333333,FUN_041675-T1,Q5R7U2,PEX19_PONAB,,Peroxisomal biogenesis factor 19 (Peroxin-19) (Peroxisomal farnesylated protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),39.1,276.0,2.5e-42,174.1,sp|Q5R7U2|PEX19_PONAB Peroxisomal biogenesis factor 19 OS=Pongo abelii OX=9601 GN=PEX19 PE=2 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0016020; GO:0016557; GO:0016559; GO:0032991; GO:0036105; GO:0045046; GO:0050821; GO:0051117; GO:0061077; GO:0140597,chaperone-mediated protein folding [GO:0061077]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991],ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; protein carrier chaperone [GO:0140597],GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0007031; GO:0043226; GO:0140104,nucleus; nucleoplasm; cytosol; intracellular protein transport; peroxisome organization; organelle; molecular carrier activity
OG_09809,0.2199120265081214,OG_09809,FUN_042631-T1,Peve_00030043,Pocillopora_meandrina_HIv1___RNAseq.g11506.t1,three_way,73.376,FUN_042631-T1,Q5VTB9,RN220_HUMAN,,E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220),Homo sapiens (Human),33.0,657.0,3.9999999999999997e-63,244.2,sp|Q5VTB9|RN220_HUMAN E3 ubiquitin-protein ligase RNF220 OS=Homo sapiens OX=9606 GN=RNF220 PE=1 SV=1,GO:0003358; GO:0004842; GO:0005634; GO:0005652; GO:0005654; GO:0005737; GO:0006513; GO:0008013; GO:0008270; GO:0016567; GO:0021904; GO:0032991; GO:0051091; GO:0051865; GO:0061630; GO:0090263; GO:0098794; GO:0098978; GO:0099149; GO:2000677,dorsal/ventral neural tube patterning [GO:0021904]; noradrenergic neuron development [GO:0003358]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of transcription regulatory region DNA binding [GO:2000677],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],beta-catenin binding [GO:0008013]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06934,0.2198735125585976,OG_06934,FUN_032038-T1,Peve_00013548,Pocillopora_meandrina_HIv1___RNAseq.g5928.t1b,three_way,59.332,,,,,,,,,,,,,,,,,
OG_06608,0.2198657743722735,OG_06608,FUN_029758-T1,Peve_00019497,Pocillopora_meandrina_HIv1___TS.g3083.t1,three_way,75.64366666666666,FUN_029758-T1,O75694,NU155_HUMAN,,Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155),Homo sapiens (Human),46.4,1399.0,0.0,1191.4,sp|O75694|NU155_HUMAN Nuclear pore complex protein Nup155 OS=Homo sapiens OX=9606 GN=NUP155 PE=1 SV=1,GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0017056; GO:0031965; GO:0035196; GO:0036228; GO:0044611; GO:0086014,atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005829; GO:0006886; GO:0006913; GO:0061024,structural molecule activity; nuclear envelope; cytosol; intracellular protein transport; nucleocytoplasmic transport; membrane organization
OG_01724,0.2197882158971708,OG_01724,FUN_007013-T1,Peve_00021641,Pocillopora_meandrina_HIv1___RNAseq.g20538.t1,three_way,66.045,,,,,,,,,,,,,,,,,
OG_06750,0.2197152787391875,OG_06750,FUN_031559-T1,Peve_00032865,Pocillopora_meandrina_HIv1___RNAseq.g5076.t1,three_way,48.826166666666666,FUN_031559-T1,Q8WXE1,ATRIP_HUMAN,,ATR-interacting protein (ATM and Rad3-related-interacting protein),Homo sapiens (Human),30.7,153.0,1.1e-07,60.8,sp|Q8WXE1|ATRIP_HUMAN ATR-interacting protein OS=Homo sapiens OX=9606 GN=ATRIP PE=1 SV=1,GO:0000077; GO:0005634; GO:0005654; GO:0006139; GO:0006281; GO:0070310; GO:0070530; GO:2000779,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779],ATR-ATRIP complex [GO:0070310]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530],GO:0005634; GO:0005654; GO:0006281; GO:0043226,nucleus; nucleoplasm; DNA repair; organelle
OG_07251,0.21970120180719,OG_07251,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,9.999999999999999e-116,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_06304,0.2196849001893669,OG_06304,FUN_028510-T1,Peve_00008103,Pocillopora_meandrina_HIv1___TS.g11897.t1,three_way,78.13066666666667,FUN_028510-T1,Q96RQ3,MCCA_HUMAN,,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)",Homo sapiens (Human),60.7,687.0,8.1e-238,824.7,"sp|Q96RQ3|MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=MCCC1 PE=1 SV=3",GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:1905202,biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; L-leucine catabolic process [GO:0006552],cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0006790; GO:0016874; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; sulfur compound metabolic process; ligase activity; organelle
OG_04141,0.2196012017066645,OG_04141,FUN_016596-T1,Peve_00033776,Pocillopora_meandrina_HIv1___RNAseq.g481.t1,three_way,74.769,FUN_016596-T1,O46385,,,,,34.0,1119.0,3.3e-163,578.6,sp|O46385|SVIL_BOVIN Supervillin OS=Bos taurus OX=9913 GN=SVIL PE=1 SV=2,,,,,,
OG_08239,0.2194674458148107,OG_08239,FUN_036119-T1,Peve_00000289,Pocillopora_meandrina_HIv1___RNAseq.g27453.t1,three_way,78.82766666666666,FUN_036119-T1,Q6Q0C0,TRAF7_HUMAN,,E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7),Homo sapiens (Human),37.1,523.0,1.3999999999999998e-41,172.6,sp|Q6Q0C0|TRAF7_HUMAN E3 ubiquitin-protein ligase TRAF7 OS=Homo sapiens OX=9606 GN=TRAF7 PE=1 SV=1,GO:0000151; GO:0004842; GO:0005634; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0035519; GO:0043231; GO:0043410; GO:0043525; GO:0061630; GO:0070372; GO:2000060; GO:2001235,apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372],cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005886; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_03059,0.2194524009834965,OG_03059,FUN_012317-T1,Peve_00038600,Pocillopora_meandrina_HIv1___RNAseq.g23744.t1,three_way,77.02933333333333,FUN_012317-T1,O75027,ABCB7_HUMAN,,"Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) (ATP-binding cassette transporter 7) (ABC transporter 7 protein)",Homo sapiens (Human),62.2,640.0,2.1e-225,783.5,"sp|O75027|ABCB7_HUMAN Iron-sulfur clusters transporter ABCB7, mitochondrial OS=Homo sapiens OX=9606 GN=ABCB7 PE=1 SV=2",GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0015232; GO:0016226; GO:0016887; GO:0034755; GO:0042626; GO:0042802; GO:0042803; GO:0055085; GO:0070455; GO:0140466; GO:0140481; GO:1903331; GO:1903427,intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of iron-sulfur cluster assembly [GO:1903331]; transmembrane transport [GO:0055085],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_03746,0.2193914798623483,OG_03746,FUN_015053-T1,Peve_00001165,Pocillopora_meandrina_HIv1___RNAseq.g21269.t1,three_way,62.7195,FUN_015053-T1,Q99KR6,,,,,34.2,366.0,1.8e-46,188.0,sp|Q99KR6|RNF34_MOUSE E3 ubiquitin-protein ligase RNF34 OS=Mus musculus OX=10090 GN=Rnf34 PE=1 SV=1,,,,,,
OG_10059,0.2193673657746698,OG_10059,FUN_043355-T1,Peve_00016650,Pocillopora_meandrina_HIv1___TS.g20685.t1a,three_way,62.21816666666667,FUN_043355-T1,A1L1H3,,,,,26.3,758.0,1.4e-48,196.4,sp|A1L1H3|TDRD5_XENLA Tudor domain-containing protein 5 OS=Xenopus laevis OX=8355 GN=tdrd5 PE=2 SV=1,,,,,,
OG_02108,0.2193590802427988,OG_02108,FUN_008392-T1,Peve_00043610,Pocillopora_meandrina_HIv1___RNAseq.g6178.t1,three_way,70.05766666666668,,,,,,,,,,,,,,,,,
OG_05662,0.2193122640499339,OG_05662,FUN_025431-T1,Peve_00034116,Pocillopora_meandrina_HIv1___RNAseq.g13326.t1,three_way,68.45533333333333,FUN_025431-T1,A0A0R4IB93,UBP48_DANRE,,Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Ubiquitin specific peptidase 48),Danio rerio (Zebrafish) (Brachydanio rerio),41.9,1141.0,1.6999999999999994e-242,840.9,sp|A0A0R4IB93|UBP48_DANRE Ubiquitin carboxyl-terminal hydrolase 48 OS=Danio rerio OX=7955 GN=usp48 PE=3 SV=1,GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016579; GO:0031647; GO:1904888,cranial skeletal system development [GO:1904888]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09257,0.2192043959607748,OG_09257,FUN_040059-T1,Peve_00014920,Pocillopora_meandrina_HIv1___RNAseq.g7726.t1,three_way,86.54366666666667,FUN_040059-T1,Q99LC5,,,,,71.0,328.0,1.4000000000000001e-123,444.1,"sp|Q99LC5|ETFA_MOUSE Electron transfer flavoprotein subunit alpha, mitochondrial OS=Mus musculus OX=10090 GN=Etfa PE=1 SV=2",,,,,,
OG_07185,0.2191743811353983,OG_07185,FUN_032676-T1,Peve_00015960,Pocillopora_meandrina_HIv1___RNAseq.g24112.t1,three_way,78.02799999999999,FUN_032676-T1,Q4KMZ8,NKAI1_HUMAN,,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 1) (Protein FAM77C),Homo sapiens (Human),45.9,205.0,1.6e-45,184.1,sp|Q4KMZ8|NKAI1_HUMAN Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 OS=Homo sapiens OX=9606 GN=NKAIN1 PE=2 SV=3,GO:0002028; GO:0005886; GO:0051117,regulation of sodium ion transport [GO:0002028],plasma membrane [GO:0005886],ATPase binding [GO:0051117],GO:0005886,plasma membrane
OG_03575,0.2191350262796184,OG_03575,FUN_014729-T1,Peve_00009500,Pocillopora_meandrina_HIv1___RNAseq.g22490.t1,three_way,91.43733333333331,,,,,,,,,,,,,,,,,
OG_09580,0.21909224354131,OG_09580,FUN_041718-T1,Peve_00024454,Pocillopora_meandrina_HIv1___RNAseq.g13944.t1,three_way,59.919,FUN_041718-T1,Q92542,NICA_HUMAN,,Nicastrin,Homo sapiens (Human),35.0,718.0,6.4e-110,399.8,sp|Q92542|NICA_HUMAN Nicastrin OS=Homo sapiens OX=9606 GN=NCSTN PE=1 SV=2,GO:0000139; GO:0002262; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007219; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0016020; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0030674; GO:0031293; GO:0034205; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042500; GO:0042734; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0050673; GO:0051117; GO:0051402; GO:0061133; GO:0070062; GO:0070765; GO:0070851; GO:0071277; GO:1900271; GO:1990926,adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; epithelial cell proliferation [GO:0050673]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098],azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; ATPase binding [GO:0051117]; endopeptidase activator activity [GO:0061133]; growth factor receptor binding [GO:0070851]; protein-macromolecule adaptor activity [GO:0030674]",GO:0002376; GO:0003824; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0012501; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0051604; GO:0060090; GO:0098772; GO:0140096,"immune system process; catalytic activity; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; programmed cell death; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; protein maturation; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09941,0.2190809593434592,OG_09941,FUN_043104-T1,Peve_00026302,Pocillopora_meandrina_HIv1___RNAseq.g7898.t1,three_way,87.68966666666667,FUN_043104-T1,P53611,PGTB2_HUMAN,,Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta),Homo sapiens (Human),72.1,330.0,9.2e-51,202.2,sp|P53611|PGTB2_HUMAN Geranylgeranyl transferase type-2 subunit beta OS=Homo sapiens OX=9606 GN=RABGGTB PE=1 SV=2,GO:0004663; GO:0005829; GO:0005886; GO:0005968; GO:0006888; GO:0007601; GO:0008270; GO:0018344; GO:0031267; GO:0036211,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; visual perception [GO:0007601],cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968],Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016192; GO:0016740; GO:0050877; GO:0140096,"catalytic activity; cytosol; plasma membrane; vesicle-mediated transport; transferase activity; nervous system process; catalytic activity, acting on a protein"
OG_05869,0.2190283212461298,OG_05869,FUN_025978-T1,Peve_00002323,Pocillopora_meandrina_HIv1___RNAseq.g10504.t2,three_way,75.62133333333334,FUN_025978-T1,O93479,,,,,54.7,422.0,1.9999999999999998e-122,440.7,sp|O93479|ORC4_XENLA Origin recognition complex subunit 4 OS=Xenopus laevis OX=8355 GN=orc4 PE=2 SV=1,,,,,,
OG_08396,0.2190165529697521,OG_08396,FUN_037010-T1,Peve_00032338,Pocillopora_meandrina_HIv1___RNAseq.g26698.t1,three_way,85.58966666666667,FUN_037010-T1,Q8N2G6,,,,,56.0,234.0,5.3e-63,242.7,sp|Q8N2G6|ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 OS=Homo sapiens OX=9606 GN=ZCCHC24 PE=1 SV=1,,,,,,
OG_01614,0.218986071983975,OG_01614,FUN_006704-T1,Peve_00022810,Pocillopora_meandrina_HIv1___TS.g29383.t1,three_way,78.106,FUN_006704-T1,O15439,MRP4_HUMAN,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4),Homo sapiens (Human),33.8,1096.0,4.1e-167,590.9,sp|O15439|MRP4_HUMAN ATP-binding cassette sub-family C member 4 OS=Homo sapiens OX=9606 GN=ABCC4 PE=1 SV=3,GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0043231; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003013; GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016192; GO:0016491; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,circulatory system process; catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; vesicle-mediated transport; oxidoreductase activity; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_07071,0.2189783067077266,OG_07071,FUN_032307-T1,Peve_00001538,Pocillopora_meandrina_HIv1___RNAseq.g24762.t2,three_way,70.71366666666667,FUN_032307-T1,Q3U0J8,,,,,48.1,480.0,9.9e-126,452.6,sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2,,,,,,
OG_01334,0.2189488207510265,OG_01334,FUN_005231-T1,Peve_00042864,Pocillopora_meandrina_HIv1___RNAseq.g8114.t1,three_way,62.04833333333334,FUN_005231-T1,P97801,SMN_MOUSE,,Survival motor neuron protein,Mus musculus (Mouse),42.1,126.0,5.1e-20,100.1,sp|P97801|SMN_MOUSE Survival motor neuron protein OS=Mus musculus OX=10090 GN=Smn1 PE=1 SV=1,GO:0000387; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006353; GO:0007019; GO:0007409; GO:0010975; GO:0015030; GO:0030018; GO:0030137; GO:0030426; GO:0032797; GO:0033120; GO:0034719; GO:0036464; GO:0043005; GO:0043204; GO:0097504,axonogenesis [GO:0007409]; DNA-templated transcription termination [GO:0006353]; microtubule depolymerization [GO:0007019]; positive regulation of RNA splicing [GO:0033120]; regulation of neuron projection development [GO:0010975]; spliceosomal snRNP assembly [GO:0000387],Cajal body [GO:0015030]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; Z disc [GO:0030018],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0007010; GO:0031410; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; cytoskeleton organization; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_02652,0.2189365654059713,OG_02652,FUN_010835-T1,Peve_00030776,Pocillopora_meandrina_HIv1___RNAseq.g20920.t1,three_way,69.44516666666667,FUN_010835-T1,Q8BFW9,,,,,39.7,574.0,5.3e-110,399.8,"sp|Q8BFW9|GTR12_MOUSE Solute carrier family 2, facilitated glucose transporter member 12 OS=Mus musculus OX=10090 GN=Slc2a12 PE=2 SV=1",,,,,,
OG_02785,0.2188168565513602,OG_02785,FUN_011740-T1,Peve_00034096,Pocillopora_meandrina_HIv1___RNAseq.g23881.t1,three_way,76.12266666666666,,,,,,,,,,,,,,,,,
OG_09973,0.2188105355421714,OG_09973,FUN_043157-T1,Peve_00011373,Pocillopora_meandrina_HIv1___TS.g580.t1,three_way,67.015,FUN_043157-T1,Q5XIJ1,HMCES_RAT,,Abasic site processing protein HMCES (EC 4.-.-.-) (Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein) (ES cell-specific 5hmC-binding protein) (Peptidase HMCES) (EC 3.4.-.-) (SRAP domain-containing protein 1),Rattus norvegicus (Rat),46.5,329.0,7.700000000000001e-74,278.9,sp|Q5XIJ1|HMCES_RAT Abasic site processing protein HMCES OS=Rattus norvegicus OX=10116 GN=Hmces PE=2 SV=1,GO:0003697; GO:0005657; GO:0006508; GO:0006974; GO:0008233; GO:0016446; GO:0036297; GO:0045830; GO:0097681; GO:0106300; GO:0140431; GO:0160129,DNA damage response [GO:0006974]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; interstrand cross-link repair [GO:0036297]; positive regulation of isotype switching [GO:0045830]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; somatic hypermutation of immunoglobulin genes [GO:0016446],replication fork [GO:0005657],DNA-(abasic site) binding [GO:0140431]; peptidase activity [GO:0008233]; protein-DNA covalent cross-linking activity [GO:0160129]; single-stranded DNA binding [GO:0003697],GO:0002376; GO:0003677; GO:0003824; GO:0006281; GO:0016787; GO:0016829; GO:0140096,"immune system process; DNA binding; catalytic activity; DNA repair; hydrolase activity; lyase activity; catalytic activity, acting on a protein"
OG_05002,0.2187036414802766,OG_05002,FUN_023138-T1,Peve_00042474,Pocillopora_meandrina_HIv1___RNAseq.g1750.t1,three_way,71.85766666666667,,,,,,,,,,,,,,,,,
OG_04269,0.218645057870333,OG_04269,FUN_017827-T1,Peve_00032668,Pocillopora_meandrina_HIv1___TS.g23180.t1,three_way,68.87883333333333,FUN_017827-T1,Q6NVP8,FUT8_XENTR,,"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)",Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),41.7,434.0,3.2e-91,337.0,"sp|Q6NVP8|FUT8_XENTR Alpha-(1,6)-fucosyltransferase OS=Xenopus tropicalis OX=8364 GN=fut8 PE=2 SV=1",GO:0008424; GO:0017124; GO:0018279; GO:0032580; GO:0046368,GDP-L-fucose metabolic process [GO:0046368]; protein N-linked glycosylation via asparagine [GO:0018279],Golgi cisterna membrane [GO:0032580],glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124],GO:0003824; GO:0009101; GO:0016740; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02100,0.2185491367573117,OG_02100,FUN_008373-T1,Peve_00007049,Pocillopora_meandrina_HIv1___RNAseq.g5698.t1,three_way,56.7935,FUN_008373-T1,Q9NR16,,,,,29.6,1021.0,1.2999999999999999e-107,393.3,sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2,,,,,,
OG_04514,0.2184105571467534,OG_04514,FUN_022047-T1,Peve_00017133,Pocillopora_meandrina_HIv1___RNAseq.g4597.t1,three_way,56.1085,FUN_022047-T1,Q8JZM8,,,,,27.0,852.0,8.8e-68,261.5,sp|Q8JZM8|MUC4_MOUSE Mucin-4 OS=Mus musculus OX=10090 GN=Muc4 PE=2 SV=2,,,,,,
OG_08961,0.2183116981281373,OG_08961,FUN_038439-T1,Peve_00029443,Pocillopora_meandrina_HIv1___RNAseq.g886.t1,three_way,77.404,FUN_038439-T1,Q8VIJ8,,,,,47.7,572.0,3.7e-137,490.0,sp|Q8VIJ8|NPRL3_MOUSE GATOR1 complex protein NPRL3 OS=Mus musculus OX=10090 GN=Nprl3 PE=1 SV=1,,,,,,
OG_01766,0.2182719659762445,OG_01766,FUN_007121-T1,Peve_00043806,Pocillopora_meandrina_HIv1___RNAseq.g19005.t1,three_way,76.08166666666666,FUN_007121-T1,F1R8P4,GLRA2_DANRE,,Glycine receptor subunit alpha-2,Danio rerio (Zebrafish) (Brachydanio rerio),37.9,393.0,1.8e-73,278.1,sp|F1R8P4|GLRA2_DANRE Glycine receptor subunit alpha-2 OS=Danio rerio OX=7955 GN=glra2 PE=3 SV=2,GO:0004888; GO:0005254; GO:0016594; GO:0022824; GO:0034707; GO:0042995; GO:0045211; GO:0046872,,cell projection [GO:0042995]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211],chloride channel activity [GO:0005254]; glycine binding [GO:0016594]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824],GO:0005215; GO:0060089,transporter activity; molecular transducer activity
OG_10154,0.2182155191839667,OG_10154,FUN_043549-T1,Peve_00011559,Pocillopora_meandrina_HIv1___RNAseq.g8013.t1,three_way,40.39266666666667,,,,,,,,,,,,,,,,,
OG_06627,0.2182139304529778,OG_06627,FUN_030057-T1,Peve_00027775,Pocillopora_meandrina_HIv1___RNAseq.g17349.t1,three_way,71.34366666666666,FUN_030057-T1,Q19425,,,,,43.3,536.0,1.2e-109,398.7,sp|Q19425|S38A9_CAEEL Sodium-coupled neutral amino acid transporter 9 homolog OS=Caenorhabditis elegans OX=6239 GN=F13H10.3 PE=3 SV=2,,,,,,
OG_05617,0.2181928721505095,OG_05617,FUN_025306-T1,Peve_00027097,Pocillopora_meandrina_HIv1___RNAseq.g13454.t1,three_way,78.10933333333332,FUN_025306-T1,Q95R48,,,,,28.5,396.0,5.8e-38,159.8,sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2,,,,,,
OG_02560,0.2181798188074443,OG_02560,FUN_010659-T1,Peve_00031472,Pocillopora_meandrina_HIv1___RNAseq.g21313.t1,three_way,90.361,FUN_010659-T1,Q76I81,,,,,81.8,121.0,1.5999999999999996e-53,209.9,sp|Q76I81|RS12_BOVIN Small ribosomal subunit protein eS12 OS=Bos taurus OX=9913 GN=RPS12 PE=2 SV=1,,,,,,
OG_08400,0.2181239461729553,OG_08400,FUN_037048-T1,Peve_00032330,Pocillopora_meandrina_HIv1___RNAseq.g26794.t1,three_way,85.69433333333333,FUN_037048-T1,Q56JU9,,,,,76.4,127.0,1e-40,167.5,sp|Q56JU9|RS24_BOVIN Small ribosomal subunit protein eS24 OS=Bos taurus OX=9913 GN=RPS24 PE=2 SV=2,,,,,,
OG_05238,0.21809295887195,OG_05238,FUN_023675-T1,Peve_00012771,Pocillopora_meandrina_HIv1___RNAseq.g17757.t1,three_way,66.28833333333333,FUN_023675-T1,Q5XI46,PAAT_RAT,,ATPase PAAT (EC 3.6.1.-) (Protein associated with ABC transporters) (PAAT),Rattus norvegicus (Rat),28.2,216.0,2.6e-10,68.2,sp|Q5XI46|PAAT_RAT ATPase PAAT OS=Rattus norvegicus OX=10116 GN=Paat PE=2 SV=1,GO:0005737; GO:0005739; GO:0016887; GO:0042802,,cytoplasm [GO:0005737]; mitochondrion [GO:0005739],ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802],GO:0003824; GO:0005739; GO:0016787; GO:0043226,catalytic activity; mitochondrion; hydrolase activity; organelle
OG_07305,0.2180671150610962,OG_07305,FUN_033691-T1,Peve_00010865,Pocillopora_meandrina_HIv1___RNAseq.g25877.t1,three_way,90.88,FUN_033691-T1,A7SMR1,EIF3D_NEMVE,,Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7),Nematostella vectensis (Starlet sea anemone),76.6,475.0,2.6000000000000004e-211,736.1,sp|A7SMR1|EIF3D_NEMVE Eukaryotic translation initiation factor 3 subunit D OS=Nematostella vectensis OX=45351 GN=v1g235689 PE=3 SV=1,GO:0001732; GO:0002191; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0098808,cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852],mRNA cap binding [GO:0098808]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_02923,0.2179866438958059,OG_02923,FUN_012009-T1,Peve_00016403,Pocillopora_meandrina_HIv1___RNAseq.g24030.t1,three_way,73.988,FUN_012009-T1,Q8IXU6,,,,,45.4,350.0,6.800000000000001e-74,279.3,sp|Q8IXU6|S35F2_HUMAN Solute carrier family 35 member F2 OS=Homo sapiens OX=9606 GN=SLC35F2 PE=1 SV=1,,,,,,
OG_03205,0.217962023486058,OG_03205,FUN_012696-T1,Peve_00016827,Pocillopora_meandrina_HIv1___RNAseq.g22856.t1,three_way,62.6505,FUN_012696-T1,Q5F3A1,,,,,56.6,290.0,9.4e-52,205.7,sp|Q5F3A1|SEC62_CHICK Translocation protein SEC62 OS=Gallus gallus OX=9031 GN=SEC62 PE=2 SV=1,,,,,,
OG_07988,0.2179321391430579,OG_07988,FUN_035618-T1,Peve_00029653,Pocillopora_meandrina_HIv1___TS.g15425.t1,three_way,87.45883333333333,FUN_035618-T1,Q9Y5B9,,,,,59.7,937.0,0.0,1174.5,sp|Q9Y5B9|SP16H_HUMAN FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1,,,,,,
OG_07933,0.2178994850712204,OG_07933,FUN_035426-T1,Peve_00007639,Pocillopora_meandrina_HIv1___RNAseq.g27573.t1,three_way,42.896,,,,,,,,,,,,,,,,,
OG_04460,0.2178959558200226,OG_04460,FUN_019334-T1,Peve_00040309,Pocillopora_meandrina_HIv1___RNAseq.g20765.t1,three_way,75.1505,FUN_019334-T1,Q3TIT8,SPX3_MOUSE,,Sugar phosphate exchanger 3 (Solute carrier family 37 member 3),Mus musculus (Mouse),50.9,477.0,6.6e-120,432.6,sp|Q3TIT8|SPX3_MOUSE Sugar phosphate exchanger 3 OS=Mus musculus OX=10090 GN=Slc37a3 PE=1 SV=1,GO:0005765; GO:0005789; GO:0006855; GO:0042910,xenobiotic transmembrane transport [GO:0006855],endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765],xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_01155,0.2178673857044419,OG_01155,FUN_004766-T1,Peve_00019319,Pocillopora_meandrina_HIv1___RNAseq.g6698.t2,three_way,68.8935,FUN_004766-T1,Q5R4N8,,,,,40.4,779.0,6.3e-146,519.6,sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1,,,,,,
OG_00841,0.2178157474718549,OG_00841,FUN_004092-T1,Peve_00004703,Pocillopora_meandrina_HIv1___RNAseq.g12617.t1,three_way,83.72866666666667,FUN_004092-T1,Q6GPB9,,,,,44.4,793.0,2.2e-173,610.9,sp|Q6GPB9|DNAI4_XENLA Dynein axonemal intermediate chain 4 OS=Xenopus laevis OX=8355 GN=dnai4 PE=2 SV=1,,,,,,
OG_10142,0.2177874753213632,OG_10142,FUN_043531-T1,Peve_00011964,Pocillopora_meandrina_HIv1___RNAseq.g8001.t1,three_way,71.50766666666667,FUN_043531-T1,Q5R792,ATG5_PONAB,,Autophagy protein 5 (APG5-like),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),62.4,194.0,1.2000000000000001e-74,280.8,sp|Q5R792|ATG5_PONAB Autophagy protein 5 OS=Pongo abelii OX=9601 GN=ATG5 PE=2 SV=1,GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005776; GO:0005930; GO:0006325; GO:0006914; GO:0006995; GO:0009410; GO:0009620; GO:0010659; GO:0010667; GO:0016567; GO:0019776; GO:0019883; GO:0030424; GO:0031397; GO:0032480; GO:0034045; GO:0034274; GO:0034727; GO:0035973; GO:0039689; GO:0042311; GO:0044233; GO:0045060; GO:0045087; GO:0045824; GO:0048840; GO:0050687; GO:0050765; GO:0051279; GO:0051607; GO:0055015; GO:0060047; GO:0061908; GO:0070254; GO:0070257; GO:0071500; GO:0098685; GO:0098794; GO:0098930; GO:0098978; GO:0099072; GO:0099170; GO:1901096; GO:1902017; GO:1904093; GO:1904973; GO:2000377,aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axonal transport [GO:0098930]; blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; heart contraction [GO:0060047]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein ubiquitination [GO:0016567]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fungus [GO:0009620]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; glutamatergic synapse [GO:0098978]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; phagophore [GO:0061908]; phagophore assembly site membrane [GO:0034045]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685],Atg8-family ligase activity [GO:0019776],GO:0002376; GO:0003013; GO:0003824; GO:0005773; GO:0006325; GO:0006914; GO:0007018; GO:0012501; GO:0016740; GO:0043226; GO:0048856; GO:0098542; GO:0140096,"immune system process; circulatory system process; catalytic activity; vacuole; chromatin organization; autophagy; microtubule-based movement; programmed cell death; transferase activity; organelle; anatomical structure development; defense response to other organism; catalytic activity, acting on a protein"
OG_00216,0.21773885692043,OG_00216,FUN_000935-T1,Peve_00009730,Pocillopora_meandrina_HIv1___RNAseq.g29457.t1,three_way,84.785,FUN_000935-T1,Q5ZL33,STRAP_CHICK,,Serine-threonine kinase receptor-associated protein,Gallus gallus (Chicken),63.8,304.0,4.3e-114,412.5,sp|Q5ZL33|STRAP_CHICK Serine-threonine kinase receptor-associated protein OS=Gallus gallus OX=9031 GN=STRAP PE=2 SV=2,GO:0000122; GO:0000380; GO:0000387; GO:0003723; GO:0003729; GO:0005102; GO:0005634; GO:0005829; GO:0030182; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:1990447,"alternative mRNA splicing, via spliceosome [GO:0000380]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; spliceosomal snRNP assembly [GO:0000387]",cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; U2 snRNP binding [GO:1990447],GO:0003723; GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0022600; GO:0030154; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; digestive system process; cell differentiation; organelle; protein-containing complex assembly
OG_04655,0.217722057084404,OG_04655,FUN_022395-T1,Peve_00037598,Pocillopora_meandrina_HIv1___RNAseq.g9318.t1,three_way,95.205,FUN_022395-T1,P48643,TCPE_HUMAN,,T-complex protein 1 subunit epsilon (TCP-1-epsilon) (EC 3.6.1.-) (CCT-epsilon) (Chaperonin containing T-complex polypeptide 1 subunit 5),Homo sapiens (Human),78.8,533.0,1.0000000000000002e-248,860.5,sp|P48643|TCPE_HUMAN T-complex protein 1 subunit epsilon OS=Homo sapiens OX=9606 GN=CCT5 PE=1 SV=1,GO:0003730; GO:0005524; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044183; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0051086; GO:0061077; GO:0070062; GO:0140662; GO:1904871; GO:1904874,binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein folding [GO:0061077]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615],cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082],GO:0003723; GO:0003824; GO:0005815; GO:0005829; GO:0006457; GO:0008092; GO:0016787; GO:0043226; GO:0044183; GO:0140657,RNA binding; catalytic activity; microtubule organizing center; cytosol; protein folding; cytoskeletal protein binding; hydrolase activity; organelle; protein folding chaperone; ATP-dependent activity
OG_07233,0.2176784519662679,OG_07233,FUN_032906-T1,Peve_00014529,Pocillopora_meandrina_HIv1___RNAseq.g24991.t1,three_way,83.96633333333334,FUN_032906-T1,Q14671,,,,,46.1,1272.0,9e-53,210.7,sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3,,,,,,
OG_09038,0.2175068663293283,OG_09038,FUN_038682-T1,Peve_00013483,Pocillopora_meandrina_HIv1___TS.g19232.t2,three_way,92.927,FUN_038682-T1,Q803V5,,,,,76.8,220.0,3.699999999999999e-105,382.9,sp|Q803V5|LST8_DANRE Target of rapamycin complex subunit lst8 OS=Danio rerio OX=7955 GN=mlst8 PE=2 SV=1,,,,,,
OG_04225,0.2175031570642283,OG_04225,FUN_016992-T1,Peve_00025272,Pocillopora_meandrina_HIv1___RNAseq.g9893.t1,three_way,59.312333333333335,FUN_016992-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),28.0,318.0,1.2999999999999998e-24,115.5,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_08912,0.2174704377976264,OG_08912,FUN_038346-T1,Peve_00000091,Pocillopora_meandrina_HIv1___RNAseq.g1103.t2,three_way,68.69033333333334,FUN_038346-T1,Q9JJW6,ALRF2_MOUSE,,Aly/REF export factor 2 (Alyref) (RNA and export factor-binding protein 2),Mus musculus (Mouse),62.2,164.0,9.5e-45,181.8,sp|Q9JJW6|ALRF2_MOUSE Aly/REF export factor 2 OS=Mus musculus OX=10090 GN=Alyref2 PE=1 SV=1,GO:0003697; GO:0003723; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0051028,mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380],cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681],RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003723; GO:0016071,DNA binding; RNA binding; mRNA metabolic process
OG_02268,0.2174338207256482,OG_02268,FUN_008718-T1,Peve_00035347,Pocillopora_meandrina_HIv1___RNAseq.g76.t1,three_way,81.45666666666666,FUN_008718-T1,Q80ZJ7,,,,,25.9,382.0,7.5e-25,116.3,sp|Q80ZJ7|SNX32_MOUSE Sorting nexin-32 OS=Mus musculus OX=10090 GN=Snx32 PE=2 SV=1,,,,,,
OG_08047,0.2174293109164588,OG_08047,FUN_035735-T1,Peve_00044084,Pocillopora_meandrina_HIv1___RNAseq.g11862.t1,three_way,61.315000000000005,FUN_035735-T1,P57769,SNX16_RAT,,Sorting nexin-16,Rattus norvegicus (Rat),44.3,149.0,4.9000000000000005e-27,124.0,sp|P57769|SNX16_RAT Sorting nexin-16 OS=Rattus norvegicus OX=10116 GN=Snx16 PE=1 SV=2,GO:0001881; GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022,early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]; receptor recycling [GO:0001881],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0005764; GO:0005768; GO:0005773; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_03826,0.2173581385332458,OG_03826,FUN_015256-T1,Peve_00014304,Pocillopora_meandrina_HIv1___RNAseq.g22207.t1,three_way,71.4415,FUN_015256-T1,G1SE76,,,,,76.7,146.0,2.9999999999999995e-54,213.0,sp|G1SE76|RL23A_RABIT Large ribosomal subunit protein uL23 OS=Oryctolagus cuniculus OX=9986 GN=RPL23A PE=1 SV=1,,,,,,
OG_07752,0.2172867176482167,OG_07752,FUN_034942-T1,Peve_00028348,Pocillopora_meandrina_HIv1___RNAseq.g12181.t1,three_way,62.79666666666667,FUN_034942-T1,Q91WE2,,,,,50.6,164.0,6.1e-31,136.0,sp|Q91WE2|PIP30_MOUSE PSME3-interacting protein OS=Mus musculus OX=10090 GN=Psme3ip1 PE=1 SV=1,,,,,,
OG_01123,0.2172826698420051,OG_01123,FUN_004691-T1,Peve_00019711,Pocillopora_meandrina_HIv1___TS.g20478.t1,three_way,79.91966666666667,FUN_004691-T1,Q9Y2I6,NINL_HUMAN,,Ninein-like protein,Homo sapiens (Human),30.6,517.0,7.2999999999999975e-47,191.8,sp|Q9Y2I6|NINL_HUMAN Ninein-like protein OS=Homo sapiens OX=9606 GN=NINL PE=1 SV=2,GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0034454,microtubule anchoring at centrosome [GO:0034454],centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874],calcium ion binding [GO:0005509],GO:0005815; GO:0005829; GO:0007010,microtubule organizing center; cytosol; cytoskeleton organization
OG_10036,0.2171257811639034,OG_10036,FUN_043300-T1,Peve_00007445,Pocillopora_meandrina_HIv1___RNAseq.g8897.t1,three_way,92.66466666666666,FUN_043300-T1,Q8IRC7,AWH_DROME,,LIM/homeobox protein Awh (Protein arrowhead),Drosophila melanogaster (Fruit fly),55.3,217.0,7.2e-66,251.9,sp|Q8IRC7|AWH_DROME LIM/homeobox protein Awh OS=Drosophila melanogaster OX=7227 GN=Awh PE=1 SV=1,GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007444; GO:0010468; GO:0030182; GO:0046872; GO:0048749,compound eye development [GO:0048749]; imaginal disc development [GO:0007444]; neuron differentiation [GO:0030182]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04872,0.2171037815390697,OG_04872,FUN_022900-T1,Peve_00001844,Pocillopora_meandrina_HIv1___TS.g9874.t2,three_way,78.98066666666666,FUN_022900-T1,P14735,IDE_HUMAN,,Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin),Homo sapiens (Human),57.6,531.0,2.7e-191,669.8,sp|P14735|IDE_HUMAN Insulin-degrading enzyme OS=Homo sapiens OX=9606 GN=IDE PE=1 SV=4,GO:0001540; GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044877; GO:0045732; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0150094; GO:1901142; GO:1901143; GO:1903715,amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270],GO:0001618; GO:0002376; GO:0003824; GO:0005615; GO:0005634; GO:0005739; GO:0005777; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"virus receptor activity; immune system process; catalytic activity; extracellular space; nucleus; mitochondrion; peroxisome; cytosol; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_01079,0.2170445652106016,OG_01079,FUN_004567-T1,Peve_00016037,Pocillopora_meandrina_HIv1___RNAseq.g8223.t1,three_way,80.84933333333333,FUN_004567-T1,Q9UGJ1,GCP4_HUMAN,,Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76),Homo sapiens (Human),49.0,670.0,2.7999999999999998e-171,603.6,sp|Q9UGJ1|GCP4_HUMAN Gamma-tubulin complex component 4 OS=Homo sapiens OX=9606 GN=TUBGCP4 PE=1 SV=1,GO:0000278; GO:0000922; GO:0000930; GO:0000931; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0055037; GO:0065003,cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922],gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0005198; GO:0005768; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0008092; GO:0022414; GO:0031410; GO:0043226; GO:0065003,mitotic cell cycle; structural molecule activity; endosome; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_00613,0.2169669975217046,OG_00613,FUN_001779-T1,Peve_00026506,Pocillopora_meandrina_HIv1___TS.g5198.t1,three_way,47.594,,,,,,,,,,,,,,,,,
OG_09170,0.216948253013504,OG_09170,FUN_039836-T1,Peve_00006312,Pocillopora_meandrina_HIv1___RNAseq.g7301.t1,three_way,84.05966666666666,FUN_039836-T1,Q5R971,HEM2_PONAB,,Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),66.0,326.0,4.3e-125,449.1,sp|Q5R971|HEM2_PONAB Delta-aminolevulinic acid dehydratase OS=Pongo abelii OX=9601 GN=ALAD PE=2 SV=2,GO:0004655; GO:0005829; GO:0006782; GO:0006783; GO:0008270,heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],cytosol [GO:0005829],porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016829,catalytic activity; cytosol; lyase activity
OG_06974,0.2168675451728306,OG_06974,FUN_032109-T1,Peve_00030225,Pocillopora_meandrina_HIv1___RNAseq.g5392.t1,three_way,77.26299999999999,FUN_032109-T1,F1RAX8,,,,,55.6,444.0,2.5e-134,480.3,"sp|F1RAX8|COQ6_DANRE Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial OS=Danio rerio OX=7955 GN=coq6 PE=2 SV=1",,,,,,
OG_04589,0.2168670624319554,OG_04589,FUN_022261-T1,Peve_00043989,Pocillopora_meandrina_HIv1___RNAseq.g4717.t1,three_way,64.07733333333333,,,,,,,,,,,,,,,,,
OG_01015,0.216815398627631,OG_01015,FUN_004443-T1,Peve_00033208,Pocillopora_meandrina_HIv1___RNAseq.g11478.t1,three_way,62.060833333333335,FUN_004443-T1,Q9VE04,,,,,49.1,53.0,1.6e-06,53.9,sp|Q9VE04|RM55_DROME Large ribosomal subunit protein mL55 OS=Drosophila melanogaster OX=7227 GN=mRpL55 PE=1 SV=1,,,,,,
OG_01390,0.216746777990526,OG_01390,FUN_005365-T1,Peve_00016036,Pocillopora_meandrina_HIv1___RNAseq.g8222.t1,three_way,83.86883333333333,FUN_005365-T1,O01727,,,,,80.4,189.0,2.900000000000001e-86,319.7,sp|O01727|RS6_BRAFL Small ribosomal subunit protein eS6 OS=Branchiostoma floridae OX=7739 GN=RPS6 PE=3 SV=1,,,,,,
OG_08590,0.2166591641192252,OG_08590,FUN_037699-T1,Peve_00044124,Pocillopora_meandrina_HIv1___TS.g22767.t1a,three_way,74.662,FUN_037699-T1,A4IH88,,,,,32.0,616.0,2.3e-66,255.0,sp|A4IH88|K2013_XENTR Uncharacterized protein KIAA2013 homolog OS=Xenopus tropicalis OX=8364 PE=2 SV=1,,,,,,
OG_01918,0.2165295026382755,OG_01918,FUN_007947-T1,Peve_00021143,Pocillopora_meandrina_HIv1___TS.g21111.t2,three_way,56.5525,,,,,,,,,,,,,,,,,
OG_00048,0.2164982735153341,OG_00048,FUN_000285-T1,Peve_00033562,Pocillopora_meandrina_HIv1___RNAseq.g29071.t1,three_way,75.66833333333334,FUN_000285-T1,Q8BYH7,,,,,30.3,307.0,1.2e-37,159.1,sp|Q8BYH7|TBC17_MOUSE TBC1 domain family member 17 OS=Mus musculus OX=10090 GN=Tbc1d17 PE=1 SV=2,,,,,,
OG_08842,0.2164934678977202,OG_08842,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_09625,0.2164578751151057,OG_09625,FUN_041789-T1,Peve_00038532,Pocillopora_meandrina_HIv1___RNAseq.g15770.t1,three_way,64.701,FUN_041789-T1,O15072,ATS3_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme),Homo sapiens (Human),30.6,992.0,5.3e-119,430.6,sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4,GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748,collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573],extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615],endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_04932,0.2164233119749834,OG_04932,FUN_023000-T1,Peve_00024659,Pocillopora_meandrina_HIv1___RNAseq.g3813.t1,three_way,53.00183333333333,FUN_023000-T1,Q90Z00,FGR1A_DANRE,,Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A),Danio rerio (Zebrafish) (Brachydanio rerio),37.9,804.0,7.2e-136,486.5,sp|Q90Z00|FGR1A_DANRE Fibroblast growth factor receptor 1-A OS=Danio rerio OX=7955 GN=fgfr1a PE=1 SV=2,GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043410; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699,anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_01672,0.2163821479151369,OG_01672,FUN_006861-T1,Peve_00006606,Pocillopora_meandrina_HIv1___RNAseq.g19909.t1,three_way,69.55666666666666,FUN_006861-T1,O97860,,,,,48.4,304.0,4.8e-84,312.8,sp|O97860|PPA5_RABIT Tartrate-resistant acid phosphatase type 5 OS=Oryctolagus cuniculus OX=9986 GN=ACP5 PE=2 SV=1,,,,,,
OG_05277,0.2163418111420225,OG_05277,FUN_023935-T1,Peve_00017663,Pocillopora_meandrina_HIv1___RNAseq.g18855.t1,three_way,79.559,FUN_023935-T1,Q91X58,ZFN2B_MOUSE,,AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein),Mus musculus (Mouse),63.0,135.0,4.5e-51,203.0,sp|Q91X58|ZFN2B_MOUSE AN1-type zinc finger protein 2B OS=Mus musculus OX=10090 GN=Zfand2b PE=1 SV=1,GO:0000502; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0016020; GO:0031593; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047,"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; proteasome complex [GO:0000502],K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270],GO:0005783; GO:0006886; GO:0030163; GO:0043226; GO:0055085,endoplasmic reticulum; intracellular protein transport; protein catabolic process; organelle; transmembrane transport
OG_08709,0.2163313457273511,OG_08709,FUN_037961-T1,Peve_00009703,Pocillopora_meandrina_HIv1___RNAseq.g26230.t1,three_way,75.68066666666667,FUN_037961-T1,A7RKS5,RSSA_NEMVE,,Small ribosomal subunit protein uS2 (40S ribosomal protein SA),Nematostella vectensis (Starlet sea anemone),75.9,257.0,1e-107,391.3,sp|A7RKS5|RSSA_NEMVE Small ribosomal subunit protein uS2 OS=Nematostella vectensis OX=45351 GN=v1g198553 PE=3 SV=1,GO:0000028; GO:0002181; GO:0003735; GO:0022627,cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028],cytosolic small ribosomal subunit [GO:0022627],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0065003,cytoplasmic translation; structural molecule activity; protein-containing complex assembly
OG_05430,0.2162870283204463,OG_05430,FUN_024376-T1,Peve_00020239,Pocillopora_meandrina_HIv1___RNAseq.g18601.t1,three_way,98.059,FUN_024376-T1,Q3T169,RS3_BOVIN,,Small ribosomal subunit protein uS3 (EC 4.2.99.18) (40S ribosomal protein S3),Bos taurus (Bovine),90.4,239.0,1.4e-120,433.7,sp|Q3T169|RS3_BOVIN Small ribosomal subunit protein uS3 OS=Bos taurus OX=9913 GN=RPS3 PE=2 SV=1,GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235,apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003677; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005730; GO:0006281; GO:0012501; GO:0016829; GO:0043226; GO:0140097,"DNA binding; RNA binding; catalytic activity; structural molecule activity; nucleus; nucleolus; DNA repair; programmed cell death; lyase activity; organelle; catalytic activity, acting on DNA"
OG_04150,0.216277299218136,OG_04150,FUN_016614-T1,Peve_00024466,Pocillopora_meandrina_HIv1___RNAseq.g9617.t1,three_way,81.786,FUN_016614-T1,Q96LR5,UB2E2_HUMAN,,Ubiquitin-conjugating enzyme E2 E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E2) (UbcH8) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2),Homo sapiens (Human),71.1,190.0,2.3000000000000002e-74,280.4,sp|Q96LR5|UB2E2_HUMAN Ubiquitin-conjugating enzyme E2 E2 OS=Homo sapiens OX=9606 GN=UBE2E2 PE=1 SV=1,GO:0004842; GO:0005524; GO:0005634; GO:0006513; GO:0006974; GO:0032020; GO:0042296; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:1900087,DNA damage response [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513],nucleus [GO:0005634],ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04066,0.2162213996689791,OG_04066,FUN_016387-T1,Peve_00022900,Pocillopora_meandrina_HIv1___RNAseq.g9768.t1,three_way,79.809,FUN_016387-T1,O15229,KMO_HUMAN,,Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase),Homo sapiens (Human),57.1,417.0,7.7e-141,501.9,sp|O15229|KMO_HUMAN Kynurenine 3-monooxygenase OS=Homo sapiens OX=9606 GN=KMO PE=1 SV=2,GO:0004502; GO:0005615; GO:0005739; GO:0005741; GO:0005829; GO:0006569; GO:0009651; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1903296,"'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; L-tryptophan catabolic process [GO:0006569]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651]",cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174],GO:0003824; GO:0005615; GO:0005739; GO:0005829; GO:0006520; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; mitochondrion; cytosol; amino acid metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03395,0.2161673180875084,OG_03395,FUN_014169-T1,Peve_00037817,Pocillopora_meandrina_HIv1___TS.g11124.t1,three_way,91.21866666666666,FUN_014169-T1,Q6P2Y2,,,,,74.1,143.0,4.1e-56,220.3,sp|Q6P2Y2|DAW1_XENTR Dynein assembly factor with WD repeat domains 1 OS=Xenopus tropicalis OX=8364 GN=daw1 PE=2 SV=1,,,,,,
OG_06175,0.216152392288399,OG_06175,FUN_028032-T1,Peve_00020106,Pocillopora_meandrina_HIv1___RNAseq.g13935.t1,three_way,50.176,,,,,,,,,,,,,,,,,
OG_02429,0.2160972780235987,OG_02429,FUN_009381-T1,Peve_00026823,Pocillopora_meandrina_HIv1___RNAseq.g14538.t3,three_way,54.836,FUN_009381-T1,Q9WUU9,GANP_MOUSE,,Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase),Mus musculus (Mouse),29.7,1638.0,3.1000000000000003e-161,571.6,sp|Q9WUU9|GANP_MOUSE Germinal-center associated nuclear protein OS=Mus musculus OX=10090 GN=Mcm3ap PE=1 SV=2,GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390,nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390],chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; histone H3 acetyltransferase activity [GO:0010484]; nucleic acid binding [GO:0003676],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0006913; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; chromatin organization; nucleocytoplasmic transport; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_09322,0.2160354917041003,OG_09322,FUN_040238-T1,Peve_00021820,Pocillopora_meandrina_HIv1___RNAseq.g7784.t1,three_way,85.20433333333332,FUN_040238-T1,Q5ZIG3,,,,,44.6,332.0,5.1e-77,289.7,sp|Q5ZIG3|S2546_CHICK Mitochondrial outer membrane protein SLC25A46 OS=Gallus gallus OX=9031 GN=SLC25A46 PE=2 SV=1,,,,,,
OG_00540,0.2160310464333807,OG_00540,FUN_001562-T1,Peve_00013899,Pocillopora_meandrina_HIv1___RNAseq.g2018.t1,three_way,83.21833333333333,FUN_001562-T1,Q8IWZ3,,,,,58.1,812.0,4.4e-82,308.9,sp|Q8IWZ3|ANKH1_HUMAN Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKHD1 PE=1 SV=1,,,,,,
OG_06119,0.2160064248887328,OG_06119,FUN_027850-T1,Peve_00024333,Pocillopora_meandrina_HIv1___TS.g11653.t1,three_way,77.86916666666667,,,,,,,,,,,,,,,,,
OG_00403,0.2160007509219346,OG_00403,FUN_001290-T1,Peve_00037014,Pocillopora_meandrina_HIv1___TS.g4708.t1b,three_way,90.79066666666668,FUN_001290-T1,P10860,DHE3_RAT,,"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3) (Memory-related gene 2 protein) (MRG-2)",Rattus norvegicus (Rat),65.2,500.0,6.2e-198,691.8,"sp|P10860|DHE3_RAT Glutamate dehydrogenase 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Glud1 PE=1 SV=2",GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0006537; GO:0006538; GO:0006541; GO:0007616; GO:0010044; GO:0019899; GO:0021549; GO:0032024; GO:0042803; GO:0043531; GO:0070403; GO:0070728; GO:0072350,cerebellum development [GO:0021549]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; long-term memory [GO:0007616]; positive regulation of insulin secretion [GO:0032024]; response to aluminum ion [GO:0010044]; tricarboxylic acid metabolic process [GO:0072350],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase (NADP+) activity [GO:0004354]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; L-leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005739; GO:0005783; GO:0006520; GO:0016491; GO:0043226; GO:0048856; GO:0050877,catalytic activity; mitochondrion; endoplasmic reticulum; amino acid metabolic process; oxidoreductase activity; organelle; anatomical structure development; nervous system process
OG_03356,0.2159226709477306,OG_03356,FUN_013593-T1,Peve_00018176,Pocillopora_meandrina_HIv1___RNAseq.g13486.t1,three_way,88.194,FUN_013593-T1,O95619,YETS4_HUMAN,,YEATS domain-containing protein 4 (Glioma-amplified sequence 41) (Gas41) (NuMA-binding protein 1) (NuBI-1) (NuBI1),Homo sapiens (Human),62.1,224.0,2.1999999999999998e-75,283.5,sp|O95619|YETS4_HUMAN YEATS domain-containing protein 4 OS=Homo sapiens OX=9606 GN=YEATS4 PE=1 SV=1,GO:0000278; GO:0000786; GO:0005200; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0016363; GO:0031965; GO:0035267; GO:0042393; GO:0042981; GO:0045893; GO:0051726; GO:0140044; GO:0140119; GO:1905168; GO:2000779,chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357],NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634],histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0005198; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0060090,mitotic cell cycle; structural molecule activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; molecular adaptor activity
OG_06193,0.2159144232623923,OG_06193,FUN_028115-T1,Peve_00030850,Pocillopora_meandrina_HIv1___RNAseq.g15564.t1,three_way,78.04,FUN_028115-T1,A1A4P5,,,,,54.7,137.0,1.4e-32,141.0,sp|A1A4P5|PFD2_BOVIN Prefoldin subunit 2 OS=Bos taurus OX=9913 GN=PFDN2 PE=2 SV=1,,,,,,
OG_09562,0.2158939426358155,OG_09562,FUN_041672-T1,Peve_00007760,Pocillopora_meandrina_HIv1___RNAseq.g14001.t1,three_way,59.1795,,,,,,,,,,,,,,,,,
OG_01455,0.2158926891885933,OG_01455,FUN_005913-T1,Peve_00008487,Pocillopora_meandrina_HIv1___RNAseq.g19569.t1,three_way,86.37333333333333,FUN_005913-T1,Q922V4,,,,,67.2,497.0,3.8999999999999996e-90,333.6,sp|Q922V4|PLRG1_MOUSE Pleiotropic regulator 1 OS=Mus musculus OX=10090 GN=Plrg1 PE=1 SV=1,,,,,,
OG_06686,0.215789707180121,OG_06686,FUN_031212-T1,Peve_00041872,Pocillopora_meandrina_HIv1___RNAseq.g5200.t1,three_way,90.47633333333332,FUN_031212-T1,P36954,RPB9_HUMAN,,DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II subunit I) (RNA polymerase II 14.5 kDa subunit) (RPB14.5),Homo sapiens (Human),79.2,125.0,3.3e-55,216.1,sp|P36954|RPB9_HUMAN DNA-directed RNA polymerase II subunit RPB9 OS=Homo sapiens OX=9606 GN=POLR2I PE=1 SV=1,GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0008270,maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II [GO:0001193]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]",DNA-directed RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006351; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on RNA"
OG_01522,0.2157801074351472,OG_01522,FUN_006276-T1,Peve_00031100,Pocillopora_meandrina_HIv1___RNAseq.g20369.t1,three_way,84.9125,FUN_006276-T1,Q8K5C0,GRHL2_MOUSE,,Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3),Mus musculus (Mouse),32.7,620.0,2.6999999999999998e-70,268.1,sp|Q8K5C0|GRHL2_MOUSE Grainyhead-like protein 2 homolog OS=Mus musculus OX=10090 GN=Grhl2 PE=2 SV=1,GO:0001161; GO:0001228; GO:0001701; GO:0001843; GO:0003208; GO:0003382; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006355; GO:0006357; GO:0007155; GO:0007420; GO:0008544; GO:0010468; GO:0016020; GO:0021915; GO:0030216; GO:0030323; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0042802; GO:0043010; GO:0043565; GO:0045893; GO:0045944; GO:0048568; GO:0048701; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132; GO:0140297,anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory tube development [GO:0030323],cell-cell junction [GO:0005911]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007155; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell adhesion; cell differentiation; cell junction organization; organelle; anatomical structure development; transcription regulator activity
OG_06319,0.2157540604954127,OG_06319,FUN_028795-T1,Peve_00000745,Pocillopora_meandrina_HIv1___RNAseq.g20731.t1,three_way,70.815,FUN_028795-T1,P52756,RBM5_HUMAN,,RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9),Homo sapiens (Human),39.6,768.0,1.8e-75,285.8,sp|P52756|RBM5_HUMAN RNA-binding protein 5 OS=Homo sapiens OX=9606 GN=RBM5 PE=1 SV=2,GO:0000245; GO:0000381; GO:0000398; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0006915; GO:0008270; GO:0008285; GO:0043065; GO:0043231,"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]",cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0012501; GO:0016071; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; cytosol; programmed cell death; mRNA metabolic process; organelle; protein-containing complex assembly
OG_02573,0.2157180746322902,OG_02573,FUN_010679-T1,Peve_00044779,Pocillopora_meandrina_HIv1___RNAseq.g21345.t1,three_way,75.95,FUN_010679-T1,Q5FVA9,,,,,67.7,368.0,5.899999999999999e-147,521.9,sp|Q5FVA9|RAE1L_XENTR mRNA export factor OS=Xenopus tropicalis OX=8364 GN=rae1 PE=2 SV=1,,,,,,
OG_00055,0.2156382881510249,OG_00055,FUN_000330-T1,Peve_00033547,Pocillopora_meandrina_HIv1___RNAseq.g29083.t1,three_way,89.4465,FUN_000330-T1,A0A3G2LGI8,,,,,54.5,2571.0,0.0,2154.8,sp|A0A3G2LGI8|TLN_OSCPE Talin OS=Oscarella pearsei OX=1940113 GN=TLN PE=1 SV=1,,,,,,
OG_04072,0.2155952642659293,OG_04072,FUN_016393-T1,Peve_00006406,Pocillopora_meandrina_HIv1___RNAseq.g9756.t1,three_way,90.81433333333334,FUN_016393-T1,Q3T087,,,,,81.8,176.0,2.5e-82,306.2,sp|Q3T087|RL11_BOVIN Large ribosomal subunit protein uL5 OS=Bos taurus OX=9913 GN=RPL11 PE=2 SV=3,,,,,,
OG_03305,0.2155427436511614,OG_03305,FUN_013377-T1,Peve_00020454,Pocillopora_meandrina_HIv1___RNAseq.g22986.t1,three_way,67.67733333333334,FUN_013377-T1,Q7TS68,,,,,46.7,469.0,2e-112,407.5,sp|Q7TS68|NSUN6_MOUSE tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 OS=Mus musculus OX=10090 GN=Nsun6 PE=2 SV=2,,,,,,
OG_08690,0.2155125616584936,OG_08690,FUN_037933-T1,Peve_00025647,Pocillopora_meandrina_HIv1___RNAseq.g26215.t1,three_way,47.622,FUN_037933-T1,Q4V832,,,,,29.1,413.0,9.999999999999999e-27,123.2,sp|Q4V832|AP4AT_XENLA AP-4 complex accessory subunit tepsin OS=Xenopus laevis OX=8355 GN=tepsin PE=2 SV=2,,,,,,
OG_00654,0.2154399852871948,OG_00654,FUN_001940-T1,Peve_00024481,Pocillopora_meandrina_HIv1___RNAseq.20168_t,three_way,77.20733333333334,FUN_001940-T1,Q87PP5,,,,,35.6,547.0,4.6e-98,360.5,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_02508,0.2154299268825918,OG_02508,FUN_010020-T1,Peve_00036457,Pocillopora_meandrina_HIv1___RNAseq.g24255.t1,three_way,74.96866666666666,FUN_010020-T1,Q7ZWN6,Z703A_XENLA,,Zinc finger protein 703-A,Xenopus laevis (African clawed frog),29.2,517.0,1.9e-22,108.6,sp|Q7ZWN6|Z703A_XENLA Zinc finger protein 703-A OS=Xenopus laevis OX=8355 GN=znf703-a PE=2 SV=2,GO:0005634; GO:0005737; GO:0008270; GO:0016363; GO:0017015; GO:0030335; GO:0034111; GO:0034333; GO:0045892; GO:0051726; GO:0060828,adherens junction assembly [GO:0034333]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0006355; GO:0034330; GO:0043226,nucleus; regulation of DNA-templated transcription; cell junction organization; organelle
OG_08951,0.2152975073319036,OG_08951,FUN_038424-T1,Peve_00000118,Pocillopora_meandrina_HIv1___RNAseq.g1179.t1,three_way,52.31733333333333,FUN_038424-T1,Q9DCV4,,,,,48.9,237.0,4.7000000000000004e-57,223.0,sp|Q9DCV4|RMD1_MOUSE Regulator of microtubule dynamics protein 1 OS=Mus musculus OX=10090 GN=Rmdn1 PE=1 SV=2,,,,,,
OG_07957,0.2152422421366587,OG_07957,FUN_035504-T1,Peve_00039980,Pocillopora_meandrina_HIv1___RNAseq.g26996.t1,three_way,57.49133333333333,FUN_035504-T1,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),39.4,322.0,9.7e-57,223.8,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_09767,0.2152415188043997,OG_09767,FUN_042048-T1,Peve_00025414,Pocillopora_meandrina_HIv1___RNAseq.g15142.t1,three_way,77.533,FUN_042048-T1,Q8BH01,,,,,43.5,666.0,3.1e-136,487.3,sp|Q8BH01|TMCO3_MOUSE Transmembrane and coiled-coil domain-containing protein 3 OS=Mus musculus OX=10090 GN=Tmco3 PE=2 SV=1,,,,,,
OG_09596,0.2152193798968055,OG_09596,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_03079,0.2151949145630904,OG_03079,FUN_012351-T1,Peve_00042524,Pocillopora_meandrina_HIv1___RNAseq.g23280.t1,three_way,33.19883333333333,,,,,,,,,,,,,,,,,
OG_02877,0.2151944975465387,OG_02877,FUN_011927-T1,Peve_00039378,Pocillopora_meandrina_HIv1___RNAseq.g23328.t1,three_way,81.451,FUN_011927-T1,O60476,MA1A2_HUMAN,,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)",Homo sapiens (Human),52.3,623.0,1e-183,644.8,"sp|O60476|MA1A2_HUMAN Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB OS=Homo sapiens OX=9606 GN=MAN1A2 PE=1 SV=1",GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0036503; GO:0048286; GO:0070062; GO:1904381,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585],endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0009101; GO:0016787; GO:0030163; GO:0043226; GO:0048856; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; glycoprotein biosynthetic process; hydrolase activity; protein catabolic process; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_04012,0.2151166418255913,OG_04012,FUN_016314-T1,Peve_00024695,Pocillopora_meandrina_HIv1___RNAseq.g9699.t1b,three_way,84.1865,FUN_016314-T1,Q6TUG0,,,,,63.0,357.0,9.999999999999998e-128,458.0,sp|Q6TUG0|DJB11_RAT DnaJ homolog subfamily B member 11 OS=Rattus norvegicus OX=10116 GN=Dnajb11 PE=2 SV=1,,,,,,
OG_01436,0.2150996691165161,OG_01436,FUN_005858-T1,Peve_00015774,Pocillopora_meandrina_HIv1___RNAseq.g19665.t1,three_way,77.938,FUN_005858-T1,Q8IV35,,,,,25.4,906.0,2.2e-77,292.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_06952,0.2150918357441756,OG_06952,FUN_032065-T1,Peve_00024742,Pocillopora_meandrina_HIv1___RNAseq.g6040.t1,three_way,67.569,FUN_032065-T1,Q63HM2,,,,,39.0,1229.0,1.2e-228,795.0,sp|Q63HM2|PCX4_HUMAN Pecanex-like protein 4 OS=Homo sapiens OX=9606 GN=PCNX4 PE=1 SV=4,,,,,,
OG_06029,0.2150741038283315,OG_06029,FUN_026590-T1,Peve_00043908,Pocillopora_meandrina_HIv1___RNAseq.g4497.t1,three_way,58.6655,FUN_026590-T1,A4D1E9,GTPBA_HUMAN,,GTP-binding protein 10 (Protein obg homolog 2) (ObgH2),Homo sapiens (Human),46.9,286.0,1.5e-65,252.3,sp|A4D1E9|GTPBA_HUMAN GTP-binding protein 10 OS=Homo sapiens OX=9606 GN=GTPBP10 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003924; GO:0005525; GO:0005694; GO:0005730; GO:0005739; GO:0042254,ribosome biogenesis [GO:0042254],chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0003924; GO:0005694; GO:0005730; GO:0005739; GO:0016787; GO:0042254; GO:0043226,RNA binding; catalytic activity; GTPase activity; chromosome; nucleolus; mitochondrion; hydrolase activity; ribosome biogenesis; organelle
OG_08151,0.2150372579310833,OG_08151,FUN_035923-T1,Peve_00006710,Pocillopora_meandrina_HIv1___RNAseq.g12052.t1,three_way,56.369166666666665,,,,,,,,,,,,,,,,,
OG_01171,0.2150253670673258,OG_01171,FUN_004795-T1,Peve_00010263,Pocillopora_meandrina_HIv1___RNAseq.g8536.t1,three_way,53.3395,FUN_004795-T1,Q56A10,ZN608_MOUSE,,Zinc finger protein 608,Mus musculus (Mouse),41.6,219.0,6.9e-29,132.1,sp|Q56A10|ZN608_MOUSE Zinc finger protein 608 OS=Mus musculus OX=10090 GN=Znf608 PE=1 SV=1,GO:0000122; GO:0008270; GO:0033085,negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122],,zinc ion binding [GO:0008270],GO:0006355,regulation of DNA-templated transcription
OG_01486,0.2149888049112945,OG_01486,FUN_006162-T1,Peve_00024180,Pocillopora_meandrina_HIv1___RNAseq.g20422.t1,three_way,46.14,FUN_006162-T1,Q90827,,,,,30.2,129.0,2.5e-09,65.1,sp|Q90827|NEL_CHICK Protein NEL OS=Gallus gallus OX=9031 GN=NEL PE=2 SV=1,,,,,,
OG_09507,0.2149803132054892,OG_09507,FUN_041552-T1,Peve_00025202,Pocillopora_meandrina_HIv1___RNAseq.g15999.t1,three_way,89.03266666666666,FUN_041552-T1,Q8NBZ7,,,,,78.6,243.0,1.1e-113,411.0,sp|Q8NBZ7|UXS1_HUMAN UDP-glucuronic acid decarboxylase 1 OS=Homo sapiens OX=9606 GN=UXS1 PE=1 SV=1,,,,,,
OG_08985,0.214933765577958,OG_08985,FUN_038504-T1,Peve_00041693,Pocillopora_meandrina_HIv1___TS.g7946.t1,three_way,87.35516666666666,FUN_038504-T1,Q9Y5X2,SNX8_HUMAN,,Sorting nexin-8,Homo sapiens (Human),46.6,399.0,4.6e-97,356.7,sp|Q9Y5X2|SNX8_HUMAN Sorting nexin-8 OS=Homo sapiens OX=9606 GN=SNX8 PE=1 SV=1,GO:0005829; GO:0006886; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231,early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0043226,cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; organelle
OG_09907,0.2149254933154571,OG_09907,FUN_043004-T1,Peve_00017776,Pocillopora_meandrina_HIv1___RNAseq.g7028.t1,three_way,85.60833333333333,FUN_043004-T1,Q64380,SARDH_RAT,,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)",Rattus norvegicus (Rat),66.3,750.0,0.0,1121.7,"sp|Q64380|SARDH_RAT Sarcosine dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Sardh PE=1 SV=2",GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006545; GO:0008480; GO:0016491; GO:0035999; GO:0042426; GO:0050660; GO:1901053,choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480],GO:0003824; GO:0005739; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_00850,0.2149205998821947,OG_00850,FUN_004109-T1,Peve_00029005,Pocillopora_meandrina_HIv1___RNAseq.g11657.t1,three_way,69.28733333333334,FUN_004109-T1,Q811I0,,,,,35.7,283.0,1.5e-37,158.3,sp|Q811I0|ATPF1_MOUSE ATP synthase mitochondrial F1 complex assembly factor 1 OS=Mus musculus OX=10090 GN=Atpaf1 PE=1 SV=1,,,,,,
OG_01698,0.2149030544294785,OG_01698,FUN_006941-T1,Peve_00042016,Pocillopora_meandrina_HIv1___RNAseq.g20150.t1,three_way,80.58666666666667,FUN_006941-T1,Q32N90,,,,,36.0,566.0,4.4000000000000003e-100,367.9,sp|Q32N90|MBTD1_XENLA MBT domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=mbtd1 PE=2 SV=1,,,,,,
OG_03782,0.2148483900095753,OG_03782,FUN_015138-T1,Peve_00001080,Pocillopora_meandrina_HIv1___RNAseq.g21743.t1,three_way,64.8045,FUN_015138-T1,Q8BIY1,,,,,43.3,540.0,2.6e-92,340.9,sp|Q8BIY1|GPTC3_MOUSE G patch domain-containing protein 3 OS=Mus musculus OX=10090 GN=Gpatch3 PE=2 SV=1,,,,,,
OG_00710,0.2148417176648901,OG_00710,FUN_002577-T1,Peve_00025545,Pocillopora_meandrina_HIv1___RNAseq.g25716.t1,three_way,77.45466666666667,FUN_002577-T1,Q6NU27,,,,,52.6,196.0,2.5000000000000002e-58,226.9,sp|Q6NU27|I4E3B_XENLA Eukaryotic translation initiation factor 4E type 3-B OS=Xenopus laevis OX=8355 GN=eif4e3-b PE=2 SV=1,,,,,,
OG_02455,0.2147846890735797,OG_02455,FUN_009533-T1,Peve_00009554,Pocillopora_meandrina_HIv1___RNAseq.g24492.t1,three_way,81.537,FUN_009533-T1,Q27958,DPOLB_BOVIN,,DNA polymerase beta (EC 2.7.7.7) (5'-deoxyribose-phosphate lyase) (5'-dRP lyase) (EC 4.2.99.-) (AP lyase) (EC 4.2.99.18),Bos taurus (Bovine),65.8,336.0,2.1999999999999998e-121,436.8,sp|Q27958|DPOLB_BOVIN DNA polymerase beta OS=Bos taurus OX=9913 GN=POLB PE=2 SV=3,GO:0003677; GO:0003887; GO:0005634; GO:0005737; GO:0006261; GO:0006284; GO:0006303; GO:0006974; GO:0016829; GO:0046872; GO:0051575; GO:0140078,base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303],cytoplasm [GO:0005737]; nucleus [GO:0005634],5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; lyase activity [GO:0016829]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_05944,0.2147840952878114,OG_05944,FUN_026182-T1,Peve_00022314,Pocillopora_meandrina_HIv1___RNAseq.g3037.t1,three_way,64.16,,,,,,,,,,,,,,,,,
OG_08523,0.214541885563371,OG_08523,FUN_037456-T1,Peve_00044116,Pocillopora_meandrina_HIv1___RNAseq.g1370.t1,three_way,87.71366666666667,FUN_037456-T1,Q8BQ89,,,,,65.0,283.0,3.9e-101,369.4,sp|Q8BQ89|LIX1L_MOUSE LIX1-like protein OS=Mus musculus OX=10090 GN=Lix1l PE=2 SV=2,,,,,,
OG_05320,0.2144736782205751,OG_05320,FUN_024005-T1,Peve_00040411,Pocillopora_meandrina_HIv1___RNAseq.g19345.t1,three_way,78.31733333333334,FUN_024005-T1,Q68EH9,CRBN_DANRE,,Protein cereblon (zcrbn),Danio rerio (Zebrafish) (Brachydanio rerio),48.4,382.0,3.4e-97,356.7,sp|Q68EH9|CRBN_DANRE Protein cereblon OS=Danio rerio OX=7955 GN=crbn PE=1 SV=1,GO:0000151; GO:0005634; GO:0005737; GO:0008283; GO:0016567; GO:0031464; GO:0033333; GO:0035118; GO:0043161; GO:0046872; GO:0060173; GO:0071599; GO:0071600,cell population proliferation [GO:0008283]; embryonic pectoral fin morphogenesis [GO:0035118]; fin development [GO:0033333]; limb development [GO:0060173]; otic vesicle development [GO:0071599]; otic vesicle morphogenesis [GO:0071600]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872],GO:0005634; GO:0030163; GO:0043226; GO:0048856,nucleus; protein catabolic process; organelle; anatomical structure development
OG_02666,0.2144684494745601,OG_02666,FUN_010885-T1,Peve_00035837,Pocillopora_meandrina_HIv1___RNAseq.g21004.t1,three_way,46.05866666666667,FUN_010885-T1,Q5VXM1,,,,,36.7,109.0,4e-09,64.7,sp|Q5VXM1|CDCP2_HUMAN CUB domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CDCP2 PE=2 SV=2,,,,,,
OG_07859,0.2144237468141946,OG_07859,FUN_035214-T1,Peve_00027702,Pocillopora_meandrina_HIv1___RNAseq.g27840.t2,three_way,74.03666666666668,FUN_035214-T1,Q8RDT4,,,,,46.5,372.0,1.0000000000000001e-88,328.6,sp|Q8RDT4|MEGL_FUSNN L-methionine gamma-lyase OS=Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355) OX=190304 GN=FN1419 PE=1 SV=1,,,,,,
OG_05677,0.2143911831954556,OG_05677,FUN_025510-T1,Peve_00002253,Pocillopora_meandrina_HIv1___RNAseq.g13213.t1,three_way,72.42949999999999,,,,,,,,,,,,,,,,,
OG_00032,0.2142872902032485,OG_00032,FUN_000238-T1,Peve_00033352,Pocillopora_meandrina_HIv1___RNAseq.g28954.t1,three_way,62.998666666666665,FUN_000238-T1,Q5ZI58,,,,,35.3,552.0,1e-61,239.6,sp|Q5ZI58|ATOSA_CHICK Atos homolog protein A OS=Gallus gallus OX=9031 GN=ATOSA PE=2 SV=2,,,,,,
OG_05724,0.2142539780734987,OG_05724,FUN_025643-T1,Peve_00002527,Pocillopora_meandrina_HIv1___TS.g15983.t1,three_way,64.00683333333333,FUN_025643-T1,Q04637,IF4G1_HUMAN,,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),Homo sapiens (Human),39.4,1020.0,1.2e-159,566.2,sp|Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4,GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0016020; GO:0016281; GO:0030182; GO:0030307; GO:0031369; GO:0031669; GO:0035278; GO:0036493; GO:0045666; GO:0051247; GO:0060090; GO:0080135; GO:0097009; GO:1900087; GO:1904377; GO:1905537; GO:1905606; GO:1905612,behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840],"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]",GO:0003723; GO:0005634; GO:0005829; GO:0005840; GO:0030154; GO:0031047; GO:0043226; GO:0060090,RNA binding; nucleus; cytosol; ribosome; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity
OG_06823,0.2142339842368981,OG_06823,FUN_031733-T1,Peve_00029893,Pocillopora_meandrina_HIv1___RNAseq.g5510.t1,three_way,68.32266666666666,FUN_031733-T1,Q3UDE2,,,,,24.0,492.0,1.4000000000000002e-23,113.2,sp|Q3UDE2|TTL12_MOUSE Tubulin--tyrosine ligase-like protein 12 OS=Mus musculus OX=10090 GN=Ttll12 PE=1 SV=1,,,,,,
OG_01769,0.2141558869388256,OG_01769,FUN_007126-T1,Peve_00012336,Pocillopora_meandrina_HIv1___RNAseq.g19009.t1,three_way,74.4505,,,,,,,,,,,,,,,,,
OG_05971,0.2141239514428417,OG_05971,FUN_026385-T1,Peve_00010504,Pocillopora_meandrina_HIv1___RNAseq.g2955.t1,three_way,77.00399999999999,FUN_026385-T1,Q27960,NPT2B_BOVIN,,Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2),Bos taurus (Bovine),56.3,545.0,5.3e-150,532.7,sp|Q27960|NPT2B_BOVIN Sodium-dependent phosphate transport protein 2B OS=Bos taurus OX=9913 GN=SLC34A2 PE=1 SV=1,GO:0005436; GO:0005903; GO:0006817; GO:0016020; GO:0016324; GO:0030643; GO:0031402; GO:0031982; GO:0042301; GO:0044341,intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium-dependent phosphate transport [GO:0044341],apical plasma membrane [GO:0016324]; brush border [GO:0005903]; membrane [GO:0016020]; vesicle [GO:0031982],phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0043226,transporter activity; organelle
OG_00501,0.2141172491419488,OG_00501,FUN_001476-T1,Peve_00044705,Pocillopora_meandrina_HIv1___RNAseq.g1913.t1,three_way,79.40833333333333,FUN_001476-T1,O73742,,,,,51.9,605.0,1.0000000000000001e-159,565.1,sp|O73742|COE3_XENLA Transcription factor COE3 OS=Xenopus laevis OX=8355 GN=coe3 PE=2 SV=2,,,,,,
OG_03473,0.2140684974876593,OG_03473,FUN_014561-T1,Peve_00023543,Pocillopora_meandrina_HIv1___RNAseq.g22703.t1,three_way,65.42583333333333,FUN_014561-T1,Q96S52,PIGS_HUMAN,,GPI-anchor transamidase component PIGS (Phosphatidylinositol-glycan biosynthesis class S protein),Homo sapiens (Human),36.6,508.0,2.9e-81,304.3,sp|Q96S52|PIGS_HUMAN GPI-anchor transamidase component PIGS OS=Homo sapiens OX=9606 GN=PIGS PE=1 SV=3,GO:0005789; GO:0006506; GO:0016020; GO:0016255; GO:0042765; GO:0180046,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046],endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020],,GO:0006629; GO:0051604; GO:1901135,lipid metabolic process; protein maturation; carbohydrate derivative metabolic process
OG_07334,0.214057357615974,OG_07334,FUN_033738-T1,Peve_00027592,Pocillopora_meandrina_HIv1___RNAseq.g28761.t1,three_way,77.64833333333334,FUN_033738-T1,Q3ZBH3,,,,,37.7,244.0,3e-46,186.8,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_04332,0.2139895301175704,OG_04332,FUN_017940-T1,Peve_00001587,Pocillopora_meandrina_HIv1___RNAseq.g220.t1,three_way,56.76766666666667,,,,,,,,,,,,,,,,,
OG_06870,0.2139470527244152,OG_06870,FUN_031870-T1,Peve_00012646,Pocillopora_meandrina_HIv1___RNAseq.g5648.t1,three_way,69.29950000000001,FUN_031870-T1,Q9CYK2,QPCT_MOUSE,,Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase),Mus musculus (Mouse),41.0,351.0,6.899999999999999e-68,259.2,sp|Q9CYK2|QPCT_MOUSE Glutaminyl-peptide cyclotransferase OS=Mus musculus OX=10090 GN=Qpct PE=1 SV=2,GO:0005576; GO:0008270; GO:0016603; GO:0017186,"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]",extracellular region [GO:0005576],glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0016740; GO:0140096,"catalytic activity; extracellular region; transferase activity; catalytic activity, acting on a protein"
OG_06708,0.2139380160677073,OG_06708,FUN_031289-T1,Peve_00026529,Pocillopora_meandrina_HIv1___RNAseq.g5169.t1,three_way,74.811,FUN_031289-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),58.3,599.0,8.2e-179,629.8,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_00051,0.2138779729949526,OG_00051,FUN_000320-T1,Peve_00033574,Pocillopora_meandrina_HIv1___RNAseq.g29014.t1,three_way,81.34316666666668,FUN_000320-T1,Q9Y4E6,,,,,41.7,1189.0,5.3e-228,792.7,sp|Q9Y4E6|WDR7_HUMAN WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=WDR7 PE=1 SV=2,,,,,,
OG_08197,0.2138184675879135,OG_08197,FUN_036041-T1,Peve_00011146,Pocillopora_meandrina_HIv1___RNAseq.g27345.t1,three_way,78.86766666666666,FUN_036041-T1,A0A0D1C8Z4,GRP1_MYCMD,,Glycine-rich RNA-binding protein 1,Mycosarcoma maydis (Corn smut fungus) (Ustilago maydis),44.7,85.0,1.1e-11,72.0,sp|A0A0D1C8Z4|GRP1_MYCMD Glycine-rich RNA-binding protein 1 OS=Mycosarcoma maydis OX=5270 GN=GRP1 PE=1 SV=1,GO:0003723; GO:0005768; GO:0051028,mRNA transport [GO:0051028],endosome [GO:0005768],RNA binding [GO:0003723],GO:0003723; GO:0005768; GO:0031410; GO:0043226,RNA binding; endosome; cytoplasmic vesicle; organelle
OG_01962,0.213784988341925,OG_01962,FUN_008045-T1,Peve_00045144,Pocillopora_meandrina_HIv1___RNAseq.g30364.t1,three_way,63.13066666666666,FUN_008045-T1,Q0P4W3,,,,,41.6,125.0,3e-26,119.4,sp|Q0P4W3|RMD2_XENTR Regulator of microtubule dynamics protein 2 OS=Xenopus tropicalis OX=8364 GN=rmdn2 PE=2 SV=1,,,,,,
OG_06604,0.2137595085048682,OG_06604,FUN_029731-T1,Peve_00020200,Pocillopora_meandrina_HIv1___RNAseq.g16841.t1,three_way,41.393,,,,,,,,,,,,,,,,,
OG_08168,0.2137549762730017,OG_08168,FUN_035972-T1,Peve_00006613,Pocillopora_meandrina_HIv1___RNAseq.g12338.t2,three_way,69.5,FUN_035972-T1,P0DOC8,,,,,43.1,204.0,5.9e-40,165.6,sp|P0DOC8|CF418_DANRE Cilia- and flagella-associated protein 418 OS=Danio rerio OX=7955 GN=cfap418 PE=1 SV=1,,,,,,
OG_04512,0.2137470651235644,OG_04512,FUN_022044-T1,Peve_00007834,Pocillopora_meandrina_HIv1___RNAseq.g9290.t1,three_way,72.45516666666667,FUN_022044-T1,Q5T2R2,DPS1_HUMAN,,All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1) (EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1),Homo sapiens (Human),57.9,323.0,3e-102,373.6,sp|Q5T2R2|DPS1_HUMAN All trans-polyprenyl-diphosphate synthase PDSS1 OS=Homo sapiens OX=9606 GN=PDSS1 PE=1 SV=1,GO:0004659; GO:0005739; GO:0005759; GO:0006744; GO:0008299; GO:0032476; GO:0032478; GO:0046872; GO:0046982; GO:0052923; GO:0097269; GO:0110142,isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; polyprenyl diphosphate synthase complex [GO:0032476]; ubiquinone biosynthesis complex [GO:0110142],all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity [GO:0052923]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_07085,0.2137225240513934,OG_07085,FUN_032342-T1,Peve_00043848,Pocillopora_meandrina_HIv1___RNAseq.g24825.t1,three_way,44.547666666666665,FUN_032342-T1,Q6R5N8,TLR13_MOUSE,,Toll-like receptor 13,Mus musculus (Mouse),33.1,130.0,5.8e-15,84.3,sp|Q6R5N8|TLR13_MOUSE Toll-like receptor 13 OS=Mus musculus OX=10090 GN=Tlr13 PE=1 SV=1,GO:0002755; GO:0005737; GO:0005768; GO:0006954; GO:0009615; GO:0010008; GO:0019843; GO:0034178; GO:0042802; GO:0043408; GO:0045087; GO:0061809,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178],cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008],"identical protein binding [GO:0042802]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; rRNA binding [GO:0019843]",GO:0002376; GO:0003723; GO:0003824; GO:0005768; GO:0006954; GO:0016787; GO:0031410; GO:0043226; GO:0098542,immune system process; RNA binding; catalytic activity; endosome; inflammatory response; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism
OG_06182,0.2136997661315844,OG_06182,FUN_028092-T1,Peve_00031646,Pocillopora_meandrina_HIv1___RNAseq.g16567.t1,three_way,76.8695,FUN_028092-T1,Q5F364,MRP1_CHICK,,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),Gallus gallus (Chicken),53.1,1353.0,0.0,1347.0,sp|Q5F364|MRP1_CHICK Multidrug resistance-associated protein 1 OS=Gallus gallus OX=9031 GN=ABCC1 PE=2 SV=1,GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729,cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908],basolateral plasma membrane [GO:0016323],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; glutathione transmembrane transporter activity [GO:0034634],GO:0003824; GO:0005215; GO:0016787; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; transmembrane transport; ATP-dependent activity
OG_10223,0.213657680001437,OG_10223,FUN_044276-T1,Peve_00026563,Pocillopora_meandrina_HIv1___RNAseq.g18517.t1,three_way,81.17766666666667,FUN_044276-T1,A4FV08,GNPI1_BOVIN,,Glucosamine-6-phosphate deaminase 1 (GlcN6P deaminase 1) (EC 3.5.99.6) (Glucosamine-6-phosphate isomerase 1) (Protein oscillin),Bos taurus (Bovine),72.6,285.0,1.4e-119,430.6,sp|A4FV08|GNPI1_BOVIN Glucosamine-6-phosphate deaminase 1 OS=Bos taurus OX=9913 GN=GNPDA1 PE=1 SV=1,GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0016853; GO:0019262; GO:0042802,carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],cytoplasm [GO:0005737],glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853],GO:0003824; GO:0005975; GO:0016787; GO:0016853; GO:0055086; GO:1901135,catalytic activity; carbohydrate metabolic process; hydrolase activity; isomerase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03606,0.2136366712810615,OG_03606,FUN_014776-T1,Peve_00014600,Pocillopora_meandrina_HIv1___RNAseq.g22561.t1,three_way,82.719,FUN_014776-T1,Q96EX2,,,,,40.1,287.0,1.4e-62,241.9,sp|Q96EX2|RNFT2_HUMAN E3 ubiquitin-protein ligase RNFT2 OS=Homo sapiens OX=9606 GN=RNFT2 PE=1 SV=2,,,,,,
OG_04107,0.2134611342470267,OG_04107,FUN_016472-T1,Peve_00015305,Pocillopora_meandrina_HIv1___TS.g6873.t1,three_way,61.89483333333333,FUN_016472-T1,A4IJ06,GRP1_XENTR,,RAS guanyl-releasing protein 1,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),44.0,234.0,1.6e-47,191.4,sp|A4IJ06|GRP1_XENTR RAS guanyl-releasing protein 1 OS=Xenopus tropicalis OX=8364 GN=rasgrp1 PE=2 SV=1,GO:0000139; GO:0005085; GO:0005509; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0008270; GO:0030154,cell differentiation [GO:0030154]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270],GO:0005829; GO:0005886; GO:0030154; GO:0098772,cytosol; plasma membrane; cell differentiation; molecular function regulator activity
OG_08648,0.2134459336663647,OG_08648,FUN_037843-T1,Peve_00025123,Pocillopora_meandrina_HIv1___RNAseq.g1437.t1,three_way,91.50183333333334,FUN_037843-T1,P56701,,,,,72.5,861.0,0.0,1194.9,sp|P56701|PSMD2_BOVIN 26S proteasome non-ATPase regulatory subunit 2 OS=Bos taurus OX=9913 GN=PSMD2 PE=1 SV=2,,,,,,
OG_07955,0.2134312560009345,OG_07955,FUN_035498-T1,Peve_00033959,Pocillopora_meandrina_HIv1___RNAseq.g26992.t1,three_way,53.365833333333335,,,,,,,,,,,,,,,,,
OG_01010,0.2133639538024161,OG_01010,FUN_004437-T1,Peve_00033214,Pocillopora_meandrina_HIv1___RNAseq.g11487.t2,three_way,77.86816666666667,FUN_004437-T1,Q8NI36,WDR36_HUMAN,,WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP),Homo sapiens (Human),45.4,904.0,1.5e-236,820.8,sp|Q8NI36|WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens OX=9606 GN=WDR36 PE=1 SV=2,GO:0003723; GO:0005654; GO:0006364; GO:0007601; GO:0032040; GO:0034388; GO:0042274,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; visual perception [GO:0007601],nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0050877,RNA binding; nucleoplasm; nervous system process
OG_02958,0.2133055537800497,OG_02958,FUN_012103-T1,Peve_00007420,Pocillopora_meandrina_HIv1___TS.g16819.t1,three_way,55.96083333333333,FUN_012103-T1,B1WAS2,HUNK_XENTR,,Hormonally up-regulated neu tumor-associated kinase homolog (EC 2.7.11.1) (Serine/threonine-protein kinase MAK-V),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),41.5,135.0,5.5e-23,110.9,sp|B1WAS2|HUNK_XENTR Hormonally up-regulated neu tumor-associated kinase homolog OS=Xenopus tropicalis OX=8364 GN=hunk PE=2 SV=1,GO:0004674; GO:0005524; GO:0106310,,,ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_06226,0.2132981043691652,OG_06226,FUN_028172-T1,Peve_00020832,Pocillopora_meandrina_HIv1___RNAseq.g16468.t1,three_way,88.88433333333333,FUN_028172-T1,Q8WW35,DYT2B_HUMAN,,Dynein light chain Tctex-type protein 2B (Tctex1 domain-containing protein 2),Homo sapiens (Human),61.2,116.0,7.4e-38,157.9,sp|Q8WW35|DYT2B_HUMAN Dynein light chain Tctex-type protein 2B OS=Homo sapiens OX=9606 GN=DYNLT2B PE=1 SV=2,GO:0005737; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0045505; GO:0060271; GO:0120293; GO:1902017; GO:1905799,cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; microtubule-based movement [GO:0007018]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein axonemal particle [GO:0120293],dynein intermediate chain binding [GO:0045505],GO:0005929; GO:0007018; GO:0043226; GO:0044782,cilium; microtubule-based movement; organelle; cilium organization
OG_08202,0.2132966101882769,OG_08202,FUN_036047-T1,Peve_00029867,Pocillopora_meandrina_HIv1___RNAseq.g27387.t1,three_way,71.29666666666667,FUN_036047-T1,Q2HJ57,,,,,48.2,137.0,3.2999999999999997e-29,129.4,sp|Q2HJ57|COTL1_BOVIN Coactosin-like protein OS=Bos taurus OX=9913 GN=COTL1 PE=2 SV=3,,,,,,
OG_10079,0.2132617961801063,OG_10079,FUN_043389-T1,Peve_00024250,Pocillopora_meandrina_HIv1___RNAseq.g9000.t1,three_way,64.57716666666667,FUN_043389-T1,Q64322,,,,,41.2,131.0,5.3e-15,83.6,sp|Q64322|NPDC1_MOUSE Neural proliferation differentiation and control protein 1 OS=Mus musculus OX=10090 GN=Npdc1 PE=2 SV=2,,,,,,
OG_10129,0.2131715713153985,OG_10129,FUN_043508-T1,Peve_00033841,Pocillopora_meandrina_HIv1___RNAseq.g7974.t1,three_way,83.73433333333334,FUN_043508-T1,Q3TXU5,,,,,67.4,350.0,3.5e-144,512.7,sp|Q3TXU5|DHYS_MOUSE Deoxyhypusine synthase OS=Mus musculus OX=10090 GN=Dhps PE=1 SV=2,,,,,,
OG_02260,0.2131643315657514,OG_02260,FUN_008707-T1,Peve_00034989,Pocillopora_meandrina_HIv1___TS.g9102.t1,three_way,77.2585,FUN_008707-T1,Q99246,,,,,52.7,1458.0,0.0,1323.9,sp|Q99246|CAC1D_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1D OS=Mus musculus OX=10090 GN=Cacna1d PE=1 SV=3,,,,,,
OG_08762,0.213148292878264,OG_08762,FUN_038036-T1,Peve_00016937,Pocillopora_meandrina_HIv1___RNAseq.g26546.t1,three_way,47.29133333333333,,,,,,,,,,,,,,,,,
OG_01060,0.2131217892332011,OG_01060,FUN_004515-T1,Peve_00044063,Pocillopora_meandrina_HIv1___RNAseq.g11318.t1,three_way,65.01150000000001,FUN_004515-T1,Q9Z1P7,,,,,39.5,253.0,1.3e-45,186.8,sp|Q9Z1P7|KANK3_MOUSE KN motif and ankyrin repeat domain-containing protein 3 OS=Mus musculus OX=10090 GN=Kank3 PE=1 SV=1,,,,,,
OG_05066,0.2131152222979855,OG_05066,FUN_023269-T1,Peve_00019482,Pocillopora_meandrina_HIv1___TS.g17377.t1a,three_way,74.93916666666667,FUN_023269-T1,Q9PVF8,CTNA1_DANRE,,Catenin alpha-1 (Alpha E-catenin),Danio rerio (Zebrafish) (Brachydanio rerio),23.7,628.0,5.3e-38,162.2,sp|Q9PVF8|CTNA1_DANRE Catenin alpha-1 OS=Danio rerio OX=7955 GN=ctnna1 PE=1 SV=1,GO:0001894; GO:0005198; GO:0005634; GO:0005902; GO:0005911; GO:0005912; GO:0005938; GO:0008013; GO:0015629; GO:0016342; GO:0016477; GO:0034334; GO:0043009; GO:0045296; GO:0051015; GO:0098609,adherens junction maintenance [GO:0034334]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; chordate embryonic development [GO:0043009]; tissue homeostasis [GO:0001894],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; microvillus [GO:0005902]; nucleus [GO:0005634],actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198],GO:0005198; GO:0005634; GO:0005856; GO:0007155; GO:0008092; GO:0034330; GO:0043226; GO:0048856; GO:0048870,structural molecule activity; nucleus; cytoskeleton; cell adhesion; cytoskeletal protein binding; cell junction organization; organelle; anatomical structure development; cell motility
OG_02874,0.2130581036404052,OG_02874,FUN_011924-T1,Peve_00008895,Pocillopora_meandrina_HIv1___RNAseq.g23323.t2,three_way,64.81983333333334,FUN_011924-T1,Q6PCF7,UBE2Z_XENLA,,Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z),Xenopus laevis (African clawed frog),57.8,249.0,2.7e-84,313.5,sp|Q6PCF7|UBE2Z_XENLA Ubiquitin-conjugating enzyme E2 Z OS=Xenopus laevis OX=8355 GN=ube2z PE=2 SV=2,GO:0004869; GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0043066; GO:0061631,apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0012501; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; programmed cell death; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01456,0.2130209715958836,OG_01456,FUN_005914-T1,Peve_00008476,Pocillopora_meandrina_HIv1___RNAseq.g19568.t1,three_way,83.68299999999999,FUN_005914-T1,Q3T199,,,,,93.0,143.0,3.500000000000001e-71,268.9,sp|Q3T199|RS23_BOVIN Small ribosomal subunit protein uS12 OS=Bos taurus OX=9913 GN=RPS23 PE=1 SV=1,,,,,,
OG_06269,0.2130074474705318,OG_06269,FUN_028300-T1,Peve_00000713,Pocillopora_meandrina_HIv1___RNAseq.g15543.t1,three_way,84.12116666666667,FUN_028300-T1,Q80Z96,,,,,42.7,461.0,2.0999999999999998e-94,347.8,sp|Q80Z96|VANG1_MOUSE Vang-like protein 1 OS=Mus musculus OX=10090 GN=Vangl1 PE=1 SV=2,,,,,,
OG_09968,0.2129076649352562,OG_09968,FUN_043149-T1,Peve_00011390,Pocillopora_meandrina_HIv1___RNAseq.g6853.t1,three_way,78.382,FUN_043149-T1,Q8TE57,ATS16_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Homo sapiens (Human),35.3,1002.0,3.1000000000000004e-157,558.1,sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein"
OG_09493,0.2128829552643761,OG_09493,FUN_041532-T1,Peve_00017081,Pocillopora_meandrina_HIv1___RNAseq.g15376.t1,three_way,72.252,FUN_041532-T1,Q60525,TCAB1_MESAU,,Telomerase Cajal body protein 1 (Guanine nucleotide-binding protein beta 5) (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene homolog),Mesocricetus auratus (Golden hamster),49.7,346.0,6.4e-92,339.7,sp|Q60525|TCAB1_MESAU Telomerase Cajal body protein 1 OS=Mesocricetus auratus OX=10036 GN=Wrap53 PE=2 SV=1,GO:0000781; GO:0003723; GO:0005697; GO:0005829; GO:0006281; GO:0007004; GO:0015030; GO:0030576; GO:0031625; GO:0032203; GO:0032212; GO:0034337; GO:0035861; GO:0042393; GO:0042802; GO:0044877; GO:0045739; GO:0051087; GO:0070034; GO:0090666; GO:0090671; GO:0140597; GO:0140691; GO:1904851; GO:1904867; GO:1905168; GO:2000781; GO:2001034,Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004],"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]",histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; RNA folding chaperone [GO:0140691]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005829; GO:0006281; GO:0032200; GO:0042393; GO:0043226; GO:0140104,RNA binding; cytosol; DNA repair; telomere organization; histone binding; organelle; molecular carrier activity
OG_08803,0.212878827811765,OG_08803,FUN_038122-T1,Peve_00003003,Pocillopora_meandrina_HIv1___RNAseq.g28329.t1,three_way,90.11766666666666,FUN_038122-T1,Q9H1Z4,,,,,48.8,363.0,1.7e-85,317.8,sp|Q9H1Z4|WDR13_HUMAN WD repeat-containing protein 13 OS=Homo sapiens OX=9606 GN=WDR13 PE=1 SV=3,,,,,,
OG_04528,0.2128661573722828,OG_04528,FUN_022072-T1,Peve_00025462,Pocillopora_meandrina_HIv1___RNAseq.g4582.t1,three_way,69.28633333333333,FUN_022072-T1,Q1MTN8,,,,,29.9,324.0,1.3e-27,125.6,sp|Q1MTN8|ACL4_SCHPO Probable assembly chaperone of rpl4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC16D10.01c PE=3 SV=2,,,,,,
OG_07077,0.2128530845840824,OG_07077,FUN_032314-T1,Peve_00031926,Pocillopora_meandrina_HIv1___RNAseq.g24787.t1,three_way,73.028,FUN_032314-T1,P83205,CATB_SHEEP,,Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain],Ovis aries (Sheep),56.0,336.0,2.5e-107,390.2,sp|P83205|CATB_SHEEP Cathepsin B OS=Ovis aries OX=9940 GN=CTSB PE=1 SV=2,GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090,cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471],collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0006575; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; modified amino acid metabolic process; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06228,0.2128185253462836,OG_06228,FUN_028174-T1,Peve_00024810,Pocillopora_meandrina_HIv1___RNAseq.g16503.t1,three_way,89.96966666666667,FUN_028174-T1,P79384,,,,,77.6,510.0,8.2e-238,824.3,"sp|P79384|PCCB_PIG Propionyl-CoA carboxylase beta chain, mitochondrial OS=Sus scrofa OX=9823 GN=PCCB PE=1 SV=1",,,,,,
OG_06479,0.2127407756480405,OG_06479,FUN_029247-T1,Peve_00013745,Pocillopora_meandrina_HIv1___TS.g9395.t1,three_way,61.76716666666667,FUN_029247-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),37.3,496.0,4.5e-84,314.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_07424,0.2127188425305926,OG_07424,FUN_033886-T1,Peve_00043301,Pocillopora_meandrina_HIv1___RNAseq.20826_t,three_way,52.64116666666667,FUN_033886-T1,Q6ZQ03,,,,,35.6,219.0,1.8000000000000002e-28,129.4,sp|Q6ZQ03|FNBP4_MOUSE Formin-binding protein 4 OS=Mus musculus OX=10090 GN=Fnbp4 PE=1 SV=2,,,,,,
OG_07424,0.2127188425305926,OG_07424,FUN_033886-T1,Peve_00043301,Pocillopora_meandrina_HIv1___RNAseq.20826_t,three_way,52.64116666666667,FUN_033886-T1,Q6ZQ03,,,,,52.8,36.0,0.0003,48.9,sp|Q6ZQ03|FNBP4_MOUSE Formin-binding protein 4 OS=Mus musculus OX=10090 GN=Fnbp4 PE=1 SV=2,,,,,,
OG_06881,0.2127009128661597,OG_06881,FUN_031902-T1,Peve_00037703,Pocillopora_meandrina_HIv1___RNAseq.g30039.t1,three_way,69.01516666666666,FUN_031902-T1,Q8N9M1,,,,,36.5,241.0,4.0000000000000004e-23,110.5,sp|Q8N9M1|CS047_HUMAN Uncharacterized protein C19orf47 OS=Homo sapiens OX=9606 GN=C19orf47 PE=1 SV=1,,,,,,
OG_03540,0.2127004302707302,OG_03540,FUN_014660-T1,Peve_00032454,Pocillopora_meandrina_HIv1___RNAseq.g22661.t1,three_way,97.681,FUN_014660-T1,Q2YDI3,,,,,92.9,113.0,1.6e-58,226.5,sp|Q2YDI3|YPEL2_BOVIN Protein yippee-like 2 OS=Bos taurus OX=9913 GN=YPEL2 PE=3 SV=1,,,,,,
OG_04065,0.2126817398606308,OG_04065,FUN_016386-T1,Peve_00030460,Pocillopora_meandrina_HIv1___RNAseq.g15065.t1,three_way,69.083,FUN_016386-T1,Q9UBD5,ORC3_HUMAN,,Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo),Homo sapiens (Human),40.6,729.0,7.2e-149,529.3,sp|Q9UBD5|ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens OX=9606 GN=ORC3 PE=1 SV=1,GO:0000781; GO:0000785; GO:0000808; GO:0003688; GO:0005634; GO:0005654; GO:0005656; GO:0005664; GO:0006260; GO:0006270; GO:0006275; GO:0014009; GO:0016604; GO:0031261; GO:0061351,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; glial cell proliferation [GO:0014009]; neural precursor cell proliferation [GO:0061351]; regulation of DNA replication [GO:0006275],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication preinitiation complex [GO:0031261]; nuclear body [GO:0016604]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]",DNA replication origin binding [GO:0003688],GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA replication; organelle
OG_06449,0.2126311839225113,OG_06449,FUN_029169-T1,Peve_00042458,Pocillopora_meandrina_HIv1___RNAseq.g25480.t1,three_way,80.11266666666667,FUN_029169-T1,Q5RA02,,,,,50.7,515.0,3.8e-144,513.1,sp|Q5RA02|XPOT_PONAB Exportin-T OS=Pongo abelii OX=9601 GN=XPOT PE=2 SV=1,,,,,,
OG_07426,0.2126042486950355,OG_07426,FUN_033906-T1,Peve_00039887,Pocillopora_meandrina_HIv1___TS.g8165.t1a,three_way,38.5305,FUN_033906-T1,Q704V6,TLR6_BOVIN,,Toll-like receptor 6 (CD antigen CD286),Bos taurus (Bovine),37.8,111.0,1.4e-16,89.0,sp|Q704V6|TLR6_BOVIN Toll-like receptor 6 OS=Bos taurus OX=9913 GN=TLR6 PE=2 SV=1,GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227,cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355],"identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_09356,0.212593531238312,OG_09356,FUN_040442-T1,Peve_00004014,Pocillopora_meandrina_HIv1___RNAseq.g6514.t1,three_way,66.56633333333333,FUN_040442-T1,Q14318,,,,,43.3,319.0,1.5999999999999999e-62,241.9,sp|Q14318|FKBP8_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP8 OS=Homo sapiens OX=9606 GN=FKBP8 PE=1 SV=2,,,,,,
OG_00102,0.2125168775334376,OG_00102,FUN_000488-T1,Peve_00038241,Pocillopora_meandrina_HIv1___RNAseq.g2338.t1,three_way,92.94666666666666,FUN_000488-T1,Q5E9E6,,,,,80.0,215.0,6.099999999999999e-96,351.7,sp|Q5E9E6|RL10A_BOVIN Large ribosomal subunit protein uL1 OS=Bos taurus OX=9913 GN=RPL10A PE=2 SV=3,,,,,,
OG_02365,0.2124233647107515,OG_02365,FUN_008972-T1,Peve_00025074,Pocillopora_meandrina_HIv1___RNAseq.g14268.t1,three_way,56.09883333333333,FUN_008972-T1,Q9BXT4,TDRD1_HUMAN,,Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1),Homo sapiens (Human),22.4,961.0,1.8999999999999998e-35,153.3,sp|Q9BXT4|TDRD1_HUMAN Tudor domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TDRD1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_04120,0.2123989229302869,OG_04120,FUN_016496-T1,Peve_00010548,Pocillopora_meandrina_HIv1___RNAseq.g175.t1,three_way,69.93133333333333,FUN_016496-T1,Q5RFE6,,,,,48.9,474.0,3.5e-128,459.9,sp|Q5RFE6|THNS2_PONAB Threonine synthase-like 2 OS=Pongo abelii OX=9601 GN=THNSL2 PE=2 SV=1,,,,,,
OG_08759,0.212318850035055,OG_08759,FUN_038032-T1,Peve_00021540,Pocillopora_meandrina_HIv1___RNAseq.g26542.t1,three_way,53.04466666666666,FUN_038032-T1,Q96B70,,,,,45.8,96.0,1.3e-15,86.7,sp|Q96B70|LENG9_HUMAN Leukocyte receptor cluster member 9 OS=Homo sapiens OX=9606 GN=LENG9 PE=1 SV=2,,,,,,
OG_08869,0.2122678952243525,OG_08869,FUN_038265-T1,Peve_00007997,Pocillopora_meandrina_HIv1___RNAseq.g914.t1,three_way,86.61366666666667,FUN_038265-T1,A6HD62,CHIP_RAT,,E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1),Rattus norvegicus (Rat),58.4,238.0,7.000000000000002e-75,282.0,sp|A6HD62|CHIP_RAT E3 ubiquitin-protein ligase CHIP OS=Rattus norvegicus OX=10116 GN=Stub1 PE=1 SV=1,GO:0000151; GO:0000165; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006513; GO:0006515; GO:0010614; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030512; GO:0030544; GO:0030911; GO:0030968; GO:0031072; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032436; GO:0034392; GO:0034393; GO:0034450; GO:0034605; GO:0035359; GO:0036503; GO:0042405; GO:0042803; GO:0043066; GO:0043161; GO:0045862; GO:0046332; GO:0050821; GO:0051087; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070412; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031; GO:1901526; GO:1904294; GO:1904694,cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of mitophagy [GO:1901526]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018],enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003013; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005829; GO:0006281; GO:0006914; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"circulatory system process; catalytic activity; nucleus; nucleoplasm; mitochondrion; endoplasmic reticulum; cytosol; DNA repair; autophagy; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_08518,0.212220132885955,OG_08518,FUN_037448-T1,Peve_00027252,Pocillopora_meandrina_HIv1___RNAseq.g10987.t1,three_way,73.10766666666667,FUN_037448-T1,Q8AVL0,,,,,50.8,543.0,6.4e-150,532.3,sp|Q8AVL0|C19L1_XENLA CWF19-like protein 1 OS=Xenopus laevis OX=8355 GN=cwf19l1 PE=2 SV=1,,,,,,
OG_03178,0.2121304549414779,OG_03178,FUN_012624-T1,Peve_00040101,Pocillopora_meandrina_HIv1___RNAseq.g13730.t1,three_way,77.34,FUN_012624-T1,Q6AYY8,,,,,59.8,485.0,1.6e-169,597.4,sp|Q6AYY8|ACATN_RAT Acetyl-coenzyme A transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc33a1 PE=2 SV=1,,,,,,
OG_09639,0.2121086313499799,OG_09639,FUN_041834-T1,Peve_00029683,Pocillopora_meandrina_HIv1___RNAseq.g15086.t1,three_way,80.92266666666667,FUN_041834-T1,B0R0T1,VWA8_DANRE,,von Willebrand factor A domain-containing protein 8,Danio rerio (Zebrafish) (Brachydanio rerio),55.4,1896.0,0.0,2025.0,sp|B0R0T1|VWA8_DANRE von Willebrand factor A domain-containing protein 8 OS=Danio rerio OX=7955 GN=vwa8 PE=3 SV=1,GO:0005524; GO:0005737; GO:0005739; GO:0016887; GO:0030903,notochord development [GO:0030903],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0048856,catalytic activity; mitochondrion; hydrolase activity; organelle; anatomical structure development
OG_01704,0.2118597717623553,OG_01704,FUN_006949-T1,Peve_00001501,Pocillopora_meandrina_HIv1___RNAseq.g20122.t1,three_way,65.41066666666667,FUN_006949-T1,Q9D4H7,,,,,35.5,617.0,9e-100,365.9,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_02378,0.2118334188795569,OG_02378,FUN_008989-T1,Peve_00001693,Pocillopora_meandrina_HIv1___RNAseq.g3898.t1,three_way,97.019,FUN_008989-T1,Q9Y3B4,SF3B6_HUMAN,,"Splicing factor 3B subunit 6 (Pre-mRNA branch site protein p14) (SF3b 14 kDa subunit) (SF3B14a) (Spliceosome-associated protein, 14-kDa) (Splicing factor 3b, subunit 6, 14kDa)",Homo sapiens (Human),78.7,122.0,3.7e-53,208.8,sp|Q9Y3B4|SF3B6_HUMAN Splicing factor 3B subunit 6 OS=Homo sapiens OX=9606 GN=SF3B6 PE=1 SV=1,GO:0000398; GO:0001825; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:1903241,"blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_09908,0.2117989811397157,OG_09908,FUN_043005-T1,Peve_00017775,Pocillopora_meandrina_HIv1___RNAseq.g7029.t1,three_way,70.90416666666667,FUN_043005-T1,Q90416,RXRGA_DANRE,,Retinoic acid receptor RXR-gamma-A (Nuclear receptor subfamily 2 group B member 3-A) (Retinoic acid receptor RXR-alpha) (Retinoid X receptor alpha) (Retinoid X receptor gamma-A),Danio rerio (Zebrafish) (Brachydanio rerio),36.4,365.0,1.1999999999999999e-61,239.2,sp|Q90416|RXRGA_DANRE Retinoic acid receptor RXR-gamma-A OS=Danio rerio OX=7955 GN=rxrga PE=2 SV=2,GO:0003700; GO:0003707; GO:0004879; GO:0007399; GO:0008270; GO:0030154; GO:0044323; GO:0045893; GO:0045944; GO:0048384; GO:0090575,cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384],RNA polymerase II transcription regulator complex [GO:0090575],DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; zinc ion binding [GO:0008270],GO:0003677; GO:0006355; GO:0030154; GO:0048856; GO:0060089; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_00738,0.21178912645214,OG_00738,FUN_002720-T1,Peve_00025045,Pocillopora_meandrina_HIv1___RNAseq.g14938.t1,three_way,56.15233333333333,,,,,,,,,,,,,,,,,
OG_03995,0.2117672382706182,OG_03995,FUN_016279-T1,Peve_00003394,Pocillopora_meandrina_HIv1___RNAseq.g406.t1,three_way,53.544,,,,,,,,,,,,,,,,,
OG_09553,0.2117377324977189,OG_09553,FUN_041653-T1,Peve_00012482,Pocillopora_meandrina_HIv1___RNAseq.g13863.t1,three_way,65.15316666666666,,,,,,,,,,,,,,,,,
OG_04670,0.2117375964983828,OG_04670,FUN_022428-T1,Peve_00037611,Pocillopora_meandrina_HIv1___RNAseq.g4345.t1,three_way,59.46366666666667,FUN_022428-T1,Q9VCX3,,,,,31.2,253.0,4.2e-31,136.7,sp|Q9VCX3|RM45_DROME Large ribosomal subunit protein mL45 OS=Drosophila melanogaster OX=7227 GN=mRpL45 PE=2 SV=1,,,,,,
OG_09329,0.211703673186684,OG_09329,FUN_040263-T1,Peve_00029137,Pocillopora_meandrina_HIv1___RNAseq.g7788.t1,three_way,72.762,,,,,,,,,,,,,,,,,
OG_04954,0.2116454140572581,OG_04954,FUN_023044-T1,Peve_00008510,Pocillopora_meandrina_HIv1___TS.g10041.t2,three_way,72.67383333333333,FUN_023044-T1,Q01085,TIAR_HUMAN,,Nucleolysin TIAR (TIA-1-related protein),Homo sapiens (Human),41.0,373.0,1e-67,258.8,sp|Q01085|TIAR_HUMAN Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1 PE=1 SV=1,GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006357; GO:0006915; GO:0006952; GO:0008285; GO:0010494; GO:0035332; GO:0044194; GO:0140517; GO:2000637,apoptotic process [GO:0006915]; defense response [GO:0006952]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of transcription by RNA polymerase II [GO:0006357],cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; protein-RNA adaptor activity [GO:0140517]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; nucleoplasm; lysosome; vacuole; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; molecular adaptor activity
OG_05302,0.211635356584307,OG_05302,FUN_023972-T1,Peve_00025484,Pocillopora_meandrina_HIv1___RNAseq.g18530.t1,three_way,91.074,FUN_023972-T1,Q8K2G4,BBS7_MOUSE,,BBSome complex member BBS7 (BBS2-like protein 1) (Bardet-Biedl syndrome 7 protein homolog),Mus musculus (Mouse),68.9,718.0,1.8e-293,1009.6,sp|Q8K2G4|BBS7_MOUSE BBSome complex member BBS7 OS=Mus musculus OX=10090 GN=Bbs7 PE=1 SV=1,GO:0001654; GO:0001750; GO:0005634; GO:0005813; GO:0005930; GO:0006357; GO:0007224; GO:0007420; GO:0007507; GO:0008104; GO:0015031; GO:0016020; GO:0032436; GO:0034451; GO:0034464; GO:0036064; GO:0045444; GO:0060170; GO:0060173; GO:0060271; GO:0061629; GO:1903929; GO:1905515,brain development [GO:0007420]; cilium assembly [GO:0060271]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; limb development [GO:0060173]; non-motile cilium assembly [GO:1905515]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224],axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; membrane [GO:0016020]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0005634; GO:0005815; GO:0006355; GO:0030154; GO:0043226; GO:0044782; GO:0048856,nucleus; microtubule organizing center; regulation of DNA-templated transcription; cell differentiation; organelle; cilium organization; anatomical structure development
OG_08105,0.2116328248354911,OG_08105,FUN_035852-T1,Peve_00032510,Pocillopora_meandrina_HIv1___RNAseq.g11950.t1,three_way,70.93616666666667,FUN_035852-T1,Q63185,E2AK1_RAT,,Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (Hemin-sensitive initiation factor 2-alpha kinase),Rattus norvegicus (Rat),33.4,626.0,4.1e-72,274.2,sp|Q63185|E2AK1_RAT Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Rattus norvegicus OX=10116 GN=Eif2ak1 PE=1 SV=2,GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0006446; GO:0006909; GO:0008285; GO:0017148; GO:0020037; GO:0030225; GO:0042803; GO:0046501; GO:0046777; GO:0046984; GO:0046986; GO:0051649; GO:0060586; GO:0070585; GO:0106310; GO:0140467; GO:0140468; GO:1901526; GO:1990641,acute inflammatory response [GO:0002526]; establishment of localization in cell [GO:0051649]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; macrophage differentiation [GO:0030225]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translation [GO:0017148]; phagocytosis [GO:0006909]; positive regulation of mitophagy [GO:1901526]; protein autophosphorylation [GO:0046777]; protein localization to mitochondrion [GO:0070585]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of hemoglobin biosynthetic process [GO:0046984]; regulation of translation [GO:0006417]; regulation of translational initiation [GO:0006446]; response to iron ion starvation [GO:1990641],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005829; GO:0006954; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; inflammatory response; vesicle-mediated transport; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_08856,0.2116190250658195,OG_08856,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_00756,0.2114723698779074,OG_00756,FUN_002871-T1,Peve_00013073,Pocillopora_meandrina_HIv1___TS.g15581.t1,three_way,81.83266666666667,FUN_002871-T1,Q21086,GNL3_CAEEL,,Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1),Caenorhabditis elegans,46.8,457.0,2.7e-109,397.5,sp|Q21086|GNL3_CAEEL Guanine nucleotide-binding protein-like 3 homolog OS=Caenorhabditis elegans OX=6239 GN=nst-1 PE=3 SV=1,GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127,germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0022414; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; reproductive process; organelle; anatomical structure development
OG_09263,0.2114506783481663,OG_09263,FUN_040068-T1,Peve_00033896,Pocillopora_meandrina_HIv1___RNAseq.g7698.t1,three_way,65.987,FUN_040068-T1,Q68FU5,,,,,58.5,106.0,3.2999999999999997e-29,129.8,sp|Q68FU5|CI085_RAT Uncharacterized protein C9orf85 homolog OS=Rattus norvegicus OX=10116 PE=1 SV=1,,,,,,
OG_05271,0.2114183872864728,OG_05271,FUN_023924-T1,Peve_00026568,Pocillopora_meandrina_HIv1___RNAseq.g18866.t1,three_way,53.82933333333333,,,,,,,,,,,,,,,,,
OG_06129,0.2114099937985617,OG_06129,FUN_027933-T1,Peve_00020114,Pocillopora_meandrina_HIv1___RNAseq.g13875.t1,three_way,72.51966666666667,,,,,,,,,,,,,,,,,
OG_06100,0.2112676371067797,OG_06100,FUN_027736-T1,Peve_00036491,Pocillopora_meandrina_HIv1___RNAseq.g13903.t1,three_way,88.12533333333333,FUN_027736-T1,Q8WYA0,IFT81_HUMAN,,Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1),Homo sapiens (Human),55.2,677.0,1.5e-180,634.4,sp|Q8WYA0|IFT81_HUMAN Intraflagellar transport protein 81 homolog OS=Homo sapiens OX=9606 GN=IFT81 PE=1 SV=1,GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0031514; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0097542; GO:0120316,cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228],tubulin binding [GO:0015631],GO:0005815; GO:0005929; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0044782,microtubule organizing center; cilium; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; cilium organization
OG_00082,0.2112158121770034,OG_00082,FUN_000411-T1,Peve_00010961,Pocillopora_meandrina_HIv1___RNAseq.g2317.t1,three_way,32.01166666666666,,,,,,,,,,,,,,,,,
OG_01921,0.2111715786614124,OG_01921,FUN_007951-T1,Peve_00039191,Pocillopora_meandrina_HIv1___RNAseq.g30068.t1,three_way,75.82233333333333,,,,,,,,,,,,,,,,,
OG_03454,0.2111367321519717,OG_03454,FUN_014529-T1,Peve_00044375,Pocillopora_meandrina_HIv1___RNAseq.g22615.t1,three_way,84.25116666666666,FUN_014529-T1,P61267,,,,,57.3,267.0,9.1e-74,278.5,sp|P61267|STX1B_BOVIN Syntaxin-1B OS=Bos taurus OX=9913 GN=STX1B PE=1 SV=1,,,,,,
OG_02930,0.2110886652282408,OG_02930,FUN_012029-T1,Peve_00044958,Pocillopora_meandrina_HIv1___RNAseq.g24045.t1,three_way,82.663,FUN_012029-T1,P11533,,,,,29.7,3968.0,0.0,1575.5,sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1,,,,,,
OG_09617,0.2110685586509229,OG_09617,FUN_041777-T1,Peve_00042840,Pocillopora_meandrina_HIv1___RNAseq.g15886.t1,three_way,86.59949999999999,FUN_041777-T1,Q13627,DYR1A_HUMAN,,Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.11.23) (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB),Homo sapiens (Human),78.0,410.0,2.1e-190,667.2,sp|Q13627|DYR1A_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Homo sapiens OX=9606 GN=DYRK1A PE=1 SV=2,GO:0000381; GO:0003713; GO:0003779; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007399; GO:0007623; GO:0008092; GO:0008353; GO:0015631; GO:0016607; GO:0018108; GO:0030424; GO:0030425; GO:0031115; GO:0031452; GO:0033120; GO:0042802; GO:0043518; GO:0045893; GO:0046777; GO:0048025; GO:0048156; GO:0050321; GO:0106310; GO:0140857; GO:1902003; GO:1902996; GO:1990904; GO:1990935,"circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of heterochromatin formation [GO:0031452]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of RNA splicing [GO:0033120]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of amyloid-beta formation [GO:1902003]; regulation of neurofibrillary tangle assembly [GO:1902996]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; histone H3T45 kinase activity [GO:0140857]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; splicing factor binding [GO:1990935]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_06911,0.2110573380007259,OG_06911,FUN_031971-T1,Peve_00043665,Pocillopora_meandrina_HIv1___RNAseq.g30205.t1,three_way,62.97566666666667,,,,,,,,,,,,,,,,,
OG_09145,0.2110336233420464,OG_09145,FUN_039793-T1,Peve_00017607,Pocillopora_meandrina_HIv1___RNAseq.g7472.t1,three_way,87.68633333333334,FUN_039793-T1,Q6AZN6,PK3C3_XENLA,,Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3),Xenopus laevis (African clawed frog),66.7,884.0,0.0,1166.0,sp|Q6AZN6|PK3C3_XENLA Phosphatidylinositol 3-kinase catalytic subunit type 3 OS=Xenopus laevis OX=8355 GN=pik3c3 PE=2 SV=1,GO:0000045; GO:0000407; GO:0000425; GO:0005524; GO:0005737; GO:0005768; GO:0005777; GO:0006897; GO:0016020; GO:0016303; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0036092; GO:0048015; GO:0051301,autophagosome assembly [GO:0000045]; cell division [GO:0051301]; endocytosis [GO:0006897]; pexophagy [GO:0000425]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465],"cytoplasm [GO:0005737]; endosome [GO:0005768]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]",1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524],GO:0003824; GO:0005768; GO:0005777; GO:0006629; GO:0006914; GO:0016192; GO:0016740; GO:0031410; GO:0043226,catalytic activity; endosome; peroxisome; lipid metabolic process; autophagy; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle
OG_02543,0.2110113643026694,OG_02543,FUN_010626-T1,Peve_00004474,Pocillopora_meandrina_HIv1___RNAseq.g21298.t1,three_way,89.19266666666667,FUN_010626-T1,Q91YL3,,,,,66.8,400.0,5.5e-149,528.9,sp|Q91YL3|UCKL1_MOUSE Uridine-cytidine kinase-like 1 OS=Mus musculus OX=10090 GN=Uckl1 PE=1 SV=1,,,,,,
OG_04801,0.2109909638772547,OG_04801,FUN_022758-T1,Peve_00027945,Pocillopora_meandrina_HIv1___RNAseq.g3153.t1,three_way,64.09166666666667,,,,,,,,,,,,,,,,,
OG_06409,0.2109173594043568,OG_06409,FUN_029091-T1,Peve_00033472,Pocillopora_meandrina_HIv1___RNAseq.g25753.t1,three_way,63.12366666666667,FUN_029091-T1,Q8R4U0,STAB2_MOUSE,,"Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) [Cleaved into: Short form stabilin-2]",Mus musculus (Mouse),35.9,2141.0,2.6e-153,545.8,sp|Q8R4U0|STAB2_MOUSE Stabilin-2 OS=Mus musculus OX=10090 GN=Stab2 PE=1 SV=1,GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0030169; GO:0030214; GO:0038024; GO:0050830,cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],cytosol [GO:0005829]; external side of plasma membrane [GO:0009897],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044],GO:0005829; GO:0007155; GO:0016192; GO:0038024; GO:1901135,cytosol; cell adhesion; vesicle-mediated transport; cargo receptor activity; carbohydrate derivative metabolic process
OG_08200,0.2109021277799529,OG_08200,FUN_036044-T1,Peve_00011142,Pocillopora_meandrina_HIv1___RNAseq.g27348.t1,three_way,84.868,FUN_036044-T1,F1QXM5,,,,,66.1,449.0,1e-178,627.9,"sp|F1QXM5|LDHD_DANRE Probable D-lactate dehydrogenase, mitochondrial OS=Danio rerio OX=7955 GN=ldhd PE=2 SV=1",,,,,,
OG_10221,0.2108226931349248,OG_10221,FUN_043835-T1,Peve_00041794,Pocillopora_meandrina_HIv1___TS.g12323.t1,three_way,54.1065,,,,,,,,,,,,,,,,,
OG_07673,0.2108164060862015,OG_07673,FUN_034780-T1,Peve_00029729,Pocillopora_meandrina_HIv1___RNAseq.g12275.t1,three_way,82.57533333333333,FUN_034780-T1,Q9Y4W6,AFG32_HUMAN,,Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein),Homo sapiens (Human),68.9,637.0,6.099999999999999e-247,855.1,sp|Q9Y4W6|AFG32_HUMAN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Homo sapiens OX=9606 GN=AFG3L2 PE=1 SV=2,GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0030163; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0051604; GO:0055001; GO:0060013; GO:0072753; GO:0110097; GO:0141164,axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0055085; GO:0061024; GO:0140096; GO:0140657,"catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; cell junction organization; organelle; anatomical structure development; protein maturation; transmembrane transport; membrane organization; catalytic activity, acting on a protein; ATP-dependent activity"
OG_00491,0.2107986674833127,OG_00491,FUN_001461-T1,Peve_00027130,Pocillopora_meandrina_HIv1___TS.g4468.t1,three_way,90.859,FUN_001461-T1,Q8BTQ0,PCGF3_MOUSE,,Polycomb group RING finger protein 3 (RING finger protein 3A),Mus musculus (Mouse),57.9,242.0,6.200000000000001e-73,275.4,sp|Q8BTQ0|PCGF3_MOUSE Polycomb group RING finger protein 3 OS=Mus musculus OX=10090 GN=PcgF3 PE=1 SV=1,GO:0005654; GO:0008270; GO:0031519; GO:0060816; GO:0140862,random inactivation of X chromosome [GO:0060816],nucleoplasm [GO:0005654]; PcG protein complex [GO:0031519],histone H2AK119 ubiquitin ligase activity [GO:0140862]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006325; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; chromatin organization; transferase activity; catalytic activity, acting on a protein"
OG_08474,0.2107976832164933,OG_08474,FUN_037291-T1,Peve_00032666,Pocillopora_meandrina_HIv1___RNAseq.22530_t,three_way,88.56233333333334,FUN_037291-T1,Q5EAD6,RL15_BOVIN,,Large ribosomal subunit protein eL15 (60S ribosomal protein L15),Bos taurus (Bovine),76.0,204.0,2.1e-90,333.2,sp|Q5EAD6|RL15_BOVIN Large ribosomal subunit protein eL15 OS=Bos taurus OX=9913 GN=RPL15 PE=2 SV=3,GO:0002181; GO:0003723; GO:0003735; GO:0022625,cytoplasmic translation [GO:0002181],cytosolic large ribosomal subunit [GO:0022625],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198,cytoplasmic translation; RNA binding; structural molecule activity
OG_09061,0.2105782367592948,OG_09061,FUN_038756-T1,Peve_00022724,Pocillopora_meandrina_HIv1___RNAseq.g26409.t1,three_way,77.744,FUN_038756-T1,Q8NBN7,RDH13_HUMAN,,Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3),Homo sapiens (Human),46.0,302.0,6.2e-63,242.7,sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2,GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650,eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226; GO:0048856,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle; anatomical structure development
OG_03092,0.2105617804224253,OG_03092,FUN_012366-T1,Peve_00042545,Pocillopora_meandrina_HIv1___RNAseq.g23358.t1a,three_way,69.351,FUN_012366-T1,E9PYK3,PARP4_MOUSE,,Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) (mVparp),Mus musculus (Mouse),38.6,1245.0,9.999999999999999e-231,802.7,sp|E9PYK3|PARP4_MOUSE Protein mono-ADP-ribosyltransferase PARP4 OS=Mus musculus OX=10090 GN=Parp4 PE=1 SV=1,GO:0003950; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005876; GO:0006954; GO:0016779; GO:0019899; GO:0036211; GO:0140806; GO:0140807; GO:1990404; GO:1990904,inflammatory response [GO:0006954]; protein modification process [GO:0036211],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; spindle microtubule [GO:0005876],enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006954; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; inflammatory response; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03288,0.2105427094819238,OG_03288,FUN_013329-T1,Peve_00022430,Pocillopora_meandrina_HIv1___RNAseq.g12994.t1,three_way,67.42033333333333,FUN_013329-T1,Q8IS64,,,,,36.0,688.0,9.5e-131,469.2,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_05571,0.2105287245609931,OG_05571,FUN_024814-T1,Peve_00026077,Pocillopora_meandrina_HIv1___RNAseq.g18773.t1,three_way,88.77166666666666,FUN_024814-T1,Q4GZT3,PKD2_BOVIN,,Polycystin-2 (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2),Bos taurus (Bovine),54.5,751.0,1.4999999999999999e-215,751.1,sp|Q4GZT3|PKD2_BOVIN Polycystin-2 OS=Bos taurus OX=9913 GN=PKD2 PE=2 SV=1,GO:0002133; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006813; GO:0006814; GO:0006816; GO:0007166; GO:0015271; GO:0016020; GO:0016323; GO:0030659; GO:0034703; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070062; GO:0070588; GO:0071277; GO:0071805; GO:0098662; GO:0140494,calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; release of sequestered calcium ion into cytosol [GO:0051209]; sodium ion transport [GO:0006814],basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; migrasome [GO:0140494]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0008092; GO:0043226; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; Golgi apparatus; plasma membrane; cilium; cytoskeletal protein binding; organelle; transmembrane transport; protein-containing complex assembly
OG_04002,0.2105265256063216,OG_04002,FUN_016297-T1,Peve_00002880,Pocillopora_meandrina_HIv1___RNAseq.g9883.t1,three_way,94.22166666666666,FUN_016297-T1,P35224,,,,,57.2,711.0,3.1e-203,709.9,sp|P35224|CTNB_URECA Catenin beta OS=Urechis caupo OX=6431 PE=2 SV=1,,,,,,
OG_03922,0.2105195391789454,OG_03922,FUN_016031-T1,Peve_00033606,Pocillopora_meandrina_HIv1___RNAseq.g22274.t1,three_way,88.53866666666666,FUN_016031-T1,Q5BKL0,,,,,74.8,385.0,4.6e-171,602.1,sp|Q5BKL0|HPPD_XENTR 4-hydroxyphenylpyruvate dioxygenase OS=Xenopus tropicalis OX=8364 GN=hpd PE=2 SV=1,,,,,,
OG_06063,0.2104789521495492,OG_06063,FUN_026896-T1,Peve_00021663,Pocillopora_meandrina_HIv1___RNAseq.g2819.t1,three_way,56.90566666666667,,,,,,,,,,,,,,,,,
OG_10148,0.2104341389439452,OG_10148,FUN_043539-T1,Peve_00012551,Pocillopora_meandrina_HIv1___TS.g1775.t1,three_way,61.17516666666667,FUN_043539-T1,Q9DBQ9,,,,,27.4,592.0,6.5e-46,187.6,sp|Q9DBQ9|SWT1_MOUSE Transcriptional protein SWT1 OS=Mus musculus OX=10090 GN=Swt1 PE=2 SV=3,,,,,,
OG_05488,0.2104317006988096,OG_05488,FUN_024485-T1,Peve_00010581,Pocillopora_meandrina_HIv1___RNAseq.g19070.t1,three_way,78.75466666666667,,,,,,,,,,,,,,,,,
OG_04033,0.2104015304518896,OG_04033,FUN_016341-T1,Peve_00044577,Pocillopora_meandrina_HIv1___RNAseq.g9731.t1,three_way,85.63799999999999,FUN_016341-T1,Q5ZKX6,UBE2F_CHICK,,NEDD8-conjugating enzyme UBE2F (EC 2.3.2.34) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F),Gallus gallus (Chicken),60.9,184.0,1.2e-62,241.1,sp|Q5ZKX6|UBE2F_CHICK NEDD8-conjugating enzyme UBE2F OS=Gallus gallus OX=9031 GN=UBE2F PE=2 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654; GO:0061663,protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06299,0.2103571230432779,OG_06299,FUN_028503-T1,Peve_00029191,Pocillopora_meandrina_HIv1___RNAseq.g15905.t1,three_way,96.94266666666668,FUN_028503-T1,F2Z4H3,,,,,84.7,150.0,6.9e-70,264.6,"sp|F2Z4H3|RPAB3_BOVIN DNA-directed RNA polymerases I, II, and III subunit RPABC3 OS=Bos taurus OX=9913 GN=POLR2H PE=1 SV=1",,,,,,
OG_03638,0.2101993638862264,OG_03638,FUN_014858-T1,Peve_00024576,Pocillopora_meandrina_HIv1___RNAseq.g22374.t1,three_way,82.99766666666666,FUN_014858-T1,Q7ZXK9,,,,,61.6,352.0,1.4999999999999999e-96,354.8,sp|Q7ZXK9|NLE1_XENLA Notchless protein homolog 1 OS=Xenopus laevis OX=8355 GN=nle1 PE=2 SV=1,,,,,,
OG_08125,0.2101577036472853,OG_08125,FUN_035883-T1,Peve_00014427,Pocillopora_meandrina_HIv1___RNAseq.g11998.t1,three_way,92.58233333333334,FUN_035883-T1,O14662,STX16_HUMAN,,Syntaxin-16 (Syn16),Homo sapiens (Human),51.5,305.0,2.8e-73,276.9,sp|O14662|STX16_HUMAN Syntaxin-16 OS=Homo sapiens OX=9606 GN=STX16 PE=1 SV=3,GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0019905; GO:0030672; GO:0031201; GO:0031985; GO:0032456; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471,"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005794; GO:0005829; GO:0006886; GO:0016192; GO:0043226; GO:0060090; GO:0061024,Golgi apparatus; cytosol; intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity; membrane organization
OG_09913,0.2101572015138932,OG_09913,FUN_043011-T1,Peve_00017767,Pocillopora_meandrina_HIv1___RNAseq.g7035.t1,three_way,43.78216666666667,,,,,,,,,,,,,,,,,
OG_00192,0.2100745793897232,OG_00192,FUN_000898-T1,Peve_00009741,Pocillopora_meandrina_HIv1___RNAseq.g29449.t1,three_way,80.12233333333333,FUN_000898-T1,O43903,GAS2_HUMAN,,Growth arrest-specific protein 2 (GAS-2),Homo sapiens (Human),42.6,256.0,1.3000000000000001e-48,194.9,sp|O43903|GAS2_HUMAN Growth arrest-specific protein 2 OS=Homo sapiens OX=9606 GN=GAS2 PE=1 SV=1,GO:0001544; GO:0001547; GO:0001725; GO:0005829; GO:0005884; GO:0006915; GO:0008017; GO:0008360; GO:0008593; GO:0016020; GO:0030728; GO:0051015; GO:0051726; GO:0051764; GO:0071711,actin crosslink formation [GO:0051764]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593],actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; microtubule binding [GO:0008017],GO:0005829; GO:0008092; GO:0012501; GO:0022414; GO:0030198,cytosol; cytoskeletal protein binding; programmed cell death; reproductive process; extracellular matrix organization
OG_06971,0.2100352197664045,OG_06971,FUN_032104-T1,Peve_00011277,Pocillopora_meandrina_HIv1___RNAseq.g6000.t1,three_way,72.7205,FUN_032104-T1,Q8IWV8,UBR2_HUMAN,,E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II),Homo sapiens (Human),42.3,1795.0,0.0,1350.1,sp|Q8IWV8|UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens OX=9606 GN=UBR2 PE=1 SV=1,GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010526; GO:0016567; GO:0031507; GO:0032007; GO:0043161; GO:0050862; GO:0061630; GO:0070534; GO:0070728; GO:0071233; GO:0071596; GO:0141053,cellular response to L-leucine [GO:0071233]; heterochromatin formation [GO:0031507]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],histone H2A ubiquitin ligase activity [GO:0141053]; L-leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006310; GO:0006325; GO:0016740; GO:0022414; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"catalytic activity; nucleus; cytosol; DNA recombination; chromatin organization; transferase activity; reproductive process; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_08977,0.2100296856473414,OG_08977,FUN_038488-T1,Peve_00013519,Pocillopora_meandrina_HIv1___TS.g8002.t1a,three_way,57.826,FUN_038488-T1,Q8JHF2,,,,,52.1,263.0,1.5e-77,291.6,"sp|Q8JHF2|LFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe OS=Danio rerio OX=7955 GN=lfng PE=2 SV=2",,,,,,
OG_01760,0.2099924524657425,OG_01760,FUN_007115-T1,Peve_00017834,Pocillopora_meandrina_HIv1___TS.g28404.t1,three_way,70.838,FUN_007115-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),30.5,1384.0,1.1000000000000001e-164,582.8,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_08289,0.209954148465982,OG_08289,FUN_036224-T1,Peve_00025944,Pocillopora_meandrina_HIv1___RNAseq.g27547.t1,three_way,76.61933333333333,FUN_036224-T1,P41123,,,,,62.6,211.0,9e-68,258.1,sp|P41123|RL13_RAT Large ribosomal subunit protein eL13 OS=Rattus norvegicus OX=10116 GN=Rpl13 PE=1 SV=2,,,,,,
OG_05222,0.2099354794649194,OG_05222,FUN_023634-T1,Peve_00027833,Pocillopora_meandrina_HIv1___RNAseq.g17811.t1,three_way,78.49183333333333,FUN_023634-T1,Q98TX3,,,,,45.7,438.0,1.4e-94,348.2,sp|Q98TX3|PDCD4_CHICK Programmed cell death protein 4 OS=Gallus gallus OX=9031 GN=PDCD4 PE=2 SV=1,,,,,,
OG_03634,0.2099022446315685,OG_03634,FUN_014854-T1,Peve_00038807,Pocillopora_meandrina_HIv1___TS.g27144.t2,three_way,77.016,FUN_014854-T1,Q99MP8,BRAP_MOUSE,,BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING-type E3 ubiquitin transferase BRAP2),Mus musculus (Mouse),45.8,594.0,5.2e-139,496.1,sp|Q99MP8|BRAP_MOUSE BRCA1-associated protein OS=Mus musculus OX=10090 GN=Brap PE=1 SV=1,GO:0000151; GO:0000165; GO:0003676; GO:0005654; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630,MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151],identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_04281,0.2098462644902899,OG_04281,FUN_017843-T1,Peve_00018632,Pocillopora_meandrina_HIv1___RNAseq.g9587.t3,three_way,50.5255,,,,,,,,,,,,,,,,,
OG_06275,0.2098252412215193,OG_06275,FUN_028312-T1,Peve_00025176,Pocillopora_meandrina_HIv1___RNAseq.g16422.t1,three_way,50.10016666666667,FUN_028312-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),47.0,304.0,1.7e-73,279.3,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_04491,0.2098234044086916,OG_04491,FUN_021922-T1,Peve_00016338,Pocillopora_meandrina_HIv1___RNAseq.g2917.t1,three_way,68.88416666666666,,,,,,,,,,,,,,,,,
OG_07150,0.2098047767051287,OG_07150,FUN_032503-T1,Peve_00042404,Pocillopora_meandrina_HIv1___TS.g12263.t1,three_way,58.67733333333334,FUN_032503-T1,Q20191,,,,,47.1,204.0,5.400000000000001e-44,181.0,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_03987,0.2097722447496931,OG_03987,FUN_016152-T1,Peve_00022569,Pocillopora_meandrina_HIv1___RNAseq.g21229.t1,three_way,62.593833333333336,FUN_016152-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),47.1,425.0,5.6e-104,380.9,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03891,0.2096536015855325,OG_03891,FUN_015445-T1,Peve_00013658,Pocillopora_meandrina_HIv1___TS.g26948.t2,three_way,62.11333333333334,FUN_015445-T1,O75140,DEPD5_HUMAN,,GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5),Homo sapiens (Human),33.7,1699.0,4.9e-238,826.6,sp|O75140|DEPD5_HUMAN GATOR1 complex protein DEPDC5 OS=Homo sapiens OX=9606 GN=DEPDC5 PE=1 SV=2,GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0031267; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130,cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508],cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267],GO:0005764; GO:0005773; GO:0005829; GO:0043226; GO:0098772,lysosome; vacuole; cytosol; organelle; molecular function regulator activity
OG_00092,0.2096319055365541,OG_00092,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),34.1,695.0,4.9e-100,368.2,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00092,0.2096319055365541,OG_00092,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),47.9,71.0,4.6e-13,79.3,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_03230,0.2096246853152625,OG_03230,FUN_012772-T1,Peve_00007600,Pocillopora_meandrina_HIv1___RNAseq.g13653.t1,three_way,86.02266666666667,FUN_012772-T1,Q9DFQ7,,,,,76.6,111.0,5.199999999999999e-43,175.6,sp|Q9DFQ7|RL24_GILMI Large ribosomal subunit protein eL24 OS=Gillichthys mirabilis OX=8222 GN=rpl24 PE=2 SV=2,,,,,,
OG_06417,0.2096218394760523,OG_06417,FUN_029104-T1,Peve_00038072,Pocillopora_meandrina_HIv1___TS.g8929.t1,three_way,65.834,FUN_029104-T1,P41970,ELK3_HUMAN,,ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2),Homo sapiens (Human),60.0,85.0,1.5000000000000002e-22,107.8,sp|P41970|ELK3_HUMAN ETS domain-containing protein Elk-3 OS=Homo sapiens OX=9606 GN=ELK3 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060],chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0030154; GO:0042060; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; cell differentiation; wound healing; organelle; transcription regulator activity
OG_06393,0.2095865207943607,OG_06393,FUN_029041-T1,Peve_00026017,Pocillopora_meandrina_HIv1___RNAseq.g20768.t1,three_way,78.406,,,,,,,,,,,,,,,,,
OG_02175,0.2095580008493252,OG_02175,FUN_008524-T1,Peve_00027673,Pocillopora_meandrina_HIv1___RNAseq.g14752.t1,three_way,75.38833333333334,FUN_008524-T1,Q4R6K2,ZNT1_MACFA,,Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),39.8,462.0,2.9e-73,277.3,sp|Q4R6K2|ZNT1_MACFA Proton-coupled zinc antiporter SLC30A1 OS=Macaca fascicularis OX=9541 GN=SLC30A1 PE=2 SV=1,GO:0000139; GO:0005789; GO:0005886; GO:0006882; GO:0010312; GO:0016323; GO:0019855; GO:0030659; GO:0031965; GO:0042742; GO:0046872; GO:0062111; GO:0140826; GO:0140882,defense response to bacterium [GO:0042742]; detoxification of zinc ion [GO:0010312]; intracellular zinc ion homeostasis [GO:0006882]; zinc export across plasma membrane [GO:0140882]; zinc ion import into organelle [GO:0062111],basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],calcium channel inhibitor activity [GO:0019855]; metal ion binding [GO:0046872]; zinc:proton antiporter activity [GO:0140826],GO:0005215; GO:0005886; GO:0055085; GO:0098754; GO:0098772,transporter activity; plasma membrane; transmembrane transport; detoxification; molecular function regulator activity
OG_01520,0.2095434770497109,OG_01520,FUN_006266-T1,Peve_00019724,Pocillopora_meandrina_HIv1___RNAseq.g20372.t1,three_way,75.93266666666666,,,,,,,,,,,,,,,,,
OG_06722,0.2094738521074061,OG_06722,FUN_031477-T1,Peve_00026545,Pocillopora_meandrina_HIv1___RNAseq.g5079.t1,three_way,55.821,FUN_031477-T1,Q5FYA8,ARSH_HUMAN,,Arylsulfatase H (ASH) (EC 3.1.6.-),Homo sapiens (Human),29.7,536.0,5.5e-48,193.7,sp|Q5FYA8|ARSH_HUMAN Arylsulfatase H OS=Homo sapiens OX=9606 GN=ARSH PE=2 SV=1,GO:0004065; GO:0005788; GO:0016020; GO:0046872,,endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872],GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_08054,0.209467336895676,OG_08054,FUN_035749-T1,Peve_00016720,Pocillopora_meandrina_HIv1___RNAseq.g11875.t1,three_way,66.67133333333334,,,,,,,,,,,,,,,,,
OG_00040,0.2094476523479709,OG_00040,FUN_000263-T1,Peve_00027785,Pocillopora_meandrina_HIv1___RNAseq.g28977.t2,three_way,82.65166666666667,FUN_000263-T1,Q5ZLW3,,,,,49.3,690.0,7.099999999999997e-175,615.5,sp|Q5ZLW3|DYM_CHICK Dymeclin OS=Gallus gallus OX=9031 GN=DYM PE=2 SV=1,,,,,,
OG_01114,0.2094170561330434,OG_01114,FUN_004657-T1,Peve_00035095,Pocillopora_meandrina_HIv1___RNAseq.g8740.t1,three_way,89.96,FUN_004657-T1,P21575,,,,,67.2,589.0,7.3e-232,804.7,sp|P21575|DYN1_RAT Dynamin-1 OS=Rattus norvegicus OX=10116 GN=Dnm1 PE=1 SV=2,,,,,,
OG_09413,0.2094052376223231,OG_09413,FUN_040950-T1,Peve_00008820,Pocillopora_meandrina_HIv1___RNAseq.g27113.t1,three_way,67.32266666666666,FUN_040950-T1,Q969X6,UTP4_HUMAN,,U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component),Homo sapiens (Human),32.1,701.0,1.7e-102,375.2,sp|Q969X6|UTP4_HUMAN U3 small nucleolar RNA-associated protein 4 homolog OS=Homo sapiens OX=9606 GN=UTP4 PE=1 SV=1,GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0030490; GO:0030686; GO:0032040; GO:0034455; GO:0042274,"maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of DNA-templated transcription [GO:0006355]; ribosomal small subunit biogenesis [GO:0042274]",90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0043226,RNA binding; nucleoplasm; chromosome; nucleolus; regulation of DNA-templated transcription; organelle
OG_01505,0.2093242159399241,OG_01505,FUN_006237-T1,Peve_00030695,Pocillopora_meandrina_HIv1___RNAseq.g20447.t1,three_way,90.30166666666666,FUN_006237-T1,Q9GP16,,,,,72.4,123.0,3.5e-48,192.2,sp|Q9GP16|RL31_HELVI Large ribosomal subunit protein eL31 OS=Heliothis virescens OX=7102 GN=RpL31 PE=2 SV=1,,,,,,
OG_00118,0.2092892944376821,OG_00118,FUN_000536-T1,Peve_00039803,Pocillopora_meandrina_HIv1___TS.g4882.t1,three_way,81.95033333333333,FUN_000536-T1,Q921G8,,,,,55.2,944.0,5.600000000000001e-277,955.3,sp|Q921G8|GCP2_MOUSE Gamma-tubulin complex component 2 OS=Mus musculus OX=10090 GN=Tubgcp2 PE=1 SV=2,,,,,,
OG_02638,0.209272398124573,OG_02638,FUN_010805-T1,Peve_00006505,Pocillopora_meandrina_HIv1___RNAseq.g26670.t1,three_way,61.43866666666667,FUN_010805-T1,P31228,OXDD_BOVIN,,D-aspartate oxidase (DASOX) (DASPO) (DDO) (EC 1.4.3.1),Bos taurus (Bovine),26.8,406.0,3.799999999999999e-24,114.0,sp|P31228|OXDD_BOVIN D-aspartate oxidase OS=Bos taurus OX=9913 GN=DDO PE=1 SV=3,GO:0005737; GO:0005782; GO:0005829; GO:0008445; GO:0019478; GO:0047821; GO:0050877; GO:0071949,D-amino acid catabolic process [GO:0019478]; nervous system process [GO:0050877],cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782],D-aspartate oxidase activity [GO:0008445]; D-glutamate oxidase activity [GO:0047821]; FAD binding [GO:0071949],GO:0003824; GO:0005829; GO:0006520; GO:0016491; GO:0050877,catalytic activity; cytosol; amino acid metabolic process; oxidoreductase activity; nervous system process
OG_08455,0.2092593674133851,OG_08455,FUN_037222-T1,Peve_00044308,Pocillopora_meandrina_HIv1___RNAseq.g11043.t1,three_way,83.7925,FUN_037222-T1,Q3B8G4,,,,,49.3,284.0,8.2e-66,252.3,sp|Q3B8G4|YIPF3_XENLA Protein YIPF3 OS=Xenopus laevis OX=8355 GN=yipf3 PE=2 SV=1,,,,,,
OG_08647,0.2091521716643736,OG_08647,FUN_037838-T1,Peve_00000575,Pocillopora_meandrina_HIv1___TS.g22869.t1,three_way,95.46833333333332,FUN_037838-T1,P62265,,,,,88.2,152.0,1.3e-68,260.4,sp|P62265|RS14_CRIGR Small ribosomal subunit protein uS11 OS=Cricetulus griseus OX=10029 GN=RPS14 PE=2 SV=3,,,,,,
OG_10105,0.2091333701961727,OG_10105,FUN_043447-T1,Peve_00015294,Pocillopora_meandrina_HIv1___RNAseq.g7900.t1,three_way,62.12,FUN_043447-T1,Q9Z148,EHMT2_MOUSE,,Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a),Mus musculus (Mouse),35.3,538.0,2.6e-88,328.6,sp|Q9Z148|EHMT2_MOUSE Histone-lysine N-methyltransferase EHMT2 OS=Mus musculus OX=10090 GN=Ehmt2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006346; GO:0006357; GO:0007130; GO:0007286; GO:0008270; GO:0009267; GO:0009566; GO:0016279; GO:0016607; GO:0018027; GO:0035265; GO:0036166; GO:0044027; GO:0046974; GO:0046976; GO:0048148; GO:0048599; GO:0048665; GO:0070742; GO:0071314; GO:0140759; GO:0140947; GO:1902902; GO:1990841,behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130],chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],C2H2 zinc finger domain binding [GO:0070742]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K56 methyltransferase activity [GO:0140759]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9me2 methyltransferase activity [GO:0140947]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07488,0.209112575362565,OG_07488,FUN_034015-T1,Peve_00007012,Pocillopora_meandrina_HIv1___RNAseq.g26080.t1,three_way,77.31,FUN_034015-T1,A5PK16,CCNF_BOVIN,,Cyclin-F,Bos taurus (Bovine),40.1,619.0,3.5e-119,430.6,sp|A5PK16|CCNF_BOVIN Cyclin-F OS=Bos taurus OX=9913 GN=CCNF PE=2 SV=1,GO:0000082; GO:0000307; GO:0005634; GO:0005737; GO:0005814; GO:0005815; GO:0010826; GO:0016538; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0051301; GO:0051726,cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of centrosome duplication [GO:0010826]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],centriole [GO:0005814]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538],GO:0005634; GO:0005815; GO:0030163; GO:0043226; GO:0098772,nucleus; microtubule organizing center; protein catabolic process; organelle; molecular function regulator activity
OG_08397,0.2090980143514615,OG_08397,FUN_037044-T1,Peve_00032333,Pocillopora_meandrina_HIv1___RNAseq.9744_t,three_way,73.64533333333333,FUN_037044-T1,X6R8R1,ST15B_HUMAN,,Synaptotagmin-15B,Homo sapiens (Human),37.5,301.0,1.5999999999999998e-49,198.0,sp|X6R8R1|ST15B_HUMAN Synaptotagmin-15B OS=Homo sapiens OX=9606 GN=SYT15B PE=3 SV=1,GO:0000149; GO:0005544; GO:0005886; GO:0016192; GO:0017158; GO:0061891; GO:0070382,regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886],calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149],GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_01712,0.2090419044782647,OG_01712,FUN_006986-T1,Peve_00009622,Pocillopora_meandrina_HIv1___RNAseq.g20224.t1,three_way,77.79516666666666,FUN_006986-T1,O60841,IF2P_HUMAN,,Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2),Homo sapiens (Human),72.7,593.0,6e-261,902.5,sp|O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=4,GO:0000049; GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0042255; GO:0045202; GO:0046872,regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0016787,RNA binding; catalytic activity; GTPase activity; cytosol; hydrolase activity
OG_06435,0.2090331938144083,OG_06435,FUN_029129-T1,Peve_00004668,Pocillopora_meandrina_HIv1___TS.g9227.t1,three_way,79.41,,,,,,,,,,,,,,,,,
OG_05212,0.2088871320559344,OG_05212,FUN_023619-T1,Peve_00018316,Pocillopora_meandrina_HIv1___RNAseq.g3522.t2,three_way,51.43366666666667,,,,,,,,,,,,,,,,,
OG_01986,0.2088679424831703,OG_01986,FUN_008094-T1,Peve_00039003,Pocillopora_meandrina_HIv1___RNAseq.g30132.t1,three_way,76.141,FUN_008094-T1,Q8BJ37,TYDP1_MOUSE,,Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) (Protein expressed in male leptotene and zygotene spermatocytes 501) (MLZ-501),Mus musculus (Mouse),52.5,451.0,4e-133,476.5,sp|Q8BJ37|TYDP1_MOUSE Tyrosyl-DNA phosphodiesterase 1 OS=Mus musculus OX=10090 GN=Tdp1 PE=1 SV=2,GO:0000012; GO:0004527; GO:0005634; GO:0006281; GO:0017005,DNA repair [GO:0006281]; single strand break repair [GO:0000012],nucleus [GO:0005634],3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; exonuclease activity [GO:0004527],GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"catalytic activity; nucleus; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_08262,0.2088398668525068,OG_08262,FUN_036174-T1,Peve_00027212,Pocillopora_meandrina_HIv1___RNAseq.g27507.t1,three_way,77.46166666666666,FUN_036174-T1,Q5ZKI0,KCC2D_CHICK,,Calcium/calmodulin-dependent protein kinase type II delta chain (CaM kinase II subunit delta) (CaM-kinase II delta chain) (CaMK-II subunit delta) (EC 2.7.11.17),Gallus gallus (Chicken),42.4,377.0,2.1000000000000002e-73,277.7,sp|Q5ZKI0|KCC2D_CHICK Calcium/calmodulin-dependent protein kinase type II delta chain OS=Gallus gallus OX=9031 GN=CAMK2D PE=2 SV=1,GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0014069; GO:0043005; GO:0048168; GO:0106310; GO:1903076,regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein localization to plasma membrane [GO:1903076],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09375,0.2087519565929956,OG_09375,FUN_040550-T1,Peve_00015404,Pocillopora_meandrina_HIv1___RNAseq.g6474.t1,three_way,68.12883333333333,FUN_040550-T1,A7RSH7,,,,,47.5,139.0,4.399999999999999e-24,113.2,sp|A7RSH7|EIF3J_NEMVE Eukaryotic translation initiation factor 3 subunit J OS=Nematostella vectensis OX=45351 GN=v1g240395 PE=3 SV=1,,,,,,
OG_01065,0.2086926574902395,OG_01065,FUN_004525-T1,Peve_00003214,Pocillopora_meandrina_HIv1___RNAseq.g11634.t1,three_way,83.67433333333334,FUN_004525-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),49.4,857.0,3.6999999999999996e-242,839.3,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00015,0.2085644138646675,OG_00015,FUN_000208-T1,Peve_00027726,Pocillopora_meandrina_HIv1___RNAseq.g28911.t2,three_way,63.83766666666666,FUN_000208-T1,Q6NXR4,TTI2_HUMAN,,TELO2-interacting protein 2,Homo sapiens (Human),42.4,184.0,9.700000000000001e-34,144.8,sp|Q6NXR4|TTI2_HUMAN TELO2-interacting protein 2 OS=Homo sapiens OX=9606 GN=TTI2 PE=1 SV=1,GO:0005634; GO:0050821; GO:0110078; GO:2000003,positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821],nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078],,GO:0005634; GO:0043226,nucleus; organelle
OG_09558,0.2085321852951659,OG_09558,FUN_041662-T1,Peve_00033099,Pocillopora_meandrina_HIv1___RNAseq.g14009.t1,three_way,75.99116666666667,FUN_041662-T1,Q9P2U8,VGLU2_HUMAN,,Vesicular glutamate transporter 2 (VGluT2) (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6),Homo sapiens (Human),46.6,453.0,8e-115,415.6,sp|Q9P2U8|VGLU2_HUMAN Vesicular glutamate transporter 2 OS=Homo sapiens OX=9606 GN=SLC17A6 PE=1 SV=1,GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0006811; GO:0006817; GO:0015386; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0051938; GO:0055062; GO:0060076; GO:0098700; GO:0140788; GO:1990384,"hyaloid vascular plexus regression [GO:1990384]; L-glutamate import [GO:0051938]; monoatomic ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]",chloride channel complex [GO:0034707]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamate uniporter activity [GO:0140788]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0005886; GO:0023052,transporter activity; plasma membrane; signaling
OG_08953,0.2085016955842839,OG_08953,FUN_038427-T1,Peve_00000113,Pocillopora_meandrina_HIv1___RNAseq.g1177.t1,three_way,70.89833333333333,FUN_038427-T1,Q86XK2,FBX11_HUMAN,,F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1),Homo sapiens (Human),41.5,82.0,9.1e-08,59.3,sp|Q86XK2|FBX11_HUMAN F-box only protein 11 OS=Homo sapiens OX=9606 GN=FBXO11 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0036211; GO:0042981; GO:0043161; GO:1990756,negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0050877; GO:0060090; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; transferase activity; protein catabolic process; organelle; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_02758,0.2083804469390419,OG_02758,FUN_011695-T1,Peve_00027020,Pocillopora_meandrina_HIv1___RNAseq.g23905.t1,three_way,90.05033333333333,FUN_011695-T1,Q6EE31,TCPQ_CHICK,,T-complex protein 1 subunit theta (TCP-1-theta) (EC 3.6.1.-) (CCT-theta),Gallus gallus (Chicken),68.4,545.0,5.500000000000003e-218,758.4,sp|Q6EE31|TCPQ_CHICK T-complex protein 1 subunit theta OS=Gallus gallus OX=9031 GN=CCT8 PE=1 SV=3,GO:0005524; GO:0005813; GO:0005832; GO:0006457; GO:0016887; GO:0042995; GO:0051082; GO:0140662,protein folding [GO:0006457],cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082],GO:0003824; GO:0005815; GO:0006457; GO:0016787; GO:0044183; GO:0140657,catalytic activity; microtubule organizing center; protein folding; hydrolase activity; protein folding chaperone; ATP-dependent activity
OG_03341,0.2083565817228514,OG_03341,FUN_013571-T1,Peve_00018157,Pocillopora_meandrina_HIv1___RNAseq.g13477.t1,three_way,64.70566666666667,,,,,,,,,,,,,,,,,
OG_06325,0.2083555072785443,OG_06325,FUN_028843-T1,Peve_00024571,Pocillopora_meandrina_HIv1___RNAseq.g20712.t1,three_way,79.26683333333334,FUN_028843-T1,Q32M08,DUS4L_MOUSE,,tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like (EC 1.3.1.90) (tRNA-dihydrouridine synthase 4-like),Mus musculus (Mouse),60.2,299.0,5e-110,399.1,sp|Q32M08|DUS4L_MOUSE tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like OS=Mus musculus OX=10090 GN=Dus4l PE=2 SV=1,GO:0002943; GO:0050660; GO:0102266; GO:0102267,tRNA dihydrouridine synthesis [GO:0002943],,flavin adenine dinucleotide binding [GO:0050660]; tRNA-dihydrouridine20a synthase activity [GO:0102266]; tRNA-dihydrouridine20b synthase activity [GO:0102267],GO:0003824; GO:0006399; GO:0016491; GO:0140098,"catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA"
OG_09811,0.2083201927758606,OG_09811,FUN_042633-T1,Peve_00030033,Pocillopora_meandrina_HIv1___RNAseq.19516_t,three_way,82.042,FUN_042633-T1,P08651,NFIC_HUMAN,,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),Homo sapiens (Human),48.2,390.0,3.2e-79,297.7,sp|P08651|NFIC_HUMAN Nuclear factor 1 C-type OS=Homo sapiens OX=9606 GN=NFIC PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006357; GO:0006366; GO:0042475; GO:0045944; GO:1990837,DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA replication; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_00453,0.2083185813825782,OG_00453,FUN_001377-T1,Peve_00021886,Pocillopora_meandrina_HIv1___RNAseq.g2136.t1,three_way,56.78516666666667,,,,,,,,,,,,,,,,,
OG_08450,0.2082709895755882,OG_08450,FUN_037214-T1,Peve_00012947,Pocillopora_meandrina_HIv1___RNAseq.g11059.t1,three_way,90.98433333333334,,,,,,,,,,,,,,,,,
OG_09182,0.208226268119077,OG_09182,FUN_039862-T1,Peve_00020823,Pocillopora_meandrina_HIv1___RNAseq.g7281.t1,three_way,61.18333333333333,FUN_039862-T1,Q8IYT2,CMTR2_HUMAN,,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (HMTr2) (MTr2) (FtsJ methyltransferase domain-containing protein 1) (Protein adrift homolog),Homo sapiens (Human),32.7,822.0,5.5e-100,367.1,sp|Q8IYT2|CMTR2_HUMAN Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 OS=Homo sapiens OX=9606 GN=CMTR2 PE=1 SV=2,GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0032259,7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483],GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_03245,0.2081585756223181,OG_03245,FUN_012880-T1,Peve_00029266,Pocillopora_meandrina_HIv1___RNAseq.g12951.t1,three_way,80.52533333333334,,,,,,,,,,,,,,,,,
OG_10086,0.2081583175108508,OG_10086,FUN_043412-T1,Peve_00045006,Pocillopora_meandrina_HIv1___RNAseq.g7824.t1,three_way,79.78466666666667,FUN_043412-T1,P54319,,,,,54.9,814.0,2.5999999999999996e-171,604.0,sp|P54319|PLAP_RAT Phospholipase A-2-activating protein OS=Rattus norvegicus OX=10116 GN=Plaa PE=1 SV=3,,,,,,
OG_02303,0.208149431136899,OG_02303,FUN_008882-T1,Peve_00032041,Pocillopora_meandrina_HIv1___RNAseq.g14468.t1,three_way,62.712,FUN_008882-T1,Q32KN7,,,,,41.7,192.0,3.3e-26,120.9,sp|Q32KN7|ZC21B_BOVIN Zinc finger C2HC domain-containing protein 1B OS=Bos taurus OX=9913 GN=ZC2HC1B PE=2 SV=1,,,,,,
OG_02109,0.208079051933867,OG_02109,FUN_008394-T1,Peve_00043609,Pocillopora_meandrina_HIv1___RNAseq.g6176.t1,three_way,97.93,FUN_008394-T1,Q6IP65,,,,,87.8,287.0,1e-141,504.2,sp|Q6IP65|CNOT9_XENLA CCR4-NOT transcription complex subunit 9 OS=Xenopus laevis OX=8355 GN=cnot9 PE=2 SV=1,,,,,,
OG_01221,0.2080394466422774,OG_01221,FUN_004903-T1,Peve_00028646,Pocillopora_meandrina_HIv1___RNAseq.g8331.t1,three_way,93.306,FUN_004903-T1,A5PK63,,,,,79.9,134.0,9.9e-55,214.2,sp|A5PK63|RS17_BOVIN Small ribosomal subunit protein eS17 OS=Bos taurus OX=9913 GN=RPS17 PE=2 SV=1,,,,,,
OG_09850,0.207994854358059,OG_09850,FUN_042841-T1,Peve_00007267,Pocillopora_meandrina_HIv1___RNAseq.g7258.t1,three_way,84.73333333333333,FUN_042841-T1,Q2TBQ5,RL7A_BOVIN,,Large ribosomal subunit protein eL8 (60S ribosomal protein L7a),Bos taurus (Bovine),63.1,263.0,3.5e-85,316.2,sp|Q2TBQ5|RL7A_BOVIN Large ribosomal subunit protein eL8 OS=Bos taurus OX=9913 GN=RPL7A PE=2 SV=3,GO:0000470; GO:0003723; GO:0003735; GO:0005730; GO:0016020; GO:0022625; GO:0045202,maturation of LSU-rRNA [GO:0000470],cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; synapse [GO:0045202],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_00651,0.2079655349171211,OG_00651,FUN_001908-T1,Peve_00024474,Pocillopora_meandrina_HIv1___RNAseq.g2562.t1,three_way,77.906,FUN_001908-T1,Q3T108,,,,,59.8,194.0,2.7e-67,256.5,sp|Q3T108|PSB4_BOVIN Proteasome subunit beta type-4 OS=Bos taurus OX=9913 GN=PSMB4 PE=1 SV=1,,,,,,
OG_07490,0.2079531139270127,OG_07490,FUN_034017-T1,Peve_00007018,Pocillopora_meandrina_HIv1___RNAseq.g26077.t1,three_way,88.351,FUN_034017-T1,Q0VCN3,IFT27_BOVIN,,Intraflagellar transport protein 27 homolog (IFT27) (Putative GTP-binding protein RAY-like) (Rab-like protein 4),Bos taurus (Bovine),53.0,185.0,8.5e-54,211.5,sp|Q0VCN3|IFT27_BOVIN Intraflagellar transport protein 27 homolog OS=Bos taurus OX=9913 GN=IFT27 PE=2 SV=1,GO:0000139; GO:0001822; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005929; GO:0006886; GO:0007224; GO:0007283; GO:0016192; GO:0030154; GO:0030992; GO:0036126; GO:0042073,cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192],cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intraciliary transport particle B [GO:0030992]; sperm flagellum [GO:0036126],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005794; GO:0005929; GO:0006886; GO:0007018; GO:0016192; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856,catalytic activity; GTPase activity; Golgi apparatus; cilium; intracellular protein transport; microtubule-based movement; vesicle-mediated transport; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development
OG_05738,0.2079346435545133,OG_05738,FUN_025665-T1,Peve_00042167,Pocillopora_meandrina_HIv1___TS.g15949.t1,three_way,38.97733333333333,,,,,,,,,,,,,,,,,
OG_02903,0.2078700825805242,OG_02903,FUN_011973-T1,Peve_00001000,Pocillopora_meandrina_HIv1___RNAseq.g23724.t1,three_way,61.82216666666667,FUN_011973-T1,Q54G43,SHKE_DICDI,,Dual specificity protein kinase shkE (EC 2.7.11.1) (SH2 domain-containing protein 5) (SH2 domain-containing protein E),Dictyostelium discoideum (Social amoeba),31.5,251.0,1.8e-23,113.2,sp|Q54G43|SHKE_DICDI Dual specificity protein kinase shkE OS=Dictyostelium discoideum OX=44689 GN=shkE PE=3 SV=1,GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0106310,signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_07863,0.2078232865112325,OG_07863,FUN_035220-T1,Peve_00035885,Pocillopora_meandrina_HIv1___RNAseq.g27612.t1,three_way,83.25133333333333,FUN_035220-T1,D3YXS5,,,,,37.8,932.0,1.3e-153,545.4,sp|D3YXS5|KIF28_MOUSE Kinesin-like protein KIF28 OS=Mus musculus OX=10090 GN=Kif28 PE=3 SV=1,,,,,,
OG_00418,0.2078053483298517,OG_00418,FUN_001323-T1,Peve_00036961,Pocillopora_meandrina_HIv1___RNAseq.g2265.t1,three_way,51.98283333333333,,,,,,,,,,,,,,,,,
OG_00385,0.2077955210862739,OG_00385,FUN_001237-T1,Peve_00002841,Pocillopora_meandrina_HIv1___RNAseq.g2514.t1,three_way,72.78383333333333,,,,,,,,,,,,,,,,,
OG_09001,0.2077874242762709,OG_09001,FUN_038545-T1,Peve_00037480,Pocillopora_meandrina_HIv1___RNAseq.g1038.t1,three_way,81.75566666666667,FUN_038545-T1,Q28J44,,,,,62.9,342.0,1e-89,331.6,sp|Q28J44|S39AB_XENTR Zinc transporter ZIP11 OS=Xenopus tropicalis OX=8364 GN=slc39a11 PE=2 SV=1,,,,,,
OG_02764,0.2077745638885128,OG_02764,FUN_011702-T1,Peve_00025136,Pocillopora_meandrina_HIv1___RNAseq.g23824.t1,three_way,84.61633333333333,FUN_011702-T1,P59235,,,,,43.8,379.0,2.3e-90,334.0,sp|P59235|NUP43_MOUSE Nucleoporin Nup43 OS=Mus musculus OX=10090 GN=Nup43 PE=1 SV=2,,,,,,
OG_00198,0.207765317145992,OG_00198,FUN_000910-T1,Peve_00010061,Pocillopora_meandrina_HIv1___RNAseq.g29492.t1,three_way,79.57216666666666,FUN_000910-T1,P21521,,,,,57.7,317.0,9.1e-107,388.7,sp|P21521|SY65_DROME Synaptotagmin 1 OS=Drosophila melanogaster OX=7227 GN=Syt1 PE=1 SV=3,,,,,,
OG_01615,0.2077101184716467,OG_01615,FUN_006706-T1,Peve_00022745,Pocillopora_meandrina_HIv1___RNAseq.g19996.t1,three_way,57.7245,FUN_006706-T1,Q8VE88,,,,,36.3,411.0,8e-51,203.4,sp|Q8VE88|F1142_MOUSE Protein FAM114A2 OS=Mus musculus OX=10090 GN=Fam114a2 PE=1 SV=2,,,,,,
OG_05733,0.2076941934407514,OG_05733,FUN_025659-T1,Peve_00042174,Pocillopora_meandrina_HIv1___RNAseq.g23073.t1,three_way,72.82333333333334,,,,,,,,,,,,,,,,,
OG_03309,0.2076933221598094,OG_03309,FUN_013385-T1,Peve_00015992,Pocillopora_meandrina_HIv1___RNAseq.g22980.t2,three_way,65.83083333333333,FUN_013385-T1,Q24180,DEAF1_DROME,,Deformed epidermal autoregulatory factor 1 (Protein DEAF-1),Drosophila melanogaster (Fruit fly),45.2,84.0,2.6e-16,87.8,sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1,GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776,embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]; polytene chromosome [GO:0005700],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005694; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; chromosome; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_07128,0.2076618637289834,OG_07128,FUN_032428-T1,Peve_00007849,Pocillopora_meandrina_HIv1___RNAseq.g24119.t1,three_way,84.269,FUN_032428-T1,P14148,RL7_MOUSE,,Large ribosomal subunit protein uL30 (60S ribosomal protein L7),Mus musculus (Mouse),78.3,180.0,4.8e-79,295.8,sp|P14148|RL7_MOUSE Large ribosomal subunit protein uL30 OS=Mus musculus OX=10090 GN=Rpl7 PE=1 SV=2,GO:0000463; GO:0002181; GO:0003677; GO:0003729; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0022625; GO:0042802; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242; GO:1990904,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202],DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003677; GO:0003723; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; DNA binding; RNA binding; structural molecule activity; cytosol; ribosome; organelle
OG_02648,0.2076552817871993,OG_02648,FUN_010830-T1,Peve_00017535,Pocillopora_meandrina_HIv1___RNAseq.g20913.t1,three_way,81.01133333333334,FUN_010830-T1,Q9NXB0,MKS1_HUMAN,,Tectonic-like complex member MKS1 (Meckel syndrome type 1 protein),Homo sapiens (Human),42.4,557.0,5.1e-126,453.0,sp|Q9NXB0|MKS1_HUMAN Tectonic-like complex member MKS1 OS=Homo sapiens OX=9606 GN=MKS1 PE=1 SV=2,GO:0001843; GO:0003271; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0008589; GO:0010669; GO:0016020; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1905515; GO:1990403; GO:2000095,"branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway [GO:0008589]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]",centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005730; GO:0005815; GO:0005829; GO:0043226; GO:0044782; GO:0048856,nucleoplasm; nucleolus; microtubule organizing center; cytosol; organelle; cilium organization; anatomical structure development
OG_08929,0.2075113476273919,OG_08929,FUN_038387-T1,Peve_00000060,Pocillopora_meandrina_HIv1___RNAseq.g28287.t1,three_way,63.87316666666666,FUN_038387-T1,P55202,,,,,36.6,940.0,3e-137,491.1,sp|P55202|ANPRB_ANGJA Atrial natriuretic peptide receptor 2 OS=Anguilla japonica OX=7937 GN=npr2 PE=2 SV=1,,,,,,
OG_00692,0.2074761875558561,OG_00692,FUN_002379-T1,Peve_00034020,Pocillopora_meandrina_HIv1___RNAseq.g20.t2,three_way,83.75166666666667,FUN_002379-T1,Q00537,CDK17_HUMAN,,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),Homo sapiens (Human),57.9,525.0,3.6e-160,566.2,sp|Q00537|CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens OX=9606 GN=CDK17 PE=1 SV=2,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310; GO:1901987,protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02814,0.2074605170171478,OG_02814,FUN_011801-T1,Peve_00017066,Pocillopora_meandrina_HIv1___RNAseq.g23253.t1,three_way,85.05433333333333,FUN_011801-T1,Q80W54,FACE1_MOUSE,,CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog),Mus musculus (Mouse),59.5,477.0,6.3e-154,545.4,sp|Q80W54|FACE1_MOUSE CAAX prenyl protease 1 homolog OS=Mus musculus OX=10090 GN=Zmpste24 PE=1 SV=2,GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004175; GO:0004222; GO:0005635; GO:0005637; GO:0005789; GO:0006281; GO:0006325; GO:0006355; GO:0006629; GO:0006925; GO:0006974; GO:0006997; GO:0006998; GO:0007346; GO:0007628; GO:0008016; GO:0008340; GO:0008360; GO:0008544; GO:0010506; GO:0010628; GO:0010629; GO:0010906; GO:0016020; GO:0016485; GO:0019216; GO:0030282; GO:0030327; GO:0030500; GO:0031901; GO:0031902; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0040029; GO:0043007; GO:0043516; GO:0044029; GO:0046872; GO:0048145; GO:0048538; GO:0050688; GO:0050905; GO:0051276; GO:0051604; GO:0055013; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903463; GO:1903522; GO:1903799; GO:1990036; GO:2000730; GO:2000772,"adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle cell development [GO:0055013]; cardiac ventricle development [GO:0003231]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; epigenetic regulation of gene expression [GO:0040029]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA processing [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; prenylated protein catabolic process [GO:0030327]; protein maturation [GO:0051604]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of DNA-templated transcription [GO:0006355]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]",early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991],double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003677; GO:0003824; GO:0005635; GO:0006281; GO:0006325; GO:0006355; GO:0006629; GO:0012501; GO:0016787; GO:0048856; GO:0050877; GO:0051604; GO:0061024; GO:0140096,"DNA binding; catalytic activity; nuclear envelope; DNA repair; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; programmed cell death; hydrolase activity; anatomical structure development; nervous system process; protein maturation; membrane organization; catalytic activity, acting on a protein"
OG_09520,0.2074368583513227,OG_09520,FUN_041580-T1,Peve_00028462,Pocillopora_meandrina_HIv1___RNAseq.g15925.t1,three_way,85.135,FUN_041580-T1,Q2KIN5,,,,,57.0,279.0,6.7e-82,305.4,sp|Q2KIN5|HEM3_BOVIN Porphobilinogen deaminase OS=Bos taurus OX=9913 GN=HMBS PE=2 SV=1,,,,,,
OG_04734,0.2073952697122799,OG_04734,FUN_022603-T1,Peve_00012244,Pocillopora_meandrina_HIv1___RNAseq.g4420.t1,three_way,66.55866666666667,FUN_022603-T1,C0QT62,,,,,37.2,261.0,1.1e-32,142.1,sp|C0QT62|Y079_PERMH Probable transcriptional regulatory protein PERMA_0079 OS=Persephonella marina (strain DSM 14350 / EX-H1) OX=123214 GN=PERMA_0079 PE=3 SV=1,,,,,,
OG_09835,0.2073485774734028,OG_09835,FUN_042814-T1,Peve_00021878,Pocillopora_meandrina_HIv1___RNAseq.g7429.t1,three_way,82.54266666666666,FUN_042814-T1,E9Q634,MYO1E_MOUSE,,Unconventional myosin-Ie (Unconventional myosin 1E),Mus musculus (Mouse),66.0,1113.0,0.0,1439.5,sp|E9Q634|MYO1E_MOUSE Unconventional myosin-Ie OS=Mus musculus OX=10090 GN=Myo1e PE=1 SV=1,GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005903; GO:0005912; GO:0006897; GO:0016459; GO:0016887; GO:0030097; GO:0032836; GO:0035091; GO:0035166; GO:0045334; GO:0048008; GO:0051015; GO:0072015,endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091],GO:0003014; GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856,renal system process; cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development
OG_02355,0.2073371938246013,OG_02355,FUN_008958-T1,Peve_00021624,Pocillopora_meandrina_HIv1___RNAseq.g4045.t1,three_way,88.27633333333334,FUN_008958-T1,P36241,,,,,80.5,77.0,5.2e-27,121.7,sp|P36241|RL19_DROME Large ribosomal subunit protein eL19 OS=Drosophila melanogaster OX=7227 GN=RpL19 PE=1 SV=2,,,,,,
OG_00571,0.2073359373787621,OG_00571,FUN_001630-T1,Peve_00009934,Pocillopora_meandrina_HIv1___RNAseq.g2163.t1,three_way,60.408,FUN_001630-T1,Q7KM13,,,,,40.7,167.0,8.1e-17,90.1,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_07435,0.2073260105187209,OG_07435,FUN_033924-T1,Peve_00022623,Pocillopora_meandrina_HIv1___RNAseq.g26586.t2,three_way,66.44966666666667,FUN_033924-T1,Q14444,CAPR1_HUMAN,,Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105),Homo sapiens (Human),38.3,180.0,4.2e-27,123.2,sp|Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2,GO:0000932; GO:0003723; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0007416; GO:0008298; GO:0010494; GO:0016020; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0035591; GO:0043232; GO:0045202; GO:0048699; GO:0050775; GO:0061003; GO:0062029; GO:0106288; GO:0140677; GO:0140693; GO:0140694,generation of neurons [GO:0048699]; intracellular mRNA localization [GO:0008298]; membraneless organelle assembly [GO:0140694]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of stress granule assembly [GO:0062029]; regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106288]; synapse assembly [GO:0007416],cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membraneless organelle [GO:0043232]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; synapse [GO:0045202],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling adaptor activity [GO:0035591],GO:0003723; GO:0005829; GO:0030154; GO:0034330; GO:0043226; GO:0060090; GO:0098772,RNA binding; cytosol; cell differentiation; cell junction organization; organelle; molecular adaptor activity; molecular function regulator activity
OG_10082,0.2072896858158999,OG_10082,FUN_043399-T1,Peve_00024256,Pocillopora_meandrina_HIv1___RNAseq.g9063.t2,three_way,80.929,FUN_043399-T1,Q9NVG8,,,,,60.4,356.0,4.2e-118,426.0,sp|Q9NVG8|TBC13_HUMAN TBC1 domain family member 13 OS=Homo sapiens OX=9606 GN=TBC1D13 PE=1 SV=3,,,,,,
OG_05797,0.2072452200450495,OG_05797,FUN_025780-T1,Peve_00009651,Pocillopora_meandrina_HIv1___RNAseq.g10358.t1,three_way,87.72200000000001,FUN_025780-T1,P18687,,,,,71.6,556.0,2.2e-220,766.5,"sp|P18687|CH60_CRIGR 60 kDa heat shock protein, mitochondrial OS=Cricetulus griseus OX=10029 GN=HSPD1 PE=2 SV=1",,,,,,
OG_01738,0.2072293882720782,OG_01738,FUN_007057-T1,Peve_00003777,Pocillopora_meandrina_HIv1___TS.g29459.t2,three_way,64.8275,FUN_007057-T1,Q8BX17,GEMI5_MOUSE,,Gem-associated protein 5 (Gemin5),Mus musculus (Mouse),39.4,1203.0,2.2e-212,741.5,sp|Q8BX17|GEMI5_MOUSE Gem-associated protein 5 OS=Mus musculus OX=10090 GN=Gemin5 PE=1 SV=2,GO:0000340; GO:0000387; GO:0003730; GO:0005829; GO:0006412; GO:0006417; GO:0017069; GO:0030619; GO:0030621; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0097504,regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412],cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719],mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621],GO:0003723; GO:0005829; GO:0043226; GO:0065003,RNA binding; cytosol; organelle; protein-containing complex assembly
OG_05483,0.2072184565335164,OG_05483,FUN_024480-T1,Peve_00024797,Pocillopora_meandrina_HIv1___RNAseq.g19065.t1,three_way,76.45266666666667,FUN_024480-T1,Q0DAE4,,,,,49.5,95.0,1.5e-18,93.6,sp|Q0DAE4|GRXC8_ORYSJ Glutaredoxin-C8 OS=Oryza sativa subsp. japonica OX=39947 GN=GRXC8 PE=2 SV=2,,,,,,
OG_04433,0.2071938953736739,OG_04433,FUN_018604-T1,Peve_00002871,Pocillopora_meandrina_HIv1___RNAseq.g9881.t1,three_way,76.601,FUN_018604-T1,Q7TN73,CASD1_MOUSE,,N-acetylneuraminate (7)9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (CAS1 protein) (Cas1p) (Sialate O-acetyltransferase) (SOAT),Mus musculus (Mouse),41.1,794.0,1.2e-163,578.6,sp|Q7TN73|CASD1_MOUSE N-acetylneuraminate (7)9-O-acetyltransferase OS=Mus musculus OX=10090 GN=Casd1 PE=2 SV=1,GO:0000139; GO:0005975; GO:0047186,carbohydrate metabolic process [GO:0005975],Golgi membrane [GO:0000139],N-acetylneuraminate 9-O-acetyltransferase activity [GO:0047186],GO:0003824; GO:0005975; GO:0016740,catalytic activity; carbohydrate metabolic process; transferase activity
OG_05774,0.2071658182204079,OG_05774,FUN_025737-T1,Peve_00008541,Pocillopora_meandrina_HIv1___RNAseq.g10429.t1,three_way,55.18066666666667,FUN_025737-T1,Q5T7P8,SYT6_HUMAN,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Homo sapiens (Human),33.6,125.0,8.9e-12,73.6,sp|Q5T7P8|SYT6_HUMAN Synaptotagmin-6 OS=Homo sapiens OX=9606 GN=SYT6 PE=1 SV=3,GO:0000149; GO:0005829; GO:0005886; GO:0007268; GO:0009898; GO:0016020; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0046872; GO:0060478; GO:0061891; GO:0070382; GO:0097038,acrosomal vesicle exocytosis [GO:0060478]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion sensor activity [GO:0061891]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005829; GO:0005886; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0098772; GO:0140299,cytosol; plasma membrane; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_05550,0.2071163794741626,OG_05550,FUN_024757-T1,Peve_00027332,Pocillopora_meandrina_HIv1___RNAseq.g18827.t1,three_way,63.693000000000005,FUN_024757-T1,Q5XIB4,UFSP2_RAT,,Ufm1-specific protease 2 (UfSP2) (EC 3.4.22.-),Rattus norvegicus (Rat),47.7,434.0,3.8e-106,387.1,sp|Q5XIB4|UFSP2_RAT Ufm1-specific protease 2 OS=Rattus norvegicus OX=10116 GN=Ufsp2 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005783; GO:0006508; GO:0032649; GO:0032790; GO:0033146; GO:0071567; GO:0072344; GO:1903051,negative regulation of proteolysis involved in protein catabolic process [GO:1903051]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of type II interferon production [GO:0032649]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],deUFMylase activity [GO:0071567],GO:0003824; GO:0005634; GO:0005783; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01195,0.2070695075091923,OG_01195,FUN_004853-T1,Peve_00043741,Pocillopora_meandrina_HIv1___RNAseq.g8638.t1,three_way,86.89533333333333,FUN_004853-T1,Q86X52,CHSS1_HUMAN,,Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1),Homo sapiens (Human),39.8,533.0,1.5e-102,374.8,sp|Q86X52|CHSS1_HUMAN Chondroitin sulfate synthase 1 OS=Homo sapiens OX=9606 GN=CHSY1 PE=1 SV=3,GO:0000139; GO:0002063; GO:0005576; GO:0009954; GO:0016020; GO:0030279; GO:0031667; GO:0032580; GO:0045880; GO:0046872; GO:0047238; GO:0050510; GO:0050650; GO:0051923; GO:0060349,bone morphogenesis [GO:0060349]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020],glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510],GO:0003824; GO:0005576; GO:0006790; GO:0009101; GO:0016740; GO:0048856; GO:1901135,catalytic activity; extracellular region; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_01477,0.2070305833037899,OG_01477,FUN_006040-T1,Peve_00040857,Pocillopora_meandrina_HIv1___RNAseq.g20517.t1,three_way,86.46933333333332,FUN_006040-T1,Q8BMJ2,SYLC_MOUSE,,"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)",Mus musculus (Mouse),62.8,1063.0,0.0,1428.3,"sp|Q8BMJ2|SYLC_MOUSE Leucine--tRNA ligase, cytoplasmic OS=Mus musculus OX=10090 GN=Lars1 PE=1 SV=2",GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005764; GO:0005783; GO:0005829; GO:0006425; GO:0006429; GO:0008361; GO:0016604; GO:0017101; GO:0071233; GO:1904263; GO:1990253,cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604],aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823],GO:0003824; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0006399; GO:0006520; GO:0016874; GO:0043226; GO:0098772; GO:0140098,"catalytic activity; lysosome; vacuole; endoplasmic reticulum; cytosol; tRNA metabolic process; amino acid metabolic process; ligase activity; organelle; molecular function regulator activity; catalytic activity, acting on RNA"
OG_00718,0.207005206489826,OG_00718,FUN_002650-T1,Peve_00040096,Pocillopora_meandrina_HIv1___RNAseq.g25706.t1,three_way,65.42783333333333,FUN_002650-T1,Q8K2I9,FBH1_MOUSE,,F-box DNA helicase 1 (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18),Mus musculus (Mouse),38.3,757.0,1.4000000000000002e-124,449.5,sp|Q8K2I9|FBH1_MOUSE F-box DNA helicase 1 OS=Mus musculus OX=10090 GN=Fbh1 PE=1 SV=1,GO:0000724; GO:0000785; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042,DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429],chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03185,0.2070051517625298,OG_03185,FUN_012640-T1,Peve_00041557,Pocillopora_meandrina_HIv1___RNAseq.g22908.t1,three_way,69.78033333333333,FUN_012640-T1,Q7T2D1,,,,,37.7,326.0,1.1999999999999999e-61,238.4,sp|Q7T2D1|RD10B_DANRE Retinol dehydrogenase 10-B OS=Danio rerio OX=7955 GN=rdh10b PE=2 SV=2,,,,,,
OG_08596,0.2069734204753356,OG_08596,FUN_037738-T1,Peve_00014190,Pocillopora_meandrina_HIv1___RNAseq.g26602.t1,three_way,53.47566666666667,FUN_037738-T1,Q76KP1,B4GN4_HUMAN,,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)",Homo sapiens (Human),37.1,286.0,2.8e-51,204.9,sp|Q76KP1|B4GN4_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=B4GALNT4 PE=1 SV=1,GO:0008376; GO:0032580; GO:0033842,,Golgi cisterna membrane [GO:0032580],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_02986,0.2067556403965751,OG_02986,FUN_012156-T1,Peve_00040786,Pocillopora_meandrina_HIv1___RNAseq.g23443.t3,three_way,55.64566666666666,FUN_012156-T1,Q2PFX0,,,,,47.5,524.0,3.500000000000001e-118,426.8,sp|Q2PFX0|ATE1_MACFA Arginyl-tRNA--protein transferase 1 OS=Macaca fascicularis OX=9541 GN=ATE1 PE=2 SV=1,,,,,,
OG_02261,0.2066781692274832,OG_02261,FUN_008709-T1,Peve_00033504,Pocillopora_meandrina_HIv1___RNAseq.g25665.t2,three_way,54.63916666666667,FUN_008709-T1,Q3U564,,,,,46.0,113.0,6.6e-18,93.2,sp|Q3U564|DCP1B_MOUSE mRNA-decapping enzyme 1B OS=Mus musculus OX=10090 GN=Dcp1b PE=1 SV=1,,,,,,
OG_08293,0.2066732770342233,OG_08293,FUN_036231-T1,Peve_00032844,Pocillopora_meandrina_HIv1___RNAseq.g27552.t1,three_way,77.99933333333334,FUN_036231-T1,Q8WTS1,ABHD5_HUMAN,,1-acylglycerol-3-phosphate O-acyltransferase ABHD5 (EC 2.3.1.51) (Abhydrolase domain-containing protein 5) (Lipid droplet-binding protein CGI-58),Homo sapiens (Human),56.8,315.0,1.9000000000000002e-110,400.6,sp|Q8WTS1|ABHD5_HUMAN 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 OS=Homo sapiens OX=9606 GN=ABHD5 PE=1 SV=1,GO:0003841; GO:0005654; GO:0005739; GO:0005811; GO:0005829; GO:0006631; GO:0006654; GO:0010891; GO:0010898; GO:0030154; GO:0042171; GO:0043231; GO:0052689; GO:0055088; GO:0060229,cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; negative regulation of triglyceride storage [GO:0010891]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of triglyceride catabolic process [GO:0010898],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; carboxylic ester hydrolase activity [GO:0052689]; lipase activator activity [GO:0060229]; lysophosphatidic acid acyltransferase activity [GO:0042171],GO:0003824; GO:0005654; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0030154; GO:0043226; GO:0098772,catalytic activity; nucleoplasm; mitochondrion; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; cell differentiation; organelle; molecular function regulator activity
OG_02406,0.2066702000780358,OG_02406,FUN_009055-T1,Peve_00032032,Pocillopora_meandrina_HIv1___RNAseq.g14497.t1,three_way,46.194,,,,,,,,,,,,,,,,,
OG_03576,0.20662213094973,OG_03576,FUN_014730-T1,Peve_00009496,Pocillopora_meandrina_HIv1___RNAseq.g22489.t1,three_way,68.61999999999999,FUN_014730-T1,Q5R831,,,,,64.4,267.0,5e-92,339.3,sp|Q5R831|S35B3_PONAB Adenosine 3'-phospho 5'-phosphosulfate transporter 2 OS=Pongo abelii OX=9601 GN=SLC35B3 PE=2 SV=1,,,,,,
OG_02125,0.2065473223124223,OG_02125,FUN_008421-T1,Peve_00009791,Pocillopora_meandrina_HIv1___RNAseq.g18048.t1,three_way,87.42933333333333,FUN_008421-T1,Q5U3G6,,,,,56.0,273.0,3.8000000000000004e-78,293.1,sp|Q5U3G6|YIF1B_DANRE Protein YIF1B OS=Danio rerio OX=7955 GN=yif1b PE=2 SV=2,,,,,,
OG_01796,0.206543433142311,OG_01796,FUN_007181-T1,Peve_00015050,Pocillopora_meandrina_HIv1___RNAseq.g19781.t1,three_way,79.889,FUN_007181-T1,Q80UM3,NAA15_MOUSE,,"N-alpha-acetyltransferase 15, NatA auxiliary subunit (N-terminal acetyltransferase 1) (NMDA receptor-regulated protein 1) (Protein tubedown-1)",Mus musculus (Mouse),59.2,833.0,7.7e-267,921.4,"sp|Q80UM3|NAA15_MOUSE N-alpha-acetyltransferase 15, NatA auxiliary subunit OS=Mus musculus OX=10090 GN=Naa15 PE=1 SV=1",GO:0001525; GO:0005634; GO:0005737; GO:0008080; GO:0030154; GO:0048471,angiogenesis [GO:0001525]; cell differentiation [GO:0030154],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],N-acetyltransferase activity [GO:0008080],GO:0003824; GO:0005634; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nucleus; transferase activity; cell differentiation; organelle
OG_01339,0.2064434730152321,OG_01339,FUN_005238-T1,Peve_00014029,Pocillopora_meandrina_HIv1___RNAseq.g8109.t1,three_way,79.287,,,,,,,,,,,,,,,,,
OG_04134,0.2064408295881126,OG_04134,FUN_016588-T1,Peve_00000798,Pocillopora_meandrina_HIv1___RNAseq.g2973.t1,three_way,71.725,,,,,,,,,,,,,,,,,
OG_00029,0.2064119695482572,OG_00029,FUN_000232-T1,Peve_00033351,Pocillopora_meandrina_HIv1___RNAseq.g28949.t1,three_way,73.66199999999999,FUN_000232-T1,Q9R111,GUAD_MOUSE,,Guanine deaminase (Guanase) (Guanine aminase) (EC 3.5.4.3) (Guanine aminohydrolase) (GAH),Mus musculus (Mouse),50.3,441.0,2.3e-118,427.2,sp|Q9R111|GUAD_MOUSE Guanine deaminase OS=Mus musculus OX=10090 GN=Gda PE=1 SV=1,GO:0000255; GO:0005829; GO:0006147; GO:0006161; GO:0008270; GO:0008892; GO:0043605; GO:0046038; GO:0046055,allantoin metabolic process [GO:0000255]; amide catabolic process [GO:0043605]; deoxyguanosine catabolic process [GO:0006161]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147],cytosol [GO:0005829],guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04625,0.2064057417324245,OG_04625,FUN_022333-T1,Peve_00028601,Pocillopora_meandrina_HIv1___RNAseq.g4652.t1,three_way,61.93866666666667,FUN_022333-T1,Q92609,TBCD5_HUMAN,,TBC1 domain family member 5,Homo sapiens (Human),37.5,610.0,3.2e-104,381.3,sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1,GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:1905394,"autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]",autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904],AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394],GO:0005773; GO:0005794; GO:0005829; GO:0006914; GO:0016192; GO:0043226; GO:0098772,vacuole; Golgi apparatus; cytosol; autophagy; vesicle-mediated transport; organelle; molecular function regulator activity
OG_06013,0.2063983215893565,OG_06013,FUN_026540-T1,Peve_00021545,Pocillopora_meandrina_HIv1___RNAseq.g4242.t1,three_way,66.76066666666667,FUN_026540-T1,Q1LWZ0,CLXN_DANRE,,Calaxin (EF-hand calcium-binding domain-containing protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),52.5,181.0,7.400000000000001e-48,192.2,sp|Q1LWZ0|CLXN_DANRE Calaxin OS=Danio rerio OX=7955 GN=clxn PE=2 SV=2,GO:0003341; GO:0005509; GO:0005737; GO:0005856; GO:0005929; GO:0009966; GO:0036126; GO:0036158,cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; regulation of signal transduction [GO:0009966],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126],calcium ion binding [GO:0005509],GO:0005856; GO:0005929; GO:0007018; GO:0043226; GO:0065003,cytoskeleton; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_08517,0.2063861543360771,OG_08517,FUN_037447-T1,Peve_00027251,Pocillopora_meandrina_HIv1___RNAseq.g10986.t1,three_way,85.654,FUN_037447-T1,Q3T0V4,,,,,75.0,156.0,5.1999999999999995e-61,235.3,sp|Q3T0V4|RS11_BOVIN Small ribosomal subunit protein uS17 OS=Bos taurus OX=9913 GN=RPS11 PE=2 SV=3,,,,,,
OG_07173,0.2063764620734936,OG_07173,FUN_032611-T1,Peve_00026810,Pocillopora_meandrina_HIv1___RNAseq.g29794.t1,three_way,66.65333333333334,FUN_032611-T1,P23359,BMP7_MOUSE,,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1),Mus musculus (Mouse),42.2,393.0,4.2e-78,293.5,sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2,GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0036305; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312,allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; vesicle [GO:0031982],BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005615; GO:0006355; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell adhesion; programmed cell death; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05978,0.2063702112666145,OG_05978,FUN_026408-T1,Peve_00000791,Pocillopora_meandrina_HIv1___RNAseq.g2975.t1,three_way,72.372,,,,,,,,,,,,,,,,,
OG_02517,0.2063620275851305,OG_02517,FUN_010576-T1,Peve_00032735,Pocillopora_meandrina_HIv1___RNAseq.g21522.t1,three_way,61.242666666666665,,,,,,,,,,,,,,,,,
OG_05494,0.2062776254458018,OG_05494,FUN_024526-T1,Peve_00015356,Pocillopora_meandrina_HIv1___RNAseq.g18544.t1,three_way,81.946,FUN_024526-T1,B3RXR7,GUF1_TRIAD,,"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)",Trichoplax adhaerens (Trichoplax reptans),64.5,605.0,5.600000000000001e-236,818.5,"sp|B3RXR7|GUF1_TRIAD Translation factor GUF1 homolog, mitochondrial OS=Trichoplax adhaerens OX=10228 GN=TRIADDRAFT_56304 PE=3 SV=1",GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006412; GO:0045727; GO:0097177,positive regulation of translation [GO:0045727]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial ribosome binding [GO:0097177],GO:0003824; GO:0003924; GO:0005739; GO:0016787; GO:0043226,catalytic activity; GTPase activity; mitochondrion; hydrolase activity; organelle
OG_05650,0.2062186037221973,OG_05650,FUN_025373-T1,Peve_00040523,Pocillopora_meandrina_HIv1___RNAseq.g13328.t1,three_way,60.128166666666665,FUN_025373-T1,A1L0Y2,,,,,39.5,1520.0,7.3e-307,1055.0,sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1,,,,,,
OG_08956,0.2062175195796317,OG_08956,FUN_038431-T1,Peve_00000107,Pocillopora_meandrina_HIv1___RNAseq.g1060.t1,three_way,80.83533333333334,FUN_038431-T1,Q8IX18,,,,,54.5,730.0,2.7000000000000003e-223,776.5,sp|Q8IX18|DHX40_HUMAN Probable ATP-dependent RNA helicase DHX40 OS=Homo sapiens OX=9606 GN=DHX40 PE=1 SV=2,,,,,,
OG_06070,0.2061963053585224,OG_06070,FUN_026918-T1,Peve_00013241,Pocillopora_meandrina_HIv1___TS.g19711.t1,three_way,50.77583333333333,FUN_026918-T1,Q96NB3,,,,,29.6,328.0,8.3e-19,95.9,sp|Q96NB3|ZN830_HUMAN Zinc finger protein 830 OS=Homo sapiens OX=9606 GN=ZNF830 PE=1 SV=2,,,,,,
OG_02475,0.2061512263286868,OG_02475,FUN_009736-T1,Peve_00033566,Pocillopora_meandrina_HIv1___RNAseq.g29063.t1,three_way,57.04183333333333,FUN_009736-T1,G5EBQ8,CHS2_CAEEL,,Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2),Caenorhabditis elegans,32.1,764.0,9.100000000000001e-104,380.6,sp|G5EBQ8|CHS2_CAEEL Chitin synthase chs-2 OS=Caenorhabditis elegans OX=6239 GN=chs-2 PE=1 SV=1,GO:0004100; GO:0005886; GO:0006031; GO:0061063,chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063],plasma membrane [GO:0005886],chitin synthase activity [GO:0004100],GO:0003824; GO:0005886; GO:0016740; GO:1901135,catalytic activity; plasma membrane; transferase activity; carbohydrate derivative metabolic process
OG_08614,0.2060646146271981,OG_08614,FUN_037761-T1,Peve_00014333,Pocillopora_meandrina_HIv1___RNAseq.g1495.t2a,three_way,37.405,,,,,,,,,,,,,,,,,
OG_08136,0.2060239450008091,OG_08136,FUN_035898-T1,Peve_00029392,Pocillopora_meandrina_HIv1___RNAseq.g12022.t1,three_way,92.744,FUN_035898-T1,A2APC3,TTLL9_MOUSE,,Probable tubulin polyglutamylase TTLL9 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 9),Mus musculus (Mouse),68.2,444.0,1.6e-175,617.1,sp|A2APC3|TTLL9_MOUSE Probable tubulin polyglutamylase TTLL9 OS=Mus musculus OX=10090 GN=Ttll9 PE=1 SV=2,GO:0005524; GO:0005737; GO:0005874; GO:0030317; GO:0031514; GO:0036064; GO:0036211; GO:0046872; GO:0070740; GO:0106438,flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005815; GO:0005929; GO:0007018; GO:0016874; GO:0022414; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; microtubule organizing center; cilium; microtubule-based movement; ligase activity; reproductive process; organelle; cell motility; catalytic activity, acting on a protein"
OG_07674,0.2059971031388144,OG_07674,FUN_034781-T1,Peve_00029730,Pocillopora_meandrina_HIv1___RNAseq.g12276.t1,three_way,58.02466666666667,FUN_034781-T1,Q6DIJ4,UBP10_XENTR,,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),43.1,485.0,6.800000000000001e-100,366.7,sp|Q6DIJ4|UBP10_XENTR Ubiquitin carboxyl-terminal hydrolase 10 OS=Xenopus tropicalis OX=8364 GN=usp10 PE=2 SV=1,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344,"autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; rescue of stalled ribosome [GO:0072344]",cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005634; GO:0005768; GO:0006281; GO:0006914; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; DNA repair; autophagy; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_00189,0.2059208766094754,OG_00189,FUN_000894-T1,Peve_00026759,Pocillopora_meandrina_HIv1___RNAseq.g29445.t1,three_way,71.97566666666667,FUN_000894-T1,Q7SXV2,,,,,40.9,237.0,2.999999999999999e-47,190.7,sp|Q7SXV2|AEBP2_DANRE Zinc finger protein AEBP2 OS=Danio rerio OX=7955 GN=aebp2 PE=2 SV=2,,,,,,
OG_04555,0.2059202317342551,OG_04555,FUN_022186-T1,Peve_00018623,Pocillopora_meandrina_HIv1___RNAseq.g4791.t1,three_way,75.88,FUN_022186-T1,O08539,BIN1_MOUSE,,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Bridging integrator 1) (SH3 domain-containing protein 9),Mus musculus (Mouse),31.9,593.0,2e-57,224.9,sp|O08539|BIN1_MOUSE Myc box-dependent-interacting protein 1 OS=Mus musculus OX=10090 GN=Bin1 PE=1 SV=1,GO:0000122; GO:0005634; GO:0005635; GO:0005768; GO:0005874; GO:0010564; GO:0019828; GO:0030018; GO:0030100; GO:0030315; GO:0030424; GO:0030425; GO:0030838; GO:0031674; GO:0031982; GO:0032496; GO:0033268; GO:0033292; GO:0035591; GO:0042692; GO:0043065; GO:0043194; GO:0045202; GO:0045664; GO:0048156; GO:0048488; GO:0048711; GO:0051647; GO:0060987; GO:0060988; GO:0086091; GO:0090571; GO:0098793; GO:0098794; GO:0098978; GO:1901380; GO:1902430; GO:1903946; GO:1904878,lipid tube assembly [GO:0060988]; muscle cell differentiation [GO:0042692]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell cycle process [GO:0010564]; regulation of endocytosis [GO:0030100]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; response to lipopolysaccharide [GO:0032496]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292],axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; microtubule [GO:0005874]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; RNA polymerase II transcription repressor complex [GO:0090571]; synapse [GO:0045202]; T-tubule [GO:0030315]; vesicle [GO:0031982]; Z disc [GO:0030018],aspartic-type endopeptidase inhibitor activity [GO:0019828]; signaling adaptor activity [GO:0035591]; tau protein binding [GO:0048156],GO:0005634; GO:0005635; GO:0005768; GO:0006355; GO:0008092; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0065003; GO:0098772,nucleus; nuclear envelope; endosome; regulation of DNA-templated transcription; cytoskeletal protein binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity
OG_03545,0.2058833538243487,OG_03545,FUN_014672-T1,Peve_00013037,Pocillopora_meandrina_HIv1___TS.g27442.t1,three_way,77.41466666666668,FUN_014672-T1,Q8N9F7,GDPD1_HUMAN,,Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1),Homo sapiens (Human),51.2,303.0,2.2e-84,313.9,sp|Q8N9F7|GDPD1_HUMAN Lysophospholipase D GDPD1 OS=Homo sapiens OX=9606 GN=GDPD1 PE=1 SV=2,GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291,glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471],lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081],GO:0003824; GO:0005783; GO:0006629; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; hydrolase activity; organelle
OG_00158,0.2058554050866693,OG_00158,FUN_000614-T1,Peve_00036774,Pocillopora_meandrina_HIv1___RNAseq.g1715.t1,three_way,67.67916666666667,FUN_000614-T1,Q5ZLL7,,,,,44.8,397.0,5.2999999999999996e-92,340.1,sp|Q5ZLL7|WDR91_CHICK WD repeat-containing protein 91 OS=Gallus gallus OX=9031 GN=WDR91 PE=2 SV=1,,,,,,
OG_00928,0.205843649612427,OG_00928,FUN_004272-T1,Peve_00008943,Pocillopora_meandrina_HIv1___RNAseq.g11367.t1,three_way,57.94233333333333,,,,,,,,,,,,,,,,,
OG_00889,0.2058176212356715,OG_00889,FUN_004204-T1,Peve_00018652,Pocillopora_meandrina_HIv1___RNAseq.g16708.t1,three_way,74.196,FUN_004204-T1,Q96LT7,CI072_HUMAN,,Guanine nucleotide exchange factor C9orf72,Homo sapiens (Human),32.5,459.0,9.2e-60,232.6,sp|Q96LT7|CI072_HUMAN Guanine nucleotide exchange factor C9orf72 OS=Homo sapiens OX=9606 GN=C9orf72 PE=1 SV=2,GO:0000932; GO:0001933; GO:0005085; GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005776; GO:0005829; GO:0006897; GO:0006914; GO:0010494; GO:0010506; GO:0016239; GO:0030425; GO:0031267; GO:0031965; GO:0032045; GO:0032880; GO:0034063; GO:0043204; GO:0043231; GO:0044295; GO:0044304; GO:0045920; GO:0048675; GO:0050777; GO:0061909; GO:0090543; GO:0098686; GO:0098693; GO:0098794; GO:0098978; GO:0099523; GO:0110053; GO:1902774; GO:1903432; GO:2000785,autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of protein localization [GO:0032880]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063],autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005615; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0098772,extracellular space; nucleus; lysosome; endosome; vacuole; cytosol; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; molecular function regulator activity
OG_09887,0.2057675333555144,OG_09887,FUN_042961-T1,Peve_00039052,Pocillopora_meandrina_HIv1___RNAseq.g7119.t1,three_way,84.45566666666667,FUN_042961-T1,Q66II5,,,,,57.4,343.0,1.5999999999999999e-114,414.1,sp|Q66II5|T3HPD_XENTR Trans-L-3-hydroxyproline dehydratase OS=Xenopus tropicalis OX=8364 GN=l3hypdh PE=2 SV=1,,,,,,
OG_08866,0.205764017944597,OG_08866,FUN_038258-T1,Peve_00007994,Pocillopora_meandrina_HIv1___RNAseq.g917.t1,three_way,77.65366666666667,FUN_038258-T1,P51798,CLCN7_HUMAN,,H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7),Homo sapiens (Human),54.4,803.0,4.5999999999999997e-237,822.4,sp|P51798|CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens OX=9606 GN=CLCN7 PE=1 SV=2,GO:0005254; GO:0005524; GO:0005765; GO:0009268; GO:0015108; GO:0016020; GO:0030321; GO:0034707; GO:0043231; GO:0062158,response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321],chloride channel complex [GO:0034707]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; chloride:proton antiporter activity [GO:0062158],GO:0005215; GO:0043226,transporter activity; organelle
